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ABSTRACT 
Patients referred for treatment in an adult critical care unit are in, or at 
imminent risk of developing single or multiple organ failure. Despite 
the high treatment costs, knowledge of the costs of care is limited. The 
aims of this thesis were to synthesise current knowledge about the 
different methods used to estimate costs and to develop and apply a 
method for estimating daily case-mix adjusted costs for developing a 
set ofHealthcare Resource Groups (HRGs) and for use in a trial-based 
economic evaluation. HRGs were required to support the Department 
of Health's new policy on reimbursing adult critical care called 
'Reforming NHS Financial Flows: Introducing Payment By Results'. 
A systematic review of20 published studies provided the background 
to, and justification for the methods employed in two empirical studies. 
The first empirical study was performed in a single critical care unit 
and using very detailed data on individual patients evaluated factors 
that had the potential to correlate with daily costs of critical care. 
Univariate and multivariate statistical analyses were undertaken using 
two different data sets. Patients' daily organ supports were identified as 
the key 'cost generating events'. A prospective, observational, 
longitudinal multi-centre study involving a volunteer sample of 70 
critical care units followed, where organ support data on 7,243 
consecutive admissions and monthly data on critical care unit 
expenditure were collected. Different ways of modelling the organ 
support and expenditure data were explored. The overall R2 for the 
chosen model- the daily number of organs supported was 0.52. Daily 
organ support weights for the average daily costs of critical care were 
0.577 for 0 or 1 organ supported, 1.137 for 2 organs supported and 
1.156 for 3 or more organs supported. These weights were then applied 
to average daily costs estimated for patients recruited to a clinical trial 
of Extracorporeal Membrane Oxygenation (ECMO) vs. conventional 
therapy for severe, but potentially reversible, respiratory failure. 
3 
DECLARATION 
I certify that this thesis does not incorporate, without 
acknowledgement, any material previously submitted for a degree or 
diploma in any University; and that to the best of my knowledge and 
belief, it does not contain any material previously published or written 
by another person where due reference is not made in the text. 
4 
TABLE OF CONTENTS 
ABSTRACT .................................................................................................................. 3 
DECLARATION .......................................................................................................... 4 
TABLE OF CONTENTS ............................................................................................ 5 
CHAPTER 1: INTRODUCTION ............................................................................. l6 
1.1 BACKGROUND ............................................................................................... 16 
1.2 RATIONALE FOR THE THESIS ......................................................................... 17 
1.2.1 Development ofHealthcare Resource Groups .................................... 18 
1.2.2 Costing methods for economic evaluation ........................................... 19 
1.3 AIMS OF THE THESIS ...................................................................................... 21 
1.4 OUTPUTS FROM THE THESIS .......................................................................... 23 
1.5 STRUCTURE OF THE THESIS ........................................................................... 24 
REFERENCES ........................................................................................................... 27 
CHAPTER 2: BACKGROUND TO COST FUNCTIONS .................................... 35 
2.1 INTRODUCTION ............................................................................................. 35 
2.2 APPLICATIONS OF PRODUCTION AND COST THEORY TO CRITICAL CARE UNITS 
2.2.1 
2.2.2 
2.2.3 
2.2.4 
37 
Background to adult critical care ........................................................ 37 
Costs of critical care ............................................................................ 40 
Cost definitions .................................................................................... 42 
Costs and production functions In critical care .................................. 47 
REFERENCES ........................................................................................................... 52 
CHAPTER 3: A SYSTEMATIC REVIEW OF THE LITERATURE ON 
COSTING METHODS .............................................................................................. 60 
·3.1 INTRODUCTION ............................................................................................. 60 
3.2 FORMATION OF THE REVIEW ADVISORY GROUP ............................................. 61 
3.3 CHECKS FOR EXISTING OR ONGOING REVIEWS ............................................... 62 
Table 3.1: Description of searches undertaken and the number of abstracts 
retrieved (checks for existing reviews) ................................................................ 63 
3.3.1 Identification of the review by Gyldmark (1995) ................................ 63 
3.4 SCOPE OF LITERATURE IN FIELD .................................................................... 64 
Table 3.2: Description of searches undertaken and the number of abstracts 
retrieved (scope of literature I full review) .......................................................... 66 
Table 3.3: Overlap of articles considered relevant using the different search 
strategies (full review) ......................................................................................... 67 
3.5 METHODS USED FOR THE SCREENING OF ABSTRACTS .................................... 69 
3.5.1 Inclusion criteria for abstract screening ............................................. 69 
3.5.2 Exclusion criteria for abstract screening ............................................ 69 
3.6 RESULTS FROM ABSTRACT SCREENING .......................................................... 70 
3. 7 SELECTION OF RELEVANT PAPERS ................................................................. 70 
3. 7.1 Inclusion criteria for the review .......................................................... 70 
3. 7.2 Exclusion criteria for the review .......................................................... 71 
5 
3. 7.3 Bibliographic Details Of Papers That Met The Inclusion Criteria ..... 72 
3.8 DATA EXTRACTION .......•.............•...•..•...............•....•.....•............................•.• 72 
Table 3.4: Summary of included studies .............................................................. 73 
3.9 RESULTS .......•..••.........•...............•..•.................•........••....•.........•.•............•.... 83 
3.9.1 Year of publication .............................................................................. 83 
Table 3.5: Year of publication ............................................................................. 84 
3.9.2 Country of origin .................................................................................. 85 
Table 3.6: Country of origin ................................................................................ 85 
3.9.3 Number of Critical Care Units ........................................................... 86 
3.9.4 Number of Critical Care Patients ........................................................ 86 
Table 3. 7: Number of Centres I Patients ............................................................. 87 
3.9.5 Methods of cost estimation .................................................................. 90 
3.9.6 Type of cost reported .......................................................................... 90 
Table 3.8: Study design, methods of cost estimation and unit of output 
measurement ........................................................................................................ 91 
3.9. 7 Cost components ................................................................................. 94 
3.9.8 Cost components included: Staffing costs ........................................... 94 
Table 3.9: Staffing Costs ...................................................................................... 96 
3.9.9 Cost components included: Treatment-related costs ........................... 98 
Table 3.10: Treatment-related costs .................................................................... 99 
3.9.10 Cost components included: Overheads I hospital running costs ....... 100 
Table 3.11: Overheads I hospital running costs ................................................ 101 
3.9.11Method of apportioning costs .................................................................. 101 
Table 3.12: Method of apportioning costs ........................................................ 1 02 
Table 3.13: Care Grades 1-5 (Loes et al., 1987) .............................................. 106 
3.10 SUMMARY OF FINDINGS .............................................................................. 111 
3.11 ASSESSMENT OF QUALITY ........................................................................... 111 
Table 3.14: Quality criteria proposed by Burchardi et al., (2001) ................... 112 
Table 3.15: Assessment of studies according to quality criteria proposed by 
Burchardi et al., (2001) ..................................................................................... 114 
3.11.1 la: The cost bearer should be clearly identified .............................. 116 
3.11.2 1 b: Costs should be defined accordingly .......................................... 116 
3.11.3 2a: The unit of analysis (cost center, cost object) chosen should be 
shown to determine the distinction between direct and indirect costs) ............. 116 
3.11.4 2b: The choice between direct costs I unit or (direct+ some indirect) 
costs I unit should be made . ............................................................................... 116 
3.11.5 2c: If indirect costs are included, allocation rules must be described 
and justified ........................................................................................................ 116 
3.11.6 3: All direct ICU costs should be measured at the ICU level ........... 117 
3.11. 7 4: Fixed, variable and marginal costs should be made explicit and 
correctly handled . .......................... .................................................................... 117 
3.11.8 5a: Costs should be calculated comprehensively. Only immaterial 
components may be ignored ............................................................................... 117 
3.11.9 5b: Determination of each component of costs studied should be made 
explicit. Furthermore, a sensible methodology should be applied .................... 117 
3.12 RANKING OF STUDIES .................................................................................. 117 
3.13 ADVANTAGES AND DISADVANTAGES OF THE COSTING METHODS ................ 118 
Table 3.16: Levels of ICU care (Doyle et al., 1996) .......................................... 122 
3.14 DISCUSSION ................................................................................................ 124 
6 
REFERENCES ......................................................................................................... 128 
CHAPTER 4: EXPLORATORY STUDY OF COST PREDICTORS ............... 137 
4.1 INTRODUCTION ........................................................................................... 137 
4.2 BACKGROUND ............................................................................................... 138 
4.3 STUDY DESIGN ...........................................................................................• 140 
4.3.1 Study 1: Analysis of daily costs vs. APACHE 1/ scores, critical care 
unit mortality, length of stay, daily TISS points, age and gender; post-operative 
status; emergency I elective status and advanced respiratory support (YIN). ... 141 
4.3.2 Study 2: Analysis of daily costs vs. patients' organ support .............. 141 
4.4 METHODS ...•.•...........................•.................................................................. l41 
4.4.1 Collection of case-mix variables for study 1 ...................................... 142 
4.4.2 Collection of case-mix variables for study 2 ...................................... 143 
Table 4.1: Organ support definitions ................................................................. 144 
4.4.3 Costing methodology ......................................................................... 145 
Table 4.2: Summary list of activities (Hibbert et al., 1998) .............................. 146 
Table 4.3: List of included resource items ......................................................... 148 
Table 4.4: Sources of unit cost data ................................................................... 150 
4.4.4 Analysisplan ...................................................................................... 151 
4.5 RESULTS ..........................................................•................•......................... 154 
4.5.1 Results of the univariate analyses: Study 1 ........................................ 154 
Figure 4.1: Scatter plot of the costs of care in the first 2 4 hours vs. APACHE 1/ 
scores ................................................................................................................. 155 
Figure 4.2: Scatter plot of patients' average daily costs of care vs. length of stay 
............................................................................................................................ 157 
Figure 4.3: Scatter plot of daily costs of care vs. TISS points ........................... 159 
Figure 4.4: Scatter plot of average daily costs of care vs. age ....................... .. 160 
4.5.2 Results of the multivariate analysis: Study 1 ..................................... 161 
Table 4.5: Descriptive statistics of variables used in the multiple regression 
model (Jacobs et al., 2001) ................................................................................ 162 
Table 4.6: Results of the regression analysis of average daily cost (Jacobs et al., 
2001) .................................................................................................................. 163 
4.5.3 Results of the multivariate analysis: Study 2 ..................................... 163 
Table 4. 7: Frequency of the types of organ support received ........................... 164 
Table 4.8: Descriptive statistics of the daily costs of care by type and 
combination of organs supported ...................................................................... 165 
Figure 4. 5: Histogram and Q-Q plot showing the distributions of the daily costs 
of care ................................................................................................................ 166 
Table 4. 9: Results of the regression model of organ support and daily costs ... 167 
4.6 DISCUSSION .......•...........•...................................................................•........ 168 
4. 6.1 Selection of variables for study ......................................................... 168 
Table 4.10: Summary ofthe univariate and multivariate Analyses ................... 169 
4.6.2 Costing Methods ....................................................................................... 172 
4.7 CONCLUSIONS ..............•.....•....•..........................•....•..•..•.......................•..•.. 175 
REFERENCES ......................................................................................................... 176 
CHAPTERS: STUDY METHODS ........................................................................ l82 
5.1 INTRODUCTION ...........•.•.....•............•..•...•.....•.....•••..........•.••••••.•••••••...•••••.•• 182 
5.2 STUDY AIMS, OBJECTIVES AND DESIGN ....................................................... 182 
7 
5.3 RECRUITMENT STRATEGIES ............•.....•..........•..•......•............•..•.......•..•.....• 184 
5.3.1 Communication .................................................................................. 184 
5.3.2 Public relations and publicity ............................................................ 185 
5.3.3 Endorsement ...................................................................................... 186 
5.3.4 Branding ............................................................................................ 186 
5.3.5 Incentives ........................................................................................... 187 
5.4 INCLUSION CRITERIA FOR CENTRES ............................................................. 187 
5.5 EXCLUSION CRITERIA FOR CENTRES ............................................................ 187 
5.6 ETHICS COMMITTEE APPROVAL ................................................................... 188 
5. 6.1 Patient consent ................................................................................... 188 
5. 7 PROJECT PLAN AND TIMESCALES ................................................................. 190 
Table 5.1: Project plan and timescales .............................................................. 191 
5.8 DESIGN OF THE PATIENT DATA QUESTIONNAIRES ........................................ 192 
5.8.1 Method of data collection .................................................................. 192 
5.8.2 Content of the questionnaires ............................................................ 194 
Table 5.2: Patient data set ................................................................................. 194 
5.9 DESIGN OF THE EXPENDITURE QUESTIONNAIRES ......................................... 197 
5.9.1 Definitions used ................................................................................. 198 
Table 5.3: Resource items and definitions used in the expenditure sub-study 
(Dean et al., 2001) ............................................................................................. 199 
5.9.2 Advantages of the method used to estimate expenditure ................... 201 
6.9.3 Disadvantages of the method used to estimate expenditure .............. 201 
5.9.4 Measurement issues with capital equipment ...................................... 202 
Table 5.4: Capital equipment component of the Critical Care Cost Block 
Programme ........................................................................................................ 203 
5.10 DESIGN OF THE UNIT CHARACTERISTICS QUESTIONNAIRES ......................... 205 
5.11 DATA COLLECTION PROCEDURES ................................................................ 205 
5.11.1 Patient data ........................................................................................ 205 
5.11.2 Expenditure data ................................................................................ 206 
5.12 METHOD OF COLLECTION ............................................................................ 207 
5.12.1 Patientdata ........................................................................................ 207 
5.12.2 Expenditure data ................................................................................ 207 
5.13 DATA ENTRY ................................................................................................... 208 
5.13.1 Patient Data ....................................................................................... 208 
5.13.2 Expenditure Data ............................................................................... 209 
5.14 DATA PROTECTION AND CONFIDENTIALIT¥ ............................................. 209 
5.15 DATA MANAGEMENT ................................................................................... 210 
5.15.1 Patient Data ....................................................................................... 210 
Table 5.5: Structure and coding of the patient ID spreadsheet ......................... 210 
Table 5. 6: Structure and coding of the activity spreadsheet ............................. 211 
5.15.2 Expenditure Data ............................................................................... 211 
5.16 ANALYSIS PLAN .......................................................................................... 212 
5.16.1 Study methods .................................................................................... 212 
5.16. 2 Validity and accuracy of patient data ................................................ 212 
5.16.3 Characteristics of the critical care units ........................................... 212 
5.16.4 Characteristics of patients ................................................................. 213 
5.16.5 Expenditure data ................................................................................ 213 
REFERENCES ......................................................................................................... 215 
8 
CHAPTER 6: RESULTS ........................................................................................ 217 
SECTION I: PATIENT DATA COLLECTION AND VALIDATION •.•••..•••.••. 217 
6.1 INTRODUCTION ........................................................................................... 217 
6.2 PARTICIPATION RATES ......................•......................................................... 218 
6.3 COLLECTION OF PATIENTDATA ................................................................... 218 
6.3.1 Methods of data collection ................................................................. 218 
Table 6.1: Method of data collection ................................................................. 219 
6.3.2 Methods of booklet completion .......................................................... 219 
Table 6.2: Method of booklet completion .......................................................... 220 
6.3.3 Staff responsible for data collection .................................................. 220 
Table 6.3: Staffresponsiblefordata col/ection ................................................. 221 
6.3.4 Number of staff involved in data collection ....................................... 221 
FIGURE 6.1: PIE CHART SHOWING THE NUMBERS OF STAFF INVOLVED IN BOOKLET 
COMPLETION ........................................................................................................... 222 
6.3.5 Time of day when data collection took place ..................................... 222 
FIGURE 6.2: PIE CHART SHOWING WHEN THE BOOKLETS WERE COMPLETED ........... 223 
6.3.6 Reasons Given For Not Completing The Booklets ............................ 223 
6.3. 7 Measures taken when booklets were not completed .......................... 223 
Table 6.4: Reasons given for not completing the booklets ................................ 224 
FIGURE 6.3: BAR CHART SHOWING THE MEASURES TAKEN WHEN THE DATA 
COLLECTION BOOKLETS WERE NOT COMPLETED ..................................................... 224 
6.4 DATA CHECKS ............................................................................................. 225 
6.4.1 Data entry .......................................................................................... 225 
6.4.2 Data quality ....................................................................................... 225 
Table 6.5: Summary of queries .......................................................................... 226 
FIGURE 6.4: SCA TIER PLOT OF THE RELATIONSHIP BETWEEN THE NUMBER OF 
GENERATED QUERIES AND THE NUMBER OF PATIENTS STUDIED ............................... 227 
6.5 COMPLETION ISSUES ................................................................................... 228 
6. 5.1 Completeness of recruitment (of eligible patients) ............................ 229 
6.5.2 Variables included in the study .......................................................... 230 
6.5.3 Completeness of data (%variables at least 95% complete) .............. 231 
6.6 ACCURACY OF THE DATA COLLECTED ......................................................... 232 
6.6.1 Form in which continuous data (excluding dates) is collected .......... 232 
6. 6.2 Use of explicit definitions for variables ............................................. 233 
6. 6. 3 Use of explicit rules for deciding how variables are recorded .......... 23 3 
6.6.4 Reliability of coding for conditions and interventions ....................... 234 
6. 6.5 Independence of observations of primary outcome ........................... 236 
6. 6. 6 Extent to which data are validated .................................................... 236 
CHAPTER 6: RESULTS ........................................................................................ 239 
SECTION II: UNIT CHARACTERISTICS •••••••••••••.•••••••...••••••.••.•••••••••.••••••••••••• 239 
6. 7 UNIT CHARACTERISTICS ............................................................................. 239 
6. 7.1 Geographical coverage ...................................................................... 239 
FIGURE 6.5: PIE CHART SHOWING THE NUMBERS OF CRITICAL CARE UNITS BY REGION 
................................................................................................................................ 239 
Table 6.6 Number of patients and patient days by geographical location ........ 240 
6. 7.2 Teaching hospital status .................................................................... 240 
Table 6. 7: Hospital Type .................................................................................... 241 
9 
6. 7.3 Types of critical care unit .................................................................. 2 41 
Table 6.8: Types ofCritical Care Unit .............................................................. 242 
Table 6.9: Comparisons of unit type with the ICNARC CMP database (2005) 243 
6. 7.4 Number of staffed critical care beds .................................................. 243 
FIGURE 6.6: PIE CHART SHOWING THE PROPORTION OF CRITICAL CARE UNITS BY 
SIZE ....•..•.•.............•.....•.....•...•..•...........••..•••......•..•..••.•..•...•.....•..••.••.••....•.......•••.•.•• 243 
Table 6.10: Numbers of staffed critical care beds ............................................. 244 
6. 7.5 Provision of additional services ......................................................... 245 
TABLE 6.11: PROVISION OF ADDITIONAL SERVICES ..........•..•.•.•.•....•....••.••.•.•....•....•• 245 
6.8 REPRESENTATIVENESS OF THE SAMPLE ....................................................... 246 
6.8.1 Representative ofCountry (i.e. Coverage) ........................................ 246 
6.9 PERFORMANCE OF THE STUDY AGAINST THE DoCDA T CRITERIA ...••••••••.•... 248 
Table 6.12: Performance of study against DoCDat databases ......................... 248 
CHAPTER 6: RESULTS ........................................................................................ 249 
SECTION Ill: CHARACTERISTICS OF PATIENTS AND PRELIMINARY 
ANALYSES .............................................................................................................. 249 
6.10 PATIENTS' CHARACTERISTICS ...•..••...•.....••••.•...••••••.•...•.•••......••••.....•...•.••.•• 249 
Table 6.13: Patients' descriptive characteristics .............................................. 249 
6.10.1 Admission status ...................................................................................... 250 
6.10.2 Patients' length ofstay ............................................................................ 250 
6.1 0. 3 Survival status at discharge from the Critical Care Unit .................. 25 0 
6.11 TYPES OF ORGANS SUPPORTED ...••..•.....•.•.••..••.•.....•••.•.•••.....•..••••••..•.••......... 251 
6.11.1 Frequency statistics ................................................................................ 2 51 
Table 6.14: Frequency of days by type of organ support .................................. 251 
Table 6.15: Frequency Of Patient Days By Organ Support Type (And 
Combination) ..................................................................................................... 253 
6.12 RELATIONSHIP BETWEEN THE ORGANS SUPPORTED AND THE TYPE OF CRITICAL 
CARE UNIT ••...••••.........•.•......•..•....••...•.•....•.••...•.•••...•.••.•.....••.•..•..•..•..••••...•••••••..•.•...• 254 
6.12.1 Number of organ support days by type of critical care unit ................... 254 
Table 6.16: Number of organ support days by type of Critical Care Unit ........ 255 
6.12.2 Organ support ratio per patient day by type of Critical Care Unit ........ 256 
Table 6.17: Organ support ratio per patient day by type of Critical Care Unit257 
6.13 RELATIONSHIP BETWEEN THE ORGANS SUPPORTED AND THE SIZE OF THE 
CRITICAL CARE UNIT •••......•••..•..•.•••••....•.•..•••.•...•.•••.•.•••..•....••.••.....•.••.•.•......•.•.•..•..• 258 
6.13.1 Number of organ support days by size of Critical Care Unit ................. 258 
Table 6.18: Number of organ support days by size of Critical Care Unit ......... 258 
6.13.2 Organ support ratio per patient day by size of critical care unit ........... 259 
Table 6.19: Organ support ratio per patient day by size of Critical Care Unit 259 
CHAPTER 6: RESULTS ........................................................................................ 260 
SECTION IV: COLLECTION AND VALIDATION OF EXPENDITURE 
DATA ........................................................................................................................ 260 
6.14 COLLECTION OF EXPENDITURE DATA .••...••••.•••...•...•.••....•...•...••..•.•..••.••.••.•.. 260 
6.14.1 Response rates ................................................................................... 260 
Table 6.20: Response rates to the expenditure survey ....................................... 261 
6.14.2 Adherence to the definitions for estimating expenditure ................... 262 
10 
FIGURE 6.7: RESPONSE RATES TO THE EXPENDITURE SURVEY (RED) WITH THE 
NUMBER OF RESPONSES DETERMINED ACCORDING TO THE PRESCRIBED DEFINITIONS 
(BLUE) ..................................................................................................................... 262 
TABLE 6.21: DESCRIPTION OF THE RESOURCE USE AND COMPLIANCE RATES .......... 264 
6.14.3 Distribution of data returned by each critical care unit.. .................. 269 
Table 6.22: Number of critical care units contributing resource use data for 
analysis .............................................................................................................. 271 
6.14.4 Problems relating to the completion ofthe expenditure questionnaires 
274 
6.14.5 Steps taken to deal with the missing data ............................................... 276 
6.14. 6 Results obtained from the expenditure survey ........................................ 276 
Table 6.23: Descriptive statistics relating to the expenditure data ................... 277 
6.15 VALIDATION OF THE EXPENDITURE DATA ................................................... 278 
6.15.1 Internal validation .................................................................................. 278 
6.15.2 External validation ............................................................................. 278 
Table 6.24: Comparison of the mean daily cost estimates with the Critical Care 
National Cost Block Programme ....................................................................... 280 
FIGURE 6.8: BAR CHART COMPARING THE DAILY COST ESTIMATES PRODUCED BY THE 
STUDY (BLUE) WITH DATA FROM THE CRITICAL CARE COST BLOCK PROGRAMME 
(RED) ....................................................................................................................... 282 
TABLE 6.25: NHS REFERENCE COSTS FOR CRITICAL CARE (DEPARTMENT OF 
HEALTH, 2004) ....................................................................................................... 284 
CHAPTER 6: RESULTS ........................................................................................ 285 
SECTION V: ANALYSIS OF THE EXPENDITURE DATA IN RELATION TO 
THE TYPE AND SIZE OF CRITICAL CARE UNIT •••.•••••••••.•••.•••.•.••••••••••••••••• 285 
6.16 INTRODUCTION ........................................................................................... 285 
6.17 STUDY AIMS ................................................................................................ 285 
6.18 DESCRIPTION OF THE SUB-SAMPLE OF CRITICAL CARE UNITS ..................... 286 
6.18.1 Geographical Location ...................................................................... 286 
Table 6.26: Comparison of the geographical location of the sub-sample of 
critical care units with the total sample ............................................................. 287 
6.18.2 Hospital Type ..................................................................................... 287 
Table 6.27: Comparison of the hospital type of the sub-sample of Critical Care 
Units with the total sample ................................................................................ 287 
6.18.3 Type ofCritical Care Unit ................................................................. 288 
Table 6.28: Comparison of the types of Critical Care Unit included in the sub-
sample with the total sample .............................................................................. 288 
6.18.4 Size OfCritical Care Unit .................................................................. 288 
Table 6.29: Comparison of the size of Critical Care Unit included in the sub-
sample with the total sample .............................................................................. 289 
6.19 STATEMENT OF HYPOTHESES TO BE TESTED ................................................ 289 
6.20 RESULTS ..................................................................................................... 290 
6.20.1 Hypothesis 1 ............................................................................................ 290 
Table 6.30: Monthly expenditure by type ofCritical Care Unit.. ...................... 292 
6.20.2 Hypothesis 2 ............................................................................................ 293 
Table 6.31: Average daily expenditure by type of Critical Care Unit.. ............. 294 
6.20.3 Hypothesis 3 ............................................................................................ 295 
11 
FIGURE 6.9: LINE GRAPH SHOWING THE MONTHLY EXPENDITURE BY THE NUMBER OF 
STAFFED BEDS ............•.•.....•...........••......................•.•.....•...•..•.•..•.•..•..•.........•.......... 295 
Table 6.32: Monthly expenditure by size of Critical Care Unit ........................ 296 
6.20.4 Hypothesis 4 ............................................................................................ 297 
FIGURE 6.10: LINE GRAPH SHOWING THE AVERAGE DAILY EXPENDITURE BY THE 
NUMBER OF STAFFED BEDS •••......•••••.•...•..••..•...•..•.••..•.••..•...•••.•••.•.•..•..•....••.•••.....••••• 297 
Table 6.33: Average daily expenditure by size of Critical Care Unit ............... 298 
6.21 DISCUSSION •··············•··········•·····•·•····•···•··•·•··•·····•····•··•···•·····•••·••····•·•·•·•·•·· 299 
REFERENCES ......................................................................................................... 304 
CHAPTER 7: DEVELOPMENT OF PROPOSED HEALTH CARE 
RESOURCE GROUPS FOR ADULT CRITICAL CARE PATIENTS •.•...••.•••• 308 
7.1 INTRODUCTION ........................................................................................... 308 
7.2 BACKGROUND ............................................................................................. 310 
7.3 PROSPECTIVE VS. RETROSPECTIVE REIMBURSEMENT SYSTEMS ................... 312 
7.4 POLICY CONTEXT ........................................................................................ 314 
7.5 POSSIBLE GROUPINGS FOR CRITICAL CARE PATIENTS .................................. 315 
7.4.1 Possible factors for HRG Classification ............................................ 316 
7.4.2 Prerequisites to the HRGs ................................................................. 319 
7.4.3 Study aims .......................................................................................... 320 
7.5 STATISTICAL METHODS FOR DAILY CASE-MIX ADJUSTED COST ESTIMATES. 321 
FIGURE 7.1: HISTOGRAM OF MONTHLY EXPENDITURE ............................................ 322 
7.6 TYPES OF MODELS DEVELOPED FOR THE CASE-MIX ADJUSTED COST ESTIMATES 
325 
7.6.1 Random-effects model of monthly expenditure and days of organ 
support received ................................................................................................. 325 
TABLE 7.1: RESULTS OF THE RANDOM-EFFECTS MODEL (MODEL 1) ....................... 326 
8. 7 TYPES OF MODELS DEVELOPED FOR THE HRGs .......................................... 327 
TABLE7.2: RESULTSOFTHEOLS MODELS ............................................................ 329 
TABLE 7.3: PROPOSED HEALTH CARE RESOURCE GROUPS ..................................... 332 
7.8 ADDITIONAL MODELS EXPLORED FOR THE CASE-MIX ADJUSTED DAILY COSTS 
333 
7. 8.1 Types and combinations of organ support ...................................... ·· 3 3 3 
TABLE 7.4: FREQUENCY OF PATIENT DAYS BY TYPE AND COMBINATION OF ORGAN 
SUPPORT .................... 335 
······························································································ 7.8.2 Results ofmodel5 ..................................................................................... 337 
TABLE 7.5: RESULTS OF THE RANDOM-EFFECTS MODEL (MODEL 5) ....................... 338 
TABLE 7.6: RESULTS OF THE APPORTIONED ESTIMATES FOR DAILY COSTS FROM THE 
RANDOM-EFFECTS MODEL (MODEL 5) ..................................................................... 339 
7.8.3 Results of Model6 ..................................................................................... 340 
TABLE 7.7: RESULTS OF THE RANDOM-EFFECTS MODEL (MODEL 6) ....................... 340 
TABLE 7.8: RESULTS OF THE APPORTIONED ESTIMATES FOR DAILY COSTS FROM THE 
RANDOM-EFFECTS MODEL (MODEL 6) ..................................................................... 342 
7.8.4 Discussion of Models 5 and 6 ................................... ~ ............................... 342 
7.8.5 Total Number of Organs Supported .......................................................... 344 
7.8. 6 Results of Model 7 ..................................................................................... 345 
TABLE 7.9: RESULTS OF THE RANDOM-EFFECTS MODEL (MODEL 7) ....................... 345 
TABLE 7.10: RESULTS OF THE APPORTIONED ESTIMATES FOR DAILY COSTS FROM THE 
RANDOM-EFFECTS MODEL (MODEL 7) ..................................................................... 346 
12 
7.8. 7 Results of Model 8 ..................................................................................... 346 
TABLE 7.11: RESULTS OF THE RANDOM-EFFECTS MODEL (MODEL 8) ..................... 346 
TABLE 7.12: RESULTS OF THE APPORTIONED ESTIMATES FOR DAILY COSTS FROM THE 
RANDOM-EFFECTS MODEL (MODEL 8) ..................................................................... 347 
7.8.8 Results ofModel9 ..................................................................................... 347 
TABLE 7.13: RESULTS OF THE RANDOM-EFFECTS MODEL (MODEL 9) ..................... 34 7 
TABLE 7.14: RESULTS OF THE APPORTIONED ESTIMATES FOR DAILY COSTS FROM THE 
RANDOM-EFFECTS MODEL (MODEL 9) ..................................................................... 348 
7.9 EVALUATION OF THE USEFULNESS OF THE FINDINGS FOR USE IN HRGs .. 348 
7.9.1 Accuracy of Model 9 when compared to expenditure ............................... 348 
TABLE 7.15: PREDICTED EXPENDITURE USING MODEL 9 VS. ACTUAL EXPENDITURE 
BY CRITICAL CARE UNIT ........................................................................................ 349 
TABLE 7.16: MEAN COSTS OF MAJOR RESOURCE COMPONENTS PER CALENDAR DAY 
................................................................................................................................ 351 
TABLE 7.17: PER DIEM COST ESTIMATES THAT INCLUDE THE CASE-MIX ADJUSTED 
COSTS OF NURSING STAFF, DRUGS AND FLUIDS AND DISPOSABLE EQUIPMENT AND THE 
NON-MODELLED COSTS .................................•....................................................•..•. 352 
7.9.2 User Survey ............................................................................................... 353 
7.10 DISCUSSION ......................................•......................................................... 354 
REFERENCES ......................................................................................................... 3S9 
CHAPTER 8: APPLICATION OF ORGAN SUPPORT COST WEIGHTS TO A 
TRIAL- BASED ECONOMIC EVALUATION .•••••••••..•.••..••..•..•••••••..•••••••..•••••••• 366 
8.1 INTRODUCTION .................................•....................................................•..•. 366 
8.2 AIMS .................•............................. ··············••···············•···························· 367 
8.3 DESCRIPTION OF THE CESAR CLINICAL TRIAL ........................................... 367 
8.3.1 Treatments under evaluation ............................................................. 368 
8.3.2 Study Inclusion Criteria ..................................................................... 369 
8.3.3 Patient Exclusion Criteria ................................................................. 370 
8.3.4 Delivery of Treatment ....................................................................... 370 
8.3.5 Sample Size ....................................................................................... 371 
8.4 METHODS OF THE CESAR E90NOMIC EVALUATION .................................. 371 
8. 4.1 Methods for estimating the Critical Care Unit Conventional Treatment 
Costs (CTCs) ...................................................................................................... 372 
8.4.2 Methods for estimating the costs of ECMO ....................................... 374 
8.5 RESPONSE RATES FOR THE COST AND UNIT CHARACTERISTICS SURVEY: CTCs 
375 
8.5.1 Response Rates ................................................................................... 375 
TABLE 8.1: RESPONSE RATES FOR THE RETURN OF COST QUESTIONNAIRES BY 
HOSPITAL ................................................................................................................ 376 
TABLE 8.2: RESPONSE RATES FOR THE RETURN OF UNIT CHARACTERISTIC 
QUESTIONNAIRES BY HOSPITAL .............................................................................. 378 
8. 5. 2 Return of both unit characteristics and cost data .............................. 3 79 
TABLE 8.3: RESPONSE RATES FOR THE RETURN OF BOTH UNIT CHARACTERISTIC AND 
COST QUESTIONNAIRES BY HOSPITAL ..................................................................... 380 
8.5.3 Data Completeness ........................................................................... 381 
TABLE 8.4: RESPONSE RATES FOR THE RETURN OF RESOURCE USE ITEMS CONTAINED 
WITHIN THE COST QUESTIONNAIRES ........................................................................ 382 
13 
TABLE 8.5: NUMBER OF CRITICAL CARE UNITS CONTRIBUTING COST DATA FOR 
ANALYSIS .•.....•....•...•..........•...•..........•••.•....••.....•••...............••....•...•.....•...•..•••....••.•.. 383 
8.6 CHARACTERISTICS OF THE CTCS THAT RETURNED THEIR UNIT 
CHARACTERISTIC QUESTIONNAIRES .•..•..•...•.•......•..•.••......•.•...•.•...•.....•....•.••...•....... 386 
8.6.1 Geographical location of centres ....................................................... 386 
TABLE 8.6: GEOGRAPHICAL LOCATION OF CESAR CENTRES .•.•..••...•••....•.•.•.....•...• 387 
8.6.2 Hospital Type ..................................................................................... 387 
TABLE 8.7: HOSPITAL TYPE •.•••..•..•..••..•..........•••••....•.....••.•.•••..••.••.••.....••.•.•.•.•.••....• 387 
8.6.3 Unit Type ............................................................................................ 388 
TABLE 8.8: TYPES OF CRITICAL CARE UNIT ........................................................... 388 
8.6.3 Comparisons of unit type with the ICNARC CMP database (2005) and 
HRG centres ....................................................................................................... 389 
TABLE 8.9: COMPARISONS OF UNIT TYPE WITH THE ICNARC CMP DATABASE (2005) 
ANDHRG CENTRES ......••..•......•.••.•...•.•••.•.•......•.•.•••••..•..•..•..••.•.•.......••••••...••••..•.••••• 389 
8. 6. 2 Unit Size ............................................................................................. 3 89 
TABLE 8.10: NUMBERS OF STAFFED CRITICAL CARE BEDS ...................................... 390 
8.7 DAILY COSTS OF CONVENTIONAL THERAPY ................................................ 390 
TABLE 8.11: DAILY COST DATA BY RESOURCE ITEM: ABSOLUTE VALUES .............. 392 
TABLE 8.12: DAILY COST DATA BY RESOURCE ITEM: SUBSTITUTED VALUES .......... 395 
TABLE 8.13: PER DIEM COSTS BY CRITICAL CARE UNIT AND FINANCIAL YEAR ........ 399 
8.8 DAILY COSTS OF ECMO ............................................................................. 401 
TABLE 8.14: BUDGET DATA FOR THE 2 FINANCIAL YEARS FORECM0 ................... 401 
TABLE 8.15: ADDITIONAL COSTS EXCLUDED FROM THE CALCULATIONS FOR ECMO 
................................................................................................................................ 402 
8.8.1 Apportionment of budget data ........................................................... 403 
TABLE 8.16: DAILY COSTS BY FINANCIAL YEARFORECM0 .................................. 403 
8.8.2 Application of organ support weightings ........................................... 403 
TABLE 8.17: ADJUSTED DAILY COSTS OF ECM0 .................................................... 404 
8.9 DISCUSSION ...................................................................................................... 404 
REFERENCES ......................................................................................................... 41 0 
CHAPTER 9: CONCLUSIONS ............................................................................. 413 
9.1 INTRODUCTION ........................................................................................... 413 
9.2 CRITICAL APPRAISAL OF THE RESEARCH ..................................................... 414 
9.3 CONTRIBUTION OF THE RESEARCH .............................................................. 416 
9.3.1 Development of costing methods for economic evaluation ................ 416 
9.3.2 Identification of the key characteristics and cost generating events in 
Crl.tz'cal care patz'ents ........................ 417 
·································································· 
9.3.3 Specifying the cost mode/for the HRGs ............................................ 418 
9 4 PEER-REVIEWED OUTPUTS .................................. • 418 
. ······································· 9.5 LIMITATIONS OF THE RESEARCH .................................................................. 420 
9.6 FURTHER RESEARCH ................................................................................... 421 
9. 6.1 Studies of the relationship between expenditure, case-mix and 
outcomes 421 
9.6.2 Studies of efficiency ............................................................................ 422 
9. 6.3 Studies of the factors that limit the availability of expenditure data in 
hospitals 422 
9.7 CONCLUSION ............................................................................................... 423 
14 
REFERENCES ......................................................................................................... 424 
ACKN'OWLEDGEMENTS .................................................................................... 428 
ACADEMIC SUPERVISION ........................................................................................ 428 
RESEARCH ASSISTANCE .......................................................................................... 428 
LITERATURE REVIEW .............................................................................................. 428 
EXPLORATORY ANALYSES ...................................................................................... 429 
MULTI-CENTRE STUDY ........................................................................................... 430 
CESAR TRIAL GROUP ............................................................................................ 43 8 
CRITICAL CARE NATIONAL WORKING GROUP ON COSTING ................................... 438 
REVIEWERS AND FACILITATORS ............................................................................. 438 
SIGNIFICANT 0THERS .............................................................................................. 439 
15 
"The wise man doesn't give the right answers, he poses the right questions." 
Claude Levi-Strauss, Anthropolist (1908) 
CHAPTER 1: INTRODUCTION 
1.1 Background 
There is widespread evidence to suggest that expenditure on health care 
is rising in the Developed World, in line with increases in life 
expectancy and improved living standards; both greatly enhanced by 
advances in technology and better access to medical treatment 
(Maniadakis et al., 1999). As a result, health care providers are 
confronted with the unenviable challenge of reconciling limited 
resources with an increased demand and an aging population 
(Andersen et al., 1976; Cullen et al., 1976; Malek, 1996; Hoppe, 1996; 
Ely et al., 1999). 
The costs of health care need to be better understood in order to 
achieve much needed budgetary equilibrium, assess hospital efficiency 
and perform economic evaluations of different health care interventions 
(Adam et al., 2003 1). This understanding is important if the goals of 
resource allocation; that of the achievement of both efficiency and 
equity are to be met. The aim of any public health care system is to 
maximise the health and welfare of the population for a given budget 
(Robinson, 1993), yet whilst therapeutic interventions have the 
potential to improve health, they pose a major problem to society, since 
the allocation of resources [to these interventions] is constrained by the 
availability of funds, for which all areas of health care must compete. 
According to Department of Health statistics, NHS expenditure in 
England was £76.4 billion in 2006, of which an estimated £1 billion 
was spent on adult critical care. Patients referred for treatment to an 
adult critical care unit are in, or at imminent risk of developing, single 
or multiple organ system failure. Once admitted, a multidisciplinary 
team of clinical specialists, operating at a ratio of one nurse to one 
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patient, provides 24-hour specialised care that involves close 
monitoring and stabilisation and support of vital functions. Costly 
drugs and investigations together with the use of highly sophisticated 
monitoring and organ support technology explain why a day of stay 
costs four times more than a day of care received on a general hospital 
ward (Wagner et al., 1983; Royal College of Anaesthetists and Royal 
College of Surgeons, 1996). Mortality at discharge from the critical 
care unit is however high, with 20% to 25% of patients not surviving 
beyond their admission (Bennett & Bion, 1999). 
Despite the high levels of expenditure and poor patient outcomes, very 
little is known about how critical care resources are distributed, to 
whom and with what effect (Bone et al., 1993 & Shmueli & Sprung 
2005). There is also some indication of an insufficient supply, with 
costs cited as a critical barrier to the opening of new beds (Audit 
Commission, 1999). 
1.2 Rationale for the thesis 
The impetus behind this PhD thesis arose as a direct result of 
encountering problems of a practical nature when attempting to cost the 
care of individual patients to identify iso-cost groups that would form 
the basis of Healthcare Resource Groups (HRGs) to support a proposed 
reimbursement system and to perform an economic evaluation of a 
multi-centre randomised controlled trial (RCT) of Extra-Corporeal 
Membrane Oxygenation (ECMO) versus conventional therapy for 
critically ill patients with severe, but potentially reversible, respiratory 
failure. 
There were three specific problems; firstly, the absence of a reliable 
method for estimating the costs of individual patients for use in multi-
centre costing evaluations, limited knowledge of both how costs of care 
related to the characteristics of patients and what constituted the key 
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'cost generating events' of critical care treatment 1 (J ohnston et al., 
1999). These made the tasks of identifying the best way of classifying 
patients into homogeneous resource groupsand deciding what clinical 
and economic data to collect alongside the CESAR Trial fraught with 
difficulty. 
1.2.1 Development of Healthcare Resource Groups 
Healthcare Resource Groups, analogous to the American Diagnosis-
Related Group (DRG) system2, have been used for costing non-critical 
care patients by National Health Service (NHS) Hospital Trusts in 
England and Wales since the early 1990s (Appleby & Thomas, 2000). 
HRGs classify patients who exhibit similar clinical and resource use 
characteristics on the basis of ICD-1 0 (International Classification of 
Diseases Diagnostic Codes Version 10) and OPCS-4 (Office of 
Population Censuses and Survey Tabular List of Classification of 
Surgical Operations and Procedures Fourth Revision) procedure codes 
as the basis of grouping, together with information on age and 
discharge status. 
Critically ill patients are a heterogeneous group with respect to their 
clinical and cost characteristics (Stevens et al., 1998). The link between 
the case-mix of these types of patients and their costs of care has not 
been adequately explored because of difficulties with both a) the 
measurement and quantification of case-mix in adult critical care 
patients and b) the estimation of patient costs within and across critical 
care units. Previous research has found that for a significant number of 
critical care patients, a diagnosis, even retrospectively, cannot always 
be made (Stevens et al., 1998) which is at odds with the structural 
foundations of an HRG-based system. A standard method for 
comparing the amount S\)ent on critical care in different hospitals has 
1 The term 'cost' is defined within the context ofthis thesis as the amount paid by an NHS hospital trust for their 
critical care resources (Finker, 1982). 
2 Diagnosis-Related Groups are a system for describing the types of patients discharged from acute care 
hospitals that aim to promote efficiency in the production ofhospita1 care by encouraging hospitals to produce 
targeted health outcomes with the least costly inputs (Fetter, 1987; Grimaldi & Micheletti, 1983). 
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been developed (Edbrooke et al., 1999) but no work has been 
undertaken, to date, that studies the relationship between the 
expenditure on critical care units and the case-mix of patients treated in 
those units so as to develop a set ofHRGs that accurately reflect both 
the expenditure and the case-mix in this patient population. 
In order to support the implementation of a case-mix adjusted funding 
system that arose as a result of the Department of Health's policy 
'Reforming NHS Financial Flows: Introducing Payment By Results' 
(Department of Health, 2002), HRGs for adult critical care patients 
were needed. With the proposed HRGs being used to reimburse a 
proportion of the critical care unit funds, it was felt important that the 
HRGs captured both the key patient characteristics and cost-generating 
events' and were capable of reflecting the variation in costs between 
individual patients. A key output from this thesis was thus to identify 
these events and develop a costing method to reflect these, which then 
could be used to propose a set of suitable HRGs. 
1.2.2 Costing methods for economic evaluation 
Economic evaluations of new and existing interventions are used 
increasingly to inform health technology appraisal in the UK and the 
number conducted alongside clinical trials continues to grow (Coyle & 
Drummond, 2001). 
Graves et al., (2002) argue that 'appropriate and transparent costing 
methods are a pre-requisite for any statistical analysis of cost data' 
[for the purposes of economic evaluation] yet despite considerable 
progress made with respect to estimating costs in the areas ofneonatal 
intensive care, most notably with the Trial of Indomethacin 
Prophylaxis in Preterms (TIPP) (Zupancic et al., 2003 & Schmidt et 
al., 2001), the INNOVO (Neonatal Ventilation With Inhaled Nitric 
Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for 
Preterm Infants With Severe Respiratory Failure) and neonatal ECMO 
trials both reporting concurrent economic evaluations (see Field et al., 
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2005 for the INNOVO trial and Tubman et al., 1990; Field & Pearson 
1994; Howard et al., 1995, 1996; UK Collaborative ECMO Trial /'' 
Group 1996; Hallam 1996; Roberts and the ECMO Economics 
Working Group 1998; Elbourne et al., 1999; Petrou et al., 2004, 2006) 
for the work performed on neonatal ECMO), there has not been one 
multi-centre clinical trial in adult critical care that has successfully 
·estimated the costs of individual patients. Only one multi-centre trial-
based economic evaluation on the use of pulmonary artery catheters 
has been performed in the UK to date (Harvey et al., 2006 & Stevens et 
al., 2005). This latter trial however did not attempt to estimate costs at 
the patient level but instead relied on the use of (average) NHS 
reference costs for the critical care received by patients. Coyle et al., 
(1998) state that 'ideally unit costs should be calculated specifically for 
the centres participating in the clinical and economic study ... with the 
resource use for each centre multiplied by its own unit cost, rather than 
adopting an average unit cost and then applying this to pooled 
resource data' (p.l40). This is why it is so important to develop a 
standard method of estimating costs that can be applied in different 
critical care units. 
The absence of high quality economic evaluations in adult critical care 
is due in the most part to the heterogeneous case-mix that plague the 
design of clinical and observational studies of effectiveness, the 
expense of collecting detailed resource use data (Zupancic et al., 2003) 
and finally, difficulties in estimating the unit costs of such resource 
use. Performing these evaluations in adult critical care face three ~ain 
challenges: 
1) The absence of a clinically meaningful, reproducible proxy measure 
of resource use, capable of discriminating between individual patients; 
2) Uncertainty as to whether an appropriate costing method, even if 
identified, would be sufficiently acceptable to users in order to generate 
unit costs of critical care. Existing methods of costing are pitched at 
two extremes; either capable of detecting variation between patients 
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and not the variation between centres (generally referred to as 'micro-
costing' or 'bottom-up' costing), or detecting the variation between 
centres and not patients ('gross-costing' or 'top-down' costing). Given 
that methods used to estimate costs in different studies can vary 
considerably (Balas et al., 1998; Drummond, 1985; Ganiats & Wong 
1991; Gerard 1992; Gerard et al., 1999; Graham et al., 1998; 
Homberger et al., 1992; Jacobs & Fassbender 1998), a standardised 
approach would be advantageous to reduce methologic bias which 
would in turn facilitate valid comparisons between studies and ensure 
that policy makers are provided with consistent evidence (Adam et al., 
20032; Stone et al., 2000; Drummond et al., 1997; Luce & Simpson 
1995; O'Brien et al., 1997; Gyldmark, 1995); and 
3) Finally, the delicate trade-off between how one would ideally like to 
conduct an economic evaluation in adult critical care (in so ticking all 
of the check-list boxes that conform to theoretical 'best practice') with 
what can be deemed a feasible and 'do-able' evaluation .. This trade-off 
represents the biggest challenge of all. 
As already stated, prerequisite to a proposed economic evaluation of 
ECMO versus conventional therapy for severe respiratory failure is 
knowledge of how costs of care relate to the characteristics of patients 
and what constitute the key 'cost generating' events of critical care 
treatment (Johnston et al., 1999). Some assurance is required that 
observed differences in cost between the study arms can be attributed 
to the effect ofthe treatment(s) under evaluation and not as a result of 
other (unknown) factors skewing the cost estimates. For the above 
reasons, a standard methodology of estimating costs for use in 
economic evaluations was considered to be the second key output of 
the PhD. 
1.3 Aims of the thesis 
The aims of this thesis were thus to: 
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1) Synthesise current knowledge about the different methods used to 
estimate costs of care in critical care units; and 
2) To develop and apply a suitable method for multi-centre costing 
evaluations. A systematic review ofthe literature served to provide the 
background to, and justification for, the costing methods employed in 
• the empirical studies- particularly the multi-centre study, and played a 
key role in achieving the first aim of the thesis; that being to identify 
the intellectual origins of costing methods reported in the literature and 
evaluating any methods that could be used or adapted within the thesis. 
The second aim of the thesis was informed by exploratory statistical 
analyses of data obtained from a single centre, described in Chapter 4 
that evaluated different patient characteristics against the daily costs of 
care, and analyses of data on critical care unit expenditure and patients' 
organ support obtained from a multi-centre study of 46 critical care 
units described in Chapter 6. The multi-centre study set out to generate 
data to develop regression models to estimate patient costs. The 
regression models derived marginal per diem cost estimates. By 
summing together these per diem costs, total costs for individual cases 
could be determined. No attempt was made to relate these costs to 
intermediate or longer-term outcomes (i.e. survival from the critical 
care unit or from hospital). 
A key requirement for the multi-centre study described in Chapter 5 
was a standard method for estimating costs across different critical care 
units. This was important so as to avoid methodologic bias. 
In this thesis, a method using 'activities of care' was considered for 
estimating patient costs (Edbrooke et al., 1997). This method is capable 
of detecting variation in cost between patients, however the resultant 
estimates can suffer from a site selection bias (Jacobs & Baladi, 1996) 
thus affecting their generalisability to estimating patient costs in other 
critical care units. The method is not so good at estimating variation in 
costs due to differences in unit characteristics. Very detailed data 
collection at the patient-level needed to apply the 'activities of care' 
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method mean that widespread implementation of such a method would 
probably be both too costly and time consuming to consider in a multi-
centre setting. 
An alternative 'top-down' costing method, developed by the Critical 
Care National Working Group on Costs was also considered (Edbrooke 
et al., 1999). This retrospective method estimates per diem costs for a 
critical care unit by apportioning the annual expenditure of a critical 
care unit by the annual number of patient days and is presently used as 
a benchmarking tool for the purposes of cost comparison. However, a 
case-mix bias occurs since the number of patient days is not 
sufficiently refined to take into account how patients vary in terms of 
their care requirements on a daily basis. J acobs & Baladi (1996) thus 
recommend the use of case-mix weighted days over the use of per diem 
costs and so the development of a case-mix weighted day approach 
therefore formed the core objective of the thesis. 
1.4 Outputs from the thesis 
The purpose of this PhD was not only to enhance existing knowledge 
of the costs of adult critical care but to also perform two specific 
functions - the development of a set of proposed HRGs and the costing 
of patients recruited to the CESAR trial -, which would benefit the 
critical care and research community and merit peer-reviewed 
publication. 
Scientific enquiry seeks to 'combine the power of rational thought and 
systematic investigation to produce new knowledge' (Denscombe, 
2002) and the originality of the academic contribution will be 
demonstrated by three endeavours that had not been achieved before in 
the United Kingdom, namely: 
1) The development and application of a 'top-down' costing method 
for use in a multi-centre study (collecting precise and valid data) to 
support empirical investigation of the relationship between expenditure 
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on critical care and the case-mix of patients, from which 
generalisations can be made; 
2) The production of a model using the resultant cost estimates for 
proposing a set ofHRGs; and 
3) The production of cost weights from the same model for estimating 
• patient costs for the multi-centre RCT. 
1.5 Structure of the thesis 
Chapter 2 provides a background to subsequent chapters and sets out to 
pinpoint the issues that will form the substantive arguments of the 
thesis. 
I will argue why: 
1) The neoclassical theory of the firm does not readily apply to adult 
critical care units because of the complex nature of its inputs and lack 
of detailed information on the costs of such; and 
2) Ambiguity exists as to what best constitutes an appropriate output 
measure (of case-mix) for adult critical care units. 
In this Chapter, cost and production functions are explored in context 
of their application to hospitals and critical care units. The different 
types of costs that can be taken into account (dependent on the 
perspective and time horizon of the evaluation) are also described. 
A systematic review of the literature is described in Chapter 3. The 
literature review serves to provide the background to, and justification 
for, the empirical studies and plays a key role in achieving one main 
objective that being, to identify existing methods used to estimate costs 
in adult critical care units and to critically appraise those methods. 
Findings from 26 identified studies meeting the inclusion criteria of the 
review are described. The quality of each study is assessed using 
criteria proposed by Burchardi et al., (2001). 
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In Chapter 4, two exploratory studies involving patient-level data 
collected from the Critical Care Unit at the Royal Hallamshire Hospital 
are described using the 'activities of care' costing methodology 
identified from the literature review (Edbrooke et al., 1997). Here, the 
daily costs of care for individual patients are estimated so that the 
relationship between these costs and a set of case-mix related variables 
could be investigated. This study was important since it had the sole 
objective of identifying the key patient characteristics and 'cost 
generating events' of critical care (Johnston et al., 1999). Three 
different options are considered and discussed: using patients' TISS 
points; a multivariate analysis of all different types of case-mix 
variables, and finally, the use of patients' daily organ support data. 
The design of a larger multi-centre study is described in Chapter 5 that 
sets out to perform a prospective period of data collection using a 
volunteer sample of 70 adult critical care units. Monthly expenditure 
data and daily data on patients' organ support are collected over a two 
to three month period. The monthly expenditure data is estimated using 
a 'top-down' method of costing (Edbrooke et al., 1999). The results of 
this study are described in five sections in Chapter 6. Section I details 
how the patient data were collected and validated. Section II describes 
the characteristics of the volunteer sample of critical care units in terms 
of the geographical coverage of units, their teaching hospital status, the 
types of critical care units and the number of staffed beds and considers 
the representativeness of the sample. Section Ill considers the 
characteristics of patients studied, such as their length of stay, survival 
status at discharge from the critical care unit, the type of organ support 
that patients received during their stay and explores the relationship 
between patients' organ support and the type and size of the critical 
care unit. The collection and validation of expenditure data is reported 
in Section IV. Finally, preliminary analyses of the relationship between 
expenditure and the type and size of critical care unit are performed on 
a sub-sample of 46 critical care units in Section V. 
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Chapter 7 is concerned with the development of a set of proposed 
HRGs to support the Department of Health's funding policy. The aim 
r 
is to identify, from the 46 critical care units who provided data on both 
expenditure and case-mix, an appropriate model from which estimates 
of daily case-mix adjusted costs of care can be determined. Nine 
models in total are described and a random-effects model based on the 
• number of organs systems supported per day was the chosen model. 
This model was evaluated in two ways -by its ability to predict 
expenditure and by assessing through a small pilot study, its 
acceptability to users. 
Chapter 8 considers the application of daily organ support weights, 
described in the previous chapter, to an ongoing economic evaluation 
alongside a clinical trial. The overall aim ofthis study is to estimate the 
incremental costs ofECMO, over and above the costs of conventional 
therapy for patients with severe, but potentially reversible, respiratory 
failure. A survey of the costs and characteristics of the participating 
critical care units is described and the application ofthe organ support 
weights to the obtained costs is illustrated. 
Chapter 9 discusses the findings of work, its limitations and options for 
further research. 
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"Although greater awareness of costs can create a better climate for increasing 
efficiency, the question is unfortunately often posed without a real understanding 
either of the nature of the cost or of the problem" 
Gavin Mooney & Michael Drummond (1982) 
CHAPTER 2: BACKGROUND TO COST FUNCTIONS 
2.1 Introduction 
The development of diagnosis-related groups (DRGs) initially began as 
an attempt to define operationally the products of a hospital in terms of 
groups of patients receiving similar sets of outputs or services (Fetter, 
1987). Whilst a key component of the thesis is to estimate the costs of 
critical care patients for the purpose of developing a set ofHealthcare 
Resource Groups (HRGs ), the costs themselves are a function both of 
input prices and the rate of output (Shiell et al., 1993). Chapter 2 thus 
sets out to provide some theoretical context to the importance of 
understanding this cost function when attempting to quantify (and 
understand) cost variation between different individual units (and 
patients). This is important because the resultant HRGs must respond 
to changes in the cost structure of critical care units and meet demand 
increases if the case-mix system is to maintain credibility and equity 
(Antioch & Walsh, 2000). 
Cost functions describe the relationship between outputs and what is 
normally assumed to be the minimum cost of production (O'Neill & 
Largey, 1997). Scott & Parkin (1995) describe the two main 
approaches to the study of cost functions as the ad-hoc or behavioural 
cost function and that based on the theory of the firm. Based on the 
economic theory of the firm, cost functions can provide useful 
information to hospitals about economies of scale, optimal size, the 
degree of specialisation and mergers, and the marginal costs of 
services. The work of this thesis sets out to estimate the relationship 
between critical care costs per day of stay and factors thought to 
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influence such costs, where the focus is primarily on estimating the 
- marginal costs as opposed to investigating economies of scale. /~· 
Research looking at the effect of economies of scale (on the marginal 
costs) typically follows once reliable data on the costs have been 
obtained. 
·Many different regression models have been used for determining the 
association between patient characteristics and hospital costs (Austin et 
al., 2003). Cost functions can be analysed econometrically using 
models that explain how total costs change in response to differences in 
service mix, inputs, input prices and scale of operations (Barnum & 
Kutzin 1993 & Adam et al., 2003) or using non-statistical methods 
such as data envelopment analysis (DEA) (Jacobs, 2001). DEA is a 
linear programming method that estimates a deterministic frontier 
based on the observed data (Zuckerman et al., 1994). Typically, 
applications ofDEA in health economics however do not allow for a 
random error term and are likely to be sensitive to the influence of 
outliers (Jones, 2000). 
There are a number of difficulties experienced when attempting to 
define cost functions. Hospitals do not adhere to maximising I 
minimising behaviour on the basis that most hospitals are non profit 
institutions (Hadley et al., 1996). Cost functions can also be difficult to 
estimate as hospital use many inputs and produce a diversity of outputs 
(Breyer, 1987). 
According to Berki (1972) 'there appears to be no agreement either on 
a conceptual or merely definitionallevel, among those who have most 
intensively studied the economics of hospitals, on what the appropriate 
measure of output is or should be'. There is neither a uniformly agreed 
upon regression model with which to analyse cost data in order to 
define this (Glick & Polksy, 1999) nor is it known which method is 
best. From an econometric perspective, there are rarely sufficient 
degrees of freedom available to include all of the variables ofinterest 
and the interactive and squared terms required by a flexible 
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specification. This means that studies of cost functions often require 
very large samples with a reduced list of variables of interest (Bamett, 
1997). 
O'Neill & Largey (1997) and Folland et al., (2004) (see also 
Richardson et al., 2001) allude to the additional difficulties in the 
estimation of cost functions, namely the poor understanding of the 
underlying production relationship and the constraints under which 
production takes place. 
The reasons that they give for this relate to; 
• Variations in clinical practice (that include both the ways in 
which care is delivered e.g. constraints placed on 
prescribing I treatment choices; and 
• The job functions (specialisation) of clinicians- some 
concentrating on more clinical tasks, others spending time 
doing research and administration etc (e.g. functions of 
clinicians). 
They also highlight the case-mix response-to-treatment factor that can 
contribute to differences between both clinicians and critical care units, 
in terms of output. That is to say that even if critical care units treated a 
heterogeneous case-mix in the same way, it cannot be assumed that 
patients will respond in the same way as one another to their treatment. 
2.2 Applications of production and cost theory to 
critical care units 
2.2.1 Background to adult critical care 
This thesis focuses specifically on adult patients (?:16 years of age) 
receiving treatment in critical care units in NHS Hospital Trusts. A 
critical care unit 'monitors and supports failing vital functions in 
acutely ill patients' (Ferdinande, 1997 p.226) and is where patients 
'with potentially recoverable diseases can benefit from more detailed 
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observation and treatment than is generally available in the standard 
· wards and departments' (King's Fund Panel, 1989 p.428). 
Critical care developed in response to an epidemic of poliomyelitis in 
Copenhagen in 1952 (Lassen, 1953). The mortality associated with 
respiratory failure due to polio was 87% despite patients being treated 
with negative pressure ventilation with either cuirass or tank 'iron lung' 
ventilators. Using positive as opposed to negative pressure ventilation 
through a tracheostomy, the mortality rates fell to 26% (Intensive Care 
Society, 2003). In 1962, the Department of Health published 
"Progressive Patient Care' (MOH & PHLS, 1962) that resulted in 
funding to set up critical care units in the U.K, with a suggestion that 
between 2%-5% of a hospital's acute beds should be designated critical 
care beds. Research conducted during the 1970s and 1980s identified 
common features of sepsis and multi-organ failure and so the modem 
concept of critical care was founded (Intensive Care Society, 2003). 
Over the last fifty years, critical care has developed into a rapidly 
changing and complex field of medicine, dealing with an enormous 
array oflife-threatening conditions (Irwin & Rippe, 2003). As such, the 
case-mix of critical care units is very heterogeneous in terms of the 
clinical conditions treated and can include ventilator-associated 
pneumonia, systemic inflammatory response syndrome, chronic 
obstructive pulmonary disease, acute respiratory distress syndrome, 
severe community-acquired pneumonia, pancreatitis and acute renal 
failure (Marik, 2001). Patients typically require intensive monitoring, 
and most need some form of mechanical or pharmacological support 
such as mechanical ventilation, renal replacement therapy or vasoactive 
drugs (Bennett & Bion, 1999). As well as specific types of organ 
support, critical care patients require other interventions to maintain 
organ function and prevent further damage such as nutritional support, 
preserving skin integrity, psychological support and mobilisation 
(Adam & Forrest, 1999). Treating the sickest patients within the 
hospital, mortality rates at discharge from a critical care unit are high 
(between 20-30% of patients will not survive beyond their admission) 
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and a further 1 0% will die on the ward after discharge from the critical 
care unit (Bennett & Bion, 1999). The majority of patients are 
emergency admissions and their severity of illness is a major factor 
associated with patients' length of critical care unit and in-hospital 
stay, their morbidity, mortality and total costs of treatment (Shiell, 
1991 & Stevens et al., 1998). Epidemiological studies of critical care 
have found patients to be predominantly male, with a high proportion 
of elderly patients (greater than or equal to 70 years) constituting 25-
30% of the total (Dragsted & Qvist, 1992). Characteristics of patients 
that influence admission to critical care are age, severity of illness and 
reason for admission (Sprung & Eidelmann, 1997 & Azoulay et al., 
2001). However, doctors' decisions to admit patients have also shown 
to be influenced by relatives' wishes and non-medical factors such as a 
patient's personality or availability of beds (Escher et al., 2004). 
Critical care forms part of a network that makes up an acute hospital, 
with patients presenting for admission from the Accident & Emergency 
(A&E) department, the operating theatres and the general hospital 
wards (Audit Commission, 1998). In the UK, patients receive critical 
care in an Intensive Care Unit (ICU) when requiring advanced 
respiratory support alone or combinations of two or more other acute 
organ systems, whereas the High Dependency Unit (HDU) is used to 
treat patients requiring support of a single acute organ, excluding 
advanced respiratory support (Department of Health, 1996). Critical 
care is the term used interchangeably to reflect both ICU and HDU 
care. 
Critical care comprises 1-2% of total bed numbers in the UK, which is 
significantly less than the 20% reported in the United States (Bennett & 
Bion, 1997). Critical care patients are more expensive than other 
specialties because of their severity of illness and need for intensive 
care, which mean that the service is frequently scrutinised in terms of 
its growing expenditure (Cullen, 1977; Edbrooke et al., 1999; Ridley et 
al., 19931; Slatyer et al., 1986; Puig-Junoy, 1998). Nursing staff 
represent the largest component of cost due to the 1 : 1 nursing care, 
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with a lower ratio usually provided to those receiving high dependency 
· care (Intensive Care Society, 2003). 
A multidisciplinary team of nurses, doctors and professionals allied to 
medicine (clinical pharmacists, dieticians, physiotherapists, 
bacteriologists, speech therapists, clinical psychologists, occupational 
therapists, medical technical officers and clinical scientists) deliver 
critical care. Anaesthetists manage most of the critical care units in 
conjunction with the referring Clinicians (Bion, 1994). The Audit 
Commission reported the results of their survey of 193 critical care 
units in 1998 and found that the average six-bedded general critical 
care unit had 47 nurses (33.5 whole time equivalents), three consultants 
with fixed commitments to the unit with three more taking place in the 
on-call rota. There are two basic styles of medical management; closed 
(the unit's doctors take responsibility for clinical management with the 
patient's care formally transferred from the referring consultant) and 
open (patients remain under the care of the referring consultant with 
any unit doctors considered to be advisory) (Audit Commission, 1998). 
Twenty percent ofiCUs and ICU/ HDUs operate open systems, 
however open systems are practiced in 80% of the separate high 
dependency units. 
2.2.2 Costs of critical care 
Bion et al., (1999) state that 'it [critical care] is perceived as a service 
that consumes resources rather than one that generates desired 
outcomes .. .funded on the basis of political imperative rather than on 
the needs of the population' and it is commonly thought that for some 
critical care patients, the high costs far outweigh any benefits of these 
treatments (Taylor, 1979 & Teres & Rapoport, 1991). 
Reliable annual estimates of critical care expenditure are not readily 
available, although the Audit Commission quoted a figure of £700 
million in 1998 for units residing in England and Wales. Since that 
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time, an injection of funds to increase bed provision has inflated this 
estimate to approximately £1 billion. 
The costs of a critical care unit are influenced by the case-mix of 
patients (both the type of patients and the complexity of their clinical 
conditions), the quality of care, size of the critical care unit and the 
occupancy rates (Hibbert & Edbrooke, 2002). Daily costs range from 
£550 to £1,500 per day (Gilbertson et al., 1991; Ridley et al., 19932) 
and are between four to six times more than care on a hospital ward 
(Wagner et al., 1983 & Royal College of Anaesthetists and Royal 
College of Surgeons, 1996). As has been shown for many types of 
health care services, a relatively small number of patients in critical 
care units account for a disproportionately large proportion of the 
expenditure. 
The costs for individual patients can vary not only within a single 
critical care unit but also between different critical care units. The 
reasons for the variation in cost between centres include clinical 
practice styles (Knaus et al., 1982, 1986; Greenfield et al., 1992; Stano 
1993), unit size (Hibbert & Edbrooke, 2002 & Gyldmark, 1995), the 
ratio of emergency to elective admissions, the organisational structure 
of the critical care services (e.g. presence of a separate HDU or 
combined ICU) I HDU, whether the unit is located in a university or 
non-university hospital), the grade-mix of nurses and seniority of 
medical staff (Hibbert & Edbrooke, 2002), research, training activities 
and possibilities for treatment and care (Gyldmark, 1995). Added to 
this list is the quality of care (survival rates) and configuration 
(whether care is provided in specialist or generalist units, in separate or 
integrated ICU and HDUs, solely in critical care units or also in 
Accident & Emergency Departments, admission units, recovery and on 
the hospital wards) (Audit Commission, 1998). 
There is an absence of information about the costs that makes the task 
of economic evaluation, more difficult and many hospitals do not know 
what the actual costs of their services are (Rizzo & Powe, 1999). Glick 
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et al., (2003) observe that whilst 'calculation of costs is an essential 
·part of these [economic} evaluations ... little, if any research has 
examined optimal strategies for such calculation'. This view is further 
supported by Jacobs & Bachynsky (1996). More work is required 
therefore on the actual process of cost data collection (Raikou et al., 
~000) particularly in adult critical care. The current state of knowledge 
reflects Gyldmark's observation that 'it is difficult to relate the total 
cost [of running an ICU] to activity and/or patient characteristics and 
thus to optimise treatment activities and the use of limited capacity and 
resources' (Gyldmark, 1995 p.964), which is really where the 
motivation for this thesis comes from. 
There are many different ways in which costs can be defined, 
depending on whether an accountancy or economic standpoint is 
adopted. 
2. 2. 3 Cost definitions 
Accountants define costs in terms of the value of economic resources 
used as a result of producing or doing whatever is being costed. Such a 
cost can be broken down into cost elements; a cost element being, in 
effect, the cost of an individual resource (e.g. material) consumed by 
whatever is being costed. From an accountancy perspective, cost 
elements have two components: a quantity of the resource used and the 
price of that resource. The costs of all cost elements can thus be 
determined by the formula: cost = usage x price (Horngren et al., 
1999). 
Economists' generally accepted definition of cost in a given period of 
time is 'a resource sacrificed or forgone to achieve a specific 
objective' (Jegers et al., 2001). This implies that the resource cannot 
be used for alternative applications. Therefore, the value of the best 
alternative sacrificed can be considered to be the value of the resources 
used. This value is defined as the 'opportunity' cost and. refers to the 
benefit accrued from the alternative use of [the] resources (Johnston et 
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al., 1999). According to Mooney (2003) 'this concept of opportunity 
cost encourages us to place monetary values on 'costs' that might not 
normally be seen as having pound signs in front of them ' (p.6). 
In this thesis, costs are considered as the monetary value expended by 
NHS providers on a given resource, which may or may not reflect the 
opportunity cost of its alternative use. The cost is also likely to reflect 
the price of the resource because of the way in which monies are 
allocated to NHS providers for meeting the costs of patient care on a 
not-for-profit basis. In the UK, NHS providers do not charge patients 
or insurance companies for their services so the term 'price' and 'cost' 
can be used interchangeabily. 
Resources are basic services used in the production process and 
include labour time, medical supplies and medicines, machining 
services, buildings and land (Schwartzbach & V angermeesch, 1983 & 
Institute of Health Economics, 2000). Conversely, resource use can 
also be seen as a day in hospital (also referred to as a cost-generating 
event (Johnston et al., 1999). Cost is the value of these resources 
(Institute of Health Economics, 2000) with a unit cost representing the 
value I price of a resource (Johnston et al., 1999). 
Direct costs represent the resources purchased directly as a result of an 
activity and can be subdivided into fixed and variable costs. 
Richardson et al., (2001) define direct costs as those that can be linked 
to the care of a particular patient with indirect costs covering the 
overhead costs incurred for all patients; here an accountancy 
perspective is most evident. 
The interpretation of indirect costs differs when an economic 
perspective is adopted. Here, indirect costs represent 'the element of 
indirect consumption of resources in the production process, for 
example the value of lost earnings by patients or carers of patients who 
are unable to work as a result of the health care activity' (Petrou & 
Mugford, 2000). 
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All direct and indirect costs have both fixed and variable components 
- (Richardson et al., 2001). Fixed costs are costs that do not vary wit~, 
the quantity of output in the short run (about one year), e.g. rent, 
equipment lease payments, some wages and salaries - so costs that 
vary with time, rather than quantity (Drummond et al., 1997). In the 
~ontext of adult critical care, Mostafa ( 1995) in one of the first adult 
critical care cost studies describe the following resources as 'fixed': 
• Construction; 
• Maintenance of buildings; 
• Purchase and maintenance of equipment and supporting 
services; 
• Hotel costs (light, power, heat, laundry); 
• General administration and finance; 
• Admission department and records; and 
• Portering 
He categorised staff- the main elements being nursing and medical 
staff, technicians and clerks as being semi-fixed. 
Variable costs vary with the level of output, e.g. supplies, food, fees 
for service (Drummond et al., 1997). Taheri et al., (2000) describe 
variable costs as those that can be identified directly with the care of 
individual patients on a particularly day, such as laboratory tests, 
radiographs and disposable equipment. Mostafa (1995) describe the 
following resources as 'variable': 
• Respiratory therapy; 
• Disposable equipment; 
• Drugs and fluids and nutrition; 
• Blood products and substitutes; 
• Dialysis services. 
Average costs (AC) include fixed costs, such as costs ofhospital 
buildings and costs of overheads, as well as variable costs and the AC 
of a unit of service can be estimated from the total cost divided by the 
total number of units ((Johnston et al., 1999). 
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Marginal costs (MC) cover the costs of producing one additional unit 
of output. For example, given an adult critical care unit is fully staffed 
and has an empty bed, the marginal cost of providing care to one 
additional critical care patient is limited to the incremental cost of 
supplies and other variable costs. However, a full critical care unit that 
needs to use agency staff to care for an additional patient would incur 
higher marginal costs for that patient (adapted from Richardson et al., 
2001). 
A total cost (TC) is the cost of producing a particular quantity of 
output (Drummond et al., 1997). 
Intangible costs are those borne externally to the health sector, 
patients and their families (Drummond et al., 1997) and refer to the 
element of pain or grief experienced by patients and their families and 
friends. 
Charges are the prices set (asked) for a service. This may not equal the 
amount that is actually paid (Institute of Health Economics, 2000). 
Charges cannot be considered in the same way as costs because they do 
not reflect actual expenses; they are billing parameters between the 
health care providers and the payers (Jegers et al., 2001). Charges for 
services often include capital and indirect costs such as medical 
education and are often used in reports of the "costs" of clinical 
programs because such data are readily available from patients' 
hospital bills (typically in the U.S.) (Douglas et al., 1995). The 
relationship between costs and charges is the "cost-to-charge ratio". 
Capital costs are the costs to purchase the major capital assets required 
by the programme; generally equipment, buildings, and land 
(Drummond et al., 1997). 
Overheads are an accounting term for those resources that serve many 
different departments and programmes, e.g. general hospital 
administration, central laundry, medical records, cleaning, porters, 
power, etc (Drummond et al., 1997). 
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According to Robinson (1993), there are three main categories of cost 
· that must be considered if a societal perspective is to be adopted: / 
• Health service costs; 
• Costs borne by patients and their families; and 
• External costs borne by the rest of society . 
. 
Under the heading of 'health service costs' suggested by Robinson 
(1993), these should include: 
• Staff time; 
• Medical supplies (including drugs); 
• Hotel services; 
• Use of capital equipment; and 
• Overheads, such as lighting and heating. 
These items may be divided into variable costs and fixed costs. In the 
long run, the vast majority of costs become variable because those that 
are fixed in the short run may be varied- for example, by opening and 
closing critical care beds. In economic evaluation, all health service 
costs- both fixed and variable are considered 'direct' costs. The scope 
of the PhD is focused on the measurement and estimation of these 
direct costs - specifically those that fall within the budgetary remit of 
the adult critical care unit. Costs borne by patients and their families 
and external costs borne by the rest of society are thus excluded. 
Finally, an important source of cost variation that cannot be ignored is 
that of methodologic bias where differences in the methods used affect 
the estimates of such. Examples include differences in the time period, 
double-counting, exclusion of costs, method of resource measurement, 
method of cost allocation, source of unit cost data, inability to separate 
intensive care costs from the overall hospital costs, use of charges 
instead of costs, systematic errors and sampling variation (Gyldmark, 
1995). 
Whilst the issue of costs and the relationship between average per diem 
costs and the size of a critical care unit has featured heavily in the 
46 
neonatal critical care literature (John et al., 1991; Fordham et al., 1992; 
O'Neill & Largey, 1997; Richardson et al., 2001), very little work has 
been undertaken in the adult critical care setting. 
2.2.4 Costs and production functions In critical care 
Fordham et al., (1992) estimated the relative daily costs of two broad 
levels of care - intensive and non-intensive - in all neonatal intensive 
care units in the Trent region. In this study, total expenditure was 
apportioned by the total cot days at each level of care. Through a 
multiple regression analysis, the relative daily costs of each level of 
care were derived. Building on the preliminary findings ofFordham et 
al., (1992), O'Neill et al., (2000) collected cost and activity data from 
49 neonatal units to determine the relationship between unit size, case-
mix and cost, where case-mix was defined as the proportion of 
intensive care days to all care days provided. The authors' findings 
suggested the likely existence of economies of scale; that is, the cost 
per day of care provided decreased with the size of the neonatal unit, in 
terms of days of care it provided. On this basis, there are valid grounds 
for hypothesising similar findings could be observed in adult critical 
care, despite this being outside of the scope of this thesis to explore and 
test in the empirical sense beyond the exploratory analysis described in 
Chapter 6, Section V. As already mentioned and will be evident from 
subsequent chapters, the work of this thesis will not attempt to explore 
whether scale economies or allocative efficiency gains exist in the 
production of adult critical care activity. Study of such would have 
allowed one to determine whether larger sized critical care units are 
more 'efficient' than smaller sized units, which is without exception, a 
very important policy question. What work from the thesis will 
facilitate is empirical testing of the cost function since it will provide a 
means of costing some of the inputs into the critical care unit and offer 
a classification system of case-mix. 
There is presently a lack of knowledge as to the nature of the cost 
function in adult critical care units because of first, difficulties in 
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defining and quantifying the output measure (the type of patients 
- treated), lack of information about the most technically efficient w~ of 
treating patients and finally, lack of information on unit costs. Ways of 
identifying the most efficient means of treating critical care patients is 
complicated due to ethical concerns pervading the conduct of clinical 
!rials where randomisation of one unproven treatment to another causes 
concern amongst the critical care staff. Added to this, is the absence of 
routinely collected cost data on both the running costs of the critical 
care unit and the treatment costs of individual patients and that makes 
the process of both identifying technically efficient and inefficient 
organisational methods of delivering care and identifying efficient and 
inefficient treatments, fraught with difficulty. 
If a way in which input prices I costs could be determined, it would 
then be possible to estimate the cost of adopting different methods of 
production so that appropriate choices could be made as to the lowest-
cost production method. The challenge then arises as to how the quality 
of the production method can be measured so as to determine the effect 
on this, as the costs of production decrease. 
In the context of an adult critical care unit, inputs (of production) cover 
staff (e.g. nurses, doctors and professionals allied to medicine), 
consumables (e.g. drugs, fluids, disposable equipment and blood and 
blood products), capital equipment (e.g. beds, ventilators, computers, 
patient monitors and syringe drivers), clinical support services (e.g. 
radiology and laboratory tests), non-clinical support services (e.g. 
cleaners, porters, accountants, managers and administrators) and 
overheads such as heating and lighting. The critical care unit uses these 
'~ 
so-called inputs to treat patients. The number of treated patient days 
can be considered an intermediate output with patients (and ideally 
successfully treated alive and healthy patients) as the final measure of 
output in a critical care unit. 
An adequate description of case-mix does not exist for adult critical 
care patients. Whilst case-mix groups can be formed in a variety of 
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ways, Plomann & Shaffer (1983), Thompson et al., (1975) and Lave & 
Lave (1970) identify the four most common approaches to case-mix 
grouping, where case-mix is: 
• Measured in terms of the number of patients treated or the 
number of patient days of care rendered; or 
• Standardised by controlling for differences in the types or 
numbers of services the hospital can perform or provide for 
the patient; or 
• Determined by hospital size; or 
• Determined through output measures that are adjusted for 
differences in case-mix among hospitals in terms of the 
service unit treating the patient. 
This thesis will attempt to explore possible measures that could be used 
to describe case-mix. 
There are two main reasons why few attempts have been made to 
specify a cost function for adult critical care units. Critical care units do 
not collect the type of information needed to help estimate a cost 
function that includes both data describing the case-mix of patients 
treated. This is not a problem specific to critical care units but common 
to other areas of medicine where there are no straightforward 
definitions of output). Furthermore, data (presented in a standard 
format) on the expenditure of patients and the critical care unit itself 
are not collected so as to perform multi-centre studies3. 
Critical care units cannot easily adjust its inputs to a change in 
conditions, as much of its high costs are fixed (e.g. nursing and medical 
staff). Only its variable costs would decrease following a decline in 
output. Similarly, faced with pressures to increase output, their options 
are limited as it is not often feasible to physically expand the critical 
3 Most adult critical care units maintain budget statements relating to the expenditUre of the unit over a given 
period (typically on a monthly basis), however not only do these statements include different cost items from 
one critical care unit to another but the descriptors given to each cost item can be very different from one unit 
to the next. 
49 
care unit (i.e. build a new unit or extend the existing facility) and/or 
study its skill-mix of nursing staff to see whether it can treat more 
patients with a different staff configuration and/or recruit additional 
staff members. There is presently no knowledge as to the optimal size 
of a critical care unit (number of beds) or the optimal quantity of output 
(tr.eated patients). 
The concept of profit does not easily translate to a critical care unit 
unless the unit was operating in a reimbursement system where 100% 
of its output was reimbursable where surplus inputs could accrue. 
These would not easily translate into profits however. 
The goal of the critical care unit should be to ensure that the price at 
which care is reimbursed equals long run average costs (to break-even) 
or to ensure more financial stability that their long run average costs 
fall below the reimbursed price. In order to identify the best output (or 
ideal number of patients that a critical care unit should treat) to break 
even or make profits, the marginal condition (LMC = MR) is used. It is 
possible to use the average condition to see if the best positive output 
yields a profit or a loss; the average condition compares long term 
average costs at this output with the average reimbursement received. 
The critical care unit has fixed factors of production i.e. inputs that 
cannot be varied that incur fixed costs that do not vary according to the 
number of patients treated. These inputs are a certain amount of 
necessary staffing and capital 'equipment. Short-run total costs can be 
estimated from the sum of both the short-run fixed costs and short run 
variable costs. Diminishing returns to labour can be estimated when the 
' 
amount of work performed per person drops as the number of 
temporary staff employed in a'critical care unit (for example), 
increases. To illustrate this further, if there are 3 agency nurses 
required to treat 2 patients, yet 4 agency nurses are hired, the fourth 
nurse will not be able to treat an additional patient since 5 nurses are 
required in order for that to happen. This analogy results in an under-
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utilisation of the fourth nurse and also illustrates the marginal product 
of labour. 
In conclusion, it is clear that the neoclassical theory ofthe firm does 
not readily apply to critical care for the following reasons: 
• The complex nature of the inputs -that prevent 
straightforward substitution (of these inputs) and 
adjustments to changes in conditions (demand or 
otherwise); 
• Limited knowledge of what time component would 
constitute the 'long- and short-run'; 
• Limited knowledge ofwhere economies of scale can best be 
achieved; 
• Critical care units do not operate in conditions of perfect 
competition where profit maximisation is the main goal; 
• Lack of detailed information on the costs of the inputs used 
by the critical care unit thus limiting the scope for exploring 
short and long-run output decisions; and 
• Ambiguity as to what best constitutes an appropriate output 
measure (of case-mix). 
All of the above factors make the linking of inputs to the outputs from 
the critical care unit fraught with difficulty. 
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CHAPTER 3: A SYSTEMATIC REVIEW OF THE / 
LITERATURE ON COSTING METHODS 
3.1 Introduction 
• A challenging element of economic evaluation is the proper 
measurement of costs (Smith & Bamett, 2003). A systematic review of 
the literature, as described in this Chapter, aimed to identify methods of 
costing patient care that have been applied previously to the adult 
critical care setting; the objective being to identify a method for 
estimating daily costs, amenable for use across a number of different 
critical care units. Literature on other high cost areas such as neonatal 
and paediatric critical care as well as bums and liver transplantation 
was also consulted. 
A systematic review involves 'rigorous application of a methodical 
search, compilation, and inference technique to the body of literature 
identified' (Hutton & Ashcroft, 1998). The techniques of reviewing 
methods differ somewhat to the techniques of reviewing empirical 
studies because of the formalised ways in which empirical studies can 
be evaluated according to well-established checklists and the results 
synthesized using a range of statistical approaches. Unfortunately, there 
is no 'gold standard' against which different methods can be compared 
(Edwards et al., 1998). 
An Advisory Group formed prior to the commencement of the review 
(Section 3.2). Checks for ongoing and existing reviews were performed 
and the scope of the literature assessed (Section 3.4). This was 
important to determine whether a sufficient body of published evidence 
was available. A large number of abstracts were screened using pre-
defined criteria prior to obtaining the full papers (Section 3.6). For 
inclusion in the review, studies had to provide a detailed description of 
the methods used for calculating the daily costs of adult critical care 
patients. Data extracted from 26 identified studies included the study 
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aim, the number of patients and centres studied, the method used for 
measuring care and the coverage of costs (Section 3.8). The results 
were then tabulated in Section 3.9. 
The dates of publication ranged from 1980 until 2005 with the highest 
proportion of studies originating from the UK. and France and with 
most of the identified studies conducted in a single centre. As far as 
the methods of allocating costs to patients were concerned, these were 
not mutually exclusive in all instances. There was some overlap 
between the direct measurement of costs at the patient level, and 
apportioned measurement of expenditure at the critical care unit level. 
A common set of cost components was however identified from the 
studies and data extracted on this basis. Costs were described under the 
headings of staff costs, treatment-related costs and overheads I hospital 
running costs. 
Nine different approaches to estimating and apportioning costs were 
identified from the review (Section 3.9.11 ). These included direct 
measurement of costs at the patient level and the use of activities of 
care, and apportionment mechanisms that covered days by level I grade 
of care, use of dependency points, use ofTISS points4 and finally, use 
of the number of patient days, beds and patients. 
The 26 studies were assessed for quality, using a set of criteria 
developed specifically for critical care cost studies by Burchardi et al., 
(2001) (Section 3.12). The advantages and disadvantages of each ofthe 
different studies were highlighted (Section 3.13). The Chapter 
concluded with the knowledge that one method- the cost block 
method could be used in the multi-centre study (Chapter 4). 
3.2 Formation of the review advisory group 
An advisory group was formed in 2001 and guided the review. Links 
were also established with representatives from the Cochrane 
I 
4 TISS stands for the Therapeutic Intervention Scoring System and lists 76 conunonly performed interventions 
that can be scored on a daily basis to reflect the care needs of individual patients. 
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Collaboration and other researchers who were willing to provide 
supp~rt in areas of expertise that were not readily available (see / 
Acknowledgements). The advisory group met before the review 
commenced to discuss the scope and orientation [of the review] and 
help refine the specific questions that the review would address . 
. Membership of this group consisted of the following individuals: 
• John Brazier (Professor of Health Economics, Health 
Economics & Decision Science Section, School of Health 
and Related Research, University of Sheffield); 
• Mike Camp bell (Professor of Statistics, Department of 
General Practice, School of Health and Related Research, 
University of Sheffield); 
• Nigel Coad (Consultant in Critical Care at the Northern 
General Hospital, Sheffield Teaching Hospitals NHS 
Trust); 
• Miranda Mugford (Professor of Health Economics, School 
of Health Policy and Practice, University of East Anglia); 
and 
• Jon Nicholl (Professor of Health Services Research, Health 
Services Research Section, School of Health and Related 
Research, University of Sheffield). 
3.3 Checks for existing or ongoing reviews 
Prior to performing the systematic review, it was important to ascertain 
that no such reviews had already been undertaken. Given that the best 
single source of systematic reviews was deemed to be the Cochrane 
Library, this was the first database that was searched. The databases 
searched differed in terms of their indexing terms and literature 
coverage (Appendix 3.1). 
Table 3.1 describes the searches undertaken and the number of 
abstracts retrieved. 
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Search 
Number 
#1 
#2 
#3 
#4 
#5 
Table 3. 1: Description of searches undertaken and the 
number of abstracts retrieved (checks for existing reviews) 
Database 
NHS Centre for Reviews and 
Dissemination databases (DARE, 
NHS EED, HTA) 
Office of Health Economics 
Em base 
Medii ne 
National Research Register and 
Project Database 
Number of 
abstracts 
retrieved 
182 
44 
768 
68 
326 
Number of 
abstracts Initially 
rejected that were 
outside of the 
subject area (%) 
57 (31%) 
26 (59%) 
701 (91%) 
57 (84%) 
326 (100%) 
From undertaking these searches and reading all of the abstracts 
identified, it became clear that one review of costs and methods had 
already been published ( Gyldmark, 1995). 
3.3.1 Identification of the review by Gyldmark (1995) 
The review by Gyldmark ( 1995) had a broad aim; that of studying 
methods for costing critical care services. The author had performed a 
MEDLINE search of the international literature and identified 20 
English-language adult critical care cost studies published between 
1977 and 1994. Studies were selected on the basis that they: 
• Were published in English; AND 
• Described ICU costs; AND 
• Described in detail the methods used for calculating costs; 
AND 
• Costs per patient or per severity score could be derived 
from the study. 
Costs per patient were reported and a significant variation in these 
observed. The author looked for appropriate papers by searching 
MED LINE, however did not state which other bibliographic databases 
or search strategies were used and this has prevented updates or 
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additions to the review. The reference lists of the twenty papers 
identi~ed were not followed-up and Non-English language paper~were 
excluded. 
A cost-to-charge index was used to convert the charges reported in 
some studies into costs. Although acknowledged that this 
• transformation into costs was 'not very transparent', it may have been 
more appropriate to isolate those studies that reported costs from those 
reporting charges. The inclusion of different cost components was 
described in detail, however not enough was done to assess the rigour 
of the individual studies included. 
Possible reasons for the considerable variation in costs observed from 
the papers studied were given as; advances in technology, differences 
in patients' severity of illness, age? diagnoses and other characteristics 
and unit characteristics namely unit size, staffing, admission criteria, 
treatment policies and research and training activities. These were 
mooted by the author but were not substantiated by the evidence 
presented. 
A systematic review of the literature was required for this thesis to 
summarise and appraise those costing methods developed since the 
publication of this review in 1995 and as already alluded to, to identify 
a method with which daily costs of critical care patients could be 
estimated and that which could be employed across a number of 
different critical care units.-
3.4 Scope of literature in field 
It was important to assess the volume of literature in the field before 
proceeding with the full review (to ensure that an adequate quantity of 
papers existed). The search strategies (described in Appendix 3.1) were 
focused towards identifying systematic reviews and not cost studies so 
additional searches were performed. 
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Information about search terms gathered in the preliminary search for 
existing reviews was used to inform the design of the search strategies 
for the proceeding systematic review. 
Use of specific economic and other search filters (mostly written for 
MED LINE) was not extensive, as they tend not to provide the most 
accurate indication of the actual volume of the literature available, 
because of their low recall. For this reason, the search strategies were 
kept relatively broad with limits to 'Intensive Care' and 'Critical Care'. 
The problem with this however, was that despite having high 
sensitivity (i.e. ability to identify relevant articles), use of broad search 
terms also produced low specificity. This meant that a number of 
irrelevant articles were also identified and these had to be removed 
manually. Unlike reviews of effectiveness, the difficulty with reviews 
of methodology mean that it is not possible to search using design 
filters such as 'RCT' etc., so as to exclude irrelevant or inappropriate 
papers. All types of potentially relevant studies had to be included in 
case valuable details were missed. 
The abstracts already identified through the process of identifying an 
existing review were complimented by additional searches of 
MED LINE, EMBASE, the Health Management Information 
Consortium (HMIC) database, the Social Sciences Citation Index 
(SSCI) (1981-August 2001), the Science Citation Index Expanded 
(SCI-EXPANDED) (1981-August 2001), EconLit (1969-August 2001) 
and the Royal College ofNursing (RCN) Journals database (1985-
1996) (Appendix 3.2). 
Table 3.2 describes the searches undertaken together with the number 
of abstracts retrieved. Of the 2,105 abstracts identified, 885 ( 42%) were 
considered relevant. A total sample of 665 abstracts remained after 
duplicate references were removed. 
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Search 
Number 
#6 
#7 
#8 
#9 
#10 
#11 
#12 
#13 
#14 
#15 
#16 
Table 3.2: Description of searches undertaken and the 
number of abstracts retrieved (scope of literature I full 
review) /' 
Database Search terms Number Number of 
of abstracts 
abstract initially 
s rejected that 
retrieved were outside 
of the subject 
area 
1 
Medii ne Critical Care AND Health Care Costs (MeSH 188 52 (27%) 
terms} NOT editorial NOT letter 
2 
Exp Critical care/ AND exp •costs and cost 655 385 (59%) 
analysis"/ NOT editorial.pt NOT letter.pt 
1 
Em base Explode 'intensive-care' fall subheadings 33 11 (33%) 
AND explode 'economic-aspect' AND 
explode 'cost-'/all subheadings NOT editorial 
in dt NOT letter in dt AND 'resource-
allocation'/all subheadings 
1 
HMIC Intensive care AND cost AND resource* 34 14 {41%} 
2 
Critical care AND cost* 37 25 {68%} 
3 
Intensive care AND cost 145 66 (45%) 
Social 1 
Sciences Intensive Care AND Cost* (all document 226 144 (64%) 
Citation types) 
Index 
2 
Intensive Care AND Resource* (all 498 422 (85%) 
document ~Qes} 
Science (Intensive Care OR Critical Care) AND Cost* 246 76 (31%) 
Citation (title only) 
Index-
Ex~anded 
Royal Cost* AND (Critical Care OR Intensive Care) 34 21 (62%) 
College of 
Nursing 
Journals 
Database 
Econllt Intensive Care AND Cost* 9 4 (44%) 
The overlap between the different search strategies is shown in Table 
3.3. 
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Table 3.3: Overlap of articles considered relevant using the different search strategies (full review) 
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3.5 Methods used for the screening of abstracts 
The aim of the systematic searches was to provide a list of primary 
studies that met the inclusion criteria for the review - a list that was as 
comprehensive as feasible, and as unbiased as possible. The inclusion 
criteria used to identify the 665 potentially useful articles was 
subjective and a very forgiving standard was used to retain as many 
potentially relevant studies as possible. 
In order that this large number could be reduced to a more manageable 
quantity, objective screening criteria were developed and applied. The 
full papers relating to the abstracts were obtained if they met one or 
more of the following content criteria. 
3.5.1/nc/usion criteria for abstract screening 
For inclusion, the abstract needed to describe the actual costs incurred I 
projected of either: 
• The critical care unit(s) as a service; AND/OR 
• Patients treated in the adult general critical care unit; 
AND/OR 
• Treatments offered I provided within the adult general 
setting; AND 
• Describe, or appear as though it would describe in the full 
article, the methodology used for estimating these costs. 
3. 5. 2 Exclusion criteria for abstract screening 
Abstracts were excluded if they: 
• Described charges NOT costs; AND/OR 
• Described a methodology for determining charges NOT 
costs. 
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The above criteria were thought sufficiently robust to identify suitable 
studies. Screening forms were produced and each of the 665 abstracts 
. / 
identified were screened. Most of the abstracts that presented in the 
form of a letter or editorial had already been excluded through 
electronic means and hand sifting. No language restrictions were 
enforced at this stage. 
3.6 Results from abstract screening 
Figure 3.1 illustrate how many of the abstracts screened were relevant 
(57%) and of those, the numbers included in the final review (n=376). 
3. 7 Selection of relevant papers 
The full papers for 365 of the 376 references (97%) were obtained. It 
was not possible to obtain 11 papers. Of the 365, 31 papers (8.5%) 
required translation into English. Unfortunately, there were insufficient 
resources to cover translation costs, so these were excluded. A further 
process of screening the 334 papers was undertaken to eliminate any 
irrelevant articles before proceeding with the task of data extraction. 
This was done using the expanded inclusion I exclusion criteria 
described as follows: 
3. 7. 1 Inclusion criteria for the review 
For inclusion in the review, the article had to meet the following 
criteria: 
• Provide a detailed description of the methods used for 
calculating the daily costs of critical care patients. Note that 
the resultant costs had to be reported following a 
description of the methods used, so as to exclude studies 
that were theoretically as opposed to empirically grounded; 
AND 
• Describe adult patients receiving critical care. Adult 
patients were defined as those~ 16 years of age. 
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3. 7.2 Exclusion criteria for the review 
It was important to exclude studies reporting charges or methods of 
charging since these bear little resemblance to the costs of care. 
Furthermore, there is a large body of literature discussing the costs of 
adult critical care without any discussion of methods. It was felt 
important to exclude these types of studies as well. 
The formal exclusion criteria were as follows: 
A study was excluded if it: 
• Was written in the form of an editorial, letter, post-graduate 
degree thesis or conference abstracts; AND/OR 
• Described a method for estimating charges; AND/OR 
• Reported the results of studies looking at resource use e.g. 
use of drug products NOT methods for estimating the costs 
of the resources used; AND/OR 
• Reported partial components of critical care costs (e.g. 
nursing and drug costs) but not the full costs of a day of 
critical care unit stay; AND/OR 
• Reported expenditures of a critical care unit without any 
apportionment to a patient-level cost ; AND/OR 
• Described a method of workload measurement without any 
empirical validation I results; AND/OR 
• Reported costs but gave no details of the costing method; 
AND/OR 
• Studied non-critical care unit patients; AND/OR 
• Studied paediatric or neonatal critical care patients. 
After the exclusion criteria had been applied, 20 papers remained (6%). 
Following updated electronic searches ofMedline performed in 
S Conference abstracts were initially obtained however it became clear that due to the word restrictions, there 
was insufficient detail given on the costing methods to merit their inclusion in the review. 
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September 2006, 6 additional papers were identified and included in 
the review. 
3. 7.3 Bibliographic Details Of Papers That Met The Inclusion 
Criteria 
The bibliographic references of those papers selected for the review are 
listed in Appendix 3.3. 
3.8 Data Extraction 
Descriptive summary information relating to each study was extracted 
(Table 3.4). 
• Aim of Study; 
• Number of Patients (P); 
• Number of Centres (C); 
• City I Country where study was performed; 
• Method used for measuring care (i.e. name of data base or 
scoring system); 
• Coverage of included costs (i.e. types of cost covered by the 
method); and 
• Coverage of excluded costs (i.e. types of cost excluded by the 
method). 
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Table 3.4: Summary of included studies 
Study (Year) Aim of study N(P• City I Country Method Used For Coverage of costs: Coverage of costs: Excluded 
Patients, where study was Measuring Care Included 
C=Centresl performed 
Slatyer et al., To estimate the direct costs of intensive P=100 New South Wales, Not stated Direct dinical costs e.g. Capital equipment 
(1986) care and to define the relationship C=1 Australia nurses' time, salaried 
between direct cost. severity of Hlness and medical staff time, 
outcome. consultant medical staff 
time, diagnostic tests, 
disposables, drugs, 
intravenous fluids, 
physiotherapy, oxygen, 
li htand r. 
Lilies et al., To investigate the costs and benefits of P=961 Oslo, Norway Computerized Salaried costs, medical No details provided 
(1987) intensive care C=1 registration system supplies, technical 
equipment and other 
nses 
Gilbertsoriet To estimate the costs of intensiVe care P=156 Liverpool, UK Tick charts were AIIICU procedures, drugs, Emergency investigations 
al., (1991) patients C=1 used to collect data disposables, equipment, performed outside the ICU's 
that was then laboratory and radiology own laboratory 
entered into a services, physiotherapy, 
database nudear medicine, salaried 
costs, pharmacy, hospital 
administration, laundry, 
Byrick et al., To characterize the ICU patient population P=58 Ontario, 
light, stationa!:Y:. records 
TISS data Medical staff costs, drugs No details provided 
(1980) using TISS and to estimate the C=1 Canada and disposables, 
effectiveness and cost of care respiratory therapy 
supplies, nursing staff 
costs, housekeeping costs, 
respiratory technicians 
salaries. 
Parikh & To study the quality, cost, and benefits of P=993 Bombay, India FoxPro database Infrastructure, wages, No details provided 
Kamad intensive care C=1 application equipment, disposable 
(1999) (ICUREX, Medirex items, drugs, laboratory 
Corporation, tests, microbiology, blood 
Bombay) bank, radiology, 
ultrasonography, 
stationary, administration 
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Study (Year) 
Sznajder et 
al., (2001) 
Noseworthy 
et al., (1996) 
Malstam & 
Und (1992) 
Chaix et al., 
(1999) 
Doyle et al., 
(1996) 
Aim of study 
To evaluate patient outcome and the 
efficiency of stays in intensive care units 
To cost adult intensive care by 
determining inputs to production, resource 
consumption per patient. and total cost per 
intensive care unit stay 
To measure the workload generated by 
intensive care patients, to describe a way 
of determining whether ICU resources are 
optimally utilized and to estimate the costs 
of each TISS-point 
To identify, among the information 
routinely collected on patients in intensive 
care units, data that determine the total 
cost for a given patient 
To apply an activity-based costing 
methodology to determine the full cost of 
intensive care service at a community 
hospital, a university hospital and a health 
maintenance organisation (HMO)-affiliated 
hospital 
N (P • City I Country 
Patients, where study was 
C=Centres) perfonned 
P=211 Paris, France 
C=7 
P=690 Alberta, 
C=1 Canada 
P-2,693 Gi:lvle, Sweden 
C=1 
P=73+29 Paris, France 
(validation 
sample) 
C=1 
C-5 Texas, 
Pennsylvania, 
Orlando, USA 
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Method Used For 
Measuring Care 
CubRea 
Not stated 
Modified TISS data 
Retrospective 
review of medical 
records and 
existing 
computerised 
data bases 
Not stated 
Coverage of costs: 
Included 
Drugs, disposables, blood • 
products, procedures, 
nursing costs, auxiliary 
nursing costs, medical 
staff, head nurses, 
overheads (heating, 
lighting, hostelry, cleaning, 
administration, 
management and building 
amortization 
Nursing staff, medical staff, 
professional and support 
staff, laboratory, diagnostic 
imaging, supplies, drugs 
and equipment. 
Salaried costs, medicines, 
expendable supplies and 
investments in new 
techniques and apparatus 
Supplies, pharmacy and 
blood products and tests 
Personnel costs including 
non-physician clinical 
salaries and physician 
salaries and fees (including 
interns and residents). All 
nursing staff and other 
clinical personnel including 
technicians, respiratory 
therapists and 
physiotherapists. Capital 
equipment. 
Coverage of costs: Excluded 
No details provided 
Operative interventions, hospital 
administration, heating and 
lighting 
Fixed costs (not described) 
Ambulatory care and production 
costs 
Medical and non-medical 
salaries 
Social charges 
Overheads 
Other fixed costs (not 
described) 
No details provided 
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Study (Year) Aim of study N(P• City I Country Method Used For Coverage of costs: Coverage of costs: Excluded 
Patients, where study was Measuring Care Included 
c-centresl performed 
Kort<ella et To assess (1) the long-term outcome of P=62 Kuopio, Finland TISS No details provided No details provided 
al., (2000) patients requiring renal replacement C=1 
therapy in terms of 6-month and 5-year 
mortality, (2) quality of life and (3) costs of 
the intensive care. 
Edbrooke et To develop a costing method which C=11 UK Not applicable Capital equipment, estates, No details provided 
al., (1999) incorporated the major components of non-clinical support 
resource use and to test the application of services, clinical support 
such a method in a number of intensive services, consumables and 
care units staff 
Ridley et al., To cost daily ICU treatment on an C=1 Norfolk, UK Dependency points Fixed costs (capital costs, No details provided 
(1991) individual patient basis and to refine the P=20 purchase and maintenance 
method for use in a larger study of equipment and buildings 
and the supporting 
services such as portering 
and administration. 
Land opportunity cost, 
administration, utilities). 
Semi-fixed costs (nursing 
staff, medical staff) 
Marginal costs (type of 
ventilatory support, number 
and type of invasive lines, 
surgical procedures carried 
out in ICU or theatres, 
investigations performed, 
drug doses and fluids, 
laboratory services, 
disposable items, 
haematological services, 
blood products). 
Sznajderet To propose an instrument able to estimate P=121 Paris, France Omega Scoring Medical costs: drugs, blood Fixed direct costs: salaries of 
al., (1998) the direct costs of stays in intensive care C=18 System and ICU products, supplies, tests physicians, head nurses and 
regional database and procedures, secretaries, hostelry and 
equipment overheads 
Staff costs: nursing and 
auxiliary nursing costs 
75 
Study (Year) 
Edbrooke et 
al., (1997) 
Halpem et 
at., (1994) 
Aim of study 
A new method of accurately identifying 
costs of individual patients in intensive 
care: the initial results. 
To establish Department of Veteran 
Affairs' intensive care unit costs from a 
database and to use this information to 
validate the Russell equations, the most 
commonly used method of calculating ICU 
costs. 
N (P = City I Country 
Patients, where study was 
C=Centres) performed 
P=68 Sheffield, UK 
C=1 
P=Not reported USA 
C=Not reported 
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Method Used For 
Measuring Care 
Sheffield Health 
Care Costing 
System 
Department of 
Veterans Affairs' 
cost database 
Coverage of costs: 
Included 
Patient-related costs: 
Drugs, fluids, 
consumables, needles, 
catheters, equipment 
usage, laboratory services, 
medical imagining 
services, nursing time 
delivering patient care, 
medical time delivering 
patient care. 
Non-patient-related costs: 
Energy, heating, building 
maintenance, engineering 
maintenance, capital 
charges, portering 
services, cleaning and 
laundry rates, estates, 
nursing time not delivering 
patient care, medical time 
not delivering patient care. 
Direct costs: 
ICU personnel 
Clinical service costs 
Supplies, pharmacy costs 
Indirect costs: 
ICU portion of general 
hospital expenses, such as 
engineering, building 
management and capital 
depreciation. 
Coverage of costs: Excluded 
No details provided • 
No details provided 
\ 
Study (Year) 
Holt et at., 
(1994) 
Shiell et al., 
(1990) 
Griffiths et 
al., (1997) 
Dickie et al., 
(1998) 
Aim of study 
To present an intensive care episode 
costing methodology using the example of 
a cost-benefit analysis of mask CPAP for 
severe cardlogenic pulmonary oedema 
(CPO) 
To test the feasibility and value of an 
economic appraisal of intensive care. 
To test whether a glutaminEH:Ontaining 
parenteral nutrition (PN) compared with an 
isonitrogenous, isoenergetic control feed 
would influence outcome. 
To determine whether the therapeutic 
intervention scoring system (TISS) reliably 
reflects the cost of the overall intensive 
care unit population, subgroups of that 
population and individuaiiCU patients 
N (P • City I Country 
Patients, where study was 
c-centres} pertonned 
P=39 Adelaide, South 
C=1 Australia 
P=100 
C=2 
P=84 
C=1 
P=257 
C=1 
Merseyside, UK 
Essex, UK 
Liverpool, UK 
London, UK 
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Method Used for 
Measuring Care 
Not stated 
Not stated 
TISS 
TISS 
Coverage of costs: 
Included 
Nursing salaries and 
wages, medical salaries 
and wages, drug supplies, 
medical and surgical 
consumables, clerical 
salaries, linen, domestic 
supplies, stationery and 
equipment maintenance, 
allied health departments, 
pathology, radiology, 
hospital overhead costs 
Medical staff, nursing staff, 
ancillary and technical 
staff, use of major 
disposable items, drugs, 
diagnostic tests and 
procedures. 
Medical staff, nursing staff, 
drugs and consumables 
Nursing costs, 
disposables, drugs I i.v. 
fluids, enteral nutrition, 
parenteral nutrition, hired 
beds, haemofiltration, 
blood products, linen, 
physiotherapy, pathology 
and microbiology tests, 
radiology I 
echocardiography I 
neurophysiology I medical 
physics, ICU share of 
central hospital costs, ICU 
medical staff salary costs, 
non-pay items and 
equipment charged to ICU, 
ICU administration salary 
costs, ICU technicians 
salary costs. 
Coverage of costs: Excluded 
No details provided 
Capital costs, overheads, costs 
of subsequent hospital stays, 
outpatient attendances and 
visits to General Practitioners. 
No details provided 
No details provided 
Study (Year) 
Parviainen et 
at., (2004) 
Graf et at., 
(2005) 
Aim of study 
To evaluate changes of the patient 
characteristics and costs of intensive care 
over 5 years. 
To assess the five-year survival of a 
prospectively studied cohort of medical 
ICU patients, to evaluate the health-
related quality of life of all long-term 
survivors, and to perform cost-
effectiveness and cost-utility analysis on 
the basis of individual patient costs. 
N (P "' City I Country 
Patients, where study was 
C=Centres) performed 
P = 11,323 Kuopio, Finland 
C= 1 
P=303 
C= 1 
Aachen, Germany 
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Method Used For 
Measuring Care 
TISS 
The simplified 
Therapeutic 
Intervention 
Scoring System 
(TISS-28) 
Coverage of costs: 
Included 
All salaries, materials, full 
allocation of step-down 
costs (e.g. administration, 
depreciation, rents) and all 
secondary costs 
(laboratory, imaging, 
consultations, etcl). In 
addition, total costs over 
four different cost blocks 
wre shared and changes 
evaluated. The cost-block 
staff included both medical 
and nursing staff. 
Consumables included 
drugs, fluids and nutrition, 
blood and blood products 
and disposables. Clinical 
support services 
represented physiotherapy, 
laboratory services, 
radiology and consultations 
from other departments. 
Other included equipment, 
estates and non-clinical 
support. 
Clinical chemistry, 
radiology, dialysis, high-
price interventions such as 
intraaortic balloon 
counterpulsation, coronary 
angiography and 
percutaneous coronary 
intervention; staff salaries 
(nurses and physicians), 
overheads such as energy, 
heating, maintenance and 
administrative costs. 
Coverage of costs: Excluded 
Use of the operating theatre. 
No details provided 
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Study (Year) Aim of study N(P= City I Country Method Used For Coverage of costs: Coverage of costs: Excluded 
Patients, where study was Measuring Care Included 
c-centres! performed 
Grafetal., To evaluate the admission practice to a P=303 Aachen, Gennany The simplified Clinical· chemistry, No details provided 
(2002) medlcaiiCU utilising TISS-28, i.e. C=1 Therapeutic radiology, dialysis, high-
retrospectively to Identify all patients that Intervention price interventions such as 
did or did not require intensive care Scoring System intraaortic balloon 
services by means of active therapy. (TISS-28) counterpulsation, coronary 
Furthennore, to analyse expenditure for angiography and 
patients receiving active treatment and percutaneous coronary 
non-active treatment and the association intervention; staff salaries 
of severity of illness and ICU costs in order (nurses and physidans), 
to Identify cost-generating factors. overheads such as energy, 
heating, maintenance and 
administrative costs. 
Flaatten & To document costs of intensive care in a p = 1,051 Bergen, Norway Nine equivalent Staff wages (nurses and No details provided 
KvMe (2003) Norwegian University Hospital and to C= 1 manpower use physidans), all 
perform an average cost-effectiveness score. consumables induding 
study using the expected remaining life- drugs and infusions, the 
years in survivors after 18 months. costs of capital equipment 
and the costs of estates 
(deaning, electridty, 
infonnation technology 
services, laundry and 
uniforms, administration, 
security and intemal 
transport (ICU area in the 
hospital). Indirect costs 
were also induded (e.g. 
procedures such as 
laboratory analysis, blood 
bank services, x-ray 
services, physiotherapy, 
visits by consultants 
outside the ICU and the 
use of operating theatres. 
Moran et al., To assess the ability of proxy cost p = 1,333 Woodville, South TISS,Omega Drugs, procedures, Nursing time spent on 
(2004) measures, TISS and Omega scores and, C=3 Australia scores pathology costs, radiology, educational activities 
in particular, cumulative daily severity of physiotherapy, nursing 
illness scores and ventilation days, to staff, medical staff, 
predict Individual patient costs, derived overheads, other (e.g. 
from a "ground-up• utilization study. administration, repairs and 
maintenance, orderlies 
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Rechner & 
Lipman 
(2005) 
To investigate cost per occupied bed day 
In a tertiary ICU and to document cost 
drivers. 
p = 1,615 
C=1 
Brisbane, Australia 
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salaries and wages, linen 
and domestic supplies) 
Staff, consumables, clinical 
support services, capital 
equipment, top ten drugs .• 
Excluded were the costs 
Incurred for consultations from 
visiting medical teams and the 
resources used when patients 
went to the operating theatre. In 
addition, no blood products are 
paid for by the ICU, but are 
instead centrally funded through 
the Australian Red Cross. Allied 
health specialities and hospital 
overheads such as 
infrastructure were excluded, as 
were the costs that were 
incurred in the emergency 
department and other wards 
when the patient was first 
admitted. 
\ 
More detailed extraction of these data allowed the studies to be further 
classified by design, method of cost estimation, unit of output~· 
measurement and the cost components included in each study. 
• Publication Year: 1980-1983; 1984-1987; 1988-1991; 
1992-1995; 1996-1999;2000-2003;2004-2006; 
• Country of Origin: 
• Number of Critical Care Units: 1; ~ 2 ~ 5; ~ 6 ~ 10; ~ 
11; Not known; 
• Number of Critical Care Patients:~ 1 ~ 100; ~ 101 ~ 
200; ~ 201 ~ 300; ~ 301; Not known; 
• Design: Single Centre I Multi-Centre Study; 
• Method of Cost Estimation: Direct measurement at the 
patient level; apportioned measurement at the unit level; not 
known; 
• Type of Cost Reported: Average cost per day (24hr 
period); Actual cost per day (24hr period); Average cost per 
patient (admission); Actual cost per patient (admission); 
Total cost per patient (admission) derived from average cost 
per day x actual LOS; total cost per patient (admission) 
derived from cost per Therapeutic Intervention Scoring 
System (TISS) point x cumulative number ofTISS points; 
cost per patient day derived from (cost per TISS point x 
cumulative number ofTISS points)+ patients' length of 
stay; 
• Cost Components Included: These were sub-divided 
into Staffing Costs (nursing staff, consultant medical staff, 
junior medical staff, physiotherapy, pharmacy staff, 
respiratory technicians, dieticians), Treatment-Related 
Costs (diagnostic tests, drugs and fluids, disposable 
equipment, blood and blood products, nutrition, capital 
equipment, surgery I invasive procedures) and Overheads I 
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Hospital Running Costs (oxygen, light and power, 
institutional overhead costs; Paper not amenable to 
extraction6); and 
Methods of apportioning costs: These were categorised by: 
direct measurement, activities of care, days by level I grade of 
care, dependency points, TISS, number of patient days, number 
of critical care beds and the number of patients. 
3.9 Results 
· The descriptive characteristics of each study were summarized under 
the following sub-headings: 
3.9.1 Year of publication 
The review included studies published from 1980 up until2005. The 
most prolific period yielding the highest number of publications was 
between 1996 and 1999 (Table 3.5). 
6 The category 'paper not amenable to extraction' represented papers where insufficient details relating to the 
cost components included prevented data extraction (on these cost components) from taking place. 
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Table 3.5: Year of publication 
Study Year of Publication 
1984-1987 
Slatyer et al., (1986) 0 
L0es et al., (1987) 0 
Gilbertson et al., 0 (1991) 
Byrick et al., (1980) 0 
Parikh & Karnad 0 
(1999) 
Sznajder et al. , 0 
(2001) 
Noseworthy et al., 0 (1996) 
Mt:!lstam & Lind 0 (1992) 
Chaix et al., (1999) 0 
Doyle et al., (1996) 0 
Korkeila et al., 0 
(2000) 
Edbrooke et al. , 0 
(1999) 
Ridley et al., (1991) 0 
Sznajder et al. , 0 (1998) 
Edbrooke et al., 0 
(1997) 
Halpern et al., 0 (1994) 
Holt et al .. (1994) 0 
Shiell et al., (1990) 0 
Griffiths et al., 0 
(1997) . 
Dickie et al., (1998) 0 
,_ 
Parviainen et al., 0 
(2004) ~ .' . ' 
Graf et al., (2005) 
... ~ff,' 0 
Graf et al., (2002) .. ':. ·.~:: .~. .. ' .· 0 ';-
Flaatten & Kvale 
f'.o '~:~ :."~~F:·~ ... , . 0 (2003) '. ·.· 
Moran et al., (2004) 
' ·.t. 
. ' 
·, 0 
Rechner & Lipman 
·' 0 (2005) 
Total(%) 1 (3.8o/o) 2 (7.7%) 4 (15.4%) 3 (11 .5o/o) 8 (30.8%) 4 4 (15.4%) 
(15.4%) 
Key: 0 =Yes 
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3. 9. 2 Country of origin 
The highest proportion of studies included in the review originated 
from the UK followed by France. The 16 remaining studies were 
spread over the 8 other countries (Table 3.6). 
Table 3.6: Country of origin 
Study Country of Origin 
UK Canada USA Australia Finland France Sweden Norway 
Slatyer et al., (1986) 0 
L0es et al. , (1987) 0 
Gilbertson et al., (1991) 0 
Byrick et al., (1980) 0 
Parikh & Karnad (1999) 
Sznajder et al., (2001) 0 
Noseworthy et al., (1996) 0 
Mlllstam & Lind (1992) 0 
Chaix et al. , (1999) 0 
Doyle et al., (1996) 0 
Korkeila et al., (2000) 0 ... 
Edbrooke et al., (1999) 0 
Ridley et al., (1991) 0 
Sznajder et al., (1998) 0 
Edbrooke et al. , (1997) 0 
Halpern et al., (1994) 0 .. 
Halt et al., (1994) 0 
· .. 
Shiell et al., (1990) 0 •:. ·,,: 
Griffiths et al., (1997) 0 
" 
Dickie et al., (1998) 0 :I··. I .I 
... 
. 
Parviainen et al .. (2004) I · , 0 1•.'.·:: .• -.- • . ·-:: . ' ,:;~-
India 
0 
I · 
·. 
.. 
> 
p;;-
r:; 
Graf et al., (2005) •, : ; ., )' . 
.·' h , .. 
Graf et al., (2002) ,. ; .· .. '~; . ': 
Flaatten & Kvfl le (2003) I · .-
. ·· 
.,. ·.- . 0 :; . 
Moran et al., (2004) 0 F ·''' , ... ... 
Rechner & Lipman (2005) 0 I · . ' : 
Total(%) 7 2 (7.7°/e) 2 4 2 (7.7%) 3 1 (3.8%) 2 (7.7"/o) 1 
(26. (7.7%) (15.4%) (11 .5 (3.8% 
9"/o) (%) %) ) 
Key: 0 =Yes 
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Germ 
any 
,, 
·.:' 
0 
0 
.,_. 
·' 
·' 
2 
(7.7"/o 
) 
3.9.3 Number of Critical Care Units 
Most of the identified studies were conducted in a single critical care 
unit. There were only 2 studies with 11 or more critical care units 
included (Edbrooke et al., 1999 & Sznajder et al., 1998). It was not 
possible to determine in one study how many critical care units had 
been included (Halpem et al., 1994) (Table 3. 7). 
3. 9.4 Number of Critical Care Patients 
There were 10 studies with large samples(;;:: 301 patients). It was not 
possible to elucidate the size of the sample used in the study by 
Halpem et al., (1994) (Table 3.7). 
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Table 3. 7: Number of Centres I Patients 
Study Number of critical care units Number of critical care patients 
1 ~ 2 ~ 5 ~ 6 ~ 10 ~ 11 Not known I ~ 1 ~ 100 ~ 101 ~ 200 ~ 201 ~ 300 ~ 301 Not known I 
NA NA 
Slatyer et al., (1986) 0 0 
L0es et al., (1987) 0 0 
Gilbertson et al., (1991) 0 0 
Byrick et al., (1980) 0 0 
Parikh & Karnad (1999) 0 0 
Sznajder et al., (2001) 0 0 
' 
Noseworthy et al., (1996) 0 0 
Millstam & Lind (1992) 0 0 
Chaix et al., (1999) 0 0 
Doyle et al., (1996) 0 0 
Korkeila et al., (2000) 0 0 
Edbrooke et al., (1999) 0 0 
Ridley et al., (1991) 0 0 
Sznajder et al., (1998) 0 0 
Edbrooke et al., (1997) 0 0 
Halpern et al., (1994) 0 0 
Holt et al., (1994) 0 I 0 
Shiell eta/., (1990) 0 0 
Griffiths et al., (1997) 0 0 
Dickie et al., (1998) 0 .. .• 0 
.. ... 
Parviainen et al., (2004) 0 '." ~. . 0 
• ;.r-·-
" ' 
· .. 
Graf et al., (2005) 0 .·:!; ·.•• ::.' ,· 
.. 
.... ;·1 • 
..· ... J '• '·" ... 0 
Graf et al., (2002) 0 ... 0 •'-Jr··~ ··-.. ·· ., -: 
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Flaatten & Kvi le (2003) 0 0 
Moran et al., (2004) 0 0 
Rechner & Lipman (2005) 0 0 
. ". 
Total(%) 19 3 (11.5%) 1 (3.8%) 2 (7.7%) 1 (3.8%) 9 (34.6%) 2 (7.7%) 2 (7.7%) 10 (38.5%) 3(11.5%) 
(73.1%) 
-- ----
L___ _____ _ -
Key: 
0 =Yes 
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3.9.5 Methods of cost estimation 
As far as the methods of cost estimation were concerned, these were 
not mutually exclusive in all instances. There was some overlap 
between direct measurement at the patient level and apportioned 
measurement at the (critical care) unit level in 4 studies (Gilbertson et 
al., 1991; Sznajder et al., 2001; Noseworthy et al., 1996 & Moran et 
al., 2004). A slightly higher number of studies was performed at the 
critical care unit level (Table 3.8). 
3.9.6 Type of cost reported 
Eleven of the 26 studies identified estimated total costs per patient. One 
additional study estimated average total costs per patient, but these 
estimates assumed an equal use of resources per patient (Sznajder et 
al., ( 1998). Three studies estimated total patient costs by multiplying 
an average cost per day by patients' length of stay (Lees et al., 1987; 
Byrick et al., 1980 & Flaatten & Kvale (2003). Two studies calculated 
total patient costs by multiplying patients' cumulative TISS points by 
an estimated cost per TISS point (Parikh & Kamad, 1999 & Flaatten & 
Kvale (2003) (Table 3.8). 
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Table 3.8: Study design, methods of cost estimation and unit of output measurement 
Study Study Design Method(s) Of Cost Unit of Output Measurement 
Estimation 
Single Multi· Direct Apportioned Average Actual Average Actual Total cost Total cost per Cost per patient Not 
Centre centre measureme measureme cost per cost per total cost total cost per patient patient ~ derived from reported 
nt at the nt at the day(24h day(24h per per (admission) (admission) (cost per TISS 
patient level Unit level period) period) patient patient derived derived from point x 
(admissi (admissi from cost per TISS cumulative 
on) on) average pointx number of TISS 
cost per cumulative points) 7LOS day x actual number of TISS 
LOS points 
Slatyer et al., (1986) 0 0 0 0 
L0es et al. , (1987) 0 0 0 0 
Gilbertson eta/., (1991) 0 0 0 0 0 
Byrick et al., (1980) 0 
·' 
0 0 0 
Parikh & Kamad (1999) 0 0 0 0 
Sznajder et al., (2001) 0 0 0 0 
Noseworthy et al., (1996) 0 0 0 0 0 
Mlilstam & Lind (1992) 0 0 0 
Chaix et al., (1999) 0 0 0 
Doyle et al., (1996) 0 0 0 
Korkeila et al., (2000) 0 0 0 
Edbrooke et al., (1999) 0 0 0 ' 
Ridley et al., (1991) 0 0 0 0 
Sznajder et al. , (1998) 0 0 0 
Edbrooke et al., (1997) 0 0 0 0 
Halpem et al., (1994) 0 0 0 
Holt et al., (1994) 0 0 0 0 
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Study Study Design Method(s) Of Cost Unit of Output Measurement 
Estimation 
Single Multi- Direct Apportioned Average Actual Average Actual Total cost Total cost per Cost per patient Not 
Centre centre measure measureme cost per cost per total cost total cost per patient patient day derived from reported 
ment at nt at the day(24h day(24h per per (admission) (admission) (cost per TISS 
the Unit level period) period) patient patient derived derived from point x 
patient (admissi (admissi from cost per TISS cumulative 
level on) on) average point x number of TISS 
cost per cumulative points) 7LOS day x actual number of TISS 
LOS points 
Shiell et al., (1990) 0 0 0 0 
--
Griffiths et al., (1997) 0 0 0 
Dickie et al., (1998) 0 0 0 0 
.... 
Parviainen et al., (2004) 0 0 0 
Graf et al., (2005) 0 ., - ' 0 0 
Graf et al., (2002) 0 0 0 
Flaatten & Kv~le (2003) 
..... 0 . 0 0 0 
Moran et al., (2004) 0 0 0 
Rechner & Lipman (2005) 0 .. 0 0 
Total (0/o) 19 7 12 18 (69.2 6 7 1 (3.8%) 11 3 (11.5%) 7 (26.9%) 2(7.7%) 1 (3.8%) 
(73.1°/o) (26.9'1.) (46.2%) •t.) (23.1%) (26.9"/o) (42.3%) 
·- y 
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3. 9. 7 Cost components 
A common set of cost components was identified from the studies and 
data extracted on this basis. 
3. 9. 8 Cost components included: Staffing costs 
Nursing 
Twenty-three studies captured nursing costs. There were 2 studies 
where it was not clear whether nurses had been included in the cost 
estimates (Lees et al., 1987 & Malstam & Lind 1992). Only one study 
excluded nursing staff (Chaix et al., 1999) (Table 3.9). 
Consultant Medical Staff 
Most studies captured senior or consultant medical staff costs. There 
were 2 studies where it was not clear whether senior medical staff had 
been included in the cost estimates (Lees et al., 1987 & M~ilstam & 
Lind 1992). There were also 2 studies where senior medical staff costs 
had been excluded from the cost calculations (Chaix et al., 1999 & 
Sznajder et al., 1998) {Table 3.9). 
Junior Medical Staff 
A similar pattern was observed with the junior medical staff as with 
the senior medical staff, other than an additional exclusion of junior 
medical staff costs by Noseworthy et al., (1996) (Table 3.9). 
Physiotherapy 
Only 10 studies reported capturing physiotherapy costs. None of the 
remaining 16 studies explicitly excluded these costs but it was not clear 
from the remainder - with the exception of Rechner & Lipman (2005) 
and Moran et al., (2004) whether physiotherapy costs had been 
included or excluded from the cost calculations (Table 3.9). 
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Pharmacy Staff 
The term 'pharmacy staff' is open to misinterpretation. It can relate to 
either phannacists working in a central pharmacy department servicing 
the hospital (as a whole) or to designated clinical phannacists working 
exclusively for the critical care unit. It was not clear in 19 studies 
whether phannacy staff had been included in the cost calculations. 
None of the 6 studies where this was captured provided a clear 
definition of what was meant by 'phannacy staff' (Table 3.9). 
Respiratory Technicians 
Respiratory technicians attend to the equipment needs of ventilated 
patients. Five studies included these costs. It was not clear in 14 studies 
whether these costs had been included and two studies excluded these 
costs (Noseworthy et al .• 1996 & Rechner & Lipman, 2005) (Table 
3.9). 
Dieticians 
Dieticians attend to the nutritional needs of critically ill patients. They 
tend not to work exclusively for the critical care unit but service the 
hospital as a whole, making daily visits to the critical care unit to 
recommend appropriate feeds. Only six studies included the costs of 
dieticians (Table 3.9). 
Administrative Staff 
The term 'administrative staff refers to secretarial staff and 
administrative assistants working within the critical care unit -not 
hospital administrators i.e. managers. Eleven studies captured these 
costs. Whilst two studies excluded these costs (Sznajder et al .• 1998 & 
Rechner & Lipman, 2005), it was not clear from 13 studies whether 
these costs had been included {Table 3.9). 
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Table 3.9: Staffing Costs 
Study Nursing staff Consultant Junior medical Physiotherapy Pharmacy Staff Respiratory Dieticians Administrative 
Medical staff staff technicians staff 
Slatyer et al., (1986) 0 0 0 0 ? ? ? ? 
Lees et al., (1987) ? ? ? ? ? ? ? ? 
Gilbertson et al., (1991) 0 0 0 0 0 ? ? ? 
Byrick et al., (1980) 0 0 0 0 ? 0 ? ? 
Parikh & Kamad (1999) 0 0 0 ? ? ? ? ? 
Sznajder et al., (2001) 0 0 0 ? ? ? ? ? 
Noseworthy et al., (1996) 0 0 IBI 0 0 IBI 0 ? 
Malstam & Lind (1992) ? ? ? ? ? ? ? ? 
Chaix et al., (1999) IBI IBI IBI ? ? ? ? ? 
Doyle et al., (1996) 0 0 0 0 ? 0 ? 0 
Korkeila et al., (2000) 0 0 0 ? ? ? ? ? 
Edbrooke et al., (1999) 0 0 0 0 0 0 0 0 
Ridley et al., (1991) 0 0 0 ? ? ? ? 0 
Sznajder et al., (1998) 0 IBI IBI ? ? ? ? [El 
Edbrooke et al., (1997) 0 0 0 0 ? 0 0 0 
Halpem et al., (1994) 0 0 0 ? ? ? 0 0 
Holt et al., (1994) 0 0 0 ? 0 ? ? 0 
Shiell et al., (1990) 0 0 0 ? ? ? ? ? 
Griffiths et al., ( 1997) 0 0 0 ? ? ? ? ? 
Dickie et al., (1998) 0 0 0 0 0 0 0 0 
Parviainen et al., (2004) 0 0 0 0 0 ? 0 0 
Graf et al., (2005) 0 0 0 ? ? ? ? 0 
Graf et al., (2002) 0 0 0 ? ? ? ? 0 
Flaatten & KvAle (2003) 0 0 0 ? ? ? ? ? 
Moran et al., (2004) 0 0 IBI 0 ? ? ? 0 
Rechner & Upman (2005) 0 0 0 IB [El IBI IBI IBI 
Total(%} ~~(~~!·> 
-
22 (84.6%) 20 (76.9%) 
-
10 (38.5"/o) 6 (23.1"/o) 5 (19.2"/o) 6 (23.1%) 11 (42.3%) 
Key: 0 =Yes: IBI =No:?= Not clear 
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3.9.9 Cost components included: Treatment-related costs 
Diagnostic Tests 
The term 'diagnostic tests' typically includes laboratory services and 
radiology tests. These were included in 22 studies. It was not however 
clear from 4 studies whether these were included {Table 3.1 0). 
Drugs and Fluids I Disposable Equipment 
Drugs, fluids and disposable equipment were included in 22 studies 
with 4 studies not clarifying their inclusion I exclusion {Table 3.1 0). 
Blood and Blood Products 
A lower number of studies included blood and blood products. These 
were excluded in 2 studies (Slatyer et al., 1986 & Rechner & Lipman, 
2005), and it was not clear from 9 studies whether they had been 
included {Table 3.10). 
Nutrition 
Eleven studies included nutritional products. It was not clear from 15 
studies whether these costs had been included (Table 3.10). 
Capital Equipment Depreciation I Maintenance 
Fifteen studies included the costs of capital equipment. Three studies 
however excluded these costs (Slatyer et al., 1986; Sznajder et al., 
1998 & Shiell et al., 1990) {Table 3.10). 
Surgery or Invasive Procedures 
Only a very small number of studies included surgery or invasive 
procedures (Chaix et al., 1999; Ridley et al., 1991; Halpem et al., 
1994; Shiell et al., 1990; Flaatten & Kvale (2003) {Table 3.10). 
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Table 3.10: Treatment-related costs 
Study Diagnostic tests Drugs •nd fluids Biood•nd Nutrition Capital I Surgery or I 
&dlspouble blood products equipment lnvalve 
equipment depredation I proc:edUI'M 
IIUiinteMnee 
Slatyer et al., (1986) 0 0 li1 ~ lil ? 
Lees et al., (1987) ? ? ? ? ? ? 
Gilbertson et al., (1991) ~ 0 0 ? 0 ? 
Byrick et al., (1980) ? ~ ? 0 0 ? 
Parikh & Kamad (1999) 0 0 0 ? 0 ? 
Sznajder et al., (2001) 0 0 0 ? ? ? 
Noseworthy et al., (1996) 0 0 ? 0 0 ? 
Malstam & Und (1992) ? ? ? ? ? ? 
Chaix et al., (1999) 0 ~ 0 ? ? 0 
Doyle et al., (1996) ~ ? ? ? 0 ? 
Korkeila et al., (2000) 0 ? ? ? ? ? 
Edbrooke et al., (1999) 0 0 0 0 0 ? 
Ridley et al., (1991) 0 0 0 ? 0 0 
Sznajder et al., (1998) 0 0 ~ ? lil ? 
Edbrooke et al., (1997) 0 0 0 0 0 ? 
Halpem et al., (1994) 0 0 0 0 0 0 
Holt et al., (1994) 0 0 ? ? 0 ? 
Shiell et al., (1990) 0 0 ? ? lE 0 
Griffiths et al., (1997) ? 0 ? ? ? ? 
Dickie et al., (1998) 0 0 0 0 0 ? 
Parviainen et al., (2004) 0 0 0 0 0 lil 
Graf et al., (2005) 0 0 0 ? ? ? 
Graf et al., (2002) 0 0 0 ? ? ? 
Flaatten & KvAie (2003) 0 0 0 0 0 0 
Moran et al., (2004) 0 0 0 0 0 ? 
Reclmer & Upman (2005) 0 0 lil 0 0 lE 
Total(%) 22 (84.6%) 22 (84.6%) 15 (57.7%) 11 (42.3%) 15 (57.7%) 5 (19.2%) 
Key: ~ = Yes: 1!1 = No: ? = Not clear 
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3. 9. 10 Cost components included: Overheads I hospital 
running costs 
Oxygen I medical gases 
Oxygen I medical gases were excluded from 2 studies (Shiell et al., 
1990 & Rechner & Lipman, 2005) and included in only 4 studies 
(Slatyer et al., 1986; Doyle et al., 1996; Edbrooke et al., 1997 & Holt 
et al., 1994). A large number of studies failed to state whether these 
costs had been included (Table 3.11). 
Light and power 
Three studies excluded light and power from their cost calculations 
(Noseworthy et al., 1996; Shiell et al., 1990 & Rechner & Lipman, 
2005). Thirteen studies however did include these (Table 3.11). 
Institutional overhead costs 
Institutional overhead costs cover hospital running costs such as the 
cost ofbuildings, hospital administration costs etc. The components of 
costs included within this broad category will however vary between 
hospitals depending on the infrastructure in place. Fourteen studies did 
make some attempt to include these costs and 7 studies excluded 
institutional I overhead costs from their calculations (Table 3.11). 
Not amenable to extraction 
Of the 26 studies, there were 2 studies where it was not possible to 
determine from the information presented whether any of the above 
cost components had been included or excluded (Lees et al., 1987 & 
Malstam & Lind 1992) (Table 3.11). It is important to be able to 
ascertain what components of cost are included in costing studies, so as 
to understand the reasons why the results may differ between studies. 
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Table 3. 11: Overheads I hospital running costs 
Study Oxygen/ Light and power Institutional Not amenable to 
Medical Gases overhead costs extraction 
Slatyer et al., (1986) 0 0 ~ ~ 
Lees et al., (1987) ? ? ? 0 
Gilbertson et al., (1991) ? 0 0 ~ 
Byrick et al., (1980) ? ? ~ ~ 
Parikh & Kamad (1999) ? ? 0 ~ 
Sznajder et al., (2001) ? 0 0 ~ 
NoseoM:Irthy et al., ? 
-(1996) ~ ~ ~ 
Mllstam & Und (1992) ? ? ? 0 
Chaix et al., (1999) ? ? ~ ~ 
Doyle et al., (1996) 0 0 0 ~ 
Korkeila et al., (2000) ? ? ? ~ 
Edbrooke et al., (1999) ? 0 0 ~ 
Ridley et al., (1991) ? 0 0 ~ 
Sznajder et al., (1998) ? ? ~ ~ 
Edbrooke et al., (1997) 0 0 0 ~ 
Halpem et al., (1994) ? ? 0 ~ 
Holt et al., (1994) 0 0 0 ~ 
Shlell et al., (1990) ~ !El ~ ~ 
Grlfflths et al., (1997) ? ? ? ~ 
Dlckle et al., (1998) ? 0 0 ~ 
Parvlainen et al., (2004) ? 0 ? ~ 
Graf et al., (2005) ? 0 0 ~ 
Graf et al., (2002) ? 0 0 ~ 
Flaatten & Kvlle (2003) ? 0 0 ~ 
Moran et al., (2004) ? ? 0 ~ 
Rechner & Upman 
(2oo5) 
~ ~ ~ ~ 
Total(%) 4(15.4%) 13 (50.0%) 14 (53.8%) 2 (7.7-Je) 
Key: 0 = Yes: 1!1 = No: ? = Nol clear 
3. 9. 11 Method of apportioning costs 
Table 3.12 describes the method(s) of apportioning costs used in each 
study. 
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Table 3. 12: Method of apportioning costs 
Study Direct Activities of Days by level Dependency TISS Unweighted Number of Throughput 
Measurement care I grade of care points number of patient Critical Care (Volume) of 
days Beds Patients 
Slatyer et al., (1986) 0 
L0es et al., (1987) 0 
Gilbertson et al., (1991) 0 0 
Byrick et al., (1980) 0 
Parikh & Kamad {1999) 0 0 0 0 
Sznajder et al. , (2001) 0 0 
Noseworthy et al., (1996) 0 0 
Malstam & Lind (1992) 0 
Chaix et al., (1999) 0 
Doyle et al., (1996) 0 
Korkeila et al., (2000) 0 
Edbrooke et al., (1999) 0 0 
Ridley et al., (1991) 0 0 0 
Sznajder et al., {1998) 0 
Edbrooke et al., (1997) 0 0 
Halpem et al., {1994) 0 
Holt et al., {1994) 0 0 
Shiell et al., (1990) 0 0 0 
Griffiths et al., (1997) 0 
Dickie et al., {1998) 0 0 
Parviainen et al., (2004) 0 
Graf et al. , (2005) 0 0 
Graf et al., (2002) 0 0 
Flaatten & KvAie (2003) 0 0 
Moran et al., {2004) 0 0 
Rechner & Upman 0 I 
---- -- - ------
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Nine different approaches were identified and are described as follows: 
Direct measurement 
Direct measurement describes studies where resources have been 
captured at the patient-level (normally at the bed-side) using either 
prospective or retrospective means of data collection. Typically these 
sorts of studies are designed to study consecutive admissions over a 
defined period oftime (Slatyer et al., 1986; Gilbertson et al., 1991; 
Noseworthy et al., 1996; Ridley et al., 1991; Holt et al., 1994 & Dickie 
et al., 1998), although Sznajder et al., (200 1) collected data on every 
one in three consecutive stays. With direct measurement, resources are 
broken down into their smallest quantity (e.g. a syringe, a needle, a 
minute of a nurse's time etc) and counted for each patient according to 
their identified use of resources. Eleven studies reported costs that had 
been estimated using this approach. One of the difficulties with direct 
measurement studies, aside from their time consuming nature is being 
able to determine how many resources (and costs) are captured as a 
percentage of the overall expenditure of the critical care unit. Methods 
of validation are a problem with these these approaches and are rarely, 
if ever, undertaken. 
To improve the accuracy of the data, it is preferable to collect these 
sorts of data prospectively. However, it is possible, as demonstrated by 
Chaix et al., (1999) to perform a retrospective review of patients' 
medical records and existing computerized databases to extract 
resource use data. Shiell et al., (1990) also adopted a retrospective 
design however they added 'this approach is not advocated in 
preference to a prospective study design ' (page 257). 
Activities of care 
There was only one study where activities of care were used to estimate 
the costs of patients. The 'activities of care' methodology is not the 
same as 'activity-based' costing (which is an accounting approach that 
apportions total expenditure using activity measures in a clearly 
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defined and transparent manner). The study by Edbrooke et al., (1997) 
partitioned the care received by patients into discrete activities [of care] 
so that individual resources could be grouped together to facilitate their 
prospective collection at the patients' bedside. Activities of care were 
defined by Wilson et al., (1995) as 'any patient related task requiring 
the use of ICU resources' and were prospectively recorded by the 
nursing and medical staff [as and when each activity was performed on 
patients] into Patient Data Management Systems (PMDS) that were 
located at the patients' bedside. These data were then extracted at 
regular time intervals and stored in an Access database. Patients' use of 
drugs and fluids was entered into the PDMS but the unit costs attached 
to the drugs and fluids were based on standard instead of actual doses 
received by patients. The list of activities was compiled based on the 
clinical knowledge and experience ofthe critical care staff(See 
Chapter 4, Section 4.4.3). Consultation with the senior nursing staff 
was performed when any changes in clinical practice occurred in order 
to add to the list of activities covered, however during this study, no 
changes were made to the list. 
The way in which activities of care compares to direct measurement is 
that with the former approach, resources are allocated to each activity 
on the basis of their expected use and the costs of these (resources) 
estimated instead of counting each unit of resource separately which is 
required with the latter (Wilson et al., 1995). 
Days by level I grade of care 
Two studies allocated costs to patients using days by level of care I 
grade of care. Doyle et al., (1996) defined 4 distinct levels ofiCU care 
in order to develop their activity-based costing model (Table 3.14). 
They then established the types of resources needed when delivering 
each level of care, the quantity of those resources, and the cost per unit 
of resource use. One limitation of this approach was its focus on 
neuromuscular blocking drugs (NMBs) that limited the generalisability 
of the described levels of care to non-NMB patients. 
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In the study by Loes et al., ( 1987) patients were allocated care grades 
according to their severity of illness. The care grade scale ranged from 
1 to 5 with defined criteria for each grade {Table 3.13). The average 
care grade during the stay in the critical care unit multiplied by the 
duration of stay in days produced the 'care product' that reflected the 
patients' requirements for critical care. The sum of care products for an 
patients (over a given time period) was regarded as an expression of the 
total workload in the unit over that same given time period. To 
calculate the costs of individual patients, the authors assumed a linear 
relationship between care grade and expenditure. By relating the total 
care product for one year to the total critical care unit expenses 
obtained from the hospital accounts for the same year, costs for 
treatment of individual patients or groups of patients were calculated. 
Table 3.13: Care Grades 1-5 (Loes et al., 1987) 
Care Grade Definition 
1 
2 
3 
4 
5 
No special therapeutic measures required. Several patients under 
observation by one nurse. Minor risk of developing need for intensive 
thera 
Closer observation necessary. Substantial risk of developing need for 
intensive therapy 
Increasing need for stabilizing therapy. Near constant observation by 
one nurse. Nurse I patient ratio = 1 
Uninterrupted supportive treatment of disturbed organ functions, i.e. 
mechanical ventilation 
Intensive therapy of failing vital organ functions. More than one person 
present for therapy and control. 
Dependency Points 
Three studies used dependency points to allocate nursing staff costs to 
patients (Ridley et al., 1991; Dickie et al., 1998; Shiell et al., 1990). 
They used the Intensive Care Society of Great Britain's dependency 
point classification of nursing support for intensive therapy. The 
dependency points ranged from 2 for the most seriously ill patients to 
0.5 for patients that needed little nursing care. In the study by Ridley et 
al., (1991 ), the dependency points were allocated to patients on a daily 
basis by a senior nurse. Limited details were reported in the study by 
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Shiell et al., (1990) as to how these costs were allocated, however it 
was possible to elicit more information from the other two studies. 
Ridley et al., (1991) calculated the gross combined salaries ofthe 
nursing staff present on each of the study days using records of daily 
work rosters and pay scales (including overtime). The nursing staff cost 
per patient dependency point was then calculated for each day of stay. 
An estimate of the costs for nursing care for each patient was obtained 
by multiplying the cost per dependency point by the number of 
dependency points ascribed to that patient. 
Dickie et al., (1998) adopted a slightly different approach to allocating 
nursing staff costs to patients' dependency points. Instead of estimating 
daily costs that took into account staffing variability, they apportioned 
the total nursing staff costs over a 12-week period by the cumulative 
number of dependency points. 
Therapeutic Intervention Scoring System (TISS) 
The Therapeutic Intervention Scoring (TISS), developed at the 
Massachusetts General Hospital in 1974 (Cullen et al., 1974) and 
updated in 1983 (Keene & Cullen, 1983) included 57 therapeutic 
activities, each weighted using a point scale of 1 to 4. The activities 
with 4 points were used only for the most severely compromised 
patients, for example those who received artificial ventilation with 
PEEP, G. Suit and pressurised blood transfusions. In 1983, the number 
of therapeutic interventions increased to 76. 
The aims ofTISS were to measure the severity of patients' illness and 
therapy level, to compare critical care units, to calculate the number of 
nurses required and to assess the costs of care (Dickie et al., 1998). 
Seven of the 26 studies used TISS as a means of apportioning costs 
(Parikh & Karnad 1999; Korkeila et al., 2000; M~ilstam & Lind 1992; 
Griffiths et al., 1997; Parviainen et al., 2004; Graf et al., 2002 & 2004). 
TISS has also been employed as a method of cost apportionment in the 
paediatric intensive care population (de Keizer et al., 1998) 
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Parikh & Kamad (1999) assessed TISS points daily until discharge or 
death for each patient admitted over a three-month period. Costs were 
prospectively calculated for each month and by dividing these costs by 
the total number ofTISS points, a cost per TISS point was estimated. 
Korkeila et al., (2000), Griffiths et al., (1997) and Parviainen et al., 
(2004) estimated costs per patient in a very similar manner by dividing 
the yearly total costs of the critical care unit by the total number of 
TISS points. In all 4 studies, patient costs were then calculated on the 
basis of their individual TISS points. Graf et al., (2002 & 2004) 
estimated a cost per TISS point using data gathered over a 3-month 
period for their patient-specific costs. M~ilstam & Lind (1992) did a 
very similar study but instead used a heavily modified version ofTISS 
to apportion the variable costs of their patients (staff, drugs and fluids 
and disposables) on the basis of their scores. 
Number of patient days I length of stay 
Sixteen studies used the observed number of patient days incurred by 
the critical care unit to allocate their costs. Four studies used this 
approach exclusively to estimate patient costs (Byrick et al., 1980; 
Edbrooke et al., 1999; Halpem et al., 1994; Flaatten & KvAie 2003 & 
Rechner & Lipman 2005, whereas the other 12 studies used this 
approach in combination with other approaches. Gilbertson et al., 
(1991) allocated the fixed costs of the critical care unit to patients on 
the basis of their length of stay. They described these fixed costs as: 
• Salaries for all staff (medical, nursing and ancillary) 
employed directly or indirectly with the ICU; 
• The entire stock of equipment in the ICU (e.g. ventilators 
and ECG monitors etc ); and 
• Hospital administrative and estate costs (that included 
laundry, records, lights and stationery). 
Byrick et al., (1980) used the number of patient days to estimate 
average daily costs for patients' use of drugs (with alimentation), 
medical and surgical supplies, respiratory therapy equipment, printing, 
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stationery, housekeeping, nursing salaries, physiotherapist salaries, 
respiratory technologist salaries and physician costs (including 
anaesthetic and surgical fees for procedures carried out during the 
study period). 
Parikh & Kamad (1999) in addition to estimating total patient costs 
using TISS points apportioned the critical care expenditure by the 
number of patient days to estimate average costs per day. 
Sznajder et al., (1998) estimated the variable costs using direct 
measurement but allocated the fixed and indirect costs of the critical 
care unit by the number of patient days. They described the fixed costs 
as those for the medical staff and head nurses. The indirect costs 
included heating, lighting, hostelry, cleaning, administration, 
management and building amortization. 
Noseworthy et al., (1996) allocated indirect patient care costs on the 
basis of patients' length of stay. They described these costs as follows: 
• Nursing management (unit manager [8 hours I day; 5 days I 
week], Associate unit manager [24 hours I day], Patient care 
coordinator [20 hours I week]; 
• Differential rates for overtime; 
• Float time; 
• Orientation; 
• Educational costs. 
• Costs for a clerk (8 hours I day; 5 days I week), unit clerk 
(24 hours I day), ward aide (24 hours I day), housekeeper 
(12 hours I day) and biomedical technician (8 hours I day, 5 
days I week). 
Edbrooke et al., (1997) allocated what they described as the non-
patient-related costs on the basis of patients' length of stay. These 
included energy, heating, building maintenance, engineering 
maintenance, capital charges, portering services, cleaning and laundry, 
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rates, estates, nursing time not delivering patient care and medical time 
not delivering patient care. 
Holt et al., (1994) allocated costs associated with the provision of 
services to critical care patients but not costed directly to the critical 
care unit on the basis of patients' length of stay. These costs included 
administration, electricity, piped gases and cleaning. 
Shiell et al., (1990) apportioned medical, ancillary and technical staff 
expenditure to patients on the basis of their length of stay. 
Graf et al., (2002 & 2005) divided the non-patient-specific costs which 
they itemised as heating, lighting, capital costs, management and 
administrative services, equipment, maintenance and cleaning, linen, 
hidred beds and 'back-up' salaries for off-duty nurses and physicians, 
by the number of patient days to estimate a daily cost. 
Flaatten & Kvale (2003) employed a 'top-down' costing method to 
estimate an average cost of an ICU day as well as an average cost per 
patient. Included in their castings were expenditures on staff, 
consumables, capital equipment, estates and clinical support services 
which included visits by consultants outside the ICU and the use of 
operating theatres. 
Moran et al., (2004) allocated overhead costs and unallocated costs to 
patients such as administration, repairs and maintenance, orderlies 
salaries and wages, linen and domestic supplies on the basis of ICU 
length of stay. 
Rechner & Lipman (2005) also employed a 'top-down' approach in 
order to estimate an average daily cost of care. Costs included in the 
calculations related to staff, consumables, clinical support services and 
capital equipment. 
Number of critical care beds 
In addition to allocating total costs to patients using their cumulative 
TISS points and the number of patient days, Parikh & Kamad (1999) 
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also allocated costs using the number of critical care beds to produce a 
cost per bed. Edbrooke et al., ( 1999) also apportioned the total 
expenditures of their sample of critical care units by the number of 
beds to estimate average costs per bed. 
Throughput (volume) of patients 
There were only 2 studies where the total costs of the critical care unit 
were spread over the number of patients admitted to produce average 
total costs per patient (Parikh & Karnad 1999 & Flaatten & K vale 
2003). 
3.10 Summary of findings 
Overall, there were 9 different approaches to estimating costs identified 
from the literature review that fell into two broad categories of direct 
measurement at the patient level and apportionment of total costs using 
levels of care, dependency points, scoring systems and the number of 
patient days, beds and patients. Section 3.11 attempts to evaluate the 
quality of each study. 
3.11 Assessment of quality 
Reviews of methodology differ from effectiveness reviews insofar that 
conventional checklists with criteria covering both study quality and 
level ofinforrnativeness such as the CONSORT statement are not 
strictly applicable. Chilcott et al., (2003) explore the difficulties of 
appraising studies of methodologies and conclude that 'in a 
methodology review there is likely to be a broad range of types of 
evidence, hence a single checklist orientated to a particular study 
design is unlikely to suffice'. 
Jacobs & Bacnynsky (1996) propose a set of criteria for assessing 
costing methods used in economic evaluation. However, criteria 
specific to adult critical care proposed by Burchardi et al .• (200 1) was 
felt more applicable to studies included in the review. They 
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Criterion 
1a 
1b 
2a 
2b 
2c 
3 
4 
5a 
recommend a system of quality assessment focused around nine criteria 
(Table 3.14). 
Table 3.14: Quality criteria proposed by Burchardi et al., 
(2001) 
Definition 
The cost bearer should be 
clearly identified 
Costs should be defined 
accordingly 
The unit of analysis (cost 
center, cost object) chosen 
should be shown to determine 
the distinction between direct 
and indirect costs). 
The choice between direct 
costs I unit or (direct + some 
indirect) costs I unit should be 
made. 
If indirect costs are included, 
allocation rules should be 
described and justified. 
All direct ICU costs should be 
measured at the ICU level. 
Fixed, variable and marginal 
costs should be made explicit 
and correctly handled. 
Costs should be calculated 
comprehensively. Only 
immaterial components may 
be ignored. 
Notes 
The cost bearer relates to the study's perspective (that of a hospital, 
insurer and/or a patient or society). lt is important that the point(s) of 
view considered are clearly defined and consistently taken into 
consideration when calculating costs or, as is frequently done, 
studying cost containment effects 
lt must be clear that costs are not a concept per se but foregone 
alternatives for an individual or a specific organisation, implying that a 
cost for one particular cost bearer is not automatically a cost for 
someone else (Drummond et al., 1987). 
The choice of cost canters must be made clear as it impinges on the 
distinction between direct and indirect costs. 
The choice must be explicitly made as to whether to include only 
direct costs or include the full costs (defined as the sum of direct and 
indirect costs). 
When including indirect costs, the allocation rules applied should be 
described and justified. 
Direct ICU cost measurement should be performed at the ICU level 
instead of being derived from a more aggregate cost figure, such as 
hospital costs. 
Apart from the distinction between direct and indirect costs, the 
difference between fixed and variable costs is equally important and 
different in nature. The traditional economic concepts of total costs, 
average costs, total fixed costs, average fixed costs, total variable 
costs, average variable costs and marginal costs, cover differing 
economic contents and mechanisms, and should therefore be used 
thoughtfully, especially when cost data are used for simulation 
purposes and ensuring policy recommendations. lt is generally 
known that in the long run, all costs are variable. The authors 
propose that one year can be considered as a relevant time span to 
make the distinction between fixed and variable costs. Particularly, 
when indirect methods such as TISS-based expressions are applied, 
the distinction between cost categories can be blurred. Furthermore, 
in ICU cost studies, fixed costs and indirect costs are frequently, but 
wrongly, considered to be equivalent concepts (Dickie et al., 1998; 
Gilbertson et al., 1991 ). 
Once researchers have determined the kind of cost they wish to 
determine, they should aim at comprehensiveness; all important 
components of the costs studied should be included in the 
calculation, and for others it should be justified why they were left out, 
the only good reason being their relative unimportance. Difficulties in 
determining or estimating costs are not a good argument to ignore 
them. In the same vein, the way in which costs are determined 
should be made explicit, allowing the reader to assess the quality of 
the data presented. 
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5b Determination of each 
component of costs studied 
should be made explicit. 
Furthermore a sensible 
methodology should be 
a lied. 
lt is clear that an assessment of cost studies in respect of Criterion 5b 
can only be made on an ad hoc basis. 
Table 3.15 shows how each study performed against each criterion. 
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Table 3.15: Assessment of studies according to quality criteria proposed by Burchardi et al., (2001) 
Study 1a 1b 2a 2b 2c 3 4 5a 5b Total 
Slatyer et al., (1986) 0 0 0 0 n/a 0 ~ 0 0 7/8 
L0es et al., (1987) ~ ~ 0 1!1 n/a 0 ~ 1!1 1!1 2/8 
Gilbertson et al., (1991) 0 0 0 0 1!1 0 1!1 0 0 7/9 
Byrick et al., (1980) 1!1 1!1 ~ 1!1 1!1 0 1!1 0 1!1 2/9 
Parikh & Kamad (1999) 1!1 1!1 1!1 1!1 n/a 0 1!1 0 ~ 2/8 
Sznajder et al., (2001) 0 0 0 0 0 0 0 0 0 9/9 
Noseworthy et al., (1996) 0 0 0 0 0 0 1!1 0 0 8/9 
Malstam & Lind (1992) ~ 1!1 1!1 1!1 1!1 0 1!1 ~ ~ 1/9 1 
Chaix et al., (1999) 0 0 0 0 n/a 0 0 ~ 0 7/8 
Doyle et al., (1996) 0 0 0 0 0 0 0 0 0 9/9 
Korkeila et al., (2000) 0 1!1 ~ 1!1 n/a 0 1!1 ~ 1!1 2/8 
Edbrooke et al., (1999) 0 0 0 0 0 0 ~ 0 0 8/9 
Ridley et al., (1991) 1!1 0 0 ~ ~ 0 0 0 0 6/9 
Sznajder et al., (1998) 0 0 0 0 0 0 0 0 0 9/9 
Edbrooke et al., (1997) 0 0 0 0 0 0 1!1 0 0 8/9 
Halpem et al., (1994) 0 ~ 1!1 0 ~ 0 1!1 0 0 5/9 I 
Holt et al., (1994) 1!1 0 0 0 0 0 1!1 0 0 7/9 
Shiell et al., (1990) ~ 0 0 1!1 ~ 0 ~ ~ 0 4/9 
Griffiths et al., (1997) ~ 1!1 0 ~ 1!1 0 ~ ~ ~ 2/9 I 
Dickie et al., (1998) 1!1 0 0 1!1 0 0 1!1 0 0 6/9 
Parviainen et al., (2004) 1!1 0 0 0 1!1 0 [!] 0 0 6/9 
Graf et al., (2005) 0 [!] 0 0 0 0 [!] 0 0 7/9 
Graf et al., (2002) 0 [!] 0 0 0 0 [!] 0 0 7/9 
Flaatten & Kvllle (2003) 0 ~ 0 0 0 0 [!] 0 0 7/9 
Moran et al., (2004) 0 0 0 0 0 0 [!] 0 0 8/9 
Rechner & Lipman 0 1!1 ~ [!] n/a 0 [!] 0 0 4/8 
_(_2005) 
Total 16 15 20 16 12 (46.2%) 26 (100"/a) 5 20 20 (76.9%) 
(61.5"/o) (57.7"/o} (76.9"/o} (61.5'/o) (19.2"/o) (76.9"/o) 
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11') 
-
-
3. 11. 1 1 a: The cost bearer should be clearly identified 
Only 16 of the 26 studies clearly stated the perspective of the study. 
3. 11.2 1 b: Costs should be defined accordingly 
Fifteen studies provided some form of description relating to each of 
the cost components included. 
3.11.3 2a: The unit of analysis (cost center, cost object) 
chosen should be shown to determine the distinction 
between direct and indirect costs). 
Three quarters of the studies specified the unit of analysis adopted in 
their respective studies (e.g. the patient, the patient day or the critical 
care unit). 
3. 11.4 2b: The choice between direct costs I unit or (direct 
+ some indirect) costs I unit should be made. 
A smaller proportion of studies ( 61.5%) made a distinction between 
direct and indirect costs in their cost calculations and provided a 
rationale for their inclusion I exclusion. 
3. 11.5 2c: If indirect costs are included, allocation rules 
must be described and justified. 
There were 6 studies for which this criterion did not apply (Slatyer et 
al., 1986; Lees et al., 1987; Parikh & Kamad 1999; Chaix et al., 1999; 
Korkeila et al., 2000 & Rechner & Lipman, 2005). The allocation rules 
applied to the inclusion of indirect costs were described in 12 of the 
remaining 20 studies. 
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3.11.6 3: All direct ICU costs should be measured at the 
ICU level. 
All of the 26 studies performed the measurement of costs at the critical 
care unit level as opposed to deriving these costs from total hospital 
costs. 
3. 11. 7 4: Fixed, variable and marginal costs should be 
made explicit and correctly handled. 
Only a very small number of studies engaged in any discussion of the 
fixed, variable and marginal components of critical care unit costs. As 
was observed by Burchardi et al., (2001), fixed costs and indirect costs 
are frequently, but wrongly, considered to be equivalent concepts 
(Dickie et al., 1998 & Gilbertson et al., 1991). 
3. 11.8 Sa: Costs should be calculated comprehensively. 
Only immaterial components may be ignored. 
All of the important components of cost were included in 20 studies. 
3. 11.9 Sb: Determination of each component of costs 
studied should be made explicit. Furthermore, a sensible 
methodology should be applied. 
Twenty studies made explicit each component of cost included in their 
studies and applied an appropriate methodology for their calculation. 
3.12 Ranking of studies 
There were only 3 studies that met all of the 9 criteria (Doyle et al., 
1996; Sznajder et al., 1998; Sznajder et al., 2001 ). The studies by 
Noseworthy et al., (1996), Edbrooke et al., (1997 & 1999) and Moran 
et al., (2004) met 8 of the 9 criteria and there were 7 studies that met 7 
of the 9 criteria (Slatyer et al., 1986; Gilbertson et al., 1991; Chaix et 
al., 1999; Holt et al., 1994; Graf et al., 2002 & 2005 and Flaatten & 
Kvlle 2003). The studies by Ridley et al., (1991), Dickie et al., (1998) 
& Parviainen et al., (2004) met 6 of the 9 criteria. Ha1pern et al., 
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(1994) met 5 ofthe 9 criteria with Shiell et al., (1990) and Rechner & 
Lipman (2005) meeting 4 criteria. Five studies met only 2 criteria 
(Loes et al., 1987; Byrick et al., 1980; Parikh & Karnad 1999; Korkeila 
et al., 2000 & Griffiths et al., 1997). Finally, there was one study that 
met only 1 of the 9 criteria (Malstam & Lind 1992). 
3.13 Advantages and disadvantages of the costing 
methods 
The aim of the systematic review was to identify what methods exist 
for costing critically ill patients. Although lack of detailed reporting 
has been identified as a problem with the cost literature (Jacobs & 
Bachynsky (1996), nine different costing methods were identified 
(Section 3.9.11). 
The quality of studies as determined according to the criteria proposed 
by Burchardi et al., (2001) was variable. Of particular interest to the 
work of the thesis were studies that employed methods that could be 
applied to a multi-centre setting and for practical reasons, did not 
require detailed measurement of resource use at the patient-level. For 
this reason, the 12 studies that had employed direct measurement 
techniques were not considered further (Slatyer et al., 1986; Gilbertson 
et al., 1991; Sznajder et al., 2001; Noseworthy et al., 1996; Chaix et 
al., 1999; Ridley et al., 1991; Sznajder et al., 1998; Edbrooke et al., 
1997; Holt et al., 1994; Shiell et al., 1990; Dickie et al., 1998 and 
Moran et al., 2004). 
There were 19 studies that were performed in a single center. 
The study by L0es et al., (1987) weighted average daily patient costs 
by care grade (see table 3.13). The limitation of these care grades was 
that most patients treated in British Critical Care Units would incur the 
highest care grade, hence reducing the potential of this method to 
discriminate effectively between individual patients. The first three 
care grades would typically relate to patients treated in a hospital ward 
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environment or post-operative unit. As such, this approach was not 
considered further. 
The study by Byrick et al., (1980) estimated average daily costs for 
individual patients by apportioning the total expenditure of the critical 
care unit by the observed number of patient days. In doing so, they 
assumed that patients consumed the same level of resource use on a 
daily basis - which is not the case in normal clinical practice. The 
standard method for measuring expenditure was not described in the 
paper and so this study was also excluded from further consideration. 
The study by Parikh & Karnad (1999) apportioned the expenditure of 
the critical care unit by the cumulative number of patients' TISS points 
to derive a mean cost per TISS point. Total patient costs were 
estimated by summing together their TISS points and multiplying these 
by the derived mean cost. Malstam & Lind (1992}, Korkeila et al., 
(2000), Griffiths et al., (1997) and Parviainen et al., (2004) adopted the 
same design, however Malstam & Lind (1992) used a modified version 
of the TISS scoring system (limiting the generalisability of its 
methodology and resultant findings to other critical care units). 
The TISS scoring system is designed to be collected on individual 
patients on a daily basis. It aims to document the nature of therapeutic 
interventions performed over the previous 24-hour period. Whilst the 
TISS costing approach has some appeal in its simplicity, there are 
several limitations and methodological problems in adopting this 
method for routine use, as a costing tool, in the UK: 
• Although the elements that make up the TISS score are 
related to the care delivered to the patient, a wide variety of 
combinations of care with very different resource 
implications can give the same score; 
• TISS has not been updated since 1983 nor the weighting of 
items validated; and 
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• TISS has also been extensively adapted in individual 
critical care units to reflect local practice (as was observed 
in the study by Malstam & Lind ( 1992). Indeed in the UK, 
some 4 71 different statements were in use in 200 1 
(Nightingale, P. Intensive Care National Audit & Research 
Centre, TISS Working Group, Personal Communication). 
This clearly undermines any valid comparison between 
different critical care units. 
Left remaining were 3 studies where attempts had been made to cost 
patient care in a multi-centre setting (Doyle et al., 1996; Edbrooke et 
al., 1999 & Halpem et al., 1994)- all of which adopted a 'top-down' 
method of costing. J acobs & Bachynsky (1996) offer a straightforward 
description for this type of costing method where 'the base statistic is 
usually the total cost of the cost cent er in which the services are 
provided divided by the quantity of output of that cost cent er.' 
Doyle et al., (1996) employed an activity-based costing (ABC) 
approach to allocating the critical care unit costs to individual patients. 
This paper received top scores for quality (see Table 3.16) and 
appeared methodological robust and scientifically sound. Activity-
based costing 'accounts for the inter-relationship between cost and 
activity by dividing total cost by individual activity-measuring 
units ... accordingly, a graduation of cost level correlates with a 
gradation of care level' (Doyle et al., 1996 page 396). Doyle et al., 
(1996) advocate the merits of activity-based costing as a means of 
providing 'a systematic means of determining the full cost of a service ' 
(Hilton, 1991). The financial accounting definition of'full cost' 
consists of the following elements: consumables, labour and facility. In 
determining an average cost per service, the total accounting cost is 
divided by a predetermined activity base. The ABC approach to 
valuing resource utilisation, accounts for the inter-relationship between 
cost and activity by dividing total cost by individual activity-measuring 
units (Doyle et al. 1996). In this paper, the authors presented an ABC 
model for full-cost determination of different levels of care in the 
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critical care unit. In this study, no patient-level cost data are collected, 
instead the total expenditure of the critical care unit is allocated to 
patients in a way that takes into account their length of stay and the 
level of care received during their stay. 
Cost allocation based on levels of care has been successfully employed 
in neonatal critical care. A study by Tubman et al., (1990) apportioned 
the total costs ofneonatal intensive care (that included staff salaries, 
laboratory and radiology tests, hospital maintenance and capital 
equipment) by the number of cot days that were then weighted on the 
basis of the levels of care received by the babies. The weightings had 
been derived from a detailed study at Birmingham Maternity Hospital 
that determined ratios of costs per cost day for levels I (intensive7) and 
11 (high dependencyS) and special care9 of6:3:1 (see Newns et al., 
1984). 
The major problem with the study by Doyle et al., (1996) related to the 
levels of care proposed by the authors. The levels of care (described in 
table 3.16) are based around patients' need for mechanical ventilation 
and the use ofNMB therapy. These levels of care fail to consider other 
forms of organ support that can influence the level of care received by 
patients and so the paper was excluded from further scrutiny. 
7 Intensive care. Those infants requiring positive pressure mechanical ventilation or total parenteral nutrition, and 
initially all those infants with birthweights ofless than I 000 g. 
8 High dependency care. Those infants requiring constant positive airway pressure, continuous monitoring of vital 
functions, oxygen therapy, intravenous therapy, and initially, those babies with birthweights of less than 1500 
g. 
9 Special care. Those infants who have required intensive care and high dependency care, but now require skilled 
nursing supervision of temperature regulation, feeding, and simple treatments, and those infants admitted only 
for this form of care. 
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Table 3.16: Levels of ICU care (Doyle et al., 1996) 
Level of care Definition Resources Related To Care 
1 
2 
3 
4 
Usual or normal care for Direct nursing I physician care + 
patients breathing normally or consumables (e.g. drugs)+ 
without assistance overheads 
Care for patients receiving 
mechanical ventilation 
Care for patients receiving 
mechanical ventilation and 
NMB therapy 
Care for patients 
experiencing NMB-attributed 
prolonged neuromuscular 
blockade 
Level 1 + increase in nursing care 
and consumables+ ventilator + 
respiratory and physical therapy 
Level2 + NMB costs and concomitant 
medication 
Level 3 + neurological evaluation + 
possible increase in ICU length of 
stay + rehabilitation + NMB costs 
The study by Halpem et al., (1994) did not score as highly as the study 
by Doyle et al., (1996) meeting only 5 of the 9 criteria. Here the ICU 
patient cost per day was estimated using the Russell Equation: 
A = (B X C) + (D X E) 
Where A is patient cost per day; B is percentage of occupied non-ICU 
beds; C is non-ICU patient cost per day; D is percentage of occupied 
ICU beds; and E is ICU patient cost per day. 
The authors attempt to solve the Russell equation using aggregated 
financial data. This method was employed to compare United States' 
health care cost trends with trends in the gross domestic product, so 
was not intended for estimating individual patient costs (more for 
studying overall patient populations) and hence was excluded from 
further scrutiny. 
The Cost Block Method developed by the Critical Care National 
Working Group on Costing identified the budgetary components 
associated with resource use in critical care and defined a series of 
'Cost Blocks' with which to perform top-down costing of adult critical 
care units (Edbrooke et al., 1999). The full definitions of each cost 
block are shown in Appendix 3.4). 
These cost blocks are described as follows: 
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• Cost Block 1: Current cost of using equipment (linear 
standard depreciation; total maintenance and annual lease I 
hire charges); 
• Cost Block 2: Estates (building depreciation; water, 
sewerage, waste disposal and energy; building maintenance, 
engineering maintenance and decoration; rates); 
• Cost Block 3: Non-Clinical Support Services 
(administration; management and cleaning); 
• Cost Block 4: Clinical Support Services (pharmacy, 
physiotherapy, radiology, dieticians, cardiology, renal 
support from another critical care unit , clinical 
neuroservices and laboratory services); 
• Cost Block 5: Consumables (drugs, fluids and nutrition, 
blood and blood products and disposables); and 
• Cost Block 6: Staff (medical staff- consultant and non-
consultants; nursing staff and technicians). 
After a period ofpiloting the collection of cost data (according to the 
definitions) in those hospitals represented by members of the Group, 
discussions were held amongst the Working Group to modify the 
definitions, with the aim of improving clarity and ease of use. Having 
refined the definitions relating to the 6 cost blocks, pilot studies were 
undertaken in 11 critical care units over two consecutive financial years 
( 1994/1995 and 1995/1996) (Edbrooke et al., 1999) and in 21 critical 
care units over one financial year (1996/1997) (Edbrooke et al., 2001). 
Cost components within cost blocks 1 to 3 (Current Cost of Using 
Equipment, Estates and Non-Clinical Support Services) were difficult 
to collect, inaccurate and not within the control of the critical care unit, 
e.g. overhead costs that were difficult to apportion. Given that these 
costs accounted for only 15 percent of the total cost, it was agreed by 
the Group that they would not be collected in any future studies. 
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Having been involved in the development and piloting of the cost block 
method, its main limitation became evident; that a single average daily 
cost is used for all patients, regardless of case-mix (Baskett & Parsons, 
1990). 
3.14 Discussion 
Hutton & Ashcroft (1998) observe that 'systematic reviews of methods 
have become an important issue as the quantity and forms of research 
done vary enormously'. At the time of the review, there was a dearth of 
information on standards and guidelines for methodological reviews 
(Chilcott et al., 2003). 
Whilst attempts were made to conduct exhaustive searches for 
potentially relevant studies, the review had some limitations because of 
the language restrictions that biased the review towards English-
language studies. One reviewer was charged with the entire review that 
involved both screening the abstracts and full papers and performing 
the data extraction and quality assessment tasks. Had resources 
allowed, it would have been better practice to use an additional 
reviewer. The quality criteria proposed by Burchardi et al., (2001) were 
focused very much toward the inclusion and classification of the cost 
components of the studies and less towards the generalisability and 
transferability of the methods, which was another potential limitation 
ofthe review. 
The strengths of the review were its comprehensiveness; that being the 
efforts made to identify all relevant studies through the coverage of 
databases searched and the amount of screening that took place at the 
beginning with the abstracts. 
The literature on adult critical care has been well described by the 
review however there is much to be learned from the research 
conducted in other high cost specialties such as neonatal and paediatric 
intenhe costing literature on these other high cost areas of medicine 
was examined so as to determine whether any of the methods I 
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approaches employed in these other areas could help inform the work 
of this thesis. 
A review ofthe neonatal cost literature by Mugford (1995) identified a 
number of studies that had estimated mean patient costs by birth weight 
category (see Boyle et al., 1983; John et al., 1983; Sandhu et al., 1986, 
Connolly et al., 1989; Stevenson et al., 1991, Kitchen et al., 1993 and 
more recent studies by Stevenson et al., 19961-2 ; Kotagal et al., 1997; 
Rogowski, 1998 & St. John et al., 2000). Preterm or low birth weight 
infants are significantly more likely to be rehospitalized than infants 
born at full term or at normal birth weight (Petrou et al., 2001). Mean 
health service costs per day had also been determined by level of 
neonatal intensive care, stratified into 3 care areas (intensive, high 
dependency and special care) (see Kaufinan & Shepard, 1982; Newns 
et al., 1984, Tudehope et al., 1989, Marshall et al., 1989 & Ewald 
1991 ). Interestingly, the same methodological considerations required 
when predicting the costs of neonatal care also appear to apply to adult 
critical care insofar that the process of cost measurement can 
encompass a variety of methods of varying degrees of complexity. Like 
adult intensive care, the use of mechanical ventilation (see Phibbs et 
al., 1981 for neonates and Dasta et al., 2005 for adults) and the 
duration of stay on the unit have been found to relate to the costs of 
care (see Cooke, 1988). Furthermore, specific organizational features 
have been found to affect the costs of neonatal intensive care like adult 
intensive care (e.g. the high proportion of fixed costs relating to 
staffing and capital equipment requirements that can result in scale 
economies (see Fordham et al., 1992 & O'Neill et al., 2000). The 
design of economic studies also appears to be predominantly 
observational in both. 
The method of 'top-down' costing has been successfully employed in 
neonatal intensive care units to determine average costs per day for 
different levels of care (Petrou & Davidson, 2000; Petrou & Edwards, 
2004; Roberts et al., 1998) yet data on levels of care are not routinely 
collected in adult critical care. The study by O'Neill et al., (2000) was 
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mentioned in Chapter 2 but these authors performed a major 
multi centre study of neonatal units in the UK in order to better 
understand the relationship between costs and activity to investigate 
possible economies of scale. Five statistical models were developed in 
order to identify the best model fit for the data collected where a model 
defined by a double-log function relating variations in total costs to 
total days, case-mix and an interaction term was deemed most 
appropriate. Evidence of scale economies present in neonatal unit daily 
costs of care was found. This study also successfully employed the use 
of postal questionnaires in order to estimate neonatal unit expenditure 
on medical, nursing, overhead and support costs measured using 'top-
down' costing. 
Garcia et al., (1999) performed a cost analysis of paediatric ICU 
patients and De Keiser et al., (1998) studied the relationship between 
TISS and paediatric ICU costs. Interestingly, exactly the same 
problems identified with the TISS scoring system in paediatric patients 
exist with the adult population, namely its inability to capture the costs 
related to medical staff and issues with the same score incuring 
differing use of resources. As far as the literature on liver 
transplantation patients, only one empirical study was identified where 
the costs of 8 liver transplantation patients had been estimated (Skeie et 
al., 2002), however very little could be gleaned from such a small 
sample. 
From performing the literature review, the main endeavour of the thesis 
became clear; that being to incorporate a case-mix measure or weight 
into the average daily cost estimates so as to reflect the variation in cost 
(on a daily basis) between individual patients. The cost block method 
was identified as the method of choice for this task based on its 
previous applications. 
The cost block method had an important advantage, other than scoring 
highly for quality, that standard definitions had been developed and 
piloted in a number of critical care units (Edbrooke et al., 1999 & 
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2001). By 2001, the cost block method was being routinely adopted in 
approximately 80 critical care units across the UK through the 
implementation ofthe Critical Care National Cost Block Programme 
(Dean et al., 2002). The Cost Block Programme was further endorsed 
by the Department of Health who recommended in their 
'Comprehensive Critical Care' Report (2000) that all critical care units 
be encouraged to take part (Department of Health, 2000). This 
endorsement carried with it an acceptance of the method as the method 
of choice for costing critical care units so rather than adapt the method 
significantly (thus introducing the problem of having different versions 
in use), it seemed logical and sensible to use the method and explore 
ways in which its use could be enhanced (by investigating an 
appropriate case-mix adjustor). 
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"Not everything that can be counted counts, and not everything that counts can be 
counted" 
Albert Einstein (1879-1955) 
CHAPTER 4: EXPLORATORY STUDY OF COST 
PREDICTORS 
4.1 Introduction 
The aim of Chapter 4 was to identify a set of case-mix related variables 
that could be used to predict the daily costs of critical care patients. To 
this end, two exploratory analyses of patient level case-mix and cost 
data were performed. 
This study was important since it had the core objective of exploring 
statistically the key 'cost generating events' and patient characteristics 
of critical care units (Johnston et al., 1999). Knowledge gained in this 
way would then be used to determine the design of a multi-centre study 
to generate the necessary data with which to develop a set of 
appropriate HRGs (Chapters 5, 6 and 7) and to inform the design of the 
economic evaluation alongside the CESAR trial (Chapter 8). To 
achieve this, patient-level data permitting exploratory analyses of a set 
of case-mix related variables and their statistical relationship to the 
daily costs of critical care were needed. 
Selection of the case-mix related variables included in the first analysis 
were directed, in the most part, by a survey of clinical opinion 
conducted by Dr. John Morris in 1995. Added to these variables were 
patients' age, gender and some very crude data on organ support .. 
Two exploratory studies were performed; the first study used data 
collected over a 12-month period (from 1st April 1996 until 31st March 
1997). The second study was conducted over a 6-month period (from 
1st October 1997 until 31st March 1998) and collected additional (daily) 
data on patients' organ support and their daily costs of care. 
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Nursing and medical staff collected all of the data used in these 
analyses from consecutively admitted patients receiving treatment in 
the adult critical care unit based at the Royal Hallamshire Hospital in 
Sheffield. Data were provided in an anonymous form so as to protect 
the identity of patients. The 'activities of care' costing methodology 
was used to estimate the costs of individual patients, which is a form of 
'bottom-up' costing. This method of costing care is explained in detail 
in Section 4.4.3. The statistical relationship between each of the case-
mix variables and patients' daily costs of care were evaluated using 
univariate and multivariate techniques. 
The results of this exploratory work found patients' TISS points to 
yield the highest predictive power of all of the case-mix variables 
included in the first study (R2 =0.378). None of the other variables 
were found to influence patients' costs of care, when studied 
separately. However, when these variables were studied in a 
multivariate analysis, 35.8% of the variation in average daily costs of 
care could be explained. The second study investigated the relationship 
between daily costs of care and patients' daily organ support. A 
multivariate analysis showed organ support alone to explain 30.7% of 
the variation in daily costs, which was considered a favourable result. 
A discussion of these findings and the implications for the multi-centre 
study conclude this Chapter. 
4.2 Background 
The systematic review performed in Chapter 3 described the 'activities 
of care' costing methodology reported by Edbrooke et al., (1997). This 
method was used here in these exploratory analyses to estimate detailed 
costs of individual critical care patients in order that the relationship 
between these and a list of potentially relevant case-mix variables 
could be evaluated. Case-mix variables of interest had been identified 
previously through a survey of clinical opinion conducted by Morris 
(1995) (see Chapter 7). Those variables that the clinicians had 
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proposed and reasons for their inclusion in these exploratory analyses 
are hereby described: 
1. Patients' severity of illness within the first 24 hours of admission 
• Acute Physiology and Chronic Health Evaluation 
(APACHE) 11 scores were measured within the first 24 
hours of admission to the critical care unit. APACHE 11 
is the most widely used severity of illness score in adult 
critical care units and provides a validated means of 
enumerating a patient's severity of illness by 
quantifying the acute changes of 14 physiological 
parameters and includes the patients' chronic health 
status and age (Knaus et a/, 1985). It was developed 
through the screening of a selection of clinical variables 
for their ability to predict resource use and patient 
outcomes (death) (Bardsley, 1987). 
2. Critical Care Unit Mortality 
• The costs of patients were described according to their 
survival status at discharge from the critical care unit 
(expressed as survivors I non-survivors). 
3. Length of Critical Care Unit Stay 
• Length of stay was measured in fractions of a day from 
the date and time of admission to the critical care unit 
until the date and time of discharge from the critical 
care unit. 
4. Daily Therapeutic Intervention Scoring System Scores 
• A modified version of the TISS scoring system was 
used (Keene & Cullen, 1983). Daily TISS data was 
collected on all patients from the point of admission to, 
and discharge from the critical care unit. 
5. Clinical Procedures 
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• Clinical procedures were suggested as potentially 
important by the clinicians surveyed; however, there 
was no validated classification system of describing 
clinical procedures that could be tested in this 
exploratory study. For this reason, a simple method of 
describing patients' organ support based on the 
Augmented Period Data Set (ACP) was used (National 
Case-Mix Office, 1997). The ACP data set contained 
organ support variables that covered basic respiratory 
support, advanced respiratory support, circulatory 
support, renal support and neurological support. 
6. Patient Dependency 
• Patient dependency (on the nursing staff) was identified 
as a potentially relevant variable by the clinicians 
surveyed but was not studied due to the absence of a 
patient dependency scoring system in routine use in the 
critical care unit where the data collection took place. 
7. Emergency or Elective Admission (to the Critical Care Unit) 
• This descriptor related to whether patients presented as 
planned (elective) or unplanned (emergency) 
admissions to the critical care unit. 
Added to the above list of variables was the age and gender of critical 
care patients that had not been picked up in the consensus of opinion 
survey but were data items routinely collected in the critical care unit. 
4.3 Study design 
Two exploratory analyses were performed using patient-level case-mix 
and cost data collected from the Adult General Critical Care Unit at the 
Royal Hallamshire Hospital in Sheffield. The design of the first study 
is described in Section 4.3.1, and the second study described in Section 
4.3.2. 
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4.3. 1 Study 1: Analysis of daily costs vs. APACHE 11 
scores, critical care unit mortality, length of stay, daily 
TISS points, age and gender; post-operative status; 
emergency I elective status and advanced respiratory 
support (YIN). 
The first study used data from a cohort of patients consecutively 
admitted to the critical care unit over a 12-month period to investigate 
the statistical relationship between their daily costs of care and 6 case-
mix variables (APACHE 11 scores, critical care unit mortality, length of 
critical care unit stay, daily TISS scores, age and gender). Data on three 
additional variables (advanced respiratory support- yln; post-operative 
status and emergency I elective status) were collected retrospectivelyio. 
Data on the 6 variables had been routinely collected by staff working in 
the critical care unit and were readily available for analysis, with the 
exception of data on advanced respiratory support - yln, post-operative 
status and emergency I elective status) which were obtained 
retrospectively using patients' medical records. The time frame of the 
study was 1st April 1996 and 31st March 1997. 
4.3.2Study 2: Analysis of daily costs vs. patients' organ 
support 
The second study analysed six months of data collected over a different 
time period because detailed data on patients' organ support had not 
been routinely collected during the financial year 1st April 1996 - 31st 
March 1997. This meant that additional parameters on patients' organ 
support were introduced into the routine data collection programme 
and so from 151 October 1997 until 31st March 1998 these data were 
collected. 
4.4 Methods 
As explained in Sections 4.3.1 and 4.3.2, different case-mix variables 
were collected for each study. The same exclusion criterion applied for 
10 This decision was made in accordance with the wishes of the journal reviewers once a manuscript reporting the 
findings of the multivariate analysis had been submitted for publication 
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both studies, which was the exclusion ofpatients with a length of stay 
of less than 24 hours. 
Section 4.4.1 describes how the data used in the analyses performed in 
the first study were recorded. 
4.4. 1 Collection of case-mix variables for study 1 
Severity of Illness 
• The nursing staff calculated and recorded patients' 
APACHE 11 scores within 24 hours oftheir admission to 
the critical care unit. 
Length of Critical Care Unit Stay 
• Length of stay was calculated automatically using the 
dates and times of admission to (and discharge from) 
the critical care unit. Time was measured in fractions of 
a day. 
Critical Care Unit Mortality 
• Patients' survival status was recorded by the nursing 
staff upon discharge from the critical care unit. 
Therapeutic Intervention Scoring System (TISS) Scores 
• The nursing staff recorded patients' daily TISS scores 
to reflect patients' need for therapeutic intervention 
over the previous 24-hour period. 
Age and Gender 
• These variables were routinely recorded for each patient 
at the point of admission to the critical care unit. Gender 
was coded in dichotomous form and age analysed as a 
continuous variable as advised by Altman & Royston 
2006; Normand, 2006; Owen & Froman 2006; 
Finkelstein, 2005; Streiner, 2002; Dinero, 1996). 
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Post-Operative Status 
• If patients had received surgery immediately prior to 
admission to the critical care unit, they were assigned a 
'yes' against the post-operative status variable. All 
remaining patients were assigned a 'no'. 
Emergency I Elective Status 
• Patients whose admission was planned in advance of 
admission were considered to be 'elective' admissions 
and all remaining patients were considered 'emergency' 
admissions. 
Advanced Respiratory Support (Y IN) 
• Patients who received mechanical ventilation at any 
point during their critical care unit admission were 
assigned a 'yes' against this variable. All other patients 
were assigned a 'no'. 
4.4.2 Collection of case-mix variables for study 2 
The second study focused solely on patients' organ support. Note that 
these data constituted the 'proxy' for clinical procedures identified in 
the consensus of opinion survey (Section 4.2). 
• Patients' Organ Support 
o Definitions relating to the five types of organ 
support, collected on a daily basis from the point 
of admission to the critical care unit until 
discharge from the critical care unit are given in 
Table 4.1. Patients with no organ support were 
those that did not score on any of the organ 
support variables. A coded value of 1 was 
assigned to individual patient days against each 
of the different types of organ support if they 
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were given during that patient day. A value ofO 
was assigned if that type of organ support was 
not given. Note that the last day of each patient's 
stay was excluded from the analysis as this day 
varied from 0.1 -0.9 days and the costs 
produced would not have reflected a complete 
day of stay. 
Table 4. 1: Organ support definitions 
Type of organ support 
No organ support 
Basic respiratory support 
Advanced respiratory support 
Circulatory support 
Definitions 
Patients were recorded as having received no organ support if no organs were 
supported. 
Basic respiratory monitoring and support was indicated by one or more of the 
following: 
1. More than 50% oxygen by fixed performance mask. 
2. The potential for deterioration to the point of needing advanced respiratory 
support. 
3. Physiotherapy to clear secretions at least two hourly, whether via a 
tracheostomy, minitracheostomy, or in the absence of an artificial airway. 
4. Patients recently extubated after a prolonged period of intubation and 
mechanical ventilation. 
5. Mask CPAP or non-invasive ventilation. 
6. Patients who are intubated to protect the airway but needing no ventilatory 
support and who are otherwise stable. 
Advanced respiratory monitoring and support was indicated by one or more of 
the following: 
1. Mechanical ventilatory support (excluding mask (CPAP) by non-invasive 
methods e.g. mask ventilation. 
2. Extracorporeal respiratory support. 
Circulatory monitoring and support was indicated by one or more of the 
following: 
1. Vasoactive drugs used to support arterial pressure or cardiac output 
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2. Circulatory instability due to hypovolaemia from any cause. 
3. Patients resuscitated following cardiac arrest where intensive care is 
considered clinically appropriate. 
4. Intra aortic balloon pumping. 
Neurological support 
Renal support 
Neurological monitoring and support was indicated by one or more of the 
following: 
1. Central nervous system depression, from whatever cause, sufficient to 
prejudice the airway and protective reflexes. 
2. Invasive neurological monitoring, e.g. ICP, jugular bulb sampling. 
Renal monitoring and support was indicated by: 
1. Acute renal replacement therapy (haemodialysis, haemofiltration etc.) 
4.4.3Costing methodology 
The 'activities of care' costing method was briefly described in Chapter 
3, Section 3.9.11. The list of activities, relating to this methodology and 
collected on the patients studied, is shown in table 4.2. 
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Group 
Administration 
Drugs 
Colloids 
Crystalloids 
Drug method 
Investigations 
Table 4.2: Summary list of activities (Hibbert et al., 1998) 
litem Group litem 
Admission to the ICU Procedures Abdominal drain 
Discharge from the ICU Arterial line 
Organ donation Cardiac output monitoring 
Relatives interview Chest drain 
Colostomy 
Standard doses for the products Central Venous Pressure (CVP) line 
identified 
Continuous Veno-Venous 
Haemofiltration (CWH) filter change 
Cryoprecipitate Epidural procedure 
Fresh frozen plasma Endotracheal tube 
Haem ace I Formal tracheostomy 
Human Albumin Solution (HAS) !Ileostomy 
HAS20% Mini tracheostomy 
Hespan Naso gastric tube 
Packed cells Nasojejeunal 
Platelets Percutaneous tracheostomy 
Whole blood Urine output 
Venous line 
Continuous Veno-Venous Wound drain 
Haemofiltration (CWH) 
Nasogastric feeds Treatment CPAP 
All fluids listed in the BNF Defibrillation 
Epidural Inspired Oxygen 
Intramuscular KCI bed 
Intravenous bolus Plasmapheresis (FFP) 
Intravenous infusion Plasmapheresis (HAS) 
Nasogastric Ventilatory support 
Nebulised 
Oral 
Rectal 
Short infusion Ward rounds Weekday AM 
Weekday Bacteriologist 
Weekday Biochemist 
Subcutaneous Weekday Evening 
Sublingual Weekday PM 
Topical Weekend 
Vaginal 
Bronchoscopy Nursing shifts Morning 
Cardiac echo Afternoon 
CAT scan (body) Night 
CAT scan (head) 
Electrocardiogram (ECG) 
Gastroscopy 
Lumbar puncture 
MRI/NMR scan 
Ultrasound 
Section 4.4.3.1 will describe how resources were allocated to the 
activities of care in order to estimate the costs of each activity. 
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4.4.3.1 Allocation of resources to the activities of care 
The overall costing was achieved by: 1) allocating resources to each 
activity on the basis of their expected use and 2) assigning unit costs to 
these resources (Wilson et al., 1995 & Edbrooke et al., 1997). In this 
way, a cost per activity of care could be estimated. 
The ways in which the first task was achieved (i.e. the determination of 
resource use) was by using a combination ofprotocols of care and by 
employing a consensus method based on the opinions and experience 
of clinicians and nurses working within the critical care unit. The 
consensus group comprised a small sample of clinicians (n=2), nurses 
(n=4), medical technical officers (n=2) and ward clerks (n=1) who 
studied the list of activities and using the protocols of care stipulated 
for each activity and their knowledge base, identified those resources 
that would typically be used to deliver the activity. The advantage of 
having more than one individual staff member involved in this task was 
that the care of patients is essentially multidisciplinary so it brought a 
wider range of direct knowledge and experience to the task. 
Furthermore, interaction between the individuals involved stimulated 
consideration of a wide range of treatment (hence resource) options 
(Murphy et al., 1998). Care needed to be taken over the choice of 
individuals (ensuring that the different staff disciplines were 
sufficiently represented) and that no one person dominated the 
discussions. 
Each member of staff recorded their lists of resource use independently 
and then were brought together to look over their responses (as a 
group) to ensure that for each activity, all of the resources involved in 
performing the activities of care had been correctly identified (i.e. the 
list was complete and the quantities corrected estimated). All initial 
estimates were shared among the respondents who were given the 
opportunity to refine their estimates based on those provided by their 
colleagues. The arithmetic means of the final estimates were used in 
the configuration (Murphy et al., 1998). 
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4.4.3.2 Configuration of activities 
Table 4.3 describes those resources included in the list of activities. 
Table 4.3: List of included resource items 
Staff Clinical support services 
Nursing staff Laboratory tests 
Medical staff Radiology tests 
Administrative staff 
Medical Technical Officers 
Physiotherapists 
Dieticians 
Consumables Capital Equipment 
Drugs and fluids Ventilators 
Disposable equipment Monitors 
Blood and blood products Humidifiers 
Specialised bed therapy 
Maintenance costs 
Mereu et al., (1994) found that much of the care delivered in a critical 
care unit has a significant time-based component rather than the 
delivery of single isolated activities of care. For this reason, the 
activities of care methodology incorporated Mereu et al., 's suggestion 
of describing the activities in terms of start-up events 11; point eventsi2 
and intervals events13. All activities had to have at least one type of 
event, but not all activities had to have all three types of event. 
For each activity, respondents were asked to specify (in minutes) the 
time taken for each (relevant) staff member to perform each activity, 
the type and quantity of disposable equipment and blood and blood 
products used, the type of laboratory and radiology tests performed 
within the activities and finally, the time taken to set up items of capital 
equipment (then clean them). 
11 Start-up events- the resources used to initiate a clinical activity (e.g. insertion of a Swann Ganz catheter for 
cardiac output monitoring) 
12 Point events- the resources used for discrete interventions in an ongoing activity of care (e.g. taking a 
measurement of cardiac output) 
13 Interval events- the resources used for the ongoing care of the patient required as a result of a particular 
activity. This is measured in terms of the costs per hour. 
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The non-direct costs of care represented the 'overhead' costs that were 
defined by Wilson et al., (1995) as 'costs not directly attributable to 
the care of an individual patient'. Only the costs of the activities were 
included in the analysis as the overhead costs would have been 
constant (i.e. the same for every day) so were excluded. It is considered 
acceptable to do this on the basis that 'in order to study the relationship 
between [outcome}, resource use and patient characteristics, there is 
no need to include overheads and capital costs' (Gyldmark, 1995). 
Appendix 4.1 tabulates the resources used (and their quantities) by 
activity of care. The consurnables were expressed in single units 
(quantities), as were the drugs, contracts and equipment. Note that the 
drugs listed were just local anaesthetics and saline. All of the other 
drugs were assigned to individual patients rather than to the activities 
of care. Quantities assigned to staff members were units oftime 
(minutes) taken to perform each activity. Time and motion studies were 
conducted to validate the completeness and accuracy of the identified 
configuration. 
4.4.3.3 Allocation of unit costs to the activities of care 
The costs of care were determined by allocating unit costs against the 
resources listed for each activity. 
The costing of drug therapies, on the other hand was divided into two 
components: 
• The unit costs of the drug multiplied by the quantities 
needed in vials (not necessarily used); and 
• The resources used in administering the drug to the 
patient (according to the method of delivery e.g. 
intravenous infusion, short infusion, bolus 
administration). 
Added together these two components formed the cost of the drugs and 
fluids. 
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Resources 
4.4.3.4 Sources of unit cost data 
The unit cost data came from a variety of sources, mainly within the 
Hospital (table 4.). 
Table 4.4: Sources of unit cost data 
Data Sources 
Nursing staff costs Critical Care Unit budget statement 
Anaesthetic budget statement 
Supplies Department within Hospital 
Equipment manufacturers 
Medical staff costs 
Disposable Equipment costs 
Capital Equipment costs 
Laboratory test costs 
Radiology test costs 
Blood and Blood Products 
Microbiology tests 
Physiotherapy costs 
Dietetic costs 
Drug and fluid costs 
Department of Laboratory Medicine within Hospital 
Department of Radiology within Hospital 
Pharmacy Department within the Hospital and the National Blood 
Bank 
Department of Microbiology within the Hospital 
Department of Physiotherapy within the Hospital 
Department of Dietetics within the Hospital 
Pharmacy Department within the Hospital 
4.4.3.5 Estimation of unit cost data 
The unit cost for a minute of nursing time was estimated using annual 
expenditure and whole-time equivalent data by grade-mix apportioned 
down to an hourly rate then to a rate per minute. The Departments of 
Laboratory Medicine and Radiology produced the unit costs of 
laboratory and radiology tests respectively, as did the Department of 
Microbiology with the microbiology tests. The hourly cost for a 
physiotherapist and a dietician was estimated from annual salaried 
information provided by the relevant Departments within the hospital. 
The Hospital Supplies Department produced a print out of all of the 
disposable items used by the critical care unit with a list of the unit 
costs. The drug costs used were supplied by the Hospital Pharmacy 
Department and were the prices paid by the Hospital rather than the 
British National Formulary costs. All of the unit costs were entered into 
the Access database. 
In the second study the unit costs for each of the resource items had 
been updated, not by the use of inflation indices but by the re-
collection of these unit costs. 
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No validation ofthe accuracy and completeness of the identified 
configuration (of activities) were performed. 
4.4.4Analysis plan 
In the first study, the statistical relationship between each of the case-
mix variables and patients' daily costs of care (described in Section 
4.4.1) were evaluated using univariate and multivariate techniques. 
TISS was the only variable where daily data were recorded which 
allowed an analysis of the actual (as opposed to average) daily costs of 
care to be performed. Other data items were collected at different 
times; the collection of APACHE 11 scores took place within 24 hours 
of critical care unit admission (i.e. a one-off collection of data) and 
other variables such as age and gender were collected on admission. 
Length of stay was calculated upon discharge from the critical care 
unit. For these data, it was not permissible to use daily costs of care in 
the analysis, so average daily costs were instead used. Average daily 
costs were estimated by apportioning the total costs of care by the time 
spent in the critical care unit (measured in fractions of a day from the 
time of admission). Actual daily costs were those that reflected the cost 
of activities received during that day. 
4.4.4. 1 Univariate analyses 
Univariate statistical techniques were used to study the explanatory 
power of each of the independent variables on their ability to predict 
average daily cost variation. 
Each of the dependent variables (cost predictors) were regressed 
against the daily costs of care which produced information on the 
overall model fit, namely the correlation (R) between cost and the 
variable(s) under evaluation and the extent to which the variation in 
cost could be explained (R2). Linear regression was used on the basis 
that the model is additive, with the regression coefficients interpretable 
as the increase in cost for a one-unit increase in a given predictor 
variable (Myers, 1990). Analysis of variance (ANOVA) determined 
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whether the model, overall, resulted in a significantly good degree of 
cost prediction. It produced the sums of squares and the degrees of 
freedom associated with each and from these two values, the average 
sums of squares (the mean squares) could be calculated. The most 
important component of this analysis was the F-ratio- which tests the 
overall fit of the model to the data- and the associated significance 
value. The t-test statistic tests the null hypothesis that there is no linear 
relationsip between the dependent variable and the independent 
variable (i.e. Ho states that the regression coefficient is 0) (Kinnear & 
Gray, 2000) with a statistically significant result confirming the view 
that the predictor variable is an important contributing factor to 
estimating costs (Field, 2000). The most accurate predictive model 
from the univariate analysis was judged on the strength of the R2 value, 
the F ratio and significance value and the t-test statistic. The value R2 is 
the proportion of variance of the original data explained by the model 
and the F ratio is the ratio of the mean square for regression to the 
residual mean square. For models with only one independent variable, 
like here, the R2 is simply the square of the correlation coefficient 
(Campbell, 2001 & Swinscow, 1996). 
Scatter plots of the variables were produced in order to assess whether 
the relationship between the two variables was genuinely linear. For 
each model, the regression equation was determined which was 
specified by the constant term and the coefficients. There are two main 
methods of cross-validation; the first involves calculation of the 
adjusted R2 value that indicates the loss of predictive power or 
shrinkage, and the second method is concerned with data splitting. As 
the sample of data upon which the models were based was small, it was 
decided not to employ the data splitting approach and instead focus on 
the adjusted R2 value. 
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4.4.4.2 Multivariate analyses 
Multiple linear regression models attempt to predict or estimate the 
value of a single continuous response variable from the known values 
of two or more continuous or categorical explanatory variables (Lang 
& Secic, 1997) and are frequently used in health services and outcomes 
research to determine the association between patient characteristics 
and hospital costs {Taylor et al., 1990; Ghali et al., 1999; Austin et al., 
2003). The standard linear regression analysis is depicted 
mathematically using the equation of a straight line, where Y is the 
variable that one would wish to predict, Po is the constant value (or 
intercept term),/31 is the coefficient of the first predictor (X1), {32 is the 
coefficient of the second predictor (X2), Pn is the coefficients of the nth 
predictor (Xn) and the residual term (E) represents the difference 
between the variable (e.g. average daily cost for emergency 
admissions) predicted by the line for the critical care unit i and the 
average daily cost of emergency admissions actually incurred by the 
unit. The regression equation fork independent variables is given by: 
Where Po, f3t. /32, .. . , f3k are the regression coefficients that need to be 
estimated. 
Three additional variables were included in the multivariate analysis 
that had not been included in the univariate analysis; these were 
emergency I elective admissions, whether patients had received 
advanced respiratory support at any point during their stay (Y IN) and 
whether patients had received surgery prior to admission to the critical 
care unit, denoted as post-operative (Y/N) (Jacobs et al., 2001)14. In the 
second study, the statistical relationship between patients' daily costs 
of care and their type of organ support received on that day was 
explored. The organ support data were treatment-based, and not 
measures of organ failure. Organ support therefore could be viewed as 
14 This was because the univariate analyses proceeded the multivariate analysis, and here these additional 
variables had not been considered relevant to the analysis. 
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a driver of cost. However, this was not considered a problem as the aim 
of this study was to develop a greater understanding of the extent to 
which different variables could predict treatment costs and thus form 
part of a reimbursement system that was capable of accurately 
reflecting incurred costs at the point of discharge from the critical care 
unit. 
In each study, forced entry was used whereby all variables were 
entered into the model simultaneously and log-transformations were 
performed to achieve a better model fit. A common analytical approach 
employed when faced with non-normal data is to transform the data 
(typically the dependent variable) to a scale on which it is reasonable to 
assume normality (Manning, 1998; Alman, 1991; Manning & Mullahy, 
2001; Kilian et al., 2002). Log transformation was defined by the 
equation y =In (x}, where x represents the original variable and y the 
transformed variable. When the coefficients are translated back into 
their natural units, they produce a non-linear relationship between the 
dependent and independent variables (Armitage & Berry 1994). 
4.5 Results 
4.5. 1 Results of the univariate analyses: Study 1 
Data on 265 consecutively admitted patients were available for analysis 
in Study 1 during the financial year 1st April1996- 31st March 1997. 
4.5.1.1 APACHE 11 vs. Daily costs of Care during the first 24 
hour period 
The relationship between patients' APACHE II scores and costs 
incurred in the first 24 hours was studied using linear regression 
analysis where APACHE II scores were found to explain 8.7% ofthe 
variation in cost (R2). 
The model equation was defined as: 
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Predicted 24 Hour Cost (standard error)= £543 (£74) + (£18 (£4) x 
APACHE II score). 
And suggested a positive relationship between the costs of care and 
severity of illness (see Figure 4.1 ), but whilst this relationship was 
statistically significant (p<O.OOOl) confirming a significantly better 
prediction of cost than the use of mean APACHE 11 scores alone, the 
increase in APACHE 11 scores represented only a small increase in cost 
as evident from the value oft ( 4.399). 
Figure 4.1 shows a scatter plot of the APACHE II scores plotted 
against these costs together with the positive sloping regression line. 
As can be seen from the plot, the upward sloping direction of the line 
indicates that costs of care increase with patients' severity of illness, 
although there are a number of scores that deviate from the line. 
Figure 4. 1: Scatter plot of the costs of care in the first 24 
hours vs. APACHE 11 scores 
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4.5.1.2 Critical care unit length of stay vs. average daily costs 
It was not permissible to study the relationship between critical care 
unit length of stay and daily costs of care because length of stay is 
expressed as a summed observation and daily costs present as 
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individual observations. Instead data on patients' length of stay were 
studied in a linear regression analysis to estimate the relationship 
between patients' average daily costs. The downward sloping 
regression line illustrated in Figure 4.2 is indicative of an inverse 
relationship between these two variables, suggesting a decrease in 
average daily costs as length of stay increases. The model equation 
confirms this hypothesis, as follows: 
Predicted Average daily cost (standard error)= £727 (£36) +(Length 
of stay x -£3 (£3). 
The statistical relationship was not highly significant (p=0.220) and 
explained only 8% of the variation in average daily costs between 
patients. Figure 4.2 illustrates the skewed distribution of the data, with 
a small number of outlier patients contributing to a long right-hand tail. 
Outliers are extreme values (Kinnear & Gray, 2000) (or 'cases that do 
not belong in the group to which they are assigned provisionally' 
(Palm er & Reid, 2001 ). 
Figure 4.2 shows a scatter plot of patients' length of stay against their 
average daily costs of care together with the regression line. 
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Figure 4.2: Scatter plot of patients' average daily costs of 
care vs. length of stay 
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4. 5. 1.3 Survival status vs. average daily costs 
Non-survivors were found to cost more to treat on a daily basis than 
survivors. Although this difference was statistically significant with 
average daily costs for non-survivors costing close to £400 more than 
for survivors, the explanatory power of survival status was low (R2 = 
0.152). This was however better than the predictive accuracy of 
APACHE II scores and length of stay and the F -ratio of 34.480 was 
statistically significant (p<O.OOOl). This suggested that like the 
APACHE II data, adjusting for survival status produced a better 
prediction of average daily cost than using average daily costs alone. 
The model produced equations for the average daily cost of survivors 
and non-survivors respectively: 
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Predicted average daily cost of survivors (standard error)= £1,001 
(£58) - £388 (£66). 
Predicted average daily cost of non-survivors= £1,001 (£58). 
4.5.1.4 TISS points vs. daily costs 
The analysis between patients' daily TISS points and their 
corresponding daily costs of care found TISS to explain 37.8% of the 
variation in cost (p<0.0001). 
The upward sloping regression line seen in Figure 4.3 illustrates the 
linear relationship between TISS points and daily costs of care- with 
the higher the TISS point, the greater the daily cost. There are a small 
number of outliers but generally, the relationship between the two 
variables appears strong. 
The model equation was defined as: 
Predicted Daily Cost (standard error)= £59 (£26) + (£20 (£1) x TISS 
score). 
Figure 4.3 shows a scatter plot for patients' daily TISS points plotted 
against their daily costs of care (for that day) together with the 
regression line. 
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Figure 4.3: Scatter plot of daily costs of care vs. TISS 
points 
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4. 5. 1. 5 Gender vs. average daily costs 
80 
Gender was not a significant predictor of average daily cost in the 
sample studied (p=0.740) with very low explanatory power (R2 = 
0.003). Women were found to cost £687 per day to treat and men cost 
marginally more at £727. 
The model produced equations for the average daily cost of women and 
men respectively: 
Predicted average daily cost (standard error) of women= £707 (£31)-
£20(£31) 
Predicted average daily cost (standard error) of men= £707 (£31) + 
£20 (£31). 
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4.5.1.6 Age vs. average daily costs 
Age only explained 0.3% of the variation in average daily cost between 
the patients studied making it, along with gender, the weakest predictor 
of cost explored in this series of analyses and did not reach statistical 
significance (p=0.423) 
The model equation was defined as: 
Predicted average daily cost (standard error)= £633 (£92) + (£1 (£1.5) 
xAge) 
which for every year of age an increase of£ 1 was incurred. 
Figure 4.4 shows a scatter plot of patients' age plotted against their 
average daily costs and the poor statistical relationship between the two 
is evident from the absence of any pattern as such. There are a small 
number of outlier cases (low age I high cost cases). 
Figure 4.4: Scatter plot of average daily costs of care vs. 
age 
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4. 5. 2 Results of the multivariate analysis: Study 1 
Data on 193 patients with a length of stay > 24 hours were included in 
the multivariate regression analysis. Excluded were patients staying 
less than 24 hours in the critical care unit for which average daily costs 
could not be estimated. 
A multiple regression analysis was undertaken using average daily 
costs as the dependent variable and independent variables that included 
age, gender, APACHE 11 scores, length of critical care unit stay, 
survival at critical care unit discharge, admission status (emergency or 
elective admission), the percentage of patients receiving advanced 
respiratory support and whether patients had received surgery prior to 
their critical care unit admission (post-operative (Y/N)) (Jacobs et al., 
2001). Data on the latter three variables were included in this analysis 
but were not included in the univariate analysis. TISS data were 
excluded. 
The exponential regression or double-log equation was found to best fit 
the data: 
In a double-log linear regression, all variables (both X and Y) are 
translated into natural logarithms. One attractive feature ofthis model 
is that the slope coefficient p 2 measures the elasticity of Y with respect 
to X, that is, the percentage change in Y for a given (small) percentage 
change in X. The model also assumes that the elasticity coefficient 
between Y and X, P2, remains constant throughout (Gujarati, 1995). Of 
particular interest was the functional form of the model with respect to 
length of stay. The results for the double-log case only (which 
expressed all variables except dummy variables in terms of natural 
logs) were reported since it performed as well as any other form. In a 
double-log regression equation, all variables except dummy variables 
are translated into logarithmic form. This means that the regression 
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coefficients of the logarithmic variables are expressed as relative rates 
of change. When the coefficients are transferred back into their original 
forms they produce a non-linear relationship between dependent and 
independent variables (Jacobs et al., 2001). 
Descriptive statistics relating to the variables included in the analysis 
are shown (table 4.5). 
Table 4. 5: Descriptive statistics of variables used in the 
multiple regression model (Jacobs et al., 2001) 
Variable Mean (SO) Median (IQR) 
Average daily cost(£) 703 (422) 578 (469-776) 
Age (years) 55.3 (19.3) 58.6 (41-71) 
Gender (% female 43 
Post-operative (% surgical) 44 
Emergency admissions, % 86.5 
APACHE 11 score 15.6 {7.1) 15.0 {10-20) 
Advanced respiratory support{%) 69 
Length of critical care unit stay {days) 7.2 (11.0) 3.0 (1.8-8.1) 
Survival at ICU discharge(%) 77 
The regression model explained 35.8% of the variation in average daily 
costs. The regression coefficient of the log of average daily costs on the 
log of length of critical care unit stay yielded a coefficient of -0.12, 
which meant that a 10% increase in length of stay was associated with 
a 12% decrease in cost per day (table 4.6). 
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Table 4. 6: Results of the regression analysis of average 
daily cost (Jacobs et al., 2001) 
Variable Coefficient P value 
Constant 5.994 0.000 
Age 0.0022 0.972 
Gender 0.0169 0.738 
Postoperative (1=Yes, 0 =No) 0.1040 0.057 
Emergency admission (1=Yes, O=No) 0.0281 0.729 
APACHE 11 score on admission 0.211 0.000 
Advanced respiratory support (1=Yes, O=No) 0.255 0.000 
Length of critical care unit stay -0.120 0.000 
Survival at ICU discharge (1=Yes, O=No) -0.256 0.000 
Age, gender and emergency admissions were not found to be 
statistically significant, which is not surprising for gender or age given 
the findings from the univariate analyses. A non-linear relationship 
between average daily cost and length of stay suggested however that 
the longer the stay in the critical care unit, the lower the average daily 
costs of care. 
4.5.3Results of the multivariate analysis: Study 2 
Data on 116 consecutively admitted patients over a six-month period 
was used in Study 2. Eighty-five patients (73%) had a critical care unit 
length of stay in excess of 24 hours and so were included in the study, 
yielding a total of 527 patient days for analysis. There were 5 (of the 
527) patient days where no organs were supported. In 89 patient days 
there was only basic respiratory support, and in 225 patient days there 
was only advanced respiratory support. The remainder of cases had 
multiple organ support. The most frequently observed combinations of 
multiple organ support were advanced respiratory and circulatory (71 
patient days) and advanced circulatory and neurological (54 patient 
days). The frequency of types of support is summarised in table 4.7. 
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Table 4. 7: Frequency of the types of organ support 
received 
No Basic Advanced Circulator Renal Neurologl Number 
support respirat respiratory y support support cal of days 
ory support support observed 
sueeort !%} 
X 5 0.9 
X 89 {16.9} 
X 226 ~42.9} 
X 
X 
X 
X X X 1 (0.2} 
X X 2 ~0.4} 
X X 3 (0.6} 
X X X X 6 (1.1} 
X X X 6 (1.1} 
X X 
X X 
X X X 19 (3.6} 
X X X 24 ~4.6} 
X X 54 ~10.2} 
X X 71 (13.5) 
Descriptive statistics for the daily costs of care by organ support are 
shown in table 4.8. 
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Table 4. 8: Descriptive statistics of the daily costs of care 
by type and combination of organs supported 
N (days)(%) Mean (SO) (£) Median (25%-75% IQR [Min· 
Organ 
support type 
0 5 (0.9) 
1 89 (16.9) 
2 226 (42.9) 
3 4 (0.8) 
4 1 (0.2) 
5 9 (1.7) 
6 7 (1.3) 
7 3 (0.6) 
8 1 (0.2) 
9 6 (1.1) 
10 71 (13.5) 
11 54 (10.2) 
12 2 (0.4) 
13 24 (4.6) 
14 19 (3.6) 
15 6 (1.1) 
Key 
0 = No organ support 
1 = Basic respiratory support 
2 = Advanced respiratory support 
3 = Circulatory support 
4 = Neurological support 
5 = Basic respiratory & circulatory support 
6 = Basic respiratory & neurological support 
7 = Basic respiratory & renal support 
8 =Basic respiratory, circulatory & neurological 
support 
Max]) 
625 (479) 427 (373- 976 [344-1,478]) 
496(224) 430 (359 - 528 [275 - 1 ,460]) 
640(352) 574 (415- 758 [276- 3,934]) 
667 (537) 431 (359- 1,212 [338- 1 ,470]) 
655 
687(374) 503 (422- 1,061 [364- 1 ,350]) 
580 (154) 575 (434- 719 [345.- 749]) 
577 (143) 527 (467 - n/a [467- 739]) 
694 
2,090 (1 ,322) 1,847 (1 ,074-2,887 [838 -4,513]) 
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877 (455) 795 (542 - 1 ,028 [394 - 2,801]) 
804 (836) 596 (419- 817 [296- 6,011)) 
1,475 (455) 1,475 (1, 153- n/a [1, 153- 1 ,796)) 
1,023 (382) 912 (729- 1 '192 [538- 2,038]) 
1,459 (519) 1 ,627 (859 - 1 ,846 [554 - 2,202]) 
1,391 (614) 1 ,591 (686 - 1 .001 [609 - 1 .96m 
9 = Basic respiratory, circulatory & renal support 
10 =Advanced respiratory & circulatory support 
11 = Advanced respiratory & neurological support 
12 =Advanced respiratory & renal support 
13 =Advanced respiratory, circulatory & neurological support 
14 =Advanced respiratory, circulatory & renal support 
15 = Advanced respiratory, circulatory, renal & neurological 
support 
As can be seen from table 4.8, multiple organ upp rt i m re tly 
than supporting a single organ. Ad anced re piratory, ir ulat ry and 
renal support incurred the highest cost. 
The type and combinations of organ support recei ed y patient on a 
daily basis (over a six-month period) was mapped out and a multipl 
regression analysis of these data and patients' daily co ts of car 
performed. It was thought appropriate to use regre sion analy i here to 
characterize the relationship between cost per day (Y) and the number 
of days of different types (and combinations) of organ sy tern upp rt 
(X1, X2 ... Xk). As can be seen from the Figure 4.5, daily cost of c r 
do not appear to follow a normal distribution and show evidence of 
substantial skewness. 
Figure 4.5: Histogram and Q-Q plot showing the 
distributions of the daily costs of care 
Slid Oev • 389 38 
Mean • &05 
......... _______ ............ ._. N • 733 00 
Normal Q-Q Plot of daily cost (£) 
·• 
~~~~~~~~~,~~~'~'~ 
Daily costs of care 
Oboe<vlld Value 
Daily costs Median (25%-75% Skew Kurtosis Kolmogorov- df Slg 
Mean (SO) IQR [Min-Max]) ne ss Smirnov 
£ statistic 
605 (389) 469 (373-698 2.472 7.828 0.197 733 0.000 
[106-3107D 
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The Kolmogorov-Smimov statistic is significant. Briggs & Gray 
(1999) recommend the use of median as opposed to mean estimates of 
central tendency when data are skewed, however add that it is 
inappropriate to use median costs in a cost analysis on the basis that the 
median cost will be below the mean (a view supported by the data 
presented below each histogram). The log-linear form of equation, by 
which costs were expressed in logarithmic form, the day of stay in 
ordinary form, and the categorical variables expressed as dummy 
variables was the best fit. The coefficients (and level of significance) 
are shown (table 4.9). 
Table 4.9: Results of the regression model of organ 
support and daily costs 
Dependent Variable 
Independent variables 
Constant 
Day of care 
Advanced respiratory support 
Circulatory support 
Renal support 
Neurological support 
Log of cost per day 
(£) (p values) 
6.428 (p<0.0001) 
-0.0108 (p<0.0001) 
.235 (p<0.0001) 
.257 (p<0.0001) 
.588 (p<0.0001) 
.0707 (p=0.162) 
The results suggest a statistically relationship between patients' organ 
support and their daily costs of care, and which also suggests that daily 
costs decline slightly as length of stay increases. Organ support does 
appear to influence the cost per day, especially for renal and circulatory 
support. With regard to the daily cost equation, the R2 was 0.307, 
p<O.OOOl. The predicted daily cost for the basic reference case (1 day 
stay, basic respiratory support only) was £612. The coefficients for 
advanced respiratory support, circulatory support, and renal support 
were also statistically significant; the coefficient for neurological 
support was not however. Advanced respiratory support was found to 
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add £162 to each day above basic respiratory support; circulatory 
support added £179. Renal support by itself added £490 above basic 
respiratory support. Compounded, these differences were greater. 
Advanced and renal support added £389 above basic respiratory 
support; and renal, circulatory and advanced respiratory together added 
£1,190 above basic respiratory support. 
4.6 Discussion 
Regression analysis has been frequently used in different studies to 
both identify factors found to contribute to variation in cost (Ruttcn-
van Molken et al., 1998; Rutten-van Molken & Van Doorslaer 1999; 
Koopmanschap et al., 2001); to predict costs and length of stay in 
patients (Antonow et al., 2001) and to estimate resource use i.e. 
patients' TISS score during the first 7 days in the critical care unit 
(Zimmerman et al., 1993). The dependent variable in the analysis is 
typically cost (per day or per stay) and the independent variables can be 
diagnosis, length of stay or other identifiably important factors (Smith 
& Bamett, 2003). The transformation of data from one scale to another 
can be used to overcome problems associated with skewness (Briggs & 
Gray, 1999), and is deemed to be an appropriate correction (Hay, 
2005). There are however problems with the transformation of data 
which are worthy of note. Cantoni & Ronchetti (2006) alude to these, 
in particular, the difficulties in the interpretability of the model 
coefficients and the quality of the retransformed parameter estimates is 
typically poor. Alternative approaches, such as the use of non-
parametric bootstrapping which employs the empirical distribution of 
costs to make inferences about the uncertainty of the sample mean 
could have been considered (Barber & Thompson, 2000). 
4. 6. 1 Selection of variables for study 
The variables available for the exploratory analyses were those 
routinely collected by the critical care unit staff. Table 4.10 summarises 
the main findings from the univariate analyses. 
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Table 4. 10: Summary of the univariate and multivariate 
Analyses 
Choice of independent Choice of R2 F T P Value 
variables dependent 
variable 
APACHE 11 scores Costs of care 0.087 19.347 4.399 <0.0001 
in the first 24 
hours 
Critical care unit length of stay Average 0.008 1.517 -1 .231 <0.0001 
daily costs 
Survival status Average 0.152 34 .480 -5.872 <0.0001 
daily costs 
Daily TISS scores Actual daily 0.378 443.782 21 .066 <0.0001 
costs 
Gender Average 0.003 0.301 
Male daily costs 0.642 0.522 
Female -0.648 0.518 
Age Average 0.003 0.644 0.803 0.423 
daily costs 
APACHE 11 scores, critical care Average 0.358 <0.0001 
unit length of stay, survival daily costs 
status, admission status, % of 
patients receiving advanced 
respiratory support, post-
operative status vs. average 
daily costs 
Multivariate analysis of Actual daily 0.307 <0.0001 
patients' organ support vs. costs 
dail costs 
Each variable will now be discussed in turn. 
APACHE 11 Scores 
Based on the findings of this study, patients' APACHE II scores could 
not be considered a strong predictor of daily cost. The scoring system 
was primarily intended for prediction of mortality, not for describing 
critical care patients or predicting costs of care (Dragsted & Qvist, 
1992). It was thus not surprising to observe such a poor correlation. An 
additional problem with APACHE II scores is put best by Bimbaun 
(1986)- 'the severity of the disease process(es) does not necessarily 
reflect the level of care required to support the patient ... . with very ill 
patients possibly only requiring supporting care whilst minimally ill 
patients may require profound levels of care'. APACHE II scores are 
only recorded within the first 24 hours of admission, which limits its 
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ability to reflect changes in resource use and cost over time. Finatly, a 
large amount of data is required in order to calculate the APACIIE 11 
scores which is a further problem for routine data collection. 
Critical Care Unit Length of Stay 
Patients' length of stay in the critical care unit has always been a 
naturally strong predictor of patients' total costs of care, but was not 
found to be a very good predictor of average daily costs in the 
univariate analysis. 
Patients' Survival Status 
There is a belief that it costs twice as much to die in a critical care unit 
as it does to survive (Sage et al., 1986). The findings in this study 
suggest that the extent to which non-survivors cost more is certainly 
less than this. Non-survivors did cost more to treat on a daily basis than 
the survivors. They did however stay on average, a shorter period of 
time in the critical care unit than the survivors. The regression analysis 
however found patients' survival status to be a very poor predictor of 
average daily costs. 
T/SS 
Patients' TISS points were able to explain about 38% of the variation 
in daily costs in this study, which was a significant result. The practical 
and methodological problems of using TISS as a method of cost 
estimation in a multi-centre setting have already been described 
(Chapter 3, Section 3.13). The critical care unit at the Royal 
Hallamshire Hospital like many other critical care units had modified 
the TISS scoring system to reflect modem clinical practice thus the 
values obtained are not comparable with those reported in the 
literature. The version ofTISS used in this study contained modified 
entries for respiratory and renal support. 
Gender 
Despite epidemiological studies of critical care finding patients to be 
predominantly male, this was not a trend reflected in the study sample. 
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Whilst there were males than females, the extent to which a difference 
existed was not marked. Gender was not considered to play any role in 
explaining cost differences between patients based on the findings from 
this study. 
Contrary to the findings ofBemard et al., 1993), who studied 19,387 
hospital admissions in the United States and found women to spend 
longer in the critical care unit than men, no significant differences in 
length of stay or total costs of care were observed in the sample 
studied. 
Age 
Although crude mortality is higher in the elderly compared to younger 
critical care patients (Power, 1999), previous studies have found age 
not to be a factor that would explain differences in resource use 
(Katzman McClish et al., 1987; Campion et al., 1981). Approximately 
30% of patients in my study were more than 70 years of age and reflect 
a similar trend to that reported in the literature (Horn, 1997 & Schuster, 
1991) with increases in the average age of patients being attributed to 
rising life expectancy and increases in cardiovascular disease that make 
critical care necessary (Horn, 1997). 
The power of age to predict average daily costs of care was found to be 
poor; the results for total costs were marginally better but still not a 
reliable predictor of cost. 
Organ Support 
Organ support ranked the third best predictor of daily cost after TISS 
and the multivariate analysis of the other variables, with an R2 of0.307. 
This was an important finding for consideration in the thesis. It was felt 
that if this variable could be used to predict daily costs and when 
summed together could be used to estimate total patient costs. These 
total costs would thus be a function of patients' length of stay and also 
reflect the care received during that stay. 
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The advantages to this approach for consideration in a multi-centre 
setting were as follows: 
• The organ support variables were contained within the ACP 
data set that all critical care units in England and Wales 
were required to collect on every patient from 151 October 
1997; 
• Staff working within the critical care units were familiar 
with the definitions used for the different types of organ 
support and the data is straightforward and quick to collect; 
• The ACP data set cannot be modified by critical care units, 
in the same way in which TISS is because it forms part of a 
mandatory Department of Health data set; and 
• Being collected on a daily basis, it was sufficiently sensitive 
to changes in care requirements (and costs) over time. 
4. 6.2 Costing Methods 
The activities of care costing methodology used in this study was 
effective in allowing the costs of individual patients to be estimated for 
the purposes of identifying potential cost predictors from the variables 
studied. Due to the limited availability of patient-level cost data, no 
such study to date has investigated each of these potential predictors of 
cost in as much detail. 
The limitations of this study include the small sample size upon which 
these findings are based that raise questions as to the generalisability of 
these findings both from the perspective of the critical care unit where 
the study was performed, and from a broader perspective being that of 
other critical care units in England and Wales. In this study, 
specifically, the relationship between renal support and daily costs was 
not tested as no patients received this support (alone). Six types of 
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organ support IS were delivered on 92% of days, which left a very small 
number of days that were spread across the remaining 9 types of organ 
supporti6. Whilst one can be reassured by the costs produced for the 
former 6 types of organ support, the relationship between the costs and 
the latter need to be interpreted with caution because of the small 
numbers of observations. 
The activities of care costing method had the advantage over a 
'bottom-up' approach because with the latter, all resources are directly 
measured at the bedside, whereas with the activities of care method, 
resource use is grouped together. This means that data collection is less 
laborious at the bedside, because instead of having to record every 
single resource item, the nursing and medical staff just had to record 
that a patient had received a given activity of care. 
There are however limitations of this method of costing. First, the 
configuration of activities assumes an expected resource use for a given 
activity, rather than an observed resource use. This means that for some 
patients where an activity took longer to perform or required more staff 
than expected, their costs will be underestimated. The same reasoning 
applies to activities taking shorter amount of times and incurring less 
staff than expected. What was found after having conducted this study 
was that there was another component to the activities that was 
missing; that is, the finishing of an activity of care (or termination). For 
example, when a patient is weaned from mechanical ventilation and the 
costs incurred with this. If I chose to perform the study again, I would 
have adapted the method accordingly or at least, produced a series of 
activities to reflect this. 
IS Basic respiratory support, Advanced respiratory support, Advanced respiratory & circulatory support, 
Advanced respiratory & neurological support, Advanced respiratory, circulatory & neurological support, 
Advanced respiratory, circulatory, renal & neurological support. 
16 No organ support, Circulatory support, Neurological support, Basic respiratory & circulatory support, 
Basic respiratory & renal support, Basic respiratory, circulatory & neurological support, Basic 
respiratory, circulatory & renal support, Advanced respiratory & renal support, Advanced respiratory, 
circulatory, renal & neurological support. 
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Secondly, the activities of care only account for only a proportion of 
the true expenditure of the critical care unit. To apply these estimates to 
studies seeking to develop HRGs, this represents a problem; that of the 
funding not reflecting all of the costs. 
With respect to testing the generalisability of these findings, further 
problems emerge. Firstly, the configuration of activities changes from 
year to year with changes in clinical practice. This can alter the 
estimates of costs from one study to the next, and care needs to be 
taken to ensure that such observed differences can be explained (either 
by a change in the configuration or in the nature of activities of care 
received by patients). Secondly, the configuration would need adapting 
to reflect differences in resource use and clinical practice if this method 
was applied in a multi-centre setting. The amount of time spent 
maintaining and updating the configuration, based on my experience of 
performing these tasks, was considerable as was the collection of unit 
cost data required to estimate the costs of resources used. Coupled with 
the programming tasks and the amount of time spent by staff at the 
bed-side recording the activities of care, as and when they were 
delivered, raised further questions as to the reproducibility of this 
approach in a multi-centre study. The drug costs were determined from 
transferring the records made on the drug kardexes over to a database 
where the unit costs of these were stored; this was also a labour-
intensive process. 
It would have been useful to have a benchmark against which the 
activities of care could have been compared to assess the activities' 
criterion validity. Although the critical care unit collected TISS scores 
on individual patients, they had modified this measure to reflect the 
care delivered in the unit. Still, this may have proved helpful in 
identifying any mismatch between the two systems and perhaps in 
explaining where some of the nursing time may have been missed. 
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4. 7 Conclusions 
This small exploratory study was able to identify the case-mix 
variables most likely to explain the variation in daily costs between 
individual patients. This study provided focus and direction to the 
design of the proposed multi-centre study in terms of identifying 
important predictors of daily cost. 
The reasons for preferring the organ support approach over the TISS 
scoring system were well explained, however what is worthy of note is 
the benefits that former approach has over the use of a multivariate 
model using patients' APACHE 11 scores etc. described in Section 
4.5.2. A simpler costing method that is dependent on a small number of 
variables is infinitely preferable to one where multiple items of data 
need to be recorded, particularly at different points during a patient's 
stay. 
For the relationship between daily costs and organ support to be tested 
in a multi-centre setting, an alternative method of estimating costs has 
to be considered. The method would need to reflect more closely, the 
expenditure of the critical care unit but be able to detect variation in 
resource use between individual patients. 
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"When you can measure what you are speaking about and express it in numbers, you 
know something about it. But when you cannot measure it, when you cannot express it 
in numbers, your knowledge is of a meagre and unsatisfactory kind'' 
Lord Kelvin 
CHAPTER 5: STUDY METHODS 
5.1 Introduction 
This chapter describes the design of a multi-centre study of adult 
critical care units that was needed to collect the necessary case-mix and 
cost data to propose a set of appropriate HRGs (Chapter 7) and to 
identify the key cost generating events for critical care patients to 
inform the economic evaluation of the CESAR trial (Chapter 8). 
Section 5.2 describes the aims and objectives of the study and explains 
how critical care units were recruited and the incentives offered to 
participants. Multi-Centre Research Ethics Committee approval was 
achieved for this study (Section 5.6). The different options for 
capturing the case-mix data were explored before deciding on using 
specially designed data collection booklets provided in a paper format 
(Section 5.8). The definitions used to estimate costs are described in 
Section 5.9 together with the advantages and disadvantages of the cost 
block method, which was the chosen method. Finally, the data 
collection processes, method of collection and the arrangements made 
for data entry and data management are described. 
5.2 Study aims, objectives and design 
The aim of this study was to generate the necessary data with which to 
propose a set of appropriate HRGs (Chapter 7) and to identify the key 
cost generating events for critical care patients to inform the concurrent 
economic evaluation ofthe CESAR trial (Chapter 8). 
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To this end, this study adopted a different design than that described in 
Chapter 4 based around the collection of monthly expenditure and daily 
organ support data from a representative sample of adult critical care 
units. The cost block method (described in Chapter 3) was used to 
measure expenditure on key areas of resource use during the study 
period. The 'top-down' method of costing is a retrospective method 
frequently used for reimbursement purposes, and as such was 
considered appropriate for devising the HRGs (Gyldmark, 1995). This 
method of costing has also been used to provide overall estimates of 
critical care costs in different countries (Jacobs & Noseworthy, 1990; 
Halpem et al., 1994 & Clermont et al., 1998), as well as in the UK as 
part of the Critical Care National Cost Block Programme (Dean et al., 
2002). 
The objective of this multi-centre study was to identify the most 
appropriate model from which estimates of daily case-mix adjusted 
costs of care (reflecting the organ support received by patients) could 
be determined. The results of this analysis had two specific 
applications: the first being to develop a set ofHRGs for adult critical 
care patients to support reimbursement (Chapter 7) and the second, to 
produce a set of daily cost weights relating to patients' organ support 
for use in the CESAR trial (Chapter 8). 
A prospective, observational, longitudinal study of a representative 
sample of adult critical care units located in England, Scotland and 
Northern Ireland was undertaken. Data were collected over a two-three 
month period during the second trimester of2003. 
The participating critical care units consisted of a volunteer sample and 
whilst it was hoped that a geographically representative sample would 
be recruited, no formal sampling strategies were employed. This was 
because of the 400 critical care units that were invited to participate in 
the study, it had only been expected that a very small number would 
agree to participate. Critical care units are under constant pressure to 
collect data and participate in studies, so it can be difficult to 
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encourage them to take on additional work for no financial 
recompense. The 400 units represented all critical care units in the 
United Kingdom. A sample involving 40 critical care units was thought 
achievable however funding for the study was based on an expected 
recruitment of6 critical care units. 
The Directory of Critical Care (2002) was chosen as the sampling 
frame and was considered the most effective, given its complete 
coverage of all NHS hospitals housing critical care services in the UK 
and the lack of other reliable sources. The Directory comprises over 
400 pages of information on general and specialised critical care units 
and covers the England, Scotland, Wales and the Irish Republic. 
5.3 Recruitment strategies 
The numbers of volunteer centres depended in the most part on the 
successfulness of the recruitment strategies employed. A recruitment 
strategy was devised because the study was considered to be at high 
risk of not recruiting sufficient numbers of critical care units. This was 
for three reasons; firstly, the quantity of data collection was large; 
secondly, there was no funding available to support collection of these 
data and finally, there was little flexibility in the time scales. The 
successfulness of this campaign depended on sound organisational 
planning and effective communication with named individuals working 
in the critical care units. 
5.3. 1 Communication 
The effectiveness ofthe communication strategy depended on correctly 
identifying the most appropriate member of staff to which 
communications should be directed. It was decided to focus on the 
medical staff in the preliminary communications about the study. The 
Clinical Directors I Lead Clinicians of the critical care units were 
approached because they have the greatest levels of responsibility and 
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autonomy for decision-making. The option of contacting individuals by 
e-mail was rejected over postal mail. 
A letter was mailed to all adult general critical care units identified 
from the sampling frame in January 2003, asking for expressions of 
interest in participating in the study. The letter emphasised the 
importance of the study for informing proposed changes in government 
policy, which was felt to be the strongest message to get across to the 
Clinical Directors and the one that would have the greatest impact 
when deciding whether or not to participate. A reply slip and a self-
addressed envelope were enclosed with the letter explaining that a 
study information pack would be forwarded to the named person upon 
receipt of this slip upon return. Interested parties were encouraged to 
make contact with the University to discuss the study over the 
telephone or e-mail if they so wished. Within this mailing also 
contained a contact form where interested critical care units were asked 
to provide details of the name, job title, telephone number, fax number 
and e-mail address of the person who would be co-ordinating the study 
in the unit. Having this information greatly facilitated the task of 
effective and timely communication during the study. 
A positive response to this initial mailing supported the viability of the 
study. As the nature of the study was of interest to Critical Care 
Managers, network managers were contacted at the same time as the 
Clinical Directors .. This two-tiered approach proved to be particularly 
effective. 
5.3.2 Public relations and publicity 
Defined by the Institute of Public Relations as 'the deliberate, planned 
and sustained effort to establish and maintain mutual understanding 
between an organisation and its public' (Institute of Public Relations, 
1986), public relations was a key element in this study. Four critical 
care units requested a site visit where the doctors and nurses were 
given more information about the study and the opportunity to ask 
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questions. Details ofthe study were also presented to representatives 
from two critical care networks and at a well-attended National Critical 
Care Conference. An article was also published in the Intensive Care 
Society's Journal to alert the critical care community as to the 
importance of the impending study and to enhance levels of 
participation and commitment to data collection (Hibbcrt et al., 2003) 
(see Appendix 5.1). 
5. 3.3 Endorsement 
Key policy makers within the Department of Health and the NHS 
Information Authority publicly supported the study, which helped to 
boost recruitment levels. Endorsement from key opinion leaders was 
particularly important as a means of persuading otherwise reluctant 
critical care units to consider participating. Lead clinicians such as Dr. 
John Morris, Dr. Bob Winter, Dr. Giles Morgan and the current 
President of the Intensive Care Society (Dr. Peter Nightingale) 
supported and encouraged participation in the study. 
5.3.4 Branding 
It was felt important to establish a corporate image by means of a logo 
for the study that could be easily identified by the study participants. 
The logo featured on all of the data collection booklets, the posters to 
ritical 
HRGStudy 
staff and to the relatives, all questionnaires and correspondence 
(Appendix 5.2-5.3). 
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5. 3. 5 Incentives 
Incentives offered to both the networks and the participating critical 
care units included feedback in terms of a unit-specific, and where 
applicable, a network-specific report of their data provided for the 
study. All critical care units received their reports at the end of the 
study with a copy of the final report produced for the Department of 
Health. 
5.4 Inclusion criteria for centres 
The study focused on adult general critical care units, defined as 
intensive care units (ICUs), combined ICU I high dependency units 
(HDUs) and combined general care I coronary care units admitting 
mixed medical I surgical patients predominantly older than 16 years. 
Cardio thoracic and neurological intensive care units were also 
included. 
5.5 Exclusion criteria for centres 
Excluded were specialist liver intensive care units, spinal injuries units, 
neonatal intensive care units and paediatric intensive care units. 
Specialist liver intensive care units and spinal injuries units were 
excluded on the basis that their case-mix and costs would be atypical of 
those observed in adult general critical care units (our study 
population) and may skew the results leading to inaccurate conclusions. 
Those critical care units already participating in an evaluation of the 
clinical and cost-effectiveness of Pulmonary Artery Catheters led by 
the Intensive Care National Audit & Research Centre17 (ICNARC) 
were not formally approached. This was because it was felt that critical 
care units would become over-burdened with requests for data. 
Nevertheless, a small number of these centres expressed an interest in 
participating and so were included. In addition, those critical care units 
who had agreed to participate in an evaluation study of the System of 
17 ICNARC is an independent charity established in 1994 and coordinates a national, comparative audit of 
patient outcomes from adult general critical care units in England, Wales and Northern Ireland. 
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Patient-Related Activities (SOPRA) data set, also led by ICNARC 
were asked not to consider participating in this study, unless they were 
able to undertake the two studies in tandem. Data from the ICNARC 
Case Mix Programme (CMP)IS were used to study the 
representativeness of the sample and discussed in more detail in 
Chapter 6. 
5.6 Ethics committee approval 
Ethics committee approval was required for the study for the reasons 
that the patient data would be used for research purposes. An 
application to Trent Multi-Centre Research Ethics Committee (MREC) 
was made in September 2002 and approval for the study granted on 
16th January 2003 (MREC/02/4/088). Due to the study being eligible 
for approval under Section D of the Department of Health's 'No local 
researcher' guidelines', it was not necessary to seek approval from the 
Local Research Ethics Committees (LRECs). Those LRECs that had 
participating hospitals listed within their remit were instead notified, in 
writing, that the study was taking place in their area and sent a copy of 
the MREC approval letter. Participating centres were asked to notify 
their respective Research & Development (R&D) Departments of the 
study and provided with a study folder containing the original MREC 
application and relevant study documentation with which the study 
could be registered in accordance with the statutory requirements for 
research governance. 
5. 6. 1 Patient consent 
There are statutory requirements for informed consent of participants in 
research studies and clinical trials of investigational medicinal products 
(CTIMPs). The requirements are set out in Schedule 1 to the Clinical 
The CMP is a comparative audit of patient outcome from critical care. Case mix and outcome 
data are collected on consecutive admission to participating critical care units located in 
England, Wales and Northern Ireland and encompass data on patients' eo-morbidity, surgical 
status, reason for admission and outcome. 
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Trials Regulations. The Regulations transpose the provisions of the 
European Clinical Trials Directive (EC2001/20) into UK law. 
5. 6. 1. 1 Definition of informed consent 
Paragraph 3(1) ofPart 1 of Schedule 1 to the Regulations, 
implementing Article 2(j) of the EU Directive, gives the following 
definition of informed consent: A person gives informed consent to take 
part in a clinical trial only if his or her decision is given freely after 
that person is informed of the nature, significance, implications and 
risks of the trial; and is either evidenced in writing, dated and signed, 
or otherwise marked, by that person so as to indicate his consent, or if 
the person is unable to sign or to mark a document so as to indicate his 
consent, is given orally in the presence of at least one witness and 
recorded in writing. 
5.6. 1.2 Definition of an incapable adult 
Critical care patients are normally unconscious which means that they 
are unable to give informed consent to their participation in research 
studies and thus deemed 'incapable'. The term used for this in the 
Regulations of the EU Directive is "an adult unable by virtue of 
physical or mental incapacity to give informed consent". For this 
reason, a surrogate (relative or partner) is usually approached to ask for 
their assent for participation as this person is considered to be most 
likely to know what the patient's preferences would be (Edwards et al., 
1998)19 20. 
The study overcame the need to obtain informed consent from 
individual surrogates by use of a poster that was displayed in the 
Relatives' waiting area and in the critical care unit (see Appendix 5.4). 
19 The Medicines for Human Use (Clinical Trial Regulations, January 2005)) set out the 
hierarchy prescribed in the Regulations for determining what type oflegal representative 
should be approached to give informed consent on behalf of an incapable adult prior to 
inclusion of the subject in the trial. The provisions in England, Wales and Northern Ireland 
differ from those in Scotland. 
20 The conditions and principles listed in Part 5 of Schedule 1 to the Regulations and implement 
Article 5 of the EU Directive were adhered to in the study. 
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This was a necessary and important step because critical care units 
were concerned about the additional workload involved in having to 
speak to every patient's surrogate to obtain their assent, and having to 
do this would have negatively affected participation rates. If any of the 
patients' relatives I partners objected to the use of their relatives' data 
for the study, they were asked to complete a 'Declaration of Non-
Participation' form whereby data relating to their relative would not be 
used (see Appendix 5.5). Of the patients treated during the study 
period, none were excluded due to completion of this form. 
5. 7 Project plan and timescales 
A project plan was developed to assist in the correct sequencing of 
tasks involved in the study. As can be seen from table 5.1, the study 
ran over a number of months. 
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Months 
September 2002 
October 2002 
December 2002 
January 2003 
February 2003 
March 2003 
Apri12003 
May 2003 
June 2003 
July 2003 
August2003 
September 2003 
October 2003 
November 2003 
December 2003 
January 2004 
February 2004 -
December 2004 
Table 5. 1: Project plan and time scales 
Tasks 
• Preparation of Ethics Submission 
• Mailing to adult general critical care units to elicit interest in the study 
• Ethics Submission considered by Trent Multi-centre Research Ethics 
Committee (MREC) 
• Re-submission of study to Trent MREC 
• Ethics committee approval obtained 
• Recruitment of adult critical care units and critical care networks 
• Recruitment of additional centres at national meetings 
• Recruitment of specialist critical care units 
• All Local Research Ethics Committees notified with copy of MREC approval 
letter 
• Design and production of study materials 
• Packaging and distribution of materials for the March starters 
• Start of prospective collection of activity data set 
• Packaging and distribution of materials for the April starters 
• Design of spreadsheets for storing the activity data set 
• Prospective collection of activity data set 
• Distribution of additional study materials 
• Entry of activity data returned 
• Prospective collection of activity data set 
• Distribution of additional study materials 
• Entry of activity data returned 
• Deadline for the return of data collection booklets 
• Recruitment of personnel to enter the activity data set 
• Entry of activity data set 
• Entry of activity data set 
• Distribution of expenditure questionnaires 
• Distribution of study methods and unit characteristic questionnaires 
• Entry of activity data set 
• Entry of expenditure data 
• Queries performed on the activity data set 
• Queries relating to activity data set sent out 
• Entry of late returns relating to the activity data set 
• Entry of expenditure data 
• First reminder letters sent re: outstanding expenditure, study methods and 
unit characteristic questionnaires 
• Second reminder letter sent re: outstanding expenditure, study methods and 
unit characteristic questionnaires 
• Follow-up of outstanding queries relating to activity data set 
• Analysis plan produced and approved 
• Mailing to Finance Departments for outstanding expenditure questionnaires 
• Design of analysis spreadsheets 
• Transfer of queried activity data into analysis spreadsheets 
• Follow-up of outstanding queries 
• Third reminder letter with duplicate copies of study methods and unit 
characteristic questionnaires sent to non-responders 
• Entry of expenditure data 
• Transfer of queried activity data into analysis spreadsheets 
• Transfer of queried activity data into analysis spreadsheets 
• Data analysis 
• Data analysis 
• Testing of cost model 
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5.8 Design of the patient data questionnaires 
5. 8. 1 Method of data collection 
There are different modes of administering questionnaires, five of 
which are described by McColl et al., (2001) and are as follows: 
5.8.1.1 Mailed self-completion 
The main advantages to mailed self-completion are that they are less 
costly than conducting interviewers, do not introduce interviewer bias 
and offer greater anonymity for respondents. The disadvantages 
however are the lower response rates that tend to be observed when 
compared to face-to-face interviews and the lack of control over the 
process in terms of ensuring that respondents complete the 
questionnaires. Other disadvantages include more errors and delays in 
getting the questionnaires returned (McColl et al., 2001 ). 
5.8.1.2 Supervised self-completion 
Questionnaires administered for supervised self-completion, which is 
where the study researchers are available to help and explain, can be 
used for groups (Me Coli et al., 2001). A pitfall however is the costs of 
the researchers' time, which would be greater than the costs of mailed 
self-completion. 
5.8.1.3 Face-to-face interviewing 
Face-to-face interviewing is preferable for open-ended questions and 
for studies that have complex instructions or definitions. The benefits 
of this approach are the high response rates and the opportunity for 
validation by observation. The pitfalls include the high costs of their 
undertaking and the possibility that the interviewer may influence the 
answers given (Me Coli et al., 2001). 
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5.8.1.4 Telephone interviewing 
Conducting telephone interviews is a lot quicker and cheaper than face-
to-face interviews however the mode has generally lower response 
rates than face-to-face interviews. Furthermore, complex, open-ended 
questions are thought to be more difficult to pose over the telephone 
(Me Coli et al., 2001). 
5.8.1.5 Computer-assisted methods 
It is possible to develop electronic questionnaires, the answers to which 
can be directly entered by respondents into a computer. This eliminates 
the need for data entry by the study researchers (and keeps the costs 
down) but incurs a high set-up cost (e.g. designing the user-interfaces 
and database design) and can require extensive piloting (to ensure 
compatibility with existing software packages etc ). 
In this study, it was decided to opt for the use of questionnaires mailed 
for self-completion. As such, data collection booklets were produced 
for staff working within the critical care units to record the data. There 
was a blue booklet that covered days 1-21 of a patient's stay and a 
yellow booklet covering days 22-92. One other method of collecting 
the data was considered, which was the use of a software package into 
which staff working in the critical care units could enter the data. This 
would have had the advantage of eliminating the need for data entry at 
the coordinating centre. However, the disadvantage of this approach is 
the compatibility of the software package with the computer systems 
used in the different hospitals, which can often cause problems and 
result in delays. 
Ten nursing staff from the volunteer sample were selected at random 
and asked what their preferences were to the method of data collection 
(e.g. paper format or software package). All expressed a preference for 
a paper-based questionnaires designed for completion at the patients' 
bedside .. 
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5.8.2 Content of the questionnaires 
Items collected within each booklet with their accompanying 
definitions are shown (table 5.2). 
Table 5.2: Patient data set 
Part 1 
Data Data Item Definition 
Category 
General Patient initials Not defined 
General Hospital Not defined 
number 
General Local critical Not defined 
care identifier 
General Date of critical Not defined 
care unit 
admission 
General Time of Not defined 
admission 
General Planned Not defined 
admission 
General Unplanned 
admission 
General Date of critical 
care unit 
discharge 
General Time of 
discharge 
Level of care Level 3 
(intensive 
care) 
Not defined 
Not defmed 
Not defined 
For patients requiring one or more of the 
following: 
• Advanced respiratory system 
monitoring and support alone. 
• Two or more organ systems being 
monitored and supported, one of 
which may be advanced respiratory 
support. 
• Patients with chronic impairment of 
one or more organ systems 
sufficient to restrict daily activity 
(eo-morbidity) and who require 
support for an acute reversible 
failure of another organ. 
Frequency 
of data 
collection 
At unit 
admission 
At unit 
admission 
At unit 
admission 
At unit 
admission 
At unit 
admission 
At unit 
admission 
At unit 
admission 
At unit 
discharge 
At unit 
discharge 
Daily 
Level of care Level 2 (high 
dependency 
care) 
For patients requiring one of more of the Daily 
following: 
• Single organ system monitoring 
and support, excluding advanced 
respiratory support. 
• General observation and 
monitoring: more detailed 
observation and the use of 
monitoring equipment that cannot 
safely be provided on a general 
ward. This may include eldended 
post-operative monitoring for high-
risk patients. 
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Tick/ 
Number 
N/A 
N/A 
N/A 
N/A 
N/A 
Tick 
licK 
N/A 
N/A 
Tick 
Tick 
Part2 
Data 
Category 
Organ 
system 
support 
Organ 
system 
support 
Organ 
system 
support 
Data Item 
Basic 
respiratory 
support 
Advanced 
respiratory 
support 
Basic 
cardiovascul 
arsupport 
• Step-down care: patients who no 
longer need intensive care but who 
are not well enough to be returned 
to a general ward. 
Definition 
Indicated by one or more of the following: 
• More than 50% oxygen by fixed 
performance mask. 
• The potential for deterioration to 
the point of needing advanced 
respiratory support. 
• Physiotherapy to clear secretions 
at least two hourly, whether via 
tracheostomy, minitracheostomy, 
or in the absence of an artificial 
airway. 
• Patients recently extubated after a 
prolonged period of intubation and 
mechanical ventilation 
• Mask CPAP or non-invasive 
ventilation. 
• Patients who are intubated to 
protect the airway but needing no 
ventilatory support and who are 
otherwise stable. 
Indicated by: 
• Mechanical ventilatory support 
(excluding mask (CPAP) by non-
invasive methods e.g. mask 
ventilation). 
Indicated by one or more of the following: 
• Treatment of circulatory instability 
due to hypovolaemia from any 
cause 
• Use of a CVP line for basic 
monitoring or central venous 
access 
• Use of an arterial line for basic 
monitoring of arterial pressure or 
sampling of arterial blood 
• An hourly record made of pulse 
rate, blood pressure and pulse 
oximetry 
• Single vasoactive drug used to 
support arterial pressure, cardiac 
output or organ perfusion 
• Intravenous drugs to control 
cardiac arrhythmias 
• Non-invasive measurement of 
cardiac output (e.g. 
echocardiography, thoracic 
impedance) 
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Frequency 
of data 
collection 
Daily 
Daily 
Daily 
Tick I 
Number 
Tick 
Tick 
Tick 
Organ 
system 
support 
Organ 
system 
support 
Organ 
system 
support 
Organ 
system 
support 
Organ 
system 
su ort 
Advanced Indicated by one or more of the following: Daily Tick 
cardiovascul • Multiple vasoactive and/or rhythm 
arsupport controlling drugs used to support 
arterial pressure, cardiac output or 
organ perfusion. 
• Patients resuscitated after cardiac 
arrest where intensive therapy is 
considered clinically appropriate. 
• Invasive observation of cardiac 
output and derived indices (e.g. 
pulmonary artery catheter, Lithium 
dilution, pulse contour analyses, 
oesophageal doppler) 
• Intra aortic balloon pumping 
• Insertion of a temporary cardiac 
pacemaker 
• Placement of a gastrointestinal 
tonometer 
Renal Indicated by: Daily Tick 
support • Acute renal replacement therapy (haemodialysis, haemofiltration 
etc. 
Neurological Indicated by one or more of the following: Daily Tick 
support • Central nervous system 
depression, from whatever cause, 
sufficient to prejudice the airway 
and protective reflexes. 
• Invasive neurological monitoring 
e.g. ICP, jugular bulb sampling. 
Liver support Indicated by: Daily Tick 
• Extracorporeal liver replacement 
device i.e. MARS (Teraklin, 
Rostock, Germany), Bioartificial 
liver or charcoal haemoperfusion 
ECMO • Extracorporeal Membrane Daily Tick 
Oxygenation. 
The patients' hospital number was requested for the purposes of 
facilitating the querying process. This number tended to be an 
alphanumeric code. Individual identifiers such as patients' names and 
addresses were not recorded. In this way, queries relating to individual 
patients could be de-anonymised by the critical care unit using their 
hospital number to access the medical records. 
The first part of the questionnaire asked respondents to record the date 
and time of admission and discharge for individual patients, whether 
the critical care admission was planned or unplanned, and asked them 
to state which levels of care patients required during their stay in the 
critical care unit. 
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The second part of the questionnaire covered the type of organ support 
patients received on a daily basis. The organ support variables were 
extracted from an updated version of the ACP data set, that was (at the 
time ofthe study) being modified by a group of critical care opinion 
leaders belonging to the Critical Care Information Advisory Group 
(CCIAG) formed by the Department of Health and the NHS 
Modernisation Agency. This group consisted of critical care doctors, 
nurses and managers who met at regular intervals to discuss the scope 
of this dataset and formulated definitions relating to each of the data 
items within the data set. All of the organ support variables proposed 
by this Group were included in the study and added to these were two 
additional organ support fields (liver support and Extracorporeal 
Membrane Oxygenation (ECM0))21 • The dataset was selected on the 
basis that its eventual use would be to replace an existing dataset for 
routine collection in critical care units. 
A study methods questionnaire was also sent to each participating 
critical care unit to complete. This questionnaire set out to determine 
how the data collection booklets had been completed, by whom and 
what steps were taken when they had not been completed (Appendix 
5.6). 
5.9 Design of the expenditure questionnaires 
A number of expenditure questionnaires were produced that sought to 
estimate expenditure incurred on critical care patients during the same 
time period as collection of the patient data (see Appendix 5.7 for 
copies of these questionnaires). 
Although costing with the top-down method is comparatively easier to 
perform than more patient-centred methods because of being less 
resource-intensive and time consuming, it was important that the 
components of cost were specified and measured rigorously using 
standard definitions. This was to ensure that any observed differences 
21 Mr. Giles Peek is acknowledged for his help in formulating definitions for liver support. 
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could be attributed to variation in the estimates (rather than the 
methods), the costs reproduced and valid comparisons made between 
different studies (Hibbert & Edbrooke, 2002). 
5.9.1 Definitions used 
Each questionnaire contained boxes into which the expenditure data 
were entered and a text box asking for a description of how the 
expenditure data had been estimated. Precise definitions, based on 
those developed by a National Working Group on Costing (currently in 
use as part of the National Cost Block Programme) were adopted to 
ensure that these data were collected in a standard and consistent 
manner. The definitions were developed by Group consensus and 
piloted in two separate studies for ease of completion and 
comprehension (Edbrooke et al., 1999) (table 5.3). 
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Table 5.3: Resource items and definitions used in the 
expenditure sub-study (Dean et al., 2001) 
Resource items 
Nursing staff 
Drugs and fluids 
Disposable equipment 
Consultant medical staff 
Other medical staff 
Administrative support 
Blood and blood 
products 
Radiology tests 
Laboratory services 
Nutritional products 
Specialised bed therapy 
PAMS: Physiotherapists 
PAMS: Clinical 
Pharmacists 
PAMS: Dieticians 
PAMS: Medical 
Technical Officers 
(MTOs) 
PAMS: Information 
Technologists 
PAMS: Clinical and 
Biomedical Scientists 
Definitions used 
Monthly expenditure on nursing staff was extracted from the budget statements submitted 
by the critical care units. Bank and agency staff was included. 
Expenditure on drugs and fluids incurred by the critical care unit included albumin but 
excluded nutritional products and blood and blood products. 
Disposable equipment referred to all equipment used for patient care in the unit (sterile 
and non-sterile) for single or very limited use. 
Salaried costs of each Consultant working on the unit included their basic salary and all 
overheads, plus merit awards (where applicable), daytime intensity payments, night-time 
intensity payments and any discretionary points. The total number of sessions worked per 
month and number of designated sessions for work on the unit, work for outreach, other 
fixed sessions and number of flexible sessions for teaching, research etc. was also 
sought. Fixed daytime sessions were defined as those with clinical commitments (such as 
ward rounds on the unit). Flexible sessions were defined as those without clinical 
commitments and would include designated sessions for management, administration, 
teaching or research regardless of whether they were allocated for work related to the 
unit. Outreach sessions were those dedicated to the care of outreach patients. The costs 
were determined as follows: 
Monthly salary I Total number of sessions x (Number of Fixed Clinical Sessions + Number 
of Sessions for Outreach) + 50% of the flexible sessions 
The average number of hours worked per month in the unit for senior house officers, all 
SPR1 and SPR2 (registrars), all SPR3, SPR4 and SPR5 (senior registrars) and all staff 
grades (or equivalent) was used, and to this, the appropriate hourly cost was assigned. 
The hourly cost was derived from the corresponding salaries+ 50% (Band 1A and 28) to 
reflect the on-call payments. 
Monthly expenditure on administrative staff support was extracted from the budget 
statements submitted by the critical care units. 
Expenditure on blood and blood products included expenditure on whole blood and other 
blood products, but excluded albumin. 
Expenditure on radiology included all x-ray and other radiology tests by the critical care 
unit. Where salaried costs were not included in the costs of the tests, the salaried cost of 
the diagnostic radiographers were added separately. 
Expenditure on laboratory services included: bacteriology, virology, clinical chemistry, 
immunology, haematology, neuropathology and histopathology. Where salaried costs 
were not included in the costs of the tests, the salaried cost of the laboratory assistants 
were added separately. 
Expenditure on nutritional products included expenditure on all enteral and parenteral 
feeds, and special nutritional products that were administered orally. 
The expenditure on specialised bed therapy related to the monthly lease or hire charges 
incurred by the unit. 
The salaried cost of the physiotherapists normally working in the unit was used, taking 
into account the amount of time that they spent in the unit (including overheads). 
Expenditure on Clinical Pharmacists related to services provided by such to the unit. 
Where a contract was held with the Pharmacy department, the expenditure incurred by 
the unit was stated. Otherwise, the salaried cost of the clinical pharmacists normally 
working in the unit was used, taking into account the amount of time that they spent in the 
unit (including overheads). 
The salaried cost of the dieticians normally working in the unit was used, taking into 
account the amount of time that they spent in the unit (including overheads). 
The salaried cost of the Medical Technical Officers (MTOs) and Assistant MTOs normally 
working in the unit was used, taking into account the amount of time that they spent in the 
unit (including overheads). 
The salaried cost of the Information Technologists (database managers) normally working 
in the unit was used, taking into account the amount of time that they spent in the unit 
(including overheads). 
The salaried cost of the Clinical and Biomedical Scientists normally working for the unit 
was used (including overheads). 
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Resource items Definitions used 
PAMS: Speech and The salaried cost of the speech and language therapist normally working in the unit was 
Language Therapists used, taking into account the amount of time that they spent in the unit (including 
overheads. 
PAMS: Psychologists The salaried cost of Psychologists normally working for the unit was used (including 
overheads). 
PAMS: Occupational The salaried cost of the occupational therapist normally working in the unit was used, 
Therapists taking into account the amount of time that they spent in the unit (including overheads) 
and any materials. 
Other: Directorate The salaried cost of Accountants normally working for the unit was used lincluding 
Accountants overheads). 
Other: Personnel The salaried cost of Personnel Officers normally working for the unit was used (including 
Officers overheads). 
Capital Equipment 10% of the total expenditure of the unit was used to estimate the costs of capital 
e ui ment. 
The coverage of resource use in this study was greater than that 
included in the National Cost Block Programme. Added to this was the 
inclusion of Clinical Pharmacists, Dieticians, Clinical and Biomedical 
Scientists, Speech & language therapists, Psychologists, Occupational 
therapists, Directorate accountants and personnel officers. 
The perspective of the expenditure survey was taken from that of the 
Critical Care Unit, irrespective of whether the units paid for these 
resources or not. Collection of hospital overhead costs was not 
performed. The use of questionnaires limited investigation of the 
internal validity of the expenditure estimates. As such, annual data 
from the Critical Care National Cost Block Programme (which 
reported descriptive statistics relating to some of the daily costs 
covered in this study) were used later in the thesis for the purposes of 
external validation. The study used the same definitions for estimating 
costs as those used by the National Cost Block Programme for the 
resources that were captured by both studies and therefore formed the 
most reliable and appropriate source with which to make comparisons. 
Twenty-one units in our sample (30%) contributed data to the Critical 
Care National Cost Block Programme for the financial year 2000-2001 
(Hibbert et al., 2005). 
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5.9.2 Advantages of the method used to estimate expenditure 
The cost block method had several advantages including good 
coverage of the key resources; ease of collection (for some items) e.g. 
the following resource items could be extracted from a critical care 
unit's budget statement (Nursing staff, disposable equipment, drugs 
and fluids and administrative staff); consistent use of standard 
definitions; inclusion ofprofessionals allied to medicine (PAMS), 
presently excluded from the National Cost Block Programme and 
finally, the possibility for externally validating the data with that from 
the Critical Care National Cost Block Programme. 
6.9.3 Disadvantages of the method used to estimate 
expenditure 
The method was not without its limitations. Some resources were not 
included. These were as follows: 
• Catering 
• Laundry and staff uniforms 
• Cleaning 
• Portering 
• Security 
• Chaplaincy 
• Equipment maintenance contracts 
• Cardiology and renal support from outside of the ICU 
• Rates 
• Building depreciation 
• Building maintenance 
• Engineering maintenance 
• Decoration 
• Water 
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• Sewerage 
• Waste disposal 
• Heating & lighting 
It was difficult to obtain data for some items (which could have 
affected the reliability of the estimates) such as other medical staff 
working on rotating shifts around the Hospitals making it difficult to 
provide accurate estimates for the time spent in the critical care unit. 
There was also some ambiguity with some of the definitions. Staff 
completing the questionnaires for laboratory services felt the 
definitions could be misinterpreted. There was a problem relating to the 
actual vs. recorded expenditure for the P AMS. Many of the PAMS 
returned their expenditure questionnaires stating that there was no cost 
to the critical care unit, despite a level of service being provided. There 
is a belief that if a department is not charged for a service provided to 
it, that a cost is not incurred. 
Furthermore, internal validation of the data was difficult for 
expenditure on those resources not appearing on the critical care unit's 
budget statement. 
By far the weakest part of the study was its inability to capture 
expenditure on capital equipment. Assumptions had to made about 
capital equipment expenditure based on data from a small pilot study, 
where expenditure on capital equipment had been found to represent 5-
7% of the total expenditure (Edbrooke et al., 1999). An increase to 
10% was made on the basis that some of the pilot units had a large 
quantity of elderly equipment(> 10 years old), which incurred no 
depreciative cost. 
5.9.4 Measurement issues with capital equipment 
The Critical Care National Cost Block Programme included a section 
on capital equipment as shown in table 5.4. 
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Equipment 
type 
A full set of 
monitoring 
equipment 
Ventilators 
Non-invasive 
ventilators 
Renal replacement 
devices 
Syringe drivers 
Infusion pumps 
Blood gas I 
chemistry machine 
Defibrillator 
Table 5.4: Capital equipment component of the Critical 
Care Cost Block Programme 
Number 
within the 
unit 
Number 
under 
five years 
of age 
Notes 
Each ICU will typically have 1 monitor per bed and one 
or more at the central station(s). The number required 
is the total number of full sets of monitoring equipment 
within the ICU. A full set is the total amount of 
monitoring equipment needed per bed 
This should be the total number of ventilators within the 
ICU that are used for intermittent positive pressure 
ventilation. lt should include ventilators that are 
specifically used for patient transportation. 
The number of ventilators within the ICU that are used 
in combination with a mask and CPAP circuit. 
Renal replacement therapy is undertaken on the ICU 
using formal dialysis machine, continuous vena-venous 
haemofiltration or continuous vena-venous 
haemodialysis. If the equipment was purchased for use 
exclusively within the ICU, then the number of 
machines available should be indicated. Some ICUs 
may have the dialysis undertaken for them within the 
ICU by specialist renal teams. If this is the case, then 
the approximate number of dialysis sessions per week 
should be noted and accompanied by the letter R. 
Syringe pumps are pumps specifically designed to 
administer drugs or fluids from a large syringe. lt will be 
common for these pumps to be purchased or leased at 
different times. Therefore the approximate age required 
in the table should be an average of the approximate 
ages. 
Infusion pumps are defined as pumps designed to 
administer drugs and fluids from 500ml or 11itre bags. lt 
will be common for these pumps to be purchased or 
leased at different times. Therefore the approximate 
age required in the table should be an average of the 
approximate ages. 
This is a machine designed to measure arterial and 
venous blood gases. In some cases these machines 
will also measure other blood chemistry parameters 
such as serum potassium. They should only be 
included in the equipment table if they are located 
within the ICU environment. 
This is the machine normally used to corred ventricular 
fibrillation. They should only be included in the 
equipment table if they are located within the ICU 
environment. 
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Equipment 
type 
Number Number 
within the under 
unit five years 
of age 
Notes 
Fibre-optic 
bronchoscope and 
gastroscope 
This equipment describes the fibre-optic bronchoscope 
and gastroscope, the light source and any viewing 
screens. These constitute one piece of equipment. 
They should only be included In the equipment table If 
they are located within the ICU environment. 
Ultrasound and 
echocardiography 
Any machine based within the ICU using ultrasound 
and/or echocardiography techniques 
Ventricular 
assisting devices 
This is defined as any machine assisting the ventricle in 
producing a higher output. 
Whilst the coverage of the different types of capital equipment would 
appear to be complete, there was one obvious omission, that of the 
humidifiers (needed in conjunction with the ventilators). 
The second problem related to the lack of specific definitions relating 
to the type of equipment. Equipment companies produce a range of 
models that vary in terms of their features and their price. The 
assumption underpinning this simple system of 'counting' the different 
types of equipment was that it would be relatively straightforward to 
assign a unit cost to these. The unit cost however varies according to 
the model in use and the purchasing power of the critical care units has 
not been accounted for. Significant price reductions can be achieved 
through a critical care network negotiating a favourable price for a 
number of equipment items bought in a 'job lot'. No rationale was 
given for distinguishing between the quantity of a given item of 
equipment and those items under the age of 5 years, which would 
appear to be an arbitrary cut-off point. 
Given these problems, it was decided not to integrate this method of 
estimating capital equipment expenditure into the survey. 
204 
5.10 Design of the unit characteristics questionnaires 
The participating critical care units were sent a questionnaire on unit 
characteristics to complete that consisted of questions relating to 
geographical location, hospital type, unit type, unit size in terms of 
staffed bed numbers and the provision of additional services such as 
outreach and follow-up clinics. A copy of this questionnaire is 
provided in Appendix 5.8. 
5.11 Data collection procedures 
5.11.1 Patient data 
For pragmatic reasons, there were two waves of prospective data 
collection. Thirty-three critical care units (47%) commenced 
prospective data collection on 1st March 2003 for a three-month period 
and the remaining 37 units (53%) on 1st April2003 for a two-month 
period. The reason for this was that a large number of critical care units 
agreed to participate in the study (but just prior to the start of data 
collection in March). The data collection booklets were distributed to 
all of the participating centres prior to the start of the data collection 
periods. Critical care units were asked to specify levels of anticipated 
patient throughput for the study period to ensure that an adequate 
supply of booklets was delivered to them. Eleven thousand data 
collection booklets were dispatched in total. 
All patients cared for in the participating units on 1st March 2003 or 1st 
April2003 (depending on when the units started collecting the data), 
until the 31st May 2003, were included in the study. Those patients 
admitted to the unit prior to the start of the study were also included. 
For these patients, their actual date of unit admission was recorded in 
the data collection booklets but their daily data collection commenced 
on the 1st March 2003 or 1st April2003 (as appropriate). 
Staff working on the units collected data for consecutive admissions. 
As far as support for the staff was concerned, a poster listing a series of 
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frequently asked questions and answers was produced and displayed in 
each of the participating centres. A help-line telephone number was 
also disseminated to assist with any queries arising from the study. 
Two storage boxes were sent to each critical care unit to keep the 
empty booklets in and to store the completed booklets. 
To ensure that the data collection booklets were returned to the 
University at regular intervals for entry, critical care units starting data 
collection on 1st March 2003 were asked to return their completed 
booklets after the first two weeks of data collection (151h March 2003) 
and at the end of each month until the end of the study. All of the 
booklets were manually checked after the first two weeks to ensure that 
they were being correctly completed. Critical care units starting data 
collection on 1st April 2003 were asked to return their completed 
booklets on 281h April2003 and at the end of the study. 
5.11.2 Expenditure data 
For critical care units commencing data collection in March, they were 
asked to provide expenditure data for the (individual) months of 
March, April and May. Two months of expenditure data were 
requested from critical care units who started collecting data in April. 
Participating units were sent these questionnaires to distribute to the 
relevant departments (located within their hospital) to complete and 
return to the University of Sheffield. 
Each questionnaire was accompanied by a covering letter to the 
relevant recipient (Head Dietician, Head Pharmacist etc ). As this 
approach was deemed quite risky in the sense that it was not known to 
whom the questionnaires had been sent to upon their receipt by the 
named collaborator, another contact form was enclosed with this 
mailing asking that the collaborator provided details of the person to 
whom they had sent the questionnaire (name, position, telephone, fax 
number and e-mail address). They then faxed this contact form back to 
the University of Sheffield. 
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A poor response to this initial mailing led us to forward all of the 
questionnaires that had yet to be returned to the Head of Finance in 
each of the participating hospitals with a covering letter asking for their 
co-operation in completing these questionnaires. This proved to be an 
effective strategy, as the questionnaires were promptly returned. 
5.12 Method of collection 
5.12.1 Patient data 
It was left to the discretion of the participating critical care units as to 
the time of day when the booklets were completed. It is difficult to 
know in hindsight whether this was the best approach. Giving the units 
prescriptive rules as to when and how data should be collected may 
have improved the consistency of the data, but it is unlikely that units 
would have responded to such guidance, particularly when they were 
volunteers and not receiving any form of financial reimbursement for 
their time spent collecting the data. 
A short questionnaire was sent to a named person in each centre after 
data collection had finished, eliciting how the booklets were completed 
(see Appendix 5.5). The questionnaire sought to determine whether the 
booklets were used as a primary tool for recording the data, whether 
the booklets were completed in a prospective or retrospective manner, 
the member of staff responsible for collecting the data, the number of 
staff involved in data collection, the time of the day when data 
collection took place, reasons given for not completing the booklets I 
collecting the data and finally, the measures taken to provide data when 
the booklets were not completed for patients. 
5.12.2 Expenditure data 
Within each questionnaire contained a box asking respondents to 
specify the costing method used to estimate the expenditure data if they 
were not able to adhere to the definitions provided. Where applicable, 
207 
they were asked to describe the nature of the resources used (e.g. level 
of service provided in the case of the professionals allied to medicine). 
5.13 Data entry 
5.13.1 Patient Data 
The data contained within the booklets were manually entered into 
Microsoft Excel. A better approach to data entry would have been to 
use a questionnaire design software package, where the data recorded 
into the booklets by the critical care staff could have been scanned by a 
computer, which would have considered reduced the burden of data 
entry. 
The accuracy of data entry was ensured by comparing the data 
collection booklets with the electronic records in 25% of patients, 
checking for any inconsistencies between the two. 
Once all of the data had been entered, the researchers formalised a 
series of checks on the data set. This was to ensure that a) checks for 
missing and inconsistent data could be performed in a consistent 
manner (with minimal bias) b) the results of the checks could be easily 
documented in a query booklet and c) the integrity of the raw data was 
maintained. This is discussed in more detail in Chapter 6 (Section 6.3). 
In summary, patients with identical data (i.e. hospital numbers, date 
and time of admission and discharge) were identified and queried with 
the participating centres. A separate record was made of any missing 
data and units were approached with a request to supply these missing 
data, e.g. date or time of admission or discharge, admission type 
(planned or unplanned) and survival status at unit discharge (dead or 
alive). Inconsistent patient records were also queried with the units, for 
example, if a patient appeared to have been discharged before they 
were admitted or if their discharge was recorded on a completely 
different day to that indicated within the activity spreadsheet. In these 
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cases (and those of patient duplication), it was requested that each 
patient's full activity details were re-supplied. 
Patients were not permitted to have both basic respiratory and 
advanced respiratory support on the same day, as whilst it is common 
for this to occur (when a patient switches from mechanical ventilation 
to a lesser intensive form of respiratory support) for costing purposes, 
the higher level of organ support (advanced respiratory support) was 
recorded. 
5.13.2 Expenditure Data 
The data captured by the questionnaires and budget statements were 
transferred into Microsoft Excel. Any data that appeared to be 
erroneous i.e. annual estimates of expenditure given instead of 
apportioned amounts relating to the time spent in the critical care, 
mostly in the case of the PAMS, were excluded from any analysis 
performed. 
5.14 Data protection and confidentiality 
The Data Protection Act (1998) was adhered to which protects the right 
of the individual about what information is obtained, shared, processed 
or supplied whether via a computer or manual paper records. As data 
were provided in booklet form, there was no need to consider the 
transfer of electronic patient records from the critical care units to the 
University of Sheffield. Patient identifiers were not included in the 
main database but a unique individual ID included instead (i.e. 
reversibly anonymised)22. There were also firewalls in place to protect 
the database from access via the worldwide web and the database was 
password protected. The database was held on a stand alone23 not 
22 Reversibly anonymised: Individual identifiers have been removed or encrypted so those using the data 
cannot identify individuals. A unique individual ID (or 'key code') may be included. It is therefore 
possible to reverse the anonymisation of the data either by decrypting the encoded individual identifiers 
or by linking the data, through the 'key code', to individual identifiers. 
23 Data are held on a computer that is not connected to any other computers via a modem or network. Such 
computers cannot be hacked into externally, and the actual hard drive of the computer would have to be 
209 
24 
networked computer and backups24 of the database performed at 
weekly intervals with a copy of the backup held at a separate location. 
The data collection booklets were kept and placed into storage. 
5.15 Data management 
5.15.1 Patient Data 
Each hospital had two spreadsheets. The structure and coding of the 
first spreadsheet, entitled 'Patient ID' is described in table 5.5. 
Table 5.5: Structure and coding of the patient ID 
spreadsheet 
Hospital Name 
Patient Initials 
Hospital Number 
local Critical Care Unit Identifier 
Date of unit admission (date/month/year) 
Time of unit admission (00:00) 
Date of unit discharge (date/month/year) 
Time of unit discharge (00:00) 
Admission type: 
• Planned (1=Yes, O=No, 2=Missing) 
• Unplanned (1 =Yes, O=No, 2=Missing) 
Survival status at unit discharge (O=Dead, 1=Aiive, 2=Missing. 3=Unknown) 
Using the data contained in the Patient ID spreadshect, patients' length 
of stay was calculated using the exact dates and times of admission and 
discharge and an additional variable created called 'patients in for less 
than 24 hours'. A code (1 or 0) was then assigned to patients according 
to whether their length of stay was less than 24 hours. Another dummy 
stolen for the security of the data to be compromised (Directory of Clinical Databases- data definition 
manual). 
Data saved onto back-up disks: Back-up data are saved at regular intervals onto CD, floppy, Zip disk, or 
other storage device, and are stored securely. 
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variable was added called 'Complete length of stay data i.e. in the unit 
for the study period'. Each patient was then coded (1 or 0) according to 
whether their date and time of admission and discharge fell within the 
study period, so as to determine the numbers of patients for whom data 
on their complete episode of care would be missing. All patients still 
receiving care in the unit beyond 31/05/03 (when the study ended) 
were given a date and time of discharge of 31105/03 23:59. The 
survival status of patients still in the unit at the end of the study period 
was classified as 'unknown'. 
The second spreadsheet entitled 'activity data set' was structured and 
coded as described in table 5.6. 
Table 5. 6: Structure and coding of the activity spread sheet 
Hospital number 
Date of stay (date/month/year) 
Day number (1,2,3 etc) 
Level of care data 
Level3 (intensive care) (1=Yes, O=No) 
Level2 (high dependency care) (1=Yes, O=No) 
Organ support data 
Basic respiratory support (1=Yes, O=No) 
Advanced respiratory support (1=Yes, O=No) 
Cardiovascular support (1=Yes, O=No) 
Renalsupport(1=Yes,O=No) 
Neurological support (1=Yes, O=No) 
Dermatological support (1=Yes, O=No) 
Liver support (1=Yes, O=No) 
Extracorporeal Membrane Oxygenation (ECMO) (1=Yes, O=No) 
5.15.2 Expenditure Data 
After the data had been thoroughly checked for any errors incurred 
through the transfer of data from the questionnaires into the 
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spreadsheet, these data were transferred into SPSS for Windows, where 
descriptive analyses could be undertaken. 
5.16 Analysis plan 
Descriptive statistics were performed on the monthly and average daily 
expenditure data (means (SD), median (IQR) and minimum and 
maximum values that were stratified by unit type and size (where 
appropriate). 
5.16.1 Study methods 
Using the completed study methods questionnaires, simple frequency 
tables and pie charts were used to describe the methods of collecting 
the patient data, methods of booklet completion, numbers of staff 
involved in booklet completion and the time of day when booklets 
were completed. A bar chart was used to describe the frequency with 
which the different measures taken were adopted when the data 
collection booklets were not completed. 
5.16.2 Validity and accuracy of patient data 
The validity and accuracy of the patient data were assessed using 
criteria developed by the Directory of Clinical Databases and a scatter 
plot was used to explore the relationship between the number of 
queries generated from the patient data study and the number of 
patients studied. 
5.16.3 Characteristics of the critical care units 
The characteristics of the critical care units were determined from the 
unit characteristics questionnaires and described using simple 
frequency tables. The Directory of Clinical Databases was used to 
assess the representativeness of the sample (in terms of geographical 
coverage). Pie charts were used to describe the numbers of 
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participating critical care unit by Region and the proportion of critical 
care units by size. 
5.16.4 Characteristics of patients 
Simple descriptive characteristics were used to analyse the 
characteristics of patients in terms of their admission status and length 
of stay. The types and combinations of organs supported were 
described using frequency statistics. 
The relationship between the numbers of days of organ support by both 
the type of critical care unit and the size of the critical care unit was 
explored using a chi-squared test (that tested for differences between 
these characteristics). Differences between groups (denoted by unit 
type and size) were compared using the Kruskal-Wallis modification 
(non-parametric) of the analysis of variance (ANOVA) (Godfrey, 
1985). Rejection of the null hypothesis was performed where the p 
values produced from the ANOV A test failed to reach statistical 
significance (p>0.05). The same analytic technique was used to explore 
both the relationship between the organ support ratios per patient day 
both by type and size of critical care unit. 
5.16.5 Expenditure data 
The response rate to the expenditure survey was described according to 
the number and percentage of questionnaires returned on each resource 
item and of this, the quantity of data suitable for analysis. 
Compliance to the expenditure definitions was described as a 
percentage, and a narrative provided as to the description of the 
services provided (under each resource item) and the alternative 
methods used when the provided definitions were not adhered to. Bar 
charts were used to describe the response rates and the number of 
responses that accorded to the definitions. 
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Descriptive statistics relating to the monthly expenditure incurred on 
each of the resource items were performed and the percentage 
contribution of each resource item to the total costs of care compared 
with estimates reported in the published literature. To externally 
validate the mean daily cost estimates for each of the resource items, 
comparisons were made using data collected from a larger sample of 
critical care units participating in the Critical Care National Cost Block 
Programme. The mean daily costs by type of critical care unit were 
then compared against NHS Reference Costs. No formal statistics tests 
were performed for the external validations undertaken. 
In order to determine whether the critical care unit who were able to 
provide expenditure data were markedly different from those who did 
not provide these data, several comparisons of key characteristics were 
performed using frequency tables. 
Chi-squared tests were used to detect differences in monthly 
expenditure and average daily expenditure by type and size of critical 
care unit. Line graphs were used to illustrate the relationship between 
the monthly and average daily expenditure and critical care unit size. 
The results of these analyses will be described in Chapter 6. The 
development of models and the statistical techniques used (to support 
the development ofHRGs and for the economic evaluation of the 
CSEAR trial) will be described in Chapters 7 and 8 respectively. 
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"It is a capital mistake to theorize before one has data. " 
Sir Arthur Doyle 
CHAPTER 6: RESULTS 
SECTION 1: PATIENT DATA COLLECTION AND 
VALIDATION 
6.1 Introduction 
Chapter 6 describes the data collected in the multi-centre study and the 
efforts made to validate these data. The Chapter is split into five sub-
sections for ease of presentation. 
Section I reports on how the patient data were collected and the 
characteristics of the participating critical care units. An explanation of 
the checks performed on the data returned follows, and issues relating 
to the validity and reliability of the data are also discussed. The 
representativeness of the volunteer sample of units was determined by 
comparison with the Intensive Care National Audit & Research 
Centre's (ICNARC) Case-Mix Programme database and data collected 
by the Audit Commission. Herein after follows a description of the 
collection of the expenditure data and a discussion of the resultant 
response rates, adherence to the definitions provided in the 
questionnaires used and the results obtained. External validation of the 
expenditure data was achieved using data from the Critical Care 
National Cost Block Programme and published NHS Reference Costs 
for adult critical care produced by the Department of Health. 
Section II describes the characteristics of the critical care units in the 
sample. 
Section Ill describes the characteristics of the patients studied (their 
admission status, length of critical care unit stay, survival status at 
discharge from the critical care unit, and their type of organ support 
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received). Some preliminary analyses of the relationship between 
patients' organ support and the type and size of the critical care unit is 
also performed. 
Section IV describes the collection and validation of the expenditure 
data. 
The relationship between the number of organ support days and the 
organ support ratio per patient day by type and size of critical care unit 
is explored in Section V. Four null hypotheses relating to the 
relationship between a critical care unit's monthly expenditure on 
nursing staff, drugs and fluids and disposable equipment (and its 
average daily expenditure) compared to the type and size of the critical 
care unit are then tested. 
6.2 Participation rates 
Ofthe 400 critical care units approached, 84 (21%) units agreed to 
participate in the study. Of these 84, 14 (17%) critical care units 
dropped out just prior to the start of data collection, resulting in a 
sample of70 units (17.5%) located in 67 hospitals. Patient-level data 
were collected from these 70 units on 7,304 patients. Expenditure data 
were also collected (172 months of data in total). Duplicate data were 
discovered for 61 patients, which when removed, produced a complete 
sample of 7,243 patients (3 7,170 patient days) that could be analysed. 
6.3 Collection of patient data 
6.3. 1 Methods of data collection 
Data collection booklets were used to record the patient data. 
Of the 70 participating critical care units, 65 (93%) completed the 
study methods questionnaire that sought to elicit the manner in which 
the booklets had been completed. Data for the non-responders (i.e. 
those who had not completed the study methods questionnaire) were 
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represented in the 'Unknown' category in the tables presented. The 
majority of critical care units used the booklets to prospectively record 
the patient data. In some units, the relevant patient data was extracted 
from sources namely other scoring systems in routine use, such as TISS 
and ICNARC's System ofPatient-Related Activity Scoring System 
(SOPRA). Ten critical care units used data collected for the 
Augmented Care Period (ACP) Data Set to transfer into the data 
collection booklets. Due to the quantity of data collected in critical 
care, it was not surprising to note that multiple methods of data 
collection were in use. However, it is generally recommended before 
using 'already collected' data to check how these data were collected 
(0vretveit, 1998). It was for this reason that the study methods 
questionnaire had been sent out to units. The accuracy of the data 
transferred via extraction from other sources was not however assessed. 
Table 6.1 summarises the five different methods employed for data 
collection. 
Table 6.1: Method of data collection 
Method Of Data Collection N (IYo)* 
The data collection booklets provided were used as the primary method of data 
collection 
Data was transferred into the booklets after the patient was discharged from the unit i.e. 
using data from a database 
System of patient-related activity data (SOPRA) was used to complete the booklets 
Therapeutic Intervention Scoring System (TISS) data was used to complete the booklets 
Organ support data was provided retrospectively using ACP data and organ support 
definitions 
62 (89) 
17 (24) 
4 (6) 
3 (4) 
10 (14) 
Unknown 5(7) 
• Note that many of the respondents indicated multiple methods of data collection and that the figure in 
parentheses refers to the total sample, i.e. represented as a percentage of 70 (units). 
6. 3.2 Methods of booklet completion 
Although the data collection booklets were designed for facilitating 
prospective completion at the bedside, the majority of critical care units 
(64%) recorded these data on a daily basis retrospectively, to reflect the 
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care delivered over the previous 24 hours (Table 6.2). Only 10 critical 
care units completed the data collection booklets prospectively. 
Table 6.2: Method of booklet completion 
Method Of Booklet Completion N (%) 
Prospective completion of booklets at the bedside (ticking activities as and when they 
occurred 
Retrospective completion at the bedside (ticking activities to reflect the care delivered 
over the previous 24 hour period) 
Retrospective completion away from the bedside (ticking activities to reflect the care 
delivered as documented in the patients' care records} 
Other (i.e. combination of prospective and retrospective data collection methods) 
Unknown 
6.3.3 Staff responsible for data collection 
A number of different types of staff were involved in the task of data 
collection. In the majority of the critical care units, the bedside nurses 
were responsible for collecting the data followed by the Medical Staff 
and Nurse Consultants and Managers (Table 6.3). A comparison was 
made with data on the job titles of 187 staff members registered as a 
point of contact for the ICNARC's Case-Mix Programme (CMP) 
(Harrison et al., 2004). Compared to ICNARC's CMP, our study had a 
significantly higher proportion of bedside nurses and medical staff 
collecting data (65.7% compared to 17.6% and 15.7% compared to 
1.6% respectively). It was reassuring to note the large numbers of 
medically qualified individuals involved in data collection because of 
their better understanding of the patients' condition. The extent to 
which the quality of data collected varied according to the type of staff 
responsible for data collection was not however explored. 
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10 (14) 
45 (64) 
6 (9) 
4 (6) 
5 (7) 
Table 6. 3: Staff responsible for data collection 
Staff Responsible For Data Collection N (%)* Comparison 
with ICNARC 
(o/o) 
Bedside nurses looking after the patients 46 (65.7) 
Medical staff 11 (15.7) 
Audit staff (including audit clerks) 15(21.4) 
Joint audit & clerical staff N/a 
Research nurses 5 (7.1) 
Ward clerks 1 (1.4) 
Other (e.g. nurse consultants, nurse managers and critical care matrons) 8 (11.4) 
Unknown 5 (7.1) 
*Note that many of the respondents indicated that several groups of 
staff members were often responsible for data collection and that the 
figure in parentheses refers to the total sample, i.e. represented as a 
percentage of70 (units). 
6.3.4 Number of staff involved in data collection 
The majority of the critical care units studied had in excess of20 
members of staff involved in completing the data collection booklets. 
Sixteen critical care units however had between 1 and 5 people 
dedicated to this task (Figure 6.1 ). 
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33 (17.6) 
3 (1.6) 
117 (62.6) 
6 (3.2) 
N/a 
23 (12.3) 
5 (2.7) 
N/a 
Figure 6.1: Pie chart showing the numbers of staff 
involved in booklet completion 
>20 people 
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Unkno\\fl 
7% One person alone 13% 
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0% 
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23% 
6.3.5 Time of day when data collection took place 
The majority of critical care units completed the data c 11 ti n 
booklets as and when they felt it appropriate uch a afl r th m di al 
ward rounds, or at midnight. Nine critical care unit un rt k thi t k 
at the end of the nursing shift (Figure .2). 
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Figure 6.2: Pie chart showing when the booklets were 
completed 
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6.3. 7 Measures taken when booklets were not completed 
In the majority of cases when the data collection booklets were not 
completed for the reasons given in table 6.4, staff completed the 
booklets retrospectively using data from the patients' medical records. 
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Table 6.4: Reasons given for not completing the booklets 
Reasons Given For Not Completing The Booklets 
Ran out of data collection booklets 
Could not locate data col\ect10n book\ t 
Patients in for such a short period of time that it didn't seem worth it 
Unit really busy therefore did not have time and forgot to complete book\ t 
retrospectively 
Other (e.g. the person responsible for data collection was absent from the unit) 
Unknown 
N (%)* 
• Note that only 34 responses were given to this question and that multiple reason w re som times 
indicated for not completing the booklets; a total of 37 responses Therefore, the fiQur in par ntheses 
are a percentage of this. 
tThis relates to the overa ll sample (70 units) and the figure in parentheses is a percen g of this . 
Five critical care units reported not completing a b klet fi r th 
patients in question (Figure 6.3 . 
Figure 6.3: Bar chart showing the measures taken when 
the data collection booklets were not completed 
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0 
Completed the Did not complete a 
data collection booklet for the 
booklet using data said patient(s) Watcher database) 
from the patients' 
medical records 
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3 (8) 
3 (8) 
1 (3) 
20(54) 
10 (27) 
36 (51) 
6.4 Data checks 
The checks performed on the data set are categorised into those relating 
to data entry (Section 6.4.1) and data quality (Section 6.4.2). 
6.4. 1 Data entry 
All data documented within the data collection booklets had to be 
manually input into spreadsheets stored in Microsoft Excel once the 
booklets were returned to the University of Sheffield. The cross checks 
performed on all ofthe data transferred from the data collection 
booklets and the electronic records containing the entered data, 
identified data entry errors relating to omissions and inaccuracies. 
Changes were then made to the electronic records .. Whilst this 
checking procedure was not formalised in terms of recording the exact 
number and nature of errors identified, there were only a very small 
number identified in the 1,811 (25%) records that were checked at 
random. Checking was performed at the same time as data entry and 
those individuals involved in entering data were informed that their 
work would be double-checked prior to the start of data entry. There 
were 5 individuals involved in data entry (myself, Lizzie Coates, John 
Campbell, Elena Brooker and James Hibbert). Lizzie and I performed 
the checking tasks, selecting booklets at random from all of the seventy 
critical care units. 
6.4.2 Data quality 
Once the data had been entered into Microsoft Excel, a series of 
formalised checks were performed on each critical care unit's data, 
which were briefly described in Section 6.13 and an individualised 
query form issued to each unit (where appropriate). Sixty-seven critical 
care units were issued a query form; to which 62 units (93%) 
responded. Upon receipt of the query form, the data items in question 
were corrected in each critical care unit's spreadsheet. 
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Two thousand eight hundred and sixty-eight queries were issued to the 
participating centres, which represented 4.97% of all of the data 
received. Only 3 (4.28%) critical care units submitted data that did not 
generate any queries. Of the 67 critical care units who had been issued 
with query forms to complete, 49 (73%) units were able to provide data 
that satisfied the queries raised (see Appendix 6.2). 
Table 6.5 reports descriptive statistics relating to each type of query 
data item. Inconsistent (or illogical) data was observed in more than 
half of the critical care units whereby, for example, patients appeared 
to have been discharged before they were admitted or if their discharge 
was recorded on a completely different day to that indicated within 
their activity spreadsheet. 
Table 6.5: Summary of queries 
Type of Query Number of Sum of Mean (SO) Median (inter-quartile 
critical the range [mln-max]) 
care units queries 
(%) 
Number of generated 67 (100) 2 868 42.81 (59.66) 18.00 (7.00-51.00 [1.00-312.00]) 
ueries 
Number of answered 61 (91) 2406 35.91 (57.55) 13.00 (6.00-43.00 [0-312.00]) 
ueries 
Inconsistent data 38 (57) 140 2.09 (3.63) 1.00 (0.00-2.00 [0.00-19.00[) 
Missing date of admission 2 (3) 5 0.07 (0.50) 0.00 (0.00-0.00 [0.00-4.00]) 
Missing time of admission 32 (48) 142 2.13 (3.72) 0.00 (0.00-2.00 [0.00-19.00]) 
Missing date of discharge 30 (45) 278 4.15 (13.04) 0.00 (0.00-1.00 [0.00-78.00]) 
Missing time of discharge 52 (78) 730 10.90 (19.09) 3.00 (1.00-12.00 [0.00-106.00]) 
Missing type of admission 54 (81) 282 5.72 (6.72) 4.00 (1.00-8.00 [0.00-33.00]) 
Missing outcome status 63 (94) 1 329 19.84 (27.85) 7.00 (2.00-21.00 [0.00-114.00]) 
There was a positive linear relationship between the number of patients 
studied and the number of queries generated: R 2 = 0.1 08, p=0.007 
(Figure 6.4 ). 
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Figure 6.4: Scatter plot of the relationship between the 
number of generated queries and the number of patients 
studied 
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Six critical care units (9%) did not respond to the request for missing 
data, which produced a total of 462 (16%) outstanding queries. In this 
instance, the following changes were made to the dataset: 
• Missing date of admission: the first date on which data were 
collected within the data collection booklet was entered; 
• Missing date of discharge: the last date on which data were 
collected within the data collection booklet was entered; 
• Missing time of admission: the earliest possible time, i.e. 
0:00 was entered; 
• Missing time of discharge: the latest possible time, i.e. 
23:59 was entered; 
• Missing admission or survival status at unit discharge: these 
items were coded as missing. 
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Where data collection had been duplicated, the patient record that 
closely matched the record that was re-supplied was kept within the 
dataset and the other record was removed. When inconsistent data were 
not clarified, the least complete patient record was deleted from the 
dataset. In some cases, the clarification of some aspects of a patient's 
episode led to further queries. For example, differences between the 
survival status recorded in the original data collection booklet and that 
re-supplied during the query process. In this instance, every effort was 
made to clarify the characteristics of this patient's critical care episode 
with the study contact person. 
For some patients, both Level 3 and Level 2 care was received during a 
24-hour period and so both boxes were ticked in the data collection 
booklets. In this case, the researchers chose to record the highest level 
of care in the spreadsheets. All changes were documented in the unit-
specific query booklet. 
An additional variable called 'Level1 I 0 I Missing' was created within 
the data entry spreadsheet for all patients where no data on Level 3 care 
or Level2 care was provided. In instances whereby a patient receiving 
advanced respiratory support and had missing data for their level of 
care, the researchers recorded that the patient had received Level 3 care 
(in accordance with the definitions). An additional variable called 
'Missing location of care' was created in the spreadsheet for patients 
where their location of care had not been recorded. 
6.5 Completion issues 
It was important to know whether the data collected in this study were 
valid and reliable. Validity is defined as 'the extent to which a measure 
or piece of data 'reflects' what it is supposed to measure or give 
information about' (0vretveit, 1998). Bohrnstedt ( 1983) defines 
reliability as 'the extent to which the variance in an observed [piece of 
data] is due to random sources or to "noise"'. Criteria developed by 
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the Directory of Clinical Databases were used to evaluate the validity 
and accuracy of the data collected (summarised in Appendix 6.1 ). 
6.5.1 Completeness of recruitment (of eligible patients) 
Selection bias can be introduced if a significant proportion of the 
patients that the study seeks to include are not captured by the study, 
whereby those included are systematically different from those who are 
not included in the sample (Black et al., 2003). The two main 
advantages of encouraging the use of data collection booklets were that 
it allowed staff to complete them anonymously, in a consistent manner, 
and the booklets could be used by many people at a low cost. The 
disadvantages were that a proportion of the booklets may not have been 
completed fully and it was important to ensure that critical care units 
had an adequate supply of them with clear instructions for their 
completion (0vretveit, 1998). In order to determine the proportion of 
patients for whom data were collected in the study (i.e. to see how 
complete the recruitment was), it would have been useful to have 
compared these data with the critical care unit's admission book. 
Whilst each critical care unit was asked to estimate their anticipated 
throughput of patients during the study period, no data was collected on 
the actual numbers of patients treated during the study from a source 
other than the data collection booklets. 
The Directory of Clinical Databases (DoCDat) hosted by the London 
School of Hygiene & Tropical Medicine was consulted in order to 
provide an independent assessment of the study's scope and quality 
(Black et al., 2003). Their website (www.lshtm.ac.uk/docdat) describes 
DoCDat as 'an information resource for all those involved in clinical 
audit, clinical governance, health services management, health 
services research, research funding, and academic publishing'. 
DoCDat focuses primarily on centralised individual-level databases 
based either on prospectively or retrospectively collected data. 
Independent, trained interviewers assess the quality of each database 
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using a structured questionnaire developed by clinicians, 
epidemiologists, statisticians and information specialists. The 
assessment covers general aspects of the database; the data set, such as 
how many individuals are included etc; outputs i.e. who can analyse 
the data and how frequently standard audit reports are produced; 
management of the database, such as who is involved in running it and 
who funds it; quality of the data including four aspects of the coverage 
of the data and six aspects exploring the accuracy of the data. 
According to Black et al., (2003), the instrument has good face and 
content validity, has no floor I ceiling effects and is acceptable to 
database custodians. 
The 'quality' section of their assessment was used to evaluate the 
completeness of recruitment for eligible patients in this study, 
consisting of levels I to 4, with Level 1 representing the least rigorous 
method and Level 4 representing the most rigorous. 
Level 1: Unknown or few (>80%) 
Level2: Many (80-90%) 
Level3: Most (90-97%) 
Level4: All or almost all (>97%) 
Although no external validation was performed, information was 
collected on what the critical care unit did when they missed patients 
(Section 6.3.7). Due to the small number (3.5%) of critical care units 
who did not complete a booklet for their 'missed' patients, it is 
assumed that many patients (80-90%) were included in the study as the 
majority of units used data from the patients' medical records to 
complete the data collection booklets. As such, the study met Level 2 
of the DoCDat criteria for completeness. 
6.5.2 Variables included in the study 
The rationale given by DoCDat for studying the variables included is 
that it guides the scope of the kind of analyses that can be conducted 
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using the data. DoCDat provides concise definitions for these, under 
the headings of 'identifier25 ', 'admin info26', 'condition27', 
'intervention28', 'short-term outcome29', 'major, known confounders30' 
and 'long-term outcomeJI '. 
The four levels into which studies could be classified were as follows: 
• Level 1: Identifier, condition or intervention; 
• Level2: Identifier, condition or intervention, short-term 
outcome or long-term outcome; 
• Level3: Identifier, condition, intervention, short-term 
outcome or long-term outcome, major known confounders; 
• Level4: Identifier, condition, intervention, short-term 
outcome, major known confounders, long-term outcome. 
The study met Level 2 as it collected data on patient identifiers, the 
interventions and patients' short-term outcomes (i.e. survival status at 
discharge from the critical care unit). 
6.5.3 Completeness of data(% variables at least 95% 
complete) 
Data was deemed (by DoCDat32) to be complete if the percentage of 
data on variables collected were at least 95% completeJJ. The rationale 
2S Identifier: Variables by which an individual/ episode can be identified, e.g. name, address, postcode, 
date of birth, NHS number or other unique number 
26 Admin info: administrative information such as date of admission into hospital, date of operation, 
treating clinicians' code, and institutional code 
27 Condition: primary diagnosis, e.g. breast cancer or diabetes. This will often be the common circumstance 
that determines inclusion 
28 Intervention: the intervention aimed at treating the condition e.g. surgery or drugs prescribed 
29 Short-term outcome: the outcome at the end ofthat episode of care, e.g. post-operative outcome, status at 
discharge 
30 Major, known confounders: this will vary by condition, but generally would include eo-morbidity and 
age. lt could also include socio-demographic variables such as socio-economic status, behavioural 
variables such as smoking and physiological variables such as height, weight and blood pressure. These 
variables are vital for producing risk-adjusted outcome analyses 
31 Long-term outcome: this will vary according to the condition, but generally would include any follow-up 
of the patient I episode after the immediate outcome of the intervention (e.g. six months or a year after 
the first intervention, depending on the severity of the condition 
32 Information about DoCDat can be found at http://www.lshtm.ac.uk/docdat 
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given for looking at this is that difficulties occur when attempting to 
analyse these data iflarge amounts of data are missing. Selection bias 
maybe introduced where patients with missing data (excluded from 
any analysis) are systematically different from those without missing 
data. Ninety-seven percent of queries were clarified by the participating 
centres that responded to requests for missing data. It is conceivable 
that the data would have been more complete had one person within 
each critical care unit been solely responsible for data collection 
(however impractical this may have been). The category of concern 
was that of retrospective completion away from the bedside (ticking 
activities to reflect the care delivered as documented in the patients' 
care records). Assuming that the patients' records were complete and 
comprehensive, this would not have posed a problem, however it is 
unlikely that notes in the records would translate easily to the 
structured format of the booklets and thus possible that records for 
some data items may have been missed. 
The four levels into which studies could be classified were as follows: 
• Level I: Unknown or few (<50%) 
• Level2: Many (50-79%) 
• Level3: Most (80-97%) 
• Level4: All or almost all (>97%) 
The study met Level3 with most data being complete (80-97%). 
6.6 Accuracy of the data collected 
6.6.1 Form in which continuous data (excluding dates) is 
collected 
The first ofDoCDat's criteria for accuracy sought to determine the 
form in which continuous data (excluding dates) had been collected. 
The total number of variables at least 95% complete is divided by the total number of variables in the 
database. 
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No continuous data were collected in the study so this was not 
investigated. 
6.6.2 Use of explicit definitions for variables 
This was defined as 'the percentage of variables which have clear 
definitionsJ4 laid out in a document as a data manual and is calculated 
by dividing the number of variables in the database which have been 
clearly defined by the total number of variables which need to have 
definitions' (DoCDat). 
The four levels into which studies could be classified were as follows: 
• Level 1 : None 
• Level2: Some {<50%) 
• Level3: Most (50-97%) 
• Level4: All or almost all (>97%) 
All of the variables in this study had clear definitions stipulated for 
their collection with the exception of planned I unplanned admission 
which was not analysed. For this reason, the study met level4 of the 
criteria. 
6.6.3 Use of explicit rules for deciding how variables are 
recorded 
The rationale given for prescriptive guidance on data recording is to 
ensure that data are recorded in the same way, which increases the 
reliability of the collected data. 
The use of explicit rules was defined as 'the percentage of variables 
which have clear rules on how to code them ... laid on in a document 
such as a data manual and calculated by dividing the number of 
variables in the database which have clear rules by the total number of 
variables which need to have rules' (DoCDat). 
A definition is a clear description of what the variable means. 
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The four levels into which studies could be classified were as follows: 
• Level I: None 
• Level2: Some (<50%) 
• Level3: Most (50-97%) 
• Level4: All or almost all (>97%) 
The coding of variables was very much simplified in the study, guiding 
responders to record ticks into boxes for the collection of the organ 
support data and thus met level 4 of the criteria. 
6. 6.4 Reliability of coding for conditions and interventions 
The reliability of coding for conditions and interventions relates to how 
standardised the codes are and looks at intra-rater3S and intcr-rater36 
reliability. This is important to determine because it assures the 
researcher that any observed differences between patients can be 
attributed to the nature of patient, rather than the way in which the data 
has been recorded. 
The reliability of the tick boxes was perfectly adequate for this study, 
however the variance in data produced as a result of different staff 
completing the booklets at different times of the day and the member 
(type) of staff responsible for completing the booklets in the first 
instance was of greater concern. Feedback from the staff suggested 
that the booklets were not unreliable insofar that the data items were 
not difficult for them to understand. The use of the booklets would not 
have affected the quality of data collected. What would have been 
useful to know was the extent to which different types of staff gave the 
same response to the organ support categories. Tests of inter-ratcr 
reliability were not performed as it was only after the data had been 
collected that the problem of multiple staff engaging in the collection 
lntra-rater reliability is when 'the same observer gives the same value at different times, if the thing that 
he or she observes is the same (0vretveit, 1998). 
Inter-rater reliability is defined as 'the extent to which two or more observers give the same value to the 
thing that they measure at the same time' (0vretveit, 1998). 
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of the data became apparent. Had it been possible to perform an audit, 
different members of staff could have been presented with the same 
patient (on whom data could be collected) and their data compared for 
concordance (inter-rater reliability). The same member of staff could 
have been asked to collect the same information at different times of 
the day (intra-rater reliability). Kappa scores produced from these tests 
would have provided an effective means of assessing the reliability of 
the data. 
An assumption was made that the scope of organ support variables and 
their definitions had content validity37 based on these being devised by 
a select, expert Group of critical care opinion leaders. The only 
disadvantage to the collection of the organ support data was the lack of 
another dataset which could have been used to assess the criterion 
validity of these data. 
The four levels into which studies could be classified were as follows: 
• Level 1: Not tested (no inter or intra-rater reliability tests 
conducted) 
• Level2: Poor (low inter and intra-rater reliability i.e. Kappa 
<0.5) 
• Level 3: Fair inter and intra-rater reliability i.e. Kappa 0.5-
0.8) 
• Level 4: Good inter and intra-rater reliability (i.e. Kappa 
>0.8) 
As no formal tests of inter-rater and intra-rater reliability were 
performed, the study fell into the Level 1 category. 
37 Conlenl validity is concerned with measuring what one inlends to measure (Bohmstedt, 1983) 
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6.6.5/ndependence of observations of primary outcome38 
The outcome variables in the study (survival at discharge from the 
critical care unit) were objective and did not require independent 
observation. 
The four levels into which studies could be classified were as follows: 
• Level 1: Outcome not included or independence unknown 
• Level 2: Observer neither independent nor blinded to 
intervention 
• Level3: Independent observer not blinded to intervention 
• Level4: Independent observer blinded to intervention or 
not necessary as objective outcome (e.g. death or lab test). 
According to the above criteria, the study could be placed in the Level 
4 category. 
6.6.6 Extent to which data are validated 
Misleading results can follow if measures are not taken to ensure the 
validity of data. The four levels into which studies could be classified 
were as follows: 
Level 1: No audit (no data validation is conducted) 
Level 2: Range or consistency checks 
• Range checks ensure that data outside of the permitted 
range are not allowed, for example an age of 150. 
Range checks may be pre-programmed into data entry 
programmes and performed automatically at data entry, 
or performed manually at the data analysis stage. 
• Consistency checks can be performed manually or 
automatically, and involve highlighting areas where the 
data are inconsistent. For example, a consistency check 
38 Described as any bias associated with the outcome due to the way in which it was reported (DoCDat) 
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would ensure that an individual having a hysterectomy 
could not be recorded as male. 
• Some databases may go back to the original records to 
validate the data by retrieving the correct value, for 
example by sending back a list of queries to those who 
collect the data. 
Level 3: Range and consistency checks 
Level4: Range and consistency checks plus external validation 
using an alternative source 
• External validation involves going back to the original 
record and comparing the information with that held by 
the database to ensure that the database records are 
accurate. This would normally take the form of an audit 
whereby, for instance, a 1% sample of all database 
records is compared to the original medical notes. 
• Going back to the records to check inconsistencies or 
range checks by setting up a series of queries does not 
constitute external validation (DoCDat). 
Internal consistency checks of the data set were performed manually 
and these are described as follows: In order to check whether the level 
of care had been correctly determined based on the definitions 
provided, a rule was created whereby Level 2 care should not be ticked 
if a patient was receiving advanced respiratory support, so for patients 
with the Level 2 care box ticked, this was changed to Level 3 care. 
Patients neither could receive both basic and advanced respiratory 
support during the same day, so the data were changed to reflect this 
indicating the higher form of organ support (advanced respiratory 
support). The consistency checks placed the study into the Level2 
category, although the category that include ranges does not strictly 
apply as no data were collected whereby ranges could be checked. 
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A discussion of this work takes place towards the end of the Chapter 
(Section 6.20). Section 11 will now describe the characteristics of the 
participating critical care units. 
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CHAPTER 6: RESULTS 
SECTION 11 : UNIT CHARACTERISTICS 
6.7 Unit Characteristics 
6. 7. 1 Geographical coverage 
fth 70 critical care units, 65 (93%) provided data on their unit 
haract ristic . Whilst the sample achieved wide geographical coverage 
of critical care units in England with smaller numbers from Scotland 
and orth m Ireland no critical care units in Wales were represented 
in the ample (Figure 6.5). 
Figure 6.5: Pie chart showing the numbers of critical 
care units by Region 
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The three predominant participating regions were the South East, South 
West and the West Midlands that collectively generated 48% of the 
patients studied (table 6.6) 
Table 6.6 Number of patients and patient days by 
geographical location 
Geographical Location N (%) Number of Number of patient 
patients studied days Included In the 
(o/e) analysis (%) 
Northern & Yorkshire 8 {11} 745 {10} 3 627 {10) 
Trent 5{7} 488 {7) 2 267 {6} 
Eastern 7 {10} 701 {10} 3971(11} 
London 6 (9} 820 {11} 3 893 (10) 
South East 12 {17} 1158 {16} 6 070 (16} 
South West 10 114} 1107 (15) 5 377 (14) 
West Midlands 9 {13} 1115{15) 5 549(15} 
North West 8 {11} 681 {9} 4 361 (12} 
Wales 0 (0) 0 {0} 0 {0} 
Scotland 3(4) 349 {5} 1 570 (4} 
Northern Ireland 2 P! 79 i1l 484 i1l 
6. 7.2 Teaching hospital status 
As can be seen from Table 6.7, a quarter of the critical care units 
studied was located in NHS Trusts that had a Medical School. A third 
of the units considered themselves as tertiary referral centres. 
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Hospital Type 
Table 6. 7: Hospital Type 
Number 
of units 
(%) 
Medical School within the hospital 17 (24) 
Tertiary Referral Centre 25 (36) 
Unknown* 7 (10) 
• The hospital type was not indicated In two additional responding units. 
6. 7.3 Types of critical care unit 
Number of 
patients 
studied 
(IYo) 
2 322 (32) 
2 917 (40) 
545 (8) 
Number of 
patient 
days 
Included In 
the 
analysis 
(%) 
12 627 (34) 
15 612 (42) 
2 954 (8) 
The majority of critical care units were combined intensive care I high 
dependency units (HDUs) (46%), followed by adult general intensive 
care units (ICUs) (24%) and the remaining centres consisted of a 
mixture of general and surgical HDUs, cardiothoracic units, burns/ 
plastic surgery units and neurological and neurosurgical ICUs and 
HDUs. The unit type changed in two hospitals during the study period. 
One adult general ICU and adult general HDU merged to form a 
combined adult general ICU I HDU. This change occurred on 
291412003. One adult general ICU merged with an adult general HDU 
to also become a combined adult general ICUIHDU. This changed 
occurred on 114/2003 and the unit descriptors given are for the latter. In 
three of the hospitals, both the adult general ICU and adult general 
HDU participated in the study. These are categorised as adult general 
ICUIHDUs (Table 6.8). 
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Table 6. 8: Types of Critical Care Unit 
Unit Type Number Number of Number of 
of Units Patients Patient 
(%) Studied Days 
('lo) Included In 
The 
Analysis 
(%) 
Adult General Intensive Care Unit 17 (24} 1 373 {19} 8 450 (23} 
Adult General High De~endenc~ Unit 2 (3} 177 (2} 686 {2} 
Adult General Intensive Care Unit/ High De~endenc~ Unit 32 (46) 3 712 (51) 17 793 (48) 
Adult Surgical Intensive Care Unit 0 (0) 0 (0) 0 (0) 
Adult Surgical High De~endency Unit 2 (3) 274 (4) 1164 (3) 
Adult Cardiothoracic Intensive Care Unit 2 {3) 378 {5) 1 833 {5) 
Adult Corona!Y Care Unit 0 {0) 0 (0) 0 (0) 
Adult Burns I Plastic Su~e!Y Unit 2 (3) 22 (0) 96 (0) 
Adult I Paediatric Bums Unit 0 (0) 0 (0) 0 (0) 
Adult Neurological Intensive Care Unit I General Intensive 2 (3) 152 (2) 887 (2) 
Care Unit 
Adult Neurological Intensive Care Unit I High Dependency 4 (6) 433 (6) 2 258 (6) 
Unit 
Adult Combined Intensive Care Unit I High Dependency 2 (3) 176 (2) 649 (2) 
Unit I Corona!Y Care Unit 
Adult Neurosurgical & Neurological Intensive Care Unit I 1 (1) 24 (0) 205 (1) 
High De~endenc~ Unit 
Adult General Intensive Care Unit I Neuro Critical Care Unit 1 (1) 99 (1) 879 {2) 
Adult General Intensive Care Unit I High Dependency Unit I 1 (1) 215(3) 1 155 (3) 
Neuro Intensive Care Unit 
Unknown* 2 (3) 208 p~ 111s Pl 
*lt was possible to clarify the unit type in three of the five non-responding units. 
A comparison of our study was made with ICNARC's CMP database39 
and the results were as follows (table 6.9). ICNARC had a higher 
proportion of ICUs participating in their study and it would appear that 
a higher number of specialist critical care units and separate high 
dependency units participated in our study. A similar proportion of 
combined critical care units (e.g. ICU I HDU) were observed in both 
studies. 
39 Unpublished data provided by ICNARC Statisticians on 18111 May 2005 (sent by e-rnail). 
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Table 6.9: Comparisons of unit type with the ICNARC 
CMP database (2005) 
Type of Critical Care Unit ICNARC (%) Study Population (%) 
ICU 
ICU I CCU 
ICU I HDU 
ICU I HDU I CCU 
ICU I HDU I NICU 
Other e.g. HDUs, cardiothoracic ICUs, specialist 
burns etc. 
71 (42.0) 
3 (1 .8) 
87 (51.5) 
7 (4.1) 
1 (0.6) 
NIA 
6. 7.4 Number of staffed critical care beds 
The number of staffed beds provided by the critical care units ranged 
from 2 beds to 20 beds, with the majority of units having between 7 to 
9 beds (30%) and 4 to 6 beds (27%) (see Figure 6.6). The reason for 
this wide variation is not known. 
Figure 6.6: Pie Chart Showing The Proportion Of Critical 
Care Units By Size 
Unknown• 
9% 
19% 
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1-3 beds 
3% 
7-9 beds 
30% 
27% 
17 (24 .3) 
0 (0.0) 
38 (54.3) 
2 (2 .9) 
1 (1.4) 
12 (17.1) 
The median size of critical care units in the ICNARC CMP is 7 (range 
3-22) which compares with median values of 5.3 for ICUs and of 6 for 
combined ICU I HDUs in the Audit Commission Survey (Harrison et 
al., 2004 & Audit Commission, 1998). 
The largest numbers of patients and patient days was collected from 
critical care units having between 7-9 and 10-12 beds (table 6.10). 
Comparisons with ICNARC's CMP showed the study sample to have a 
lower proportion ofparticipating units with 1-3 beds (2.9% compared 
with 7.6%) and similarly, with units sized between 4-6 beds (27.1% 
and 54.7% respectively). Our study had a higher proportion of critical 
care units with 13-15 beds (8.6% compared to 2.9%). 
Table 6. 10: Numbers of staffed critical care beds 
Unit Size (Numbers of staffed Number Comparison Number Number of 
beds) of with of patient 
critical ICNARC's patients days 
care CMPo40 studied Included In 
units (%) (Ofo) the (%) analysis 
(%) 
1-3 beds 2 (2.9} 13 j7.6} 47 Pl 151 (0} 
4-6 beds 19(27.1} 93 (54.7} 1 554 (21} 7 344 (20} 
7-9 beds 21 {30.0} 38 (22.4} 2 026 {28} 10 857 (29} 
10-12 beds 13 (18.6} 19 {11.2} 1 903 {26} 8 965 (24} 
13-15 beds 6 (8.6} 5 (2.9} 798 {111 4 974 (13} 
16-18 beds 1 {1.4} 1 (0.61 240 (31 1 186 (31 
19-20 beds 1 (1.4} 0 (0.0} 215(31 1 155 {3} 
> 20 beds 0 {0} 1 (0.61 0 (0} 0 (0} 
Unknown* 7 ~10.01 0 460 l61 2 538 ~7! 
* The number of beds was not indicated in two additional responding units. 
40 Data from 170 critical care units was used between December 1995 and January 2005 
244 
6. 7.5 Provision of additional services 
Outreach services 
The Intensive Care Society (ICS) (2002) defines Outreach (as applied 
to critical care services) as "a multidisciplinary approach to the 
identification of patients, at risk of developing critical care, and those 
patients recovering from a period of critical illness, to enable early 
intervention or transfer (if appropriate) to an area suitable to care for 
that patient's individual needs." Outreach services were provided in 
40% of hospitals with a smaller proportion of hospitals offering follow-
up clinics and bereavement services (Table 6.11 ). 
According to the ICS (2002), Outreach Services have the following 
objectives: 
• To avert admissions to critical care; 
• To facilitate timely admission to critical care and discharge 
back to the wards; 
• To share critical care skills and expertise through an 
educational partnership; 
• To promote continuity of care; and 
• To ensure thorough audit and evaluation of Outreach 
Services. 
Table 6.11 : Provision of additional services 
Additional Services N (%) 
Provision of an outreach service at the time of the study 40 (57) 
Provision of a follow-up clinic at the time of the study 24 (34) 
Provision of a critical care bereavement service at the time of the study 1 0 ( 14) 
Unknown 5 (7) 
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Follow-up Clinics and Bereavement Services 
Follow-up clinics are part of the continuum ofoutreach care (NHS 
Modernisation Agency, 2003) to 'enable discharges by supporting the 
continuing recovery of discharged patients ... post discharge from 
hospital, and their relatives and friends' (Department of Health, 2000). 
As part of a Bereavement service, all recently bereaved relatives are 
sent a letter of condolence a few weeks after their loss. In this letter are 
details of people to contact regarding any unresolved issues they may 
have with their recent critical care experience. If they choose to take up 
this offer, they are given an appointment to attend the critical care unit 
to allow for clarification and offered support. 
As can be seen from table 6.11, over half of the critical care units 
operated an outreach service at the time of the study and just over a 
third were offering follow-up clinics to their patients. Only a small 
number of units had set up a bereavement service. 
6.8 Representativeness of the sample 
6.8.1 Representative of Country (i.e. Coverage) 
The Directory of Clinical Databases (DoCDat)- data definition manual 
on data quality was used to assess the extent to which the critical care 
units studied were representative of the country. 
Coverage was defined by DoCDat as 'the extent to which the eligible 
population (defined by the common circumstance that determines 
inclusion and the geographical area covered [by the study] can be 
generalised to the reference population (everyone with the common 
circumstance in the country from which the data are drawn'. 
Four levels of representativeness are given: 
Level 1: No evidence or unlikely to be representative 
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• The sample is unlikely to be representative if those 
include represent a sub group (e.g. private patients I 
patients from one ethnic group). 
Level 2: Some evidence that eligible population is representative 
• Basic comparisons have been made with the reference 
population (all those in the country with the common 
circumstance), which show that, for example, incidence 
rates or the socio-demographic distribution of the 
eligible population and the total population of the 
country are similar. 
Level 3: Good evidence the eligible population is representative 
One or more of the following: 
• Comparisons between the eligible population and the 
reference population show similar characteristics such 
as demographics or incidence; 
• A sampling frame has been used that captures a 
representative sample. 
Level 4: Total population of country included 
The Directory of Critical Care (2001) listed 213 (89%) critical care 
units in England, 16 units in Wales (6.5%) and 11 (4.5%) in Northern 
Ireland. Our study had 65 critical care units in England (30.5% of this), 
none in Wales (0%) and 2 in Northern Ireland (18% of this). 
Comparing our study to the Directory of Critical Care, our sample of 
70 critical care units represented 29% of those in England, Wales and 
Northern Ireland. Of the 70 critical care units studied, 65 (86%) were in 
England, none in Wales, 2 (3%) were in Northern Ireland. The 
percentages of units by county suggest that there is some evidence that 
the sample was geographically representative and as such, would meet 
Level 2 of the criteria. 
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6.9 Performance of the study against the DoCDat 
criteria 
The study ratings were compared with the median (interquartile [IQR] 
ranges from a11154 databases in DoCDat. The mean level achieved by 
the study across all criteria (with the exception ofE as it did not apply) 
was 2.6. The study exceeded the DoCDat median for 3 categories, 
equalled it for 2 categories and performed worse than the median in 4 
categories (table 6.12). 
Table 6.12: Performance of study against DoCDat 
data bases 
Critical Care 
Study Level 
1 2 3 4 
DoCDat databases 
Median (IQR) 
A discussion of this work takes place towards the end of the Chapter 
(Section 6.20). Section Ill will now explore the characteristics of 
patients and report on some preliminary analyses looking at the 
relationship between patients' organ support and the type and size of 
the critical care unit. 
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CHAPTER 6: RESULTS 
SECTION Ill: CHARACTERISTICS OF PATIENTS AND 
PRELIMINARY ANALYSES 
6.10 Patients' Characteristics 
As described in Section 7.1, data were collected on 7,243 critically ill 
patients. The characteristics of patients in terms of their critical care 
unit length of stay, survival status at discharge from the critical care 
unit and type of admission (planned or unplanned) are shown in Table 
6.13. 
Table 6.13: Patients' descriptive characteristics 
Descriptive Characteristics Of The Study Population N (%) 
Total number of patients studied 7,243 
Number of patients with complete data (i.e. received treatment in the unit within the 
time period of the study)(%) 
6 496 (90) 
Number of patients with a length of stay of less than 24 hours(%) 
Number of unplanned admissions(%)- where status is known 
Number of surviving patients - where outcome data is known (%) 
Total number of calendar days with data collected 
Mean ± SO Actual Length of stay (actual date and times of admission included for 
complete patients 
Median (IQR) 
Mean ± SO Actual Length of stay (actual date and times of admission included for 
incomplete patients41 
Median (IQR) 
Mean ± SO Calendar Length of stay for complete patients 
Mean ± SO Calendar Length of stay for incomplete patients 
2 019 (28) 
4 966 (69) 
83% 
37,170 
4.02 ± 5.88 
1.97 (0.91-4.39) 
13.70 ± 19.90 
7.34 (2.83-16.76) 
4.64 ± 5.34 
9.36 ± 11.74 
41 Patients• critical care unit length of stay was cut at 31/05103 23:59 for those still receiving care in the critical care 
unit at the end of the study 
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6. 10. 1 Admission status 
Thirty-one percent of patients were elective (i.e. planned) admissions. 
6.10.2 Patients' length of stay 
As the study started at the beginning of a calendar month, there were 
some patients already receiving care in the critical care unit that had 
been admitted prior to this date. Critical care units were asked to 
supply the date and time of admission for their patients so for these 
patients, complete data on their stay was missing. Comparisons of 
patients' actual length of stay were possible using published sources 
provided by ICNARC and the Audit Commission (Harrison et al., 
2004; Audit Commission, 1998) as the same methods of length of stay 
estimation were performed in all studies. The median (interquartile 
range (IQR)) length of stay was 1.7 (0.8-4.4 days) and 2 (1-5) days in 
ICNARC's CMP and in any critical care unit42 respectively. The 
median length of stay in our study was 1.97 days for patients with 
complete data and 7.34 days for patient still receiving care in the 
critical care unit; the former of which is comparable with the CMP and 
the Audit Commission's findings. 
6.10.3 Survival status at discharge from the Critical Care Unit 
Mortality rates among patients admitted to the critical care unit are 
relatively high compared with other areas of medicine (Rubenfeld et 
al., 1999). More than one of every five patients die on a critical care 
unit and as many as three out of every five die in some units, according 
to the Audit Commission (1998). Crude mortality observed at 
discharge from the critical care unit was 17%, lower than the 21.5% 
observed by the ICNARC's CMP database of 129,647 admissions to 
128 adult general critical care units. The variation in mortality rates 
between critical care units is thought to be due to case-mix differences 
(Audit Commission, 1998), however studies using data from 
Data on 'any critical care unit' were obtained from the Audit Commission Report ( 1998) 
250 
ICNARC's CMP show that some critical care units have higher death 
rates than expected, even when adjustments are made for case-mix. 
6.11 Types of organs supported 
6. 11. 1 Frequency statistics 
Table 6.14 shows the number of days where organ support was given 
to patients. The most frequently given organ support was circulatory 
support, followed by advanced respiratory and basic respiratory 
support. By subtracting the days where no organ support was received 
by patients from the total of67, 899 organ support days leaving 65,355 
days, it was possible to determine the ratio of organ support days over 
the number of patient days (37,170), which at 1.76 is indicative of 
multiple organ support. 
For this reason, it was felt important to consider the interactions 
between the organ systems. 
Forty-eight combinations of the remaining types of organ support 
(including days of no organ support) were permissible within the data 
set. However, only 37 of the 48 combinations were observed during the 
study period. 
Table 6. 14: Frequency of days by type of organ support 
Type of Organ Support N (o/o) 
No organ support 2 544 (3.7) 
Basic respiratory support 11125(16.4) 
Advanced respiratory support 19 872 (29.3) 
Circulatory support 26 860 (39.6) 
Neurological support 3 985 (5.9) 
Renal support 3136 (4.6) 
Dermatological support 377 (0.6) 
Total 67 899 (100) 
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Fourteen types and combinations of organ support (29%) reflected the 
care received by patients in 97.4% of the total number of patient days. 
Nineteen types and combinations of organ support (40%) increased this 
percentage by 1.8% to 99.2%. These are denoted in Table 6.15 by an 
asterix. Advanced respiratory and circulatory support represented the 
most frequently administered form of organ support with 31.5% of 
patient days. This was followed by basic respiratory and circulatory 
support (16.7%). 
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Table 6. 15: Frequency Of Patient Days By Organ Support 
Type (And Combination) 
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2 544 (6.8) 
3 598 (9.7) 
2 822 (7.6) 
3166(85) 
142 0.4 
33 0.1 
10 0.0 
6212 
16.7 
295 (0.8) 
121 (0.3) 
13 0.0 
11 709 
31.5 
390 (1.0) 
268 (0.7) 
32 0.1 
119 (0.3) 
131 (0.4) 
25 (0 1) 
0 0.0 
0 0.0 
0 0.0 
488 {1.3) 
337 {0.9) 
40 {0.1) 
4 (0.0} 
0 {0.0) 
4 {0.0} 
0 {0.0) 
3 {0.0) 
0 {0.0) 
1 939 {5.2) 
155 {0.4) 
2 {0.0) 
2 212 {6.0) 
6 {0.0) 
26 {0.1) 
0 {0.0) 
6 {0.0) 
2 {0.0) 
5 {0.0) 
0 {0.0) 
20 {0.1) 
231 {0.6) 
50 {0.1) 
0 {0.0) 
0 {0.0) 
0 {0.0) 
10 {0.0) 
37170 
100 
43 
From the survey of 193 critical care units conducted by the Audit 
Commission (1998), 103 critical care units that collected information 
on organ failure reported an average of 12% of patients that had three 
or more organs supported. In our study, 18% of patients had three or 
more organs supported, which would suggest that our patients had a 
greater severity of illness however, it is not clear from the Audit 
Commission Report what types of organ systems were included in their 
estimates so it is difficult to make draw any conclusions from this 
companson. 
6.12 Relationship between the organs supported and 
the type of critical care unit 
6. 12. 1 Number of organ support days by type of critical care 
unit 
The number of organ support days43 was stratified by the type of 
critical care unit (Table 6.16). Significant differences were observed 
between the different types of critical care units. The adult ICU I HDU 
I Neuro ICU incurred the highest number of organ support days and the 
adult bums I plastics unit incurred the least (though the sample upon 
which these findings were based was comparatively small). 
There appeared to be a relationship between the total number of organ 
support days and the throughput of the critical care unit, which is a 
function of the size of the critical care unit. For this reason, studying 
the total number of organ support days in this way is oflimited value in 
terms of understanding whether the type of critical care unit can 
determine organ support treatment patterns. As such, the number of 
organ support days was expressed as a ratio (calculated by dividing the 
monthly number of organ support days over the monthly number of 
patient days). 
Expressed as the monthly sum of days of basic respiratory support, advanced respiratory support, 
circulatory support, renal, neurological and dermatological support 
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Table 6.16: Number of organ support days by type of Critical Care Unit 
Unit Type Months Mean (SO) Median (inter-quartile range) Minimum - Maximum 
Adult General ICU 41 41 0 (207) 336 (265-538) 173-1 072 
Adult General/ Surgical HDU 8 243 (102) 235 (170-255) 138-471 
Adult Combined ICU I HDU 83 362 (142) 340 (270-435) 36-682 
Adult Cardio thoracic ICU 5 631 {108) 601 {535-742) 503-765 
Adult Bums I Plastics 5 40 (24) 37 {19-63} 7-69 
Adult Neuro I GeneraiiCU 6 516 {345} 313 {277 -942) 269-997 
Adult Neuro ICU I HDU 12 402{151) 406 {272-557) 169-587 
Adult ICU I HDU I CCU 6 119 {79} 118 (47-194} 35-201 
Adult ICU I HDU I Neuro ICU 2 1159 (29) 1159 {1138) 1 138-1 179 
Unknown 4 591 ~324l 561 po6-905l 295-945 
Chi-square, df, sig (49.94, 9, p<0.0001) 
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Mean 
Rank 
91.96 
41.31 
88.21 
150.60 
5.60 
99.33 
96.83 
14.50 
171.50 
121.63 
6. 12.2 Organ support ratio per patient day by type of Critical 
Care Unit 
The mean organ support ratios give a meaningful indication of the 
intensity of organ support in a given type of critical care unit. As one 
would expect, the adult general I surgical HDUs incur the lowest organ 
support ratio compared to the other types of critical care unit. The 
Unknown unit types represent the two teaching hospitals in Leeds (St. 
James' Hospital and Leeds General Infirmary), in which one would 
expect to observe a relatively severe case-mix. The differences in the 
organ support ratios between the different types of critical care units 
were statistically significant (Table 6.17). 
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Table 6.17: Organ support ratio per patient day by type of Critical Care Unit 
Unit Type Months Mean (SO) Median (Inter- Minimum- Mean Rank 
quartile range) Maximum 
Adult GeneraiiCU 41 1.96 (0.23} 1.99 (1.75-2.08) 1.61-2.71 115.46 
Adult General/ Su!lJical HDU 8 1.05 {0.34} 1.19 {0.72-1.28) 0.55-1.50 16.88 
Adult Combined ICU I HDU 83 1.68 {0.32} 1.67 {1.50-1.94) 0.73-2.35 75.51 
Adult Cardio thoracic ICU 5 1.75 {0.16} 1.68 {1.62-1.91} 1.57-1.97 79.70 
Adult Bums I Plastics 5 2.08 {0.91} 2.47 {1.25-2.70} 0.54-2.82 125.00 
Adult Neuro I General ICU 6 1.65 (0.47} 1.64 (1.14-2.17} 1.11-2.21 76.83 
Adult Neuro ICU I HDU 12 2.04 {0.43} 2.01 {1.68-2.33} 1.43-2.84 117.25 
Adult ICU I HDU I CCU 6 1.12 {0.14} 1.12 {0.99-1.26} 0.92-1.30 14.83 
Adult ICU I HDU I Neuro ICU 2 2.01 {2.60} 2.01 {1.98} 1.99-2.02 125.00 
Unknown 4 2.05 ~0.25l 2.04 ~1.81-2.29l 1.75-2.35 127.75 
Chi-square, df, sig (57.80, 9, p<0.0001) 
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6.13 Relationship between the organs supported and 
the size of the Critical Care Unit 
6. 13. 1 Number of organ support days by size of Critical Care 
Unit 
The number of organ support days44 was then stratified by the number 
of staffed beds (denoted by size) within the critical care unit (Table 
6.18). Significant differences were also observed between the different 
sizes of critical care units. The adult ICU I HDU I Neuro ICU to incur 
the highest number of organ support days and the adult bums I plastics 
unit to incur the least (though the sample upon which these findings 
were based is comparatively small). 
Table 6. 18: Number of organ support days by size of 
Critical Care Unit 
Number of Months Mean Median (inter- Minimum- Mean 
staffed beds (SO) quartile range) Maximum Rank 
1-3 beds 6 41 (22) 40 (25-62) 7-69 5.67 
4-6 beds 40 269 (78) 263 (205-313) 157-560 53.06 
7-9 beds 52 358 (101) 338 (292-428) 75-575 89.24 
10-12 beds 41 407 (189) 398 (260-572) 35-750 98.34 
13-15 beds 14 705 (200) 646 (558-935) 452-1 072 153.14 
16-18 beds 3 662 (140) 719 (503) 503-765 152.00 
19-20 beds 2 1 159 (29) 1159 (1138) 1138-1 179 171.50 
Unknown 14 357 (248) 307 (240-429) 37-945 79.00 
Chl-square, df, sig (72.74, 7, p<0.0001) 
44 Expressed as the monthly sum of days of basic respiratory support, advanced respiratory support, 
circulatory support, renal, neurological and dermatological support 
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Number of 
Staffed Beds 
6.13.2 Organ support ratio per patient day by size of critical 
care unit 
Study of the organ support ratio per patient day by size of the critical 
care unit suggested [in the most part] that the number of staffed beds 
does not have a significant bearing on the intensity of organ support 
received by patients. However, units with between 13-15 beds did 
appear to treat sicker patients than the smaller sized critical care units 
(table 6.19). Further study of the effects of size and intensity of organ 
support is required using a larger sample. 
Table 6. 19: Organ support ratio per patient day by size of 
Critical Care Unit 
Months Mean (SO) Median (Inter- Minimum- Mean 
quartile range) Maximum Rank 
1-3 beds 6 1.63 (0.77) 1.63 (1.03-2.18) 0.54-2.82 72.83 
4-6 beds 40 1.77 (0.40) 1.75 (1.56-2.00) 1.02-2.84 86.03 
7-9 beds 52 1.73 (0.37) 1.70 (1.60-1.98) 0.73-2.71 81.79 
10-12 beds 41 1.59 (0.43) 1.65 (1.29-1.99) 0.55-2.10 70.82 
13-15 beds 14 1.97 (0.21) 2.04 (1.82-2.14) 1.49-2.21 120.43 
16-18 beds 3 1.70 (0.14) 1.67 (1.57) 1.57-1.85 70.83 
19-20 beds 2 2.01 (2.60) 2.01 (1.99) 1.99-2.02 125.00 
Unknown 14 2.04 (0.36) 2.04 (1.78-2.37) 1.41-2.59 121.07 
Chl-square, df, slg (19.73, 7, p=O.OO&) 
A discussion of this work takes place towards the end of the Chapter 
(Section 6.20). Section IV will now describe the collection and 
validation of the expenditure data. 
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CHAPTER 6: RESULTS 
SECTION IV: COLLECTION AND VALIDATION OF 
EXPENDITURE DATA 
6.14 Collection of expenditure data 
6.14.1 Response rates 
A lower than expected response rate for the return of the expenditure 
questionnaires was observed (table 6.20). The first column of table 
6.20 describes the nature of each expenditure questionnaire with the 
second column displaying the response rate showing the percentage of 
these returned questionnaires of the total of70 critical care units. 
The highest response rate was observed with respect to gathering 
expenditure data on specialised bed therapy, directorate accountants 
and dieticians followed by nursing staff, drugs and fluids, disposable 
equipment and clinical pharmacists. It was much harder to extract data 
on radiology and laboratory services because of the tests being tracked 
by Consultant rather than by location (e.g. the critical care unit). 
Difficulties were also experienced with the provision of expenditure 
data on junior medical staff because of them working across the 
hospital as part of the on-call roster and therefore identifying the 
proportion of their time spent in the critical care unit was problematic. 
Access of the budget statements permitted extraction of some of these 
resources, such as nursing staff, administrative staff, drugs and fluids, 
disposable equipment, blood and blood products and specialised bed 
therapy which are denoted by •. 
The fourth column entitled 'cleaned data suitable for analysis' shows 
the percentage of returned questionnaires that could be used in the 
analysis. Some of the respondents provided expenditure data for the 
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hospital (as a whole) rather than that relating to the critical care unit 
(specifically). In this instance, their data were not included. Some 
critical care units returned the questionnaires stating that they were not 
able to complete them, which further explains the discrepancy between 
the response rate and the amount of data that was used in the analysis. 
Table 6.20: Response rates to the expenditure survey 
Expenditure Critical Data extraction I Cleaned Number 
questionnaires care unit resource items data of 
including budget response suitable for months 
statements rate(%) analysis- for 
number of analysis 
critical 
care units 
(Ofo) 
Budget statements 48 (69) Nursing staff* 46 (96) 109 
Administrative staff* 26(54} 63 
Drugs and fluids 37 (53) Drugs and fluids* 46 (124) 109 
Nutritional ~roducts 29 (78} 75 
Dis~osable egui~ment 13 (19} Dis~osable egui~ment* 46 (354} 109 
Medical staff 33 (47) Consultant medical staff 25 (76) 61 
Other medical staff 27 (82} 67 
Radio log~ 31 {44} Radiolog~ 28 (90} 70 
Laborato!Y services 24 (34} Laborato!Y services 24 (100) 64 
Blood and blood eroducts 15 {21} Blood and blood ~roducts* 23 (153} 59 
S~ecialised bed thera~~ 39 (56} Seecialised bed theraet 47 !121} 114 
Dieticians 52 {74} Dieticians 47 (90} 115 
Ph~siotheraeists 41 (59} Ph~siotheraeists 41 (100} 103 
S~eech and language therae~ 49 (70} seeech and language therae~ 38 (78} 100 
Occueational therae~ 44 (63} Occueational therae~ 28 (64} 69 
Medical Technical Officers 33 (47} Medical Technical OffiCers 31 (94} 78 
Clinical eharmacists 42 (60} Clinical ~harmacists 42 (100} 104 
Information Technol29ists 38 (54} Information Technologists 29 (76} 74 
Clinical and biomedical 37 (53) Clinical and biomedical scientists 28 (76) 70 
scientists 
Clinical Ps~chologists 47 (67} Clinical Ps~chologists 26 (55} 68 
Directorate accountants 47 (67} Directorate accountants 47 (100} 116 
Personnel Officers 32 ~46! Personnel Officers 31 ~97! 77 
* Extractable data from the budget statements 
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6. 14.2 Adherence to the definitions for estimating 
expenditure 
Respondents were asked, when completing the expenditure 
questionnaires, to provide a description of the resources used and a 
brief explanation as to how the expenditure data had been estimated 
(for this resource use). This allowed a comparison of the costing 
methods used by the respondents against the stipulated definitions (as 
described in Chapter 5, table 5.3). Figure 6.7 illustrates the number of 
responses (shown in red) and against those, the number of responses in 
which the definitions had been adhered to (shown in blue). 
Figure 6. 7: Response rates to the expenditure survey 
(red) with the number of responses determined 
according to the prescribed definitions (blue) 
50 
45 
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The Directorate Accountants were the worst offenders with 26% of the 
responders using different methods of estimating the costs than those 
recommended in the questionnaires. As some of the data were 
extracted from the budget statements, no deviation from the definitions 
occurred. Table 6.21 gives more detailed results ofthis using the 
information returned by the respondents. The alternative methods used 
to estimate the critical care unit's expenditure were generic methods 
such as cost apportionment based on overhead absorption rates and use 
of reference costs, and resource-specific methods such as the use of 
Korner Work Units (KWUs), relevant to radiology services alone. 
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Table 6.21: Description of the resource use and 
compliance rates 
Resource Description of Service Provided 
Items 
Nursing staff Information extracted from the 
budget statements so no 
descriptions given 
Administrative 
staff 
Drugs and 
fluids 
Nutritional 
products 
Disposable 
equipment 
Consultant 
medical staff 
Other medical 
staff 
Radiology 
Information extracted from the 
budget statements so no 
descriptions given 
Information provided but no 
descriptions given 
Information provided but no 
descriptions given 
Information provided but no 
descriptions given 
Information provided but no 
descriptions given 
Information provided but no 
descriptions given 
Costs associated with the 
performing of radiology 
examinations e.g. C.T. abdomen, 
Chest x-rays, C.T. abdomen with 
and without contrast 
Performing of mobile chest x-rays, 
ultrasounds, cardiac catheterisation 
and reporting on examinations 
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Compliance 
To definitions 
(%) 
46/46 (100) 
26/26 (100) 
46/46 (100) 
29/29 (100) 
46/46 (100) 
25/25 (100) 
27/27 (100) 
26/28 (93) 
Alternative 
Methods Used 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
Salaried costs 
apportioned to 
the critical care 
unit using 
overheads 
absorption rate 
but test results 
determined 
according to the 
definitions 
provided 
Cost of tests 
calculated using 
KornerWork 
Units (KWU) @ 
£18 per KWU, 
however salaried 
costs calculated 
according to the 
definitions 
rovided 
Resource Description Of Service Provided 
Items 
Laboratory Provision of full pathology support 
services including bacteriology, virology, 
clinical biochemistry, immunology, 
haematology and cellular pathology 
Provision of histological service to 
critical care mainly in the reporting 
of tissue biopsies of various sorts 
(including lymph node, liver, gall 
bladder, transplant biopsies etc). 
Compliance 
To Definitions 
(%) 
23/24 (96) 
Blood and 
blood 
roducts 
Information provided but no 23/23 (100) 
Specialised 
bed therapy 
Dieticians 
descriptions given 
Rental contracts 47/47 (100) 
Attendance at daily ward rounds 46/47 (98) 
and assessment of patients' 
nutritional needs that include 
calculating nutritional requirements, 
assessing feeding routes, 
prescribing enteral or parenteral 
nutrition and monitor feeding 
Some audit work 
Nutritional screening and 
assessment 
Multi-disciplinary protocol/ 
guidelines development and 
educational initiatives 
Actively involved in teaching 
Prescribing total parenteral nutrition 
(TPN) regimes for individual 
patients 
Provision of advice and care plans 
for enteral and parenteral feeding 
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Alternative 
Methods Used 
Costs based on 
total laboratory 
charges 
apportioned on a 
percentage 
basis to various 
wards served by 
the laboratory. 
The percentage 
basis is arrived 
at by analysis of 
total tests for 
each ward over 
one ear. 
N/A 
N/A 
Costs 
apportioned to 
the critical care 
unit using 
overheads 
absorption rate 
Resource Description Of Service Provided Compliance Alternative 
Items To Definitions Methods Used 
(%} 
Physiotherapy Vibration, suction, circulation and 40141 (98) Costs 
mobility related tasks apportioned to 
Acute respiratory work and 
the critical care 
unit using 
assessment of rehabilitation needs overheads 
Involved in weaning from absorption rate 
mechanical ventilation, changing 
tracheostomies and use of non-
invasive ventilation 
Attendance at daily ward rounds, 
critical care unit meetings, case 
conferences and clinical 
improvement team meetings. 
Involved in setting up equipment, 
making circuits, keep stock levels 
up 
Teaching sessions 
Assessment I management of 
musculo-skeletal system to maintain 
I prevent complications of long-term 
mobility 
Early mobilisation including passive 
movements, posture management 
and positioning 
Specialist assessment and 
treatment as indicated e.g. in multi-
trauma patients 
Speech & Assessment and therapy of 37138 (97) Costs 
language communication and swallowing apportioned to 
therapy disorders the critical care 
Teaching and training sessions for unit using 
overheads 
nurses in use of swallowing absorption rate 
screening tools 
Assessment and management of 
communication impairment 
Liaison with critical care nursing and 
medical staff and patients' families 
Input into the development of 
tracheostomy guidelines 
Occupational Ad-hoc service to referred critical 28/28 (100) 
therapy care unit patients for splinting and 
provision of small aids e.g. reading 
stand or prism glass 
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Resource 
Items 
Medical 
Technical 
Officers (MTOs) 
Clinical 
Pharmacists 
Description Of Service Provided 
Assembly of new ventilators 
Ventilator maintenance and 
reassembly between patients 
Technical liaison between ventilator 
manufacturers, hospital engineering 
department and the critical care unit 
Routine servicing, repair and clinical 
support to all electro-medical patient 
connected equipment 
Comprehensive repair, maintenance 
and calibration of all medical devices 
Assessment of new medical devices 
on trial for evaluation prior to purchase 
Effective control and application of 
nitric oxide therapy 
Training of medical and nursing staff to 
competency levels 
Active involvement in the transfer of 
patients for scans 
Appraisal, purchase and selection of 
new equipment 
Commissioning and disposal of 
equipment 
Compliance 
To 
Definitions 
(%) 
29131 (94) 
Ordering of stock and non-stock items 40 142 (95) 
Clinical check of prescriptions and 
problem solving 
Organisation and providing advice on 
intravenous nutrition 
Ad-hoc input into policies and protocols 
Drug kardex monitoring 
Monitoring of expenditure on drugs 
Advising medical staff on drugs and 
providing administration advice to 
nurses 
Attending ward rounds with dieticians, 
doctors and nurses 
Reviewing of patients' medication -
appropriateness of drug selection, 
dosage and form. 
Produce guidelines for high cost I high 
use I high risk medicines 
Assessment of new drugs and impact 
on costs to the critical care unit 
Production of drug administration 
guidelines for local use 
Audit of drug-related issues 
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Alternative Methods 
Used 
Costs 
apportioned to 
the critical care 
unit using 
overheads 
absorption rate 
Apportionment of 
Reference Costs 
Costs 
apportioned to 
the critical care 
unit using 
overheads 
absorption rate 
Costs 
apportioned on 
the basis of 
pharmacy issues 
to each ward I 
location 
Resource Description Of Service Provided Compliance Alternative 
Items To Definitions Methods Used 
(%) 
Information Data collection and entry for the 26/29 (90) Costs 
Technologists ICNARC Case-Mix Programme apportioned to 
Database the critical care 
Management of the ICNARC unit using overheads 
database absorption rate 
Production of reports Extraction of 
Training of staff data from 
Maintenance of computer systems 
costing system 
used in 
Maintenance of Medicus database Reference Cost 
return 
Total hospital 
I.T. costs 
apportioned by 
the number of 
computers in 
each ward I 
location 
Clinical & Laboratory analyses of patient 25/28 (89) Pro rata of actual 
Biomedical samples expenditure by 
Scientists Support services associated with number of tests 
pathology performed 
Service of blood gas machine and Extraction of data from point of care testing equipment costing system 
Maintenance and repair of medical used in 
equipment Reference Cost 
return 
Provision of echo services 
Transcranial Doppler service 
Research support 
Deep Vein Thrombosis (DVT) 
assessment 
Providing an external quality 
assurance scheme for the blood 
glucose meters 
Clinical Provision of psychological service to 26/26 (100) N/A 
Psychologists patients (and relatives) on the 
critical care unit and at the follow-up 
clinic 
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Resource 
Items 
Directorate 
accountants 
Personnel 
Officers 
Description Of Service Provided Compliance Alternative Methods 
To Definitions Used 
(%) 
Financial management advice and 35/47 (74) Costs based on 
monitoring the ICU budget 
Provision of business advice and as a percentage of the total 
support and technical guidance divisional budget 
Assistance with the preparation of which is then 
business cases and general costing applied to the 
of services and skill-mixes monthly costs of 
the divisional 
Preparation of reports on financial finance function 
position 
Costs 
Preparation of financial forecasts, apportioned to 
variance analysis, budget setting, re- the critical care 
charging and checks relating to data unit using 
integrity overheads 
Assistance with service re-design and absorption rate 
costing of efficiency plans Costs calculated 
Preparation of budget statements, based on size of 
billing costs to outside organisations budgets 
and investigating variances managed by the 
accountant. 
Processing of invoices 
HRG allocation 
Raising of purchase orders to of Finance Costs 
suppliers to the critical 
Fixed assets and stock control care unit 
Attending critical care unit 
management meetings 
Training staff in financial and 
budgeta~ awareness 
Provision of a full range of 30/31 (97%) Costs 
employment support to the critical apportioned to 
care unit team including attendance the critical care 
at interviews, issuing employment unit using 
contracts, reviewing salary scales, overheads 
dealing with staff discielinaries abso!Etion rate 
6.14.3 
unit 
Distribution of data returned by each critical care 
Table 6.22 shows for each participating critical care unit, the number of 
resource use questionnaires that (after cleaning) were suitable for 
analysis. 
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Table 6.22: Number of critical care units contributing resource use data for analysis 
Hospital Name 1 2 3 4 5 6 7 8 9 1 11 12 13 14 15 16 1 18 1 20 21 22 
0 7 9 
Aberdeen Royal Infirmary ~ ~ ~ ~ ~ ~ ~ I 
Addenbrooke's Hospital .J'l .J'l .J'l .J'l .J'l ~ 
Antrim Area Hospital .J'l .J'l .J'l ~ ~ ~ tll tJ tll ~ ~ tll tll ~ 
Bristol Royal Infirmary 
"' 
tll .J'l ~ ~ ~ J; tll tll J tJ tJ tll tll ~ 
Broornfield Hospital 
"' "' 
.J'l ..; iil1 ..; .J'l tJJ .J'l fJl .J'l .J'l ~ .J'l ..; ..; ..; ..; 
Calderdale Royal Hospital ~ tJJ ..; ~ ..; ! 
Chelsea Westminster Hospital 
Colchester General Hospital .J'l .J'l .J'l ..; .J'l ..; ..; ..; ..; ..; ..; ..; .J'l .J'l .J'l ..; ..; ..; ..*, 
Conquest Hospital 
Cumberland Infirmary, 
"' 
..; ..; ..; ..; ..; ..; ..; ..; ill ..; .Jl<J ..; ill ill 
Carlisle 
Derriford Hospital .Jl<J .Jl<J .Jl<J ill .Jl<J ..; .Jl<J .Jl<J .J'l .Jl<J ..; .Jl<J ..; ill .Jl<J ..; ..; ill I 
East Surrey Hospital .Jl<J ..; .Jl<J .Jl<J ..; .Jl<J .Jl<J .Jl<J ill I 
Eastbourne District General rJii rJii rJii ..; .Jl<J ..; ..; ill .Jl<J ..; ..; ill I Hospital 
Freeman Hospital ..; ..; ..; ..; rJii tiJ tiJ rF !ill ..; ..; ..; iiJ! ..; ..; 
Frimley Park Hospital .Jl<J .Jl<J .Jl<J . ..; tJJ tJJ !ill !ill iiJ! ill ! 
George Eliot Hospital ..; ~ . ~ .~ . _f!! ..; ..; ..; !ill tJJ !ill !ill ..; iiJ! ill 
' Glenfield Hospital .Jl<J !ill tJJ rJ .. .; ill ..*, 
Good Hope Hospital rJii .Jl<J ~ . ..; _w!'J_ . t!l. .Jl<J rJii 
'* 
tJJ .Jl<J .Jl<J ~ .Jl<J ill ~ ~ 
Grantham & District Hospital .Jl<J · .J~<J ill .Jl<J J .Jl<J ill ~ 
Hemel Hempstead General .Jl<J .Jl<J .Jl<J .Jl<J ~ ~ 
Hospital 
Hope HOSJ>ital .Jl<J .Jl<J .Jl<J .Jl<J ..; ill ..; .Jl<J ~ I 
Huddersfield Royal lnfirma_ry J; J; J; I 
Hurstwood Park Neurological 
Centre 
John Radcliffe Hospital ~ .Jl<J rJii ..; J; 
"' "' 
rtl; J; ill · ~- ..; ..; ill ,;, ~ 
Leeds General Infirmary _ili .Jl<J_ .Jl<J ..; rJii .Jl<J .Jl<J J; rJii .Jl<J J; .Jl<J ..; ..; J; ..; ..; ,;, ~ 
Leighton Hospital ili 
-"'-
_J; -~- ..; rJii J; ..; , ...*:! ~ ~ ...*:! ...*:! 
Lincoln County Hospital ili lA lA 
"'· 
rtl; ~ ~ ~ ~ 
Luton & Dunstable Hospital , J; J; J; J; , , ~ ~ J; tll ~ tll ~ ~ ~ 
Monklands District General J; J; J; rtl; rtl; rtl; wA rtl; J; J; J; tll ..; 
"' 
..; ..; 
Hospital 
New Cross Hospital -~ 
-"'- -~- -~- Jl"i rJii J; rtl; rtl; ill , 
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Hospital Name 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
North Devon District Hospital rl1 J.i rl1 rl1 rl1 liA liA liA liA ill 
North Manchester General rl1 rl1 rl1 rl1 rl1 rl1 ill ill ill 
Hos_pital ICU 
North Manchester HDU rl1 J.i rl1 .,. ill 
Northwick Par1< Hospita l rl1 rl1 rl1 rl1 J.i rl1 fA rl1 J.i rl1 rl1 J.i J.i rl1 rl1 rl1 ill .,. 
Pilgrim Hospital rl1 rl1 rl1 J.i J.i J.i J.i J.i rl1 rl1 rl1 lil1 lil1 ill .,. lil1 
Queen Elizabeth Hospital, rl1 rl1 rl1 J.i J.i . J.i J.i J.i rl1 rl1 liA lil1 ill lil1 .,. I 
Birmingham I 
Queen Elizabeth Hospital, ., ., rl1 rl1 ., ., ., ill rl1 Ji lil1 ..:'1 rl1 rl1 rl1 ., J; I Gateshead 
Queen Elizabeth Hospital, Kings rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 rl1 J.i rl1 J.i J.i ill 
Lynn 
Queen Elizabeth 11 Hospital rl1 rl1 rl1 rl1 J.i iili J.i J.i rl1 ill ill 
Queen Mary's Hospital, Sidcup rl1 ill · ~lA ..:'1 J.i rl1 rl1 J.i rl1 lil1 lil1 rl1 ill ill 
Queen Victoria Hospital J.i rl1 J.i rl1 rl1 J.i I 
Radcliffe Infirmary rl1 1111 rl1 rl1 rl1 1111 rl1 rl1 I 
Royal Brompton Hospital _Ji_ 1111 rl1 1 
Rc:>yal Cornwall Hospital rl1 rl1 I 
Royal Devon & Exeter Hospital rl1 rl1 rl1 ., rl1 lil1 .., . iiil.. rl1 .., rl1 rl1 
Royal Hallamshire Hospital rl1 rl1 rl1 rl1 rl1 J; 
Royal Liverpool University Hospital 
Ro_yal London Hospital .., .., rl1 rl1 rl1 rl1 .., .., r;}j 
..n r;}j 
Ro~l Marsden Hospital rl1 rl1 .., rl1 rl1 rl1 rl1 ..:'1 -~ 
Royal National Orthopaedic rl1 rl1 rl1 rl1 .., rl1 rl1 rl1 rl1 ..:'1 rl1 r;}j i Hospital 
Sandwell General Hospital 
_.!2 rl1 rl1 rl1 rl1 rl1 J.i J; J; .,.t; 
Scunthorpe General Hospital rl1 rl1 
rl1 ~ rl1 rl1 rl1 rl1 .I; rl1 rl1 rl1 rl1 rl1 .,.t; 
Southampton General Hospital wJ wJ ,; ,; rl1 .;, .;, rl1 .;, .;, rl1 rl1 rl1 rl1 ., ~j?;;J .,.t; .n 
---
St. James' Hospital wJ ,; ,; : '. ,; rl1 rl1 -~ .;, .;, rl1 .I; .I; rl1 .I; rl1 .,.-; ~ ., ~ r;}j ~ 
St. Peter's Hospital wJ ,; ,; J rl1 rl1 ~ !":; .. .. ;of; 
Taunton & Somerset Hospital ,; ,; ,; J rl1 1111 1111 wJ! ~ ~ ~ ,; r;}j ...., 
The Horton Hospital J J ·- ·'· rl1 rl1 ,; I 
Torbay Hospital ,; 1111 rli : rl1 rl1 1111 1111 rl1 rl1 rl1 rl1 J ., ., li' ...., 
Trafford General Hospital -~ rl1 1111 rl1 .;, 1111 1111 1111 rl1 ,; .,.-; li' 
Tyrone County Hospital ., rl1 rl1 rl1 rl1 rl1 .,.-; .,.-; rl1 ,; w/1 J, J, J, li' ...,_ 
Victoria Infirmary, Glasgow rl1 1111 .;, -rl1 rl1 ., .., 
Walsgrave Hospital C2 HDU rl1 .I;_ -rl1 .,.-; rl1 w/1 rl1 rl1 ..., I 
Walsgrave Hospital C2 ICU .;, J.i rl1 J.i rl1 rl1 J, 
-.-fj - ..., I ·r 
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Hospital Name 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
Walsgrave Hospital CS ITU 
"" "" "" "" 
J; J; 
"" 
J; .,.*, I 
I 
Walton Centre for Neurology & 
"" "" 
.,.*, 
"" "" "" 
.,.*, .,.*, 
"" "" "" "" 
.,.*, .,.*, .,.*, .,.*, ..n ..n 
Neurosurgery 
Warrington Hospital 
"" "" "" "" "" "" "" 
J; 
"" 
J; 
Worcester Royal lnfinnary 
"" "" "" "" "" 
I 
Worthing Hospital 
"" "" "" "" "" 
J; 
"" "" "" 
J; I 
Wycombe General Hospital 
"" 
~ ~ 
"" 
~ ~ J; J; I 
Yeovil District Hospital I 
Key 
1 Nursing staff 
2 Administrative staff 
3 Drugs and fluids 
4 Nutritional products 
5 Disposable equipment 
6 Consultant medical staff 
7 Other medical staff 
8 Radiology 
9 Laboratory services 
1 0 Blood and blood products 
11 Specialised bed therapy 
12 Dieticians 
13 Physiotherapists 
14 Speech and language therapy 
15 Occupational therapy 
16 Medical Technical Officers 
17 Clinical phannacists 
18 lnfonnation Technologists 
19 Clinical and biomedical scientists 
20 Clinical Psychologists 
21 Directorate accountants 
22 Personnel Officers 
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There were very few critical care units that were able to provide a 
complete resource use data set; in fact, only Queen Elizabeth Hospital, 
King's Lynn had a complete data set. St. Jamcs' Hospital, Northwick 
Park Hospital, Leeds General Infirmary, Walton Centre for Neurology 
and Neurosurgery and Colchester General Hospital were able to 
provide the majority of data with the exception of two or three resource 
items. It was not possible to get resource use from any of the following 
hospitals; Chelsea Westminster Hospital, Hurstwood Park Neurological 
Centre, Royal Liverpool University Hospital and Yeovil District 
Hospital. 
6.14.4 Problems relating to the completion of the 
expenditure questionnaires 
Feedback received from the critical care units suggested that their 
inability to complete some of the expenditure questionnaires was due to 
a number of reasons. Firstly, some hospitals found it difficult to 
complete the questionnaires on the basis that they did not have any 
information (at all) on how much their critical care unit had spent on 
the various resources (i.e. no access to reliable and detailed budget 
statements). Second, some hospitals had a central 'pot' of funding with 
which they funded all services but without tracking the quantity of 
funding spent on each service. Thirdly, a small proportion of hospitals 
grouped together services such as including neonatal, paediatric and 
adult critical care (as a whole) that resulted in difficulties when 
attempting to disaggregate the costs specifically in relation to the adult 
critical care usage. Finally, a disregard for the specified deadline for 
the return of questionnaires resulted in a very small number of critical 
care units returning their questionnaires late. Unfortunately, these data 
were not included in the analysis. 
There were many problems in obtaining some of the expenditure data, 
particularly for radiology and laboratory services because of difficulties 
in tracing the usage of these services to the critical care unit (as a 
location) and the feedback received from these departments was that 
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the definitions used were ambiguous. As such, these estimates need to 
be treated with caution. Many of the Professionals Allied to Medicine 
returned their questionnaires stating that there was no expenditure by 
the critical care unit, despite a level of service being provided and 
reported expenditures of zero. We found that there is still a belief that if 
a department is not charged for a service provided to it, that a cost is 
not incurred. It is likely therefore that expenditure on these 
professionals is higher than that reported in this survey. Exclusion of 
this professional group from the Cost Block Programme was estimated 
to result in an underestimate of cost of approximately £35 per patient 
per day. 
One of the main causes of the problems with estimating the true cost of 
a critical care unit lies with the monthly budget statements. Where 
statements were available in the 46 of the critical care units, 
expenditure data was reported for nursing staff, drugs and fluids and 
disposable equipment in the most part. However, there was very 
limited coverage of the other key service providers, such as the blood 
bank, physiotherapy and so on, which hindered efforts to compile a 
comprehensive estimate of the costs without the need for the additional 
questionnaires. We felt it important to stratify the sample (and costs) by 
unit type in addition to providing a summary overview of the daily 
costs because this kind of information is not readily available in 
published form. No statement or inference of generalisability can be 
made from these estimates due to the small sample size but it is still 
useful to observe the variation across the different types of critical care 
units. 
Collection of the data at each study site by the study team may have 
improved the quantity of data collected from the sample however it 
may still not have made a significant difference if the data was not 
available in the first instance. One limitation of this survey was the 
capture of data relating to capital equipment, which was instead 
incorporated into the daily costs as a percentage levy. Further work 
needs to be undertaken in critical care to determine the existence and 
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maintenance of computerised asset registers, which will facilitate the 
estimation of costs relating to equipment depreciation and maintenance 
in the future. 
6. 14.5 Steps taken to deal with the missing data 
Rather than substitute missing data with average values obtained for 
data received from other similar critical care units, where units were 
unable to provide these data, instead of imputing zero values into the 
spreadsheet, they were coded as providing missing data (999). 
6. 14.6 Results obtained from the expenditure survey 
Descriptive statistics for each of the resource items are shown in table 
6.23. 
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Table 6.23: Descriptive statistics relating to the 
expenditure data 
Resource Mean (SO) Median (inter-quartile range Skewness Kurtosis 
items (£) [min-max]) (£) (std. (std. 
error) error) 
Nursing staff 128 647 (54 119 179 (91 769-148 896 [41 398-304 1.165 1.604 
630) 967) (0.231) (0.459) 
Consultant 18 174 (7 994) 16 585 (11 608-22 959 [4 991 -38 0.579 -0.187 
medical staff 209]) (0.306) (0.604) 
Other medical 21 220 (14 906) 17 445 (7 574-33 927 [3 895-71 1.204 2.067 
staff 808]) (0.293) (0.578) 
Administrative 2 810 (2 300) 2 181 (1 116-3 457 [560 -12 886]) 2.206 6.099 
staff (0.302) (0.595) 
Drugs and Fluids 42 484 (22 831) 38 018 (28 580- 55 127 [5 751-101 0.776 0.189 
& Disposable 911]) (0.231) (0.459) 
Equipment 
Radiology 4 867 (5169) 3 088 (1 327-5 613 [329-20 067]) 1.590 1.604 
(0.287) (0.566) 
Laboratory 8 735 (6 664) 6 747 (4 214 -11 482 (955- 30 216]) 1.402 2.058 
services (0.299) (0.590) 
Blood and blood 7 032 (5 728) 5 370 (3 718- 8 945 [553- 22 344]) 1.420 1.544 
products (0.311) (0.613) 
Nutritional 2 021 (2 445) 1 024 (379- 2 689 [0 -12 594]) 1.958 4.262 
products (0.277) (0.548) 
Specialised bed 1 095 (1 544) 347 (0- 2 154 [0- 6 583]) 1.774 3.058 
therapy (0.226) (0.449) 
Dieticians 732 (571) 552 (350 - 960 [0 - 2 500]) 1.101 1.103 
(0.226) (0.447) 
Physiotherapists 4 650 (4 073) 3 400 (2 400 - 5 671 [328 - 24 355]) 2.717 9.628 
(0.238) (0.472) 
Speech & 170 (304) 0 (0 - 222 [0 - 1 486]) 2.518 6.790 
language therapy (0.241) (0.478) 
Occupational 116 (384) 0 (0 - 38 [0 - 2 555]) 4.823 25.923 
therapy (0.289) (0.570) 
Medical technical 2 626 (3 439) 568 (0- 5 729 [0-12 288]) 1.166 0.356 
officers (0.272) (0.538) 
Clinical 882 (943) 520 (250 - 1 242 [0 - 3 913]) 1.621 2.088 
pharmacists (0.237) (0.469) 
Information 1 160 (1 869) 300 (0- 1 516 [0- 6 277]) 1.880 2.310 
technologists (0.279) (0.552) 
Clinical & 1 573 (3 010) 130 (0 -1 604 [0- 15 818]) 3.305 13.054 
biomedical (0.287) (0.566) 
scientists 
Clinical 67 (249) 0 (0 - 0 [0 - 1 125]) 3.785 13.415 
Ps~chologists (0.291} (0.574} 
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Resource Mean (SO) Median (inter-quartile range Skewness Kurtosis 
items (£) [min-max]) (£) (std. (std. 
error) error) 
Directorate 698(1188) 264 (141- 607 [0- 6 404]) 3.205 11.037 
accountants (0.225) (0.446) 
Personnel officers 565 (915) 292 (0- 721 [0- 4 587]) 3.399 12.937 
(0 274) (0.541) 
6.15 Validation of the expenditure data 
6.15.1 Internal validation 
The possibilities for testing the internal validity of the expenditure 
estimates were limited by the use of questionnaires designed for self-
completion in the participating hospitals. The only feasible option 
available to the study (had more resources been available) would have 
been to compare the estimates returned by the questionnaires with 
expenditure data held within the hospitals' finance departments 
(despite methodological differences between the two different 
approaches to cost estimation). This would have best been performed 
through site visits. Direct measurement of the use of resources at the 
patients' bedside would unquestionably be the best method to validate 
the estimates produced. The problem with this approach relates to the 
significant deployment of resources that would have been required. 
6.15.2 External validation 
Critical Care National Cost Block Programme 
External validation of the expenditure data was performed using daily 
cost data from the Critical Care National Cost Block Programme and 
NHS Reference Costs produced by the Department of Health for adult 
critical care. 
Data from the Critical Care National Cost Block Programme (which 
reported descriptive statistics relating to some of the daily costs 
covered in this survey) were used for the purposes of external 
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validation (Dean et al. 2002) due to concerns about our sample size and 
the effect this may have had on the resultant cost estimates. Our survey 
used the same definitions for estimating costs as those used by the 
National Cost Block Programme for the resources that were captured 
by both studies, and therefore formed the most reliable and appropriate 
source with which to compare our findings. Twenty-one units in the 
sample (30%) contributed data to the National Cost Block Programme 
for the financial year 2000-2001 and was the best available evidence 
with which to perform such a validation at the time. 
The average daily costs of care were determined by apportioning the 
monthly expenditure by the number of calendar days observed in each 
critical care unit from which mean estimates of costs could be 
estimated. 
Table 6.24 compares the costs collected in this survey with those 
reported by the Critical Care National Cost Block Programme for the 
financial year 2000-2001 that had a sample of between 69 and 84 
critical care units. 
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Table 6.24: Comparison of the mean daily cost estimates 
with the Critical Care National Cost Block Programme 
Resource Category Resource Mean cost Cost block 
(£) comparisons 
(2000-2001) 
n=69-84 units 
1 STAFF Nursing staff 587 539 
2 STAFF Other Medical Staff 111 75 
3 STAFF Consultant Medical 97 79 
Staff 
4 STAFF Administrative 12 6 
su rt 
TOTAL COSTS OF STAFF 807 699 
5 CONSUMABLES Drugs and Fluids 105 103 
6 CONSUMABLES Disposable 89 90 
E ui ment 
7 CONSUMABLES Blood and blood 38 31 
roducts 
8 CONSUMABLES Nutritional products 10 11 
TOTAL COST OF CONSUMABLES 242 234 
9 CLINICAL SUPPORT SERVICES Laboratory services 42 39 
10 CLINICAL SUPPORT SERVICES Radiology 24 20 
TOTAL COST OF CLINICAL SUPPORT 66 59 
SERVICES 
11 PROFESSIONALS ALLIED TO Physiotherapists 21 23 
MEDICINE 
12 PROFESSIONALS ALLIED TO Medical Technical 10 6 
MEDICINE Officers (MTOs) & 
Assistant MTOs 
13 PROFESSIONALS ALLIED TO Clinical and 9 Not costed 
MEDICINE biomedical scientists 
14 PROFESSIONALS ALLIED TO Information 6 Not separately 
MEDICINE Technologists Identified 
15 PROFESSIONALS ALLIED TO Clinical Pharmacists 6 Not costed 
MEDICINE 
16 PROFESSIONALS ALLIED TO Dieticians 5 Not costed 
MEDICINE 
17 OTHER Directorate 3 Not costed 
Accountants 
18 OTHER Personnel Officers 3 Not costed 
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Resource Category Resource Mean cost Cost block 
(£) comparisons 
(2000-2001) 
n=69-84 units 
19 PROFESSIONALS ALLIED TO Speech & Language 1 Not costed 
MEDICINE therapists 
20 PROFESSIONALS ALLIED TO Psychologists 1 Not costed 
MEDICINE 
21 PROFESSIONALS ALLIED TO Occupational therapy Not costed 
MEDICINE 
TOTAL COST OF PROFESSIONALS 69 29 
ALLIED TO MEDICINE 
22 EQUIPMENT Specialised bed 6 6 
thera 
TOTAL COST OF EQUIPMENT 6 6 
TOTAL COST 
(rounded to the 
1,185 1,027 nearest£) 
23 TOTAL COST OF CAPITAL Capital Equipment 119 Not costed or 
EQUIPMENT (10% of the total) apportioned 
TOTAL COST INCLUDING CAPITAL 1,304 
EQUIPMENT 
Figure 6.8 provides an illustration ofthis validation exercise. 
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Figure 6.8: Bar chart comparing the daily cost estimates 
produced by the study (blue) with data from the Critical 
Care Cost Block Programme (red) 
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The Cost Block Programme reported an average daily cost of £1,028 
for their sample, which was £274 lower than estimated in the survey 
(£ 1 ,302). The difference in nursing staff costs between the costs in our 
survey and those reported by the Cost Block Programme can be 
explained in part by salaried increments and possibly different grade-
mix configurations. Our study assigned an hourly cost to the time spent 
by other medical staff on the critical care units which was derived from 
the corresponding salaries+ 50% (Band lA and 2B) to reflect the on-
call payments. The cost bandings used were based on consultation with 
personnel officers charged with appointing other medical staff, but are 
higher than those applied in the Cost Block Programme. The mean 
daily costs of consumables were very similar to those provided by the 
Cost Block Programme with marginal differences in cost for the 
clinical support services. Validation of the cost estimates provided by 
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the majority of professionals allied to medicine was not possible due to 
their exclusion from the Cost Block Programme. 
Whilst the time period of the study was limited to a two-three month 
period and the response rate from units varied considerably (due to 
difficulties in obtaining reliable information and the overlap between 
the financial years 2002-2003 and 2003-2004), costs were acquired for 
a wide range of resource inputs into the service, including those 
provided by professionals allied to medicine- for which data of this 
sort had not been previously available. External validation of the data 
using the Critical Care National Cost Block Programme (albeit from a 
different time period and sample) would suggest that for those 
estimates where comparisons could be made, they were, at the very 
least, representative of cost data collected by the Cost Block 
Programme. 
NHS Reference Costs for Critical Care 
The NHS Reference Cost document gives details on how the £33 
billion of NHS expenditure was used in 2004. Its main purpose is to 
provide a basis for comparison within (and outside) the NHS between 
organisations, and down to the level of individual treatments. Whilst it 
seemed appropriate to attempt to compare the estimates of cost 
produced in our study with the Reference Costs for Critical Care, there 
were some difficulties in doing this. 
It wasn't clear from the Department of Health's calculations, what 
exactly was included in the calculation of the Reference Costs. The 
descriptions given for the unit types were also not sufficiently explicit 
so as to make direct comparisons; for example, there was no unit type 
for combined ICU I HDUs. These costs had to be added to the costs of 
the ICUs and then averaged, in order to make a comparison with the 
NHS Reference Costs. However, what can be deduced from table 6.25 
is that the ICU costs were comparable as were the costs for the Cardiac 
ICUs, however there were differences in the costs of the HDUs that can 
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be attributed to the amount of missing data from these types ofunit in 
our study. 
Table 6.25: NHS Reference Costs for Critical Care 
(Department of Health, 2004) 
National Our study 
Average average 
Unit unit costs 
Unit Type N Costs{£) {£) 
Intensive Therapy Unit /Intensive Care Unit 160 1,328 1,253 
Burns Intensive Care Unit 6 1,039 n/a 
Neurosurgical Intensive Care Unit 12 1,017 731 
Spinal Injuries Intensive Care Unit 2 779 n/a 
Renal Intensive Care Unit 1 370 nla 
Cardiac Intensive Care Unit 19 1,025 1,054 
Coronary Care Unit 119 457 n/a 
High Dependency Unit 109 584 340 
A discussion of this work takes place towards the end of this Chapter 
(Section 6.20). Section V will now describe some analysis of the 
expenditure data in relation to the type and size of the critical care unit. 
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CHAPTER 6: RESULTS 
SECTION V: ANALYSIS OF THE EXPENDITURE DATA IN 
RELATION TO THE TYPE AND SIZE OF CRITICAL CARE 
UNIT 
6.16 Introduction 
In 2000, a Department of Health report on critical care called attention 
to the relatively small size of critical care units in the UK, where the 
average size is 6 beds. According to Jacobs et al., (2004) in Europe, 
18% of critical care units have fewer than 6 beds yet the corresponding 
figure in the UK is 48%. Groeger et al., (1992) report the average size 
of a critical care unit in the United States to be between 11 and 12 beds. 
None ofthese reports however address the role that bed numbers might 
play in affecting the issue of costs due to economies of scale. 
The systematic review by Aletras (1996) identified approximately 100 
studies that provide evidence of the existence of economies of scale 
and scope in hospitals. In the advent of further hospital mergers in so 
creating much larger critical care units, interest in the effect on cost of 
achieving greater economies of scale is likely to increase (Baker et al., 
2004). For this reason, Section V set out to perform some preliminary 
analyses of the data collected to see whether any such evidence of the 
effect of economies of scale was present within the observed sample. 
6.17 Study aims 
The aims of Section N were two-fold: 
1 . To describe the sub-sample of critical care units that were 
able to provide data on both their expenditure and unit 
characteristics (size and unit type); and 
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2. To test four null hypotheses relating to the statistical 
relationship of a critical care unit's expenditure and t)}e 
and size of critical care unit. 
There was a variable response rate from the expenditure survey where 
a high number of critical care units were unable to provide a complete 
.. data set relating to their monthly expenditure on patients' resource use 
to permit a full analysis of these data. It was thus decided to focus the 
analyses described in this Section on expenditure on nursing staff, 
drugs and fluids and disposable equipment, where these data and data 
on the type and size (of the critical care units) were available from 46 
(66%) critical care units. 
6.18 Description of the sub-sample of Critical Care Units 
The sub-sample of critical care units was compared to the total sample 
in terms of their geographical location, the type of hospital they were 
situated in, and the type and size of critical care unit. 
6.18.1 Geographical Location 
As can be seen from table 6.26, the number of critical care units in 
Trent dropped from 5 to only 1. All of the critical care units in Scotland 
remained in the data set and the majority of units in the West Midlands 
were also unaffected by the reduced data set. 
286 
Table 6.26: Comparison of the geographical location of the 
sub-sample of critical care units with the total sample 
Geographical Location Number of Number of 
Hospital Type 
critical care critical care 
units in total units in sub-
sample sample(%) 
Northern & Yorkshire 8 5 (63) 
Trent 5 1 (20) 
Ea stem 7 6 (86) 
London 6 4 (67) 
South East 12 8 (67) 
South West 10 6 (60) 
West Midlands 9 8 (89) 
North West 8 5 {63) 
Wales 0 0 (0) 
Scotland 3 3 (100) 
Northern Ireland 2 0 (0) 
6.18.2 Hospital Type 
Almost half ofthe critical care units with a medical school located 
within the hospital was excluded from the data set. It is not known how 
this would affect the cost estimates produced (table 6.27). 
Table 6. 27: Comparison of the hospital type of the sub-
sample of Critical Care Units with the total sample 
Medical School within the hospital 
Tertiary Referral Centre 
Unknown 
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Number of 
critical care 
units In total 
sample 
17 
25 
7 
Number of 
critical care 
units In sub· 
sample(% of 
total) 
9 (53) 
16 (641 
3 {43) 
6.18.3 Type of Critical Care Unit 
Comparisons by type of critical care unit showed that the majority of 
the specialist critical care unit remained within the data set, however 
the number of combined ICU I HDUs dropped from 38 to 22 (table 
6.28). 
Table 6.28: Comparison of the types of Critical Care Unit 
included in the sub-sample with the total sample 
Type of Critical Care Unit ICNARC Number of Number of 
(%of critical care critical care 
sample) units in total units in sub-
sample sample(% of 
sample) 
ICU 71 {42.0} 17 11 (65} 
ICUICCU 3 {1.8} 0 0 (0} 
ICUIHDU 87 {51.5} 38 22 (58} 
ICU I HDU I CCU 7 (4.1} 2 1 (50} 
ICU I HDU I NICU 1 (0.6} 1 1 {100} 
Other e.g. HDUs, cardiothoracic ICUs, N/A 12 11 (92) 
S[!ecialist burns etc and unknown 
6.18.4 Size Of Critical Care Unit 
Critical care units with 13-15 beds dropped from 6 to 3, a 50% drop. 
However, the other unit sizes ( 4-6 beds up to 10-12 beds) were equally 
affected with between 68% and 77% of units kept within the reduced 
sample (table 6.29). 
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Table 6. 29: Comparison of the size of Critical Care Unit 
included in the sub-sample with the total sample 
Unit Size (Numbers of staffed ICNARC Number of Number of 
beds} (%of critical care critical care 
sample} units In total units In sub-
sample sample(% of 
sample} 
1-3 beds 13 (7.6} 2 0 (0} 
4-6 beds 93 {54.72 19 13 {68} 
7-9 beds 38 {22.4} 21 16 {76} 
10-12 beds 19 {11.2} 13 10 {77} 
13-15 beds 5 (2.9) 6 3 {50) 
16-18 beds 1 (0.6} 1 1 (100} 
19-20 beds 0 (0.0} 1 1 (100} 
> 20 beds 1 (0.6) 0 0 (0} 
Unknown 0 7 2l29l 
6.19 Statement of hypotheses to be tested 
The second aim of Section IV was to test four null hypotheses: 
1. A relationship does not exist between a critical care unit's 
monthly expenditure on nursing staff, drugs and fluids 
(hereafter referred to as 'expenditure') and the type of 
critical care unit (p>0.05); 
2. A relationship does not exist between a critical care unit's 
average daily expenditure and the type of critical care unit 
(p>0.05); 
3. A relationship does not exist between a critical care unit's 
monthly expenditure and the size of critical care unit 
(p>0.05); and 
4. A relationship does not exist between a critical care unit's 
average daily expenditure and the size of critical care unit 
(p>0.05). 
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6.20 Results 
6.20.1 Hypothesis 1 
The first hypothesis set out to negate whether a relationship existed 
between the type of critical care unit and its monthly expenditure. The 
number of months contributed by each type of critical care unit is 
shown in table 6.30. 
The sample was dominated by the adult combined ICU I HDUs and the 
adult general ICUs. Most of the adult general I surgical HDUs were 
included in the study (88%). No observations were obtained for the 
adult bums I plastics critical care units. 
The mean rank statistics were generated by an ANOV A test that was 
performed to investigate whether any of the observed differences in 
expenditure between the different types of critical care unit were 
statistically significant. The results would suggest that there is a 
significant difference 1n expenditure by type of critical care unit 
(p<O.OOOl). 
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Table 6.30: Monthly expenditure by type of Critical Care Unit 
Unit Type Months Mean (SO) (£) Median (inter-quartile Minimum - Maximum (£) Mean Rank 
(%of range)(£) 
total 
sample) 
Adult General ICU 26 (63} 166 277 (64 396} 155 006 71 664-356 262 52.58 
Adult General/ Surgical HDU 7 (88} 60 098 (14 346} 54 002 48 977 - 86 353 4.71 
Adult Combined ICU I HDU 55 (66} 167 940 (45 444} 166 706 92 550- 261 748 57.27 
Adult Cardio thoracic ICU 108.00 
·-
~,~·-· •• , ... --·~~ ·~ ·~!::·· ~-;. 
Adult Bums I Plastics 
Adult Neuro I General ICU 5 (83} 170 268 (77 734} 144 979 112 326-301 724 50.00 
Adult Neuro ICU I HDU 5 (42} 185 714 (33 718} 203 614 145 974-220 897 7.50 
Adult ICU I HDU I CCU 2 (33} 71 626 (5 293} 71 626 67 883 - 75 368 69.80 
Adult ICU I HDU I Neuro ICU 2 (100} 343 422 (11 491} 343 422 335 296- 351 547 104.00 
Unknown 4 !100~ 230 324 !92 669~ 228 559 148 712-315 467 74.75 
Chi-square, df, sig (38.69, 8, p<0.0001) 
\ 
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6.20.2 Hypothesis 2 
The second hypothesis related to the average daily expenditure by type 
of critical care and the results of this analysis are shown in table 6.31. 
The results of this analysis were slightly easier to interpret than those 
shown in table 6.30, as the monthly expenditure had been apportioned 
by the number of patient days. The results followed a logical pattern, in 
that the adult general ICUs were shown to incur higher daily costs than 
the adult general I surgical HDUs (the difference in cost being due to 
the lower nurse to patient ratio in the High Dependency Units and 
patients with a lesser severity of illness). Significant differences in 
average daily costs, as with the monthly expenditures, were observed 
by unit type (p<O.OOOl). 
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Table 6.31: Average daily expenditure by type of Critical Care Unit 
Unit type 
Adult General ICU 
Months(% of 
total sample) 
Mean (SO) (£) Median (inter-quartile 
range)(£) 
26 ~-Q-!9_{~38) _1 063 (710-1 359) 
Adult General/ Surgical_HDU _ I.i§ID____2_?~_(103l ______ 241 (205- 403) 
Adult Combined ICU I HDU 55 (66) 751 (205) 708 (621 - 828) 
Cardio thoracic ICU 3 
Adult Bums I Plastics 
Adult Neuro I General ICU 5 (83} 637 (62) 654 (578- 686) 
Adult Neuro ICU I HDU 5 ~_{)40_(_1§4)__ --- 642 (401) 
Adult ICU I HDU I CCU 2 (33) 406 (7) 406 (493 - 785) 
Adult ICU I HDU I Neuro ICU 2 {!QQL_ 59~_@__ - _595 (593) 
Unknown 4 (1 00) 844 (53) 847 (792- 893) 
Chi-square, df, sig (47.59, 8, p <0.0001) 
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Minimum-
Maximum(£) 
538-1 878 
199-457 
477-1 503 
545- 712 
493-853 
401 - 411 
593-597 
785-897 
Mean Rank 
79.58 
4.43 
52.85 
37.00 
38.60 
7.00 
22.50 
76.00 
\ 
6.20.3 Hypothesis 3 
The third hypothesis focused on the relationship between the size of the 
critical care unit (i.e. number of staffed beds) and its monthly 
expenditure. As shown in table 6.32, there was a trend towards a higher 
level of expenditure as the size of the critical care unit increased, with 
the exception of units sized between 19-20 beds, but this was most 
likely due to the very small number of observations. The results from 
the ANOV A test confirmed that a relationship does appear to exist 
between the size of a critical care unit and its monthly expenditure 
(p<O.OOOl). 
To visualise this relationship, data on the monthly expenditure and the 
number of staffed beds (size) were plotted. Data provided in the 
'unknown' category were excluded (Figure 6.9). 
Figure 6.9: Line graph showing the monthly expenditure 
by the number of staffed beds 
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Table 6.32: Monthly expenditure by size of Critical Care Unit 
Number of 
staffed 
beds 
1-3 beds 
4-6 beds 
7-9 beds 
10-12 beds 
13-15 beds 
16-18 beds 
19-20 beds 
Months 
(%of 
total 
sample) 
0 
Mean (SO) (£) Median (inter-quartile range) (£) 
29 (73) 121 838 (34 462) 122 076 (97 340- 142 839) 
39 (75) 156 727 (41 542) 164 661 (126 308-183 772) 
26 (63) 175 382 (57 624) 191 279 (148 595-211 338) 
6 (43) 283 023 (59 203) 268 686 (229 878-347 978) 
3 (100) 380 474 (21 361) 381 028 (358 842) 
2 (100) 343 421 (11 491) 343 422 (335 296) 
Unknown 4 (29) 230 324 (92 669) _ 228 559 (149 433-312 98_1} 
Chi-square, df, sig (47.16, 6, p<0.0001) 
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Minimum - Maximum (£) 
67 883-219 434 
52 167-236 846 
48 977- 261 748 
229 177 - 356 262 
358 842 - 40 1 553 
335 296-351 547 
148 712-315 467 
Mean Rank 
29.79 
52.31 
64.15 
98.67 
108.00 
104.00 
74.75 
\ 
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6. 20.4 Hypothesis 4 
The fourth hypothesis tested the assumption that a relationship does not 
exist between a critical care unit's average daily expenditure and the 
size of critical care unit (p>0.05). The p value of 0.294 would suggest 
that in this case, there does not appear to be a definitive trend or 
statistical relationship between these two variables. The variable 
sample size by staffed bed category could have been a contributing 
factor, with a very small number of observations in the 16-18 beds 
category (table 6.33). 
Data on the average daily expenditure and the number of staffed beds 
were plotted using the same sample of 44 critical care units (105 
months) (Figure 6.10). 
Figure 6.10: Line graph showing the average daily 
expenditure by the number of staffed beds 
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Table 6.33: Average daily expenditure by size of Critical Care Unit 
Number of staffed Months (% of Mean (SD) 
beds total sample) (£) 
1-3 beds 0 
Median (inter-quartile range) 
(£) 
4-6beds 29(73) 821.22(332) 712(615-1119) 
7-9 beds 39 (75) 773 (301) 724 (612- 855) 
10-12 beds 26 (63) 717 (293) 649 (559- 900) 
13-15 beds 6 (43) 862 (332) 676 (636 -1 224) 
16-18 beds 3 (100) 1 031 (387) 836 (780) 
19-20 beds 2 (100) 595 (3) 595 (593) 
Unknown 4 (29) 844 (53) 847 (792- 893) 
Chi-square, df, sig (7.31, 6, p=0.294) 
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Minimum - Maximum Mean Rank 
(£) 
401- 1 478 56.90 
241 -1 878 54.21 
199-1 345 49.08 
621 -1 392 59.83 
780-1 476 82.33 
593-597 22.50 
785-897 76.00 
\ 
6.21 Discussion 
Chapter 6 set out to describe the data collected in the multi-centre study 
and the efforts made to validate these data. The response rate was 
sufficiently high so as to generate a reasonably large sample of patient 
data and exceeded that expected, given the absence of any financial 
incentive to participate in the study. However, of the 400 listed critical 
care units, only 17.5% was captured by the volunteer sample. Not 
having any critical care units from Wales was a disappointment. One of 
the unresolved issues with the study was a source of variability relating 
to the differences between those critical care units who participated in 
the study and those who do not. According to Sculpher et al., (2004), 
this is a special form of variability by location and implies that data 
collected in those centres may not be a realistic prediction of what 
might emerge should the same data have been collected in the non-
participating centres. 
The data collection booklets proved a useful and reliable means of 
collecting the patient-level data and a very high percentage of critical 
care units used the booklets to record the data. Different members of 
staff were involved in data collection that may have resulted in some 
variation in terms of the accuracy and reliability of the data. This was 
not investigated in the study, which is a potential weakness of the 
research. Had sufficient funds been available subject to it being 
feasible, it would have been a good idea to organize a training course 
for all of the data collectors to take them through the data collection 
booklets and the organ support definitions. The posters attempted to 
address obvious issues and problems that might arise during the study 
period. 
The use of the booklets generated a considerable amount of data entry, 
which was a burdensome and costly task to undertake. Electronic 
means of data capture in the adult critical care setting have been used 
in other studies with varying degrees of success, so although this option 
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would appeal under normal circumstances, in practice, it is unlikely to 
have proved as acceptable to the data collectors as the bookl;!s. If the 
'study were to be repeated, it would have been better to explore the 
possibility of designing the booklets in such a way that the data could 
have been scanned into a computer rather than to rely so much on 
manual data entry. Double-checking of the electronic records with the 
data collection booklets were randomly performed in 25% of cases, 
which was considered an acceptable threshold (albeit an arbitrary 
threshold) for identifying errors of transmission. Due to the very small 
number of errors identified, these were not formally recorded and 
evaluated which is another weakness of the research. In order to 
compensate for this, exhaustive electronic checks of the data were 
undertaken so as to minimise inconsistencies and duplications within 
the data set that had stemmed primarily from the critical care units. 
The high response rate to the issued queries (93%) meant that one 
could be reasonably confident that the data were of an acceptable 
quality, as far as accuracies relating to the date and time of admission 
and discharge, survival status and type of admission were concerned. It 
was not possible to determine the accuracy and completeness of the 
organ support data, without having audited a random sample of patient 
records. This type of audit was considered, however, data was not 
routinely recorded on patients' daily organ support profiles in their 
medical records or in databases held by the critical care units, which 
meant that there was nothing against which the data contained in the 
booklets could be compared or validated. In the absence of any 
possible means of validation, one had to assume that the organ support 
data were correct, accurate and complete. The internal consistency 
j 
checks relating to basic and advanced respiratory support were the best 
that one could hope to achieve as far as checking the organ support 
data. 
The study performed very well when compared to the DoCDat 
databases. It produced the same median values as these databases as far 
as its reliability of coding and independence of observations and 
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exceeded the median values in the following areas (completeness of 
variables, having explicit definitions and explicit rules). The only areas 
that were identified as scoring worse were the representativeness of 
country, completeness of recruitment and variables included in the 
study. In the absence of other criteria, the DoCDat criteria served as an 
effective means of describing key aspects of the study from a quality 
perspective, however there were aspects of the criteria that did not 
strictly apply such as the collection of raw data and the variables 
included category. 
The patients included in the study were similar in terms of their critical 
care unit length of stay to those captured within the ICNARC CMP 
database and published sources. Crude mortality was slightly lower 
than that reported by ICNARC. Differences in case-mix were mooted 
as a possible explanation for this. However, differences in admission 
policies (to the critical care unit) could also have been an explanatory 
factor. 
Although the number of organ support days varied by type of critical 
care unit, this analysis was not particularly useful or infonnative. What 
proved to be of greater interest was the relationship between the organ 
support ratios per patient day by type of critical care unit that yielded 
findings that one would expect to see, in as much that high dependency 
units had a lower organ support ratio per patient day than the intensive 
care units. These findings were statistically significant. 
The number of organ support days increased according to the size of 
the critical care units, which is a finding that one would expect to see. 
As far as whether larger-sized units would treat sicker patients 
(expressed as the organ support ratio per patient day), the findings were 
inconclusive. This is where a larger sample of critical care units in the 
size categories 1-3 beds and > 13 beds would have been useful. 
A lower than expected response rate for the return of the expenditure 
questionnaires proved not to affect the generalisability of the estimates 
obtained following the external validation perfonned using data from 
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the Critical Care National Cost Block Programme and the Department 
ofHealth's NHS Reference Costs. The steps taken to deal w~ the 
missing data could have been further explored. It was decided to code 
these as 'missing' rather than substitute the gaps with mean estimates 
from the sample. Given that the aim of the study is to generate data 
with which to develop a cost model using the most complete and 
reliable data available, it was appropriate not to substitute the missing 
values in this way for fear of introducing additional confounders in the 
models. In doing so however, the analyses performed in Section N 
were only able to use expenditure data on nursing staff, drugs and 
fluids and disposable equipment rather than data on the overall costs of 
the adult critical care unit (which would have included more resource 
items that these three). 
The reduction in the sample of critical care units able to provide both 
patient and expenditure data provoked some concern as to how 
representative the sub-sample was of the overall sample of units. The 
number of remaining critical care units in the Trent Region went from 
5 to 1, almost half ofthe critical care units with a medical school were 
excluded but the majority of specialist critical care units remained 
within the sample. Unfortunately, the larger sized units were most 
affected. Critical care units with 13-15 beds dropped from 6 to 3. It is 
difficult to ascertain how losing some of the critical care units from the 
sample may have affected the results of the analyses performed. 
Section N set out to test 4 hypotheses. These findings were of interest 
in as much that the expenditure of a critical care unit and its average 
cost per day was found to vary significantly according to the type of 
critical care unit. Similar findings were observed as far as the size of 
the critical care unit and its expenditure. Although the latter analysis of 
size is an obvious finding, the relationship between unit type and 
expenditure has not been previously investigated or reported. 
The analyses performed in Section V did not generate substantive 
evidence of excessive scale economies in the sample studied, however 
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a reduction in per diem costs was evident in the first three bed size 
categories with an increase in cost observed in units operating at a 
capacity of greater than 13 beds. Bertolini et al., (2003) found from a 
study of 80 Italian critical care units that labour costs per patient 
decrease almost linearly as the number of beds increases up to about 8, 
and it remains nearly constant above about 12 beds. The conclusion 
from this work was that ICUs with less than 12 beds were not cost-
effective. This is certainly an area where further research is warranted 
using data from a larger sample of critical care units. 
In conclusion, the results of this study generated a valuable, high 
quality dataset that has been fully described in this Chapter. Chapters 7 
and 8 will endeavour to use the data set to inform the development of 
HRGs and the economic evaluation of the CESAR trial. 
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'An intelligent being cannot treat every object it sees as a unique entity unlike 
anything else in the universe. It has to put objects in categories so that it may apply its 
hard-won knowledge about similar objects encountered in the past, to tht!Object at 
hand' 
Steven Pinker (1997) 
CHAPTER 7: DEVELOPMENT OF PROPOSED HEALTH 
CARE RESOURCE GROUPS FOR ADULT CRITICAL CARE 
PATIENTS 
7.1 Introduction 
The previous chapter described a sub-sample of 46 critical care units 
that generated high quality data on both unit expenditure and patients' 
daily organ support. This chapter set out to use these data to develop a 
set of proposed Healthcare Resource Groups (HRGs) to support the 
Department of Health's policy 'Reforming NHS Financial Flows: 
Introducing Payment By Results' (2002). 
A background to the development of the American Diagnosis-Related 
Groups (DRGs) is provided in Section 7.2 and some of the concerns 
surrounding the use ofDRGs for adult critical care patients are 
introduced. Healthcare Resource Groups, the British equivalent to the 
DRGs, are then described. HRGs are 'groups of patient episodes or 
treatments for the purpose of supporting both internal management 
and external contracting' (Morris, 1995). They use the ICD-1 0 
(International Classification ofDiseases diagnostic codes version 10) 
and OPCS-4 (Office of Population Censuses and Surveys Tabular list 
I' 
of Classification of Surgical Operations and Procedures Fourth 
Revision) procedure codes as the basis of grouping, together with 
information on age and discharge status. 
Section 7.3 then describes the context within which HRGs are needed 
and sets out the aims of the 'Payment By Results' policy. 
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Section 7.4 describes the findings from the survey conducted by Morris 
(1995) who was charged with eliciting the opinions of a sample of 
clinicians on possible options for HRG development in adult critical 
care. Note that this was the same survey described in Chapter 4. The 
criteria set by the NHS Information Authority (NHSIA) (2002) against 
which the HRGs should be developed are detailed, where activities 
within groups should be similar both clinically and in terms of the 
resources used, groups should be based on routinely available data and 
the number of groups should be manageable. This, coupled with the 
original DRG criteria proposed by Hombrook (1982) established the 
prerequisites for the HRGs. 
All of the factors identified as possible 'groupers' from the Morris 
Survey were then critiqued in turn (Section 7.4.1). 
The aims of this Chapter were thus to identify an appropriate model 
from which estimates of daily case-mix adjusted costs of care could be 
determined and to use this model to develop a set ofHRGs that met the 
aforementioned criteria. 
Section 7.5 describes the statistical methods used to derive the daily 
case-mix adjusted cost estimates. Random-effects models were deemed 
appropriate on the basis ofBreusch-Pagan and Hausman specification 
tests of the data set. 
Nine models in total were developed. The first model described in 
Section 7.6.1, was a maximum-likelihood random-effects model that 
excluded the constant term and used the critical care unit's monthly 
expenditure on nursing staff, drugs and fluids and disposable 
equipment as the model's dependent variable and the number of days 
of basic respiratory support, advanced respiratory support and so on, as 
the independent variables. In this model, the interactions between the 
six different organ systems were not explored in this model. The 
coefficients produced by the model were then used to estimate the total 
costs of7,243 patients in the dataset and a cluster analysis was 
performed using the total number of organs supported as the grouping 
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variable and patients' length of stay and total costs of care as the 
clustering variables. Twenty HRGs resulted from the cluster analysis. 
'The limitations of the random-effects model were discusseafogether 
with the problems associated with having clusters based on length of 
stay (i.e. introducing the risk of perverse incentives). 
Additional models were then explored in Section 7 .8, based on the 
types and combinations of organ support (Section 7 .8.1) and the total 
number of organs supported (on a daily basis) (Section 7.8.5). The 
results of the different models are presented and discussed. The model 
deemed to be the most suitable for estimating case-mix adjusted daily 
costs was the last model (Model 9) that offered a simpler way of 
costing patients than the previous models. Rather than performing a 
cluster analysis using total patient costs estimated using the coefficients 
from Model 9, it was decided that the estimates I weights themselves 
were of greater interest and use than having a defined set ofHRGs. 
The model is then evaluated in two ways; firstly, by its ability to 
predict the expenditure observed in the 46 critical care units using the 
case-mix adjusted costs and secondly, by assessing through a pilot 
study, its acceptability to users judged in a number of ways relating to 
the criteria proposed by Hombrook (1982) and the NHSIA (2002). 
Chapter 7 concludes with a discussion of these findings. 
7.2 Background 
Case-mix classification systems provide a means of defining the 
product of a hospital. The need for case-mix adjustment stems from the 
fact that each individual patient differs from others in terms of the 
services delivered (to that patient) and consequently the resources 
consumed. Maniadakis et al., (1999) explain that 'every individual case 
constitutes an intermediate output on its own and as such it is 
important to aggregate cases into groups in a manner that reflects 
differences in resource requirements such as cluster analysis against 
310 
which weights are attached. Thus, one needs a method of grouping 
cases into similar groups and a method of estimating the weights'. 
The concept of Diagnosis-Related Groups (DRGs) originated from a 
patient classification system developed at Yale University in the 1960s. 
The original aim of this system had been to identify unusual patients 
with exceptionally long lengths of stay (Fetter, 1986). As the 
expenditure on acute hospital care dramatically increased in the United 
States (U.S.)- from $13.9 billion in 1965 to $99.6 billion in 1980 
(Gibson & Waldo, 1981), the use ofDRGs then changed from a way of 
describing patients and their characteristics, to a means of fee-setting, 
introduced by the federal and state governments in an attempt to curtail 
these spiralling costs and standardize hospital reimbursement. In this 
way, a fee for service payment was provided for each hospital 
inpatient, based on the primary surgical or medical condition for which 
the patient was treated (Freyaldenhoven & Campbell, 1996). Case-mix 
adjusted output-based funding also provides specific benchmarks for 
hospital inpatient services, against which managers and clinicians can 
compare their practice (Jackson, 1995). 
Whilst case-mix groupings can be formed in a variety of different ways 
(Plomann & Shaffer, 1983 & Thompson et al., 1975), DRGs have 
revolved around patient attributes and treatment processes, developed 
using AUTOGRP (AUTOmatic GrouPing System) - a type of cluster 
analysis software. A patient's primary and secondary diagnoses and 
surgical procedures play a key part in assigning patients to a given 
DRG. Length of stay tends to be used as the proxy for resource 
consumption rather than costs or charges (Grimaldi & Micheletti, 
1983). 
Healthcare Resource Groups (HRGs) are the British equivalent to the 
American DRG system and were developed in the early 1990s by the 
NHS Information Authority (NHSIA) in conjunction with the Royal 
Colleges (Appleby & Thomas, 2000). HRGs have been described in 
broad terms as 'groups of patient episodes or treatments for the 
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purpose of supporting both internal management and external 
contracting' (Morris, 1995). A more specific definition is however 
'provided by Sanderson (1991) who describes the groupings-a"~ 'similar 
to DRGs (and in a number of cases are actually the same as DRGs) in 
that they are based upon readily available items of information 
(diagnosis, procedures, age, discharge status and specialty). They 
number just over 500 and are intended to be resource homogeneous in 
terms of length of stay. The key difference is that for surgical DRGs the 
grouping is largely driven by the procedure rather than the primary 
diagnosis.' 
Both the DRG and HRG systems use coded operative procedures or 
discharge diagnoses as primary descriptors of the resultant groups. Age 
and hospital complications form secondary descriptors although 
English HRGs have greater flexibility in some areas and need not be 
entirely linked to disease. Existing HRGs for other areas of medicine, 
which are linked primarily to diagnosis, occur only where the mean 
discharge data does not provide adequate medical procedure 
information. 
Although the DRG classification is becoming progressively more 
effective, it fails to measure many types of variations in patients' needs 
for care which is an important consideration for adult critical care 
patients (Beaver et al., 1998). HRGs have been developed for many 
different types of diagnoses with the exception of adult critical care. 
With the advent of the 'Payment by Results' policy (2002), a way of 
classifying critical care patients was urgently needed. 
7.3 r Prospective vs. retrospective reimbursement 
systems 
Traditional DRG-based payment methodology employs prospective 
reimbursement systems that result in a mix of profitable and non-
profitable cases with the total payment of all patients within a DRG 
expected to "average out" so that payment for a pool of discharges is at 
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or near the cost of providing care (Cooper & Linde-Zwirble, 2004). 
Whilst these systems are thought to provide incentives for efficiency 
and avoid adverse patient selection, they can generate problems due to 
creaming, skimping and dumping (Biom et al., 2003). Neonatal, 
paediatric and adult intensive care, trauma and bums patients 
(Pastemak et al., 1986; Bekes et al., 1988; Sharkley et al., 1991; 
Froehlich & Jarvis, 1991; Joy & Yurt, 1990) treat small numbers of 
very high cost patients that can however skew the distribution of 
expenditure and result in a financial shortfall. There are a number of 
studies in neonatal intensive care that have demonstrated the 
inadequacies of prospective pricing systems using DRG systems (Berki 
& Schneier, 1987; Lictig et al., 1989; Phibbs et al., 1986; Poland et al., 
1985; Resnick et al., 1986) and this is thought to be due to systems not 
taking into account much of the variability in cost (Khoshnood et al., 
1996). Issues relating to outlier patients receiving care in large teaching 
hospitals (Berki & Schneier, 1987), variation in case-mix severity 
(Phibbs et al., 1986) and underestimates in the number of days required 
for treatment (Poland et al., 1985) have been identified as problematic. 
The general consensus does appear to reflect the views of Sics & 
Congdon (1988) in so stating that 'funding for neonatal care should be 
based on demonstrated costs' (p.306). Prospective reimbursement 
systems are clearly better suited to a more homogeneous case-mix that 
fit better to an average cost per patient cost model (with minimal cost 
variation). Jackson (1995) explains how systems like these can 
encourage the systematic referral of more complex cases to tertiary 
referral hospitals, thus shifting the burden of resource use elsewhere. 
To reduce the financial risk to hospitals in providing intensive care 
under a case-mix adjusted reimbursement system, it was decided in this 
study to develop a retrospective as opposed to prospective method of 
reimbursement. In this way, the focus of cost would become that of a 
per diem cost rather than an a priori-determined total cost per case. 
There was evidence from the literature that supported this approach; in 
Germany a prospective payment system (G-DRG) based on the 
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Australian refined diagnosis-related ·groups (AR-DRG) found a high 
proportion of intensive care to be systematically under-funded (Hindle, 
· 1995) and the k-means cluster analysis as performed byNeilion et al., 
(2004) identified homogeneous groups based on length of stay could 
create perverse incentives for critical care units to keep patients in the 
units for longer periods so as to re-coup the higher reimbursement tariff 
for the longer length of stay. 
7.4 Policy context 
The Department ofHealth introduced the 'Reforming NHS Financial 
Flows: Introducing Payment by Results' policy in 2002 that clarified 
their vision for a new reimbursement system for adult critical care units 
to support the post-NHS Plan reforms. 
The aims of 'Payment By Results' were: 
• To pay NHS Trusts and other providers fairly and 
transparently for services delivered; 
• To reward efficiency and quality in providing services; 
• To support greater patient choice and more responsive 
services; and 
• To enable commissioners to concentrate on quality and 
quantity rather than on price (Department of Health, 2002). 
Within the 'Payment By Results' system, Primary Care Trusts would 
contract with healthcare providers of their choice based on flexible, as 
opposed to 'block' contracts, which ensure that the providers are only 
./' paid according to the work they complete, using a standard price tariff 
adjusted for case-mix on the basis ofHRGs. 
The Payment by Results Consultation: Preparing for 2005 (Department 
of Health, August 2003) recognized that the approach to funding 
critical care was a key issue. In particular, it was necessary to guarantee 
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adequate funding to ensure that critical care capacity was available 
when needed. 
Payment By Results was deemed to have particular benefits for adult 
critical care. 
• A reimbursement system based on case-mix-weighted 
activity45 and a national price would ensure that critical care 
units were funded for the activity they undertook and the 
complexity of the case-mix. Also, commissioners and 
providers would need to reach a better understanding of 
prospective activity levels, and so planning and monitoring 
of activity within critical care is given greater attention than 
in the past. 
• As far as incentives were concerned, 'Payment by Results' 
would help to ensure that incentives are in place to enable 
appropriate discharge from the Intensive Care Unit and 
High Dependency Unit to the ward, thereby improving the 
use of resources. 
In order for this to work successfully, the HRGs would need to be 
defined in a clinically meaningful manner and be amenable to a multi-
centre evaluation, where the variation in cost within each group was 
minimal and the variation in expenditure between hospitals was 
captured. 
7.5 Possible groupings for critical care patients 
Despite significant theoretical and practical difficulties, in March 1994, 
a meeting was held between representatives of the Intensive Care 
Society (ICS) and the NHSIA during which they concluded that the 
concept of classifying critical care episodes into HRGs merited further 
evaluation. Dr. John Morris, a Consultant in Critical Care from the 
William Harvey Hospital in Ashford then embarked on an 11-week 
45 Case-mix adjusted payment means that providers are not just paid for the number of patients they treat in each 
specialty, but also for the complexity or severity of the mix of patients they treat. 
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project where he visited 21 adult critical care units to elicit clinical 
opinions on the options for HRGs in critical care patients, which he did 
·through a series of semi-structured interviews with the lead-""" 
Consultants. 
The question that Dr. Morris set out to address was whether a similar 
approach - the conventional method of using diagnosis for HRG 
classification - could be used for counting and classifying episodes of 
adult critical care? 
Whilst the survey was based on clinical opinion, when the DRG system 
was implemented in the U.S., it was acknowledged that whatever 
system was adopted, it needed to be respected by the clinicians in order 
to be accepted. 
The results from the semi-structured interviews suggested eight factors 
that could be used to define HRGs or iso-resource groups for the 
critical care unit. !so-resource groups are not defined on the basis of 
expected resource use but on the ability to discriminate between costs 
of treatment (Bardsley, 1987) 
7.4. 1 Possible factors for HRG Classification 
Use of diagnostic codes 
Morris (1995) raised the first problem with the use of diagnostic codes 
for HRGs as being that of terminology, specifically, the absence of 
clear definitions. He found during his site visits that the coded 
diagnosis on hospital systems related to the coding clerk's 
interpretation of a hospital discharge summary or perusal of hand-
/ · written case notes. Feedback from the critical care units suggested that 
the hospital discharge diagnosis might not be identical to the reason for 
admission to the critical care unit, which is the more significant of the 
two for predicting resource use. Clinical opinion suggested more 
confidence in using the reason for admission as a grouping component 
compared to other diagnostic descriptors, although this was a narrative 
(subjective) data field. 
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Emergency or elective admission 
Most admissions to the critical care unit present as emergencies, with 
the remainder forming a recognisable group of planned admissions 
following either elective major surgery or surgery in the presence of 
co-existing disease as a known risk factor. Most clinicians interviewed 
felt that this component of elective surgical work would give rise to 
predictable resource use and as such, this factor could be used as a 
descriptor for HRGs. The problem however is the high number of 
emergency admissions, for whom this level of predictability (of 
resource use) would not necessarily be observed. 
Critical care unit mortality 
The survey suggested fairly strong support for the inclusion of 
mortality as a component of iso-resource grouping, however non-
survival from an episode of intensive care may seem more of an 
outcome statistic than a factor for predicting homogeneous clinical 
groups with similar resource consumption. 
Clinical procedures 
Healthcare Resource Groups for many of the surgical special ties rely 
heavily on an OPCS procedure code as a primary descriptor. It could 
be argued that if critical care unit resource consumption is strongly 
related to specific procedures such as invasive monitoring and inotrope 
infusions etc., then if these coded interventions were routinely 
collected in information systems, they could be used to partition the 
caseload into HRGs. Whilst being an attractive option, it lacks the 
availability of standardised computer codes for intensive care 
procedures. Morris (1995) felt it unlikely that the critical care 
procedure codes could be used alone in that it is unlikely they would 
correlate uniformly with the major resource factor of nursing. 
Severity of Illness 
Information gathered through the semi-structured interviews uncovered 
a common view that the observance of abnormal physiology provides 
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better information for classifying patients compared to other factors 
such as diagnoses or intervention scoring. The APACHE II score was 
'thus proposed, however, the performance of APACHE II inPredictions 
of cost has not been strong (Coulton et al., 1985). There are many 
articles that describe different severity measures in terms of their 
potential usefulness in cost monitoring, however because of 
methodological differences among the studies, it remains difficult to 
draw conclusions about their relative performance in terms of 
identifying the best scoring system (Cretin & Worthman, 1986 & 
Rosko, 1998). It is conceivable therefore that these scores could be 
used to assign patients to iso-resource groups on the basis that the more 
ill the patient then the greater the resources consumed, yet it is 
debatable whether a single measurement would allow for variations in 
sickness during a critical care unit stay. Morris (1995) suggested that 
there could be a correlation between a patient's severity score in the 
first 24 hours of their critical care unit stay and their total resource use 
(during their stay), but this is complicated by patients with high day 
one scores falling into both early or late death categories. A patient 
with a high score may respond rapidly and survive to leave the critical 
care unit but another with the same initial score may develop multi-
organ failure and stay in the critical care unit for a longer period (and 
consume more resources). 
The clinicians consulted were however, mostly in favour of the 
inclusion of severity of illness scores for this purpose. 
Length of Stay 
Patients' length of stay has traditionally been viewed as a convenient 
r variable for estimating and comparing the resources used in hospital 
care and for validating HRGs. The assumption is made that both fixed 
and variable costs are evenly spread on a day-to-day basis and this may 
also seem appropriate for intensive care where nursing costs are known 
to contribute a high and stable proportion of the fixed daily costs. 
However, daily costs of critical care are thought to vary significantly. 
The Clinicians interviewed were supportive of using patient's length of 
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stay as a possible HRG descriptor and Morris (1995) alluded to the fact 
that HRGs could indeed be defined using length of stay in combination 
with other clinical factors. 
Patient Dependency 
Existing patient dependency scoring systems were explored as a 
possible means of classifying patients, however according to Morris 
(1995) 'there are considerable theoretical and practical problems'. 
This was due to the fact that there is no single system that is acceptable 
for this purpose at present. The allocation of scores had proved to be 
either 'extremely labour intensive and poorly completed' or 'highly 
subjective despite some innovative local improvements' leading Dr. 
Morris to conclude that purchasers would question the allocation of 
patient episodes to expensive HRGs using such arbitrary data. 
TISS Scores 
There was considerable support for the use of a TISS type score as a 
variable for devising HRGs, however TISS was not routinely collected 
for purposes other than research and/or audit studies. 
7.4.2 Prerequisites to the HRGs 
When deciding how many HRGs to have for a given patient 
population, a trade-off has to be made between achieving homogeneity 
and manageability. The number of groups has to be sufficiently large in 
number so as to be sensitive to differences in resource use but not 
'managerially cumbersome' i.e. excessive in number (Grimaldi & 
Micheletti, 1983). Chapter 4 described an exploratory evaluation of the 
above factors and concluded that patients' daily organ support had 
many appealing features as a possible method ofHRG classification. 
The criteria set by the NHS Information Authority against which the 
HRGs should be developed were as follows: 
• Activities within groups should be similar both clinically 
and in terms of the resources used); 
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• Groups should be based on routinely available data; and 
• The number of groups should be manageable (Nl1S 
/ 
Information Authority, 2002). 
It was also felt important that the case-mix classification or measure 
adhered to criteria proposed by Hombrook (1982) that had been used in 
the U.S. for the DRG system: 
• Reliability 
Consistent, not susceptible to random errors 
• Validity 
Content- representative and comprehensive 
Predictive - ability to predict some hypothesised outcome 
Construct - ability to explain differences in a way that is 
theoretically coherent 
• Sensitivity 
Discriminates between hospitals 
• Cost-effectiveness 
Least cost method of measurement without significantly 
compromising performance 
• Flexibility 
Can be used for a variety of purposes 
• Acceptability 
Measure is accepted by all users 
7.4.3 Study aims 
In summary, the aims of this Chapter were to: 
• Identify an appropriate model from which estimates of daily 
case-mix adjusted costs of care could be determined; and 
• Propose a set ofHRGs that met both these criteria. 
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7.5 Statistical methods for daily case-mix adjusted 
cost estimates 
The HRG development consisted of two tasks; the first task was to use 
a statistical method to derive daily costs of care that related to patients' 
organ support (i.e. the resultant coefficients) using the expenditure and 
organ support data entered into the model. After having assigned daily 
costs to patients' organ support data collected in the multi-centre study, 
the second task was to explore ways in which the HRGs could be 
developed. 
The data set consisted of longitudinal monthly expenditure and organ 
support data from the sub-sample of 46 adult critical care units 
described in Chapter 6. Only those critical care units that supplied data 
on their expenditure, case-mix and unit characteristics were included. 
The frequency of organ support data by type and combination of organ 
support was described (Table 6.15). 
Transformation of the dependent cost variable is often used to solve the 
problems ofheteroscedasticity and skewness in linear ordinary least 
square regression (Kilian et al., 2002). However, logarithmic 
transformation or some other power transformation creates a number of 
additional complexities that are often inappropriately ignored (Hay, 
2005) such as the interpretabilities of the model coefficients and the 
fact that the transformed data will have only an approximate normal 
distribution (Cantoni & Ronchetti, 2006). 
Transformation of the expenditure data was not necessary in this study 
however as these data were normally distributed (Figure 7.1) 
(Kolmogorov-Smimov statistic= 0.094, p=0.018). Descriptive 
statistics were used to describe the dependent and independent 
variables used in the model. 
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Figure 7.1: Histogram of monthly expenditure 
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Prior to exploring different types of regression techniques, ordinary 
least-squared (OLS) multiple regression analysis was considered. 
Multiple linear regression 'attempts to predict or estimate the value of 
a single continuous response variable from the known values of two or 
more continuous or categorical explanatory variables' (Lang & Secic, 
1997). Statistical inference in this analysis, as described by Kleinbaum 
et al., (1998) was based on estimation of the cost function i.e. 
estimating daily costs of care based on organ support. First, a 
mathematical model was specified that described how a critical care 
unit's monthly expenditure on nursing staff, drugs and fluids and 
disposable equipment was related to the organ system support received 
by its patients. Here, the model provided estimates of an unknown 
daily cost for the sum of these three main resources for different types 
and combinations of organ support. 
Standard regression analysis however assumes that all observations in 
the sample are independent (Heyse et al., 2001), yet, due to the 
clustered nature of the data set (with each critical care unit contributing 
a different number of months' data to the model), the observations 
were not independent of one another. Without adjustment for 
clustering, standard OLS can produce inefficient parameter estimates 
and incorrect standard errors (Sculpher et al., 2004 & Merlo et al., 
2005). The different approaches available for dealing with this problem 
include aggregate-level analysis where information is aggregated to the 
highest level, the use of generalised estimating equations (GEE) which 
is a more sophisticated alternative statistical technique, and performing 
separate analyses for each clustered data set but this clearly reduces the 
number of observations in the analysis (Gilthorpe et al., 2000). 
A multi-level regression analysis (MLRA) (alternatively referred to as 
a hierarchiallinear or random coefficient model- see Carey, 2000) was 
employed, which is suitable for the analysis of data with some 
underlying hierarchial structure (Beacon & Thompson, 1996). MLRA 
assumes the clustered observations (months) are broadly similar, with 
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differences between the critical care units due to either random 
variation or discernible external influences (Gilthorpe et al., 2000 & 
Merlo et al., 2005). / 
Jones (2000) illustrates the basic structure of a multilevel model by 
considering a simple linear model consisting of tWo levels which 
represents months of patient data (i = l, .... ,n) nested within critical 
care units (j = 1, .... ,m). yij represents the outcome of interest which is 
related to a vector of explanatory variables x in the following manner: 
Yij = xijp + Jlj + sij. 
One assumes that the random error term of months of patient data i in 
critical care unitj, sij, has zero mean and constant variance us2• The 
effects of critical care units are estimated through Jlj which is assumed 
random and again has a mean of zero and constant variance uJL2• 
The literature on Panel data techniques places emphasis on the relative 
merits of treating higher level units (in this case, the critical care units) 
as random or fixed effects. In the above model, the individual effects 
(JLj) are specified as random effects, but they could be specified as 
fixed effects, to be estimated together with p. 
Breusch-Pagan and Hausman specification tests were used to assess the 
appropriateness of applying a random as opposed to a fixed-effects 
model. 
-
Fixed effects models assume random variation within each critical care 
unit but not potential heterogeneity between critical care units so the 
confidence interval is artificially narrow. A random effects model 
includes both sources of variation, the between and within study 
variance. The underlying effects are assumed to vary at random (Sutton 
et al., 2000). 
Based on the results ofthese tests, random-effect models were 
developed using the critical care units' monthly expenditure as the 
dependent variable and the number of days of each type and 
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combination of organ support as the independent (or explanatory) 
variables. Random-effects models overcome this problem of correlated 
data and are typically advised (Liang & Zeger, 1986). All analyses 
were performed using Stata Version 8.0 (Stata Corporation, College 
Station, TX). 
This choice of analysis had three main objectives: 
• To recognize the hierarchial and clustered structure of the 
data (Drummond et al., 2005 & Thompson et al., 2006); 
• To characterize the relationship between expenditure (Y) 
and the number of days of different types of organ system 
support (XJ, Xz ... Xk); and 
• To produce a quantitative formula to predict the 
expenditure of a critical care unit (Y) as a function of the 
number of days of the different types of organ system 
support (XI.Xz ... Xk). 
7.6 Types of models developed for the case-mix 
adjusted cost estimates 
7. 6. 1 Random-effects model of monthly expenditure and 
days of organ support received 
The first model developed was a maximum-likelihood random-effects 
model. To prepare the data for the model, the number of days where 
each type of organ support was given was summed for each critical 
care unit on a monthly basis (so, the monthly number of days of basic 
respiratory support, advanced respiratory support etc). The spreadsheet 
was structured in such a way that the model treated the organ systems 
as independent of one another, not allowing fo:r any interactions 
between the different organ systems. The organ systems included in 
this model were: basic respiratory support, advanced respiratory 
support, circulatory support, renal support, neurological support and 
dermatological support. The model used the monthly critical care unit's 
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expenditure on nursing staff, drugs and fluids and disposable 
equipment as the dependent variable and the monthly sum of the days 
of different types of organ support (namely basic respiratory~pport, 
advanced respiratory support, circulatory support, renal support and 
dermatological support) as the explanatory (independent) variables. 
In order to get the cost coefficients down to a daily level so as to derive 
estimates of daily cost from the monthly expenditure, the constant term 
(intercept) was excluded from the model. Table 7.1 presents the results 
of this model. 
Table 7.1: Results of the random-effects model (Model 1) 
Type of 
organ 
support 
Basic 
respiratory 
su ort 
Advanced 
respiratory 
su ort 
Circulatory 
su ort 
Renal su~~ort 
Neurological 
su ort 
Dermatological 
su ort 
Coefficients Standard z P>[Z] 95% confidence 
(£) Errors intervals (£) 
456 127.64 3.57 0.000 205.76-706.10 
576 124.95 4.61 0.000 330.83-820.61 
220 112.16 1.96 0.050 0.26-439.91 
528 298.63 1.77 0.077 -57.43-11113.17 
51 164.02 0.31 0.757 -270.77 - 372.18 
270 917.85 0.29 0.769 -1 ,528.94- 2,068.96 
If one considers the coefficients produced for each type of organ 
support, the results shown in Table 7.1 appeared to follow a logical 
sequence; insofar that basic respiratory support was less costly than 
advanced respiratory support (hence reflecting the findings of the 
exploratory analyses described in Chapter 4). 
Given that only the costs of nursing staff, drugs and fluids and 
disposable equipment were included in the model, it was necessary to 
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add the remaining resources to the modelled estimates of cost in order 
to estimate a complete daily cost. For this reason, the non-modelled 
costs of care (£522.50) that formed the 'overhead' component of the 
daily cost were added to the modelled cost estimates and total costs of 
care could then be calculated for the 7,243 patients in the total sample. 
Total costs were determined based on the number of days of each type 
of organ support received. 
8. 7 Types of models developed for the HRGs 
Now that the first task of daily cost estimation based on the type of 
organ support received had been completed, the next task was to 
identify the best way of 'grouping' the patients. OLS regression models 
were developed to determine the extent to which the total number of 
organs supported during a patient's stay could explain the variation in 
length of stay and total costs of care. Four different statistical models in 
total were developed - two of which included outliers (Models I and 
3). In each, the independent variables represented the total number of 
organs supported during the patients' stay, coded as dummy variables 
(I or 0) and the dependent variables were either length of stay (in 
Models 1 and 2) or total costs of care (in Models 3 and 4). 
Model I (Length of Stay) Outliers Included 
• Dependent variable (Length of critical care unit stay) 
• Independent variables (No organs supported; One organ 
supported; Two organs supported; Three organs 
supported; Four organs supported; Five organs 
supported; Six organs supported). 
Model 2 (Length of Stay) Outliers Excluded 
• Dependent variable (Length of critical care unit stay) 
• Independent variables (No organs supported; One organ 
supported; Two organs supported; Three organs 
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supported; Four organs supported; Five organs 
supported; Six organs supported). 
Model3 (Total Costs) Outliers Included ./ 
• Dependent variable (Total costs of care) 
• Independent variables (No organs supported; One organ 
supported; Two organs supported; Three organs 
supported; Four organs supported; Five organs 
supported; Six organs supported). 
Model4 (Total Costs) Outliers Excluded 
• Dependent variable (Total costs of care) 
• Independent variables (No organs supported; One organ 
supported; Two organs supported; Three organs 
supported; Four organs supported; Five organs 
supported; Six organs supported). 
One hundred and forty-nine patients (2% of the total sample) were 
identified as 'outliers' (by falling outside of3 standard deviations) in 
the regression model. These outliers were patients with very long 
lengths of stay or high total costs of care (usually both). The models 
were run in two ways: by including the 'outliers' and excluding them to 
see what effect they had on the results. The statistic of interest with 
these models was the R2 value as what was needed was a way of 
'grouping' patients that most closely reflected their total costs of care. 
As can be seen from table 7.2, the exclusion of outliers improved the 
model fit, with higher resulting explanatory power. All four models 
were statistically significant, and model4 yielded the highest R2 value 
I • 
(0.349), which was still better (statistically) than patients' length of 
stay when the outliers were included in the model. The R2 values "Were 
used as a means of guiding the focus of more detailed analysis towards 
the model most likely to explain the highest amount of variation in 
cost. Further analysis of the resulting beta coefficients (and appropriate 
face validity checks) followed once this model had been identified. 
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Table 7.2: Results of the OLS models 
Dependent Independent variables Inclusion Model R2 P value 
Variables of criteria VALU 
outliners 
E 
Model1: No organs supported (yes Yes Enter 0.192 P<0.0001 
Critical Care or no) 
Unit Length of One organ supported (yes Stay 
or no) 
Two organs supported 
(yes or no) 
Three organs supported 
(yes or no) 
Four organs supported 
(yes or no) 
Five organs supported 
(yes or no) 
Six organs supported (yes 
or no 
Model2: No organs supported (yes No Enter 0.247 P<0.0001 
Critical Care or no) 
Unit Length of One organ supported (yes 
Stay or no) 
Two organs supported 
(yes or no) 
Three organs supported 
(yes or no) 
Four organs supported 
(yes or no) 
Five organs supported 
(yes or no) 
Six organs supported (yes 
or no 
Model3: No organs supported (yes Yes Enter 0.252 P<0.0001 
Total Costs of or no) 
Care One organ supported (yes 
or no) 
Two organs supported 
(yes or no) 
Three organs supported 
(yes or no) 
Four organs supported 
(yes or no) 
Five organs supported 
(yes or no) 
Six organs supported (yes 
or no 
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Dependent Independent variables Inclusion Model R value ~ value 
Variables 
Model4: 
Total Costs of 
Care 
No organs supported (yes 
or no) 
One organ supported (yes 
or no) 
Two organs supported 
(yes or no) 
Three organs supported 
(yes or no) 
Four organs supported 
(yes or no) 
Five organs supported 
(yes or no) 
Six organs supported (yes 
or no 
of criteria 
outliners 
No Enter 0.349 P<0.0001 
K-means clustering had been used before in a study from Germany that 
had attempted to propose some DRGs for their critically ill patients 
using patients' length of stay (Neilson et al., 2004). For this reason, 
the same technique was considered here as a way in which HRGs could 
be developed for the UK. K-means clustering attempts to identify 
homogeneous groups of cases based on selected characteristics using 
an algorithm that can handle large numbers of cases (SPSS, Version 
1 0). Cluster variability is measured with respect to the mean values for 
the classifying variables. Two variables were used to define the clusters 
(critical care unit length of stay and total costs of care) and the 
distances (dissimilarities) between the clusters were measured in multi-
dimensional space (e.g. Euclidean distances). In this way, all of the 
clusters were statistically different from one another (p<O.OOOl) using 
ANOVA tests. The patients identified as 'outliers' were excluded from 
the cluster analysis. 
One of the limitations of cluster analysis is that it works on the premise 
of means clustering, so doesn't identify discrete ranges for length of 
stay by which patients can be easily assigned to their appropriate 
cluster. For this reason, histograms were plotted and using the 
percentile values for each cluster, it was possible to identify 
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appropriate ranges for length of stay between the clusters. As can be 
seen from the histograms and box plots, some overlap does occur 
between some of the clusters. 
The costs for each cluster are more difficult to assign a range to 
because HRG costs need to be a standard cost, weighted in the same 
way as reference costs are for university hospitals and hospitals located 
in London. Costs were assigned to each HRG using the mean and 95% 
confidence intervals. 
The proposed 20 HRG classifications consist of the six organs and the 
no organ support, each of which had sub-groups (clusters) relating to 
length of stay and total cost. Table 7.3 presents the 20 HRGs where the 
length of stay ranges and total costs are described. The key to the codes 
shown in table 7.3 is as follows: 
HRG Code HRG Description 
HRGO No organs supported 
HRG I One organ supported 
HRG2 Two organs supported 
HRG3 Three organs supported 
HRG4 Four organs supported 
HRG5 Five organs supported 
HRG6 Six organs supported 
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HRG 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Table 7.3: Proposed Health Care Resource Groups 
/ 
HRG Cluster N %of %of LOS Ranges Total costs (£) 
HRG total (95% Confidence Intervals) 
occupie sample 
d by the {7,094 
clusters eatients} 
HRG 0 Cluster 1 362 91.2 5.1 0!: 1 day s 4 days 1,059 (1 ,013-1 '1 06) 
HRG 0 Cluster 2 35 8.8 0.5 0!: 5 days s 12 days 3,195 (2,903-3,486) 
HRG 1 Cluster 1 1214 82.2 17.1 0!: 1 day s 3 days 1,736 {1,699-1,773) 
HRG 1 Cluster 2 236 16.0 3.3 0!: 4 days s 8 days 4,377 {4,254-4,500) 
HRG 1 Cluster 3 26 1.8 0.4 0!: 9 days s 20 days 10,919 {9,694-12,144) 
HRG 2 Cluster 1 2088 77.1 29.4 0!: 1 day s 4 days 2,523 {2,480-2,566) 
HRG 2 Cluster 2 505 18.6 7.1 0!: 5 days s 10 days 6,928 (6,778-7,077) 
HRG 2 Cluster 3 115 4.2 1.6 0!: 11 days s 25 days 15,421 (14,730-16,112) 
HRG 3 Cluster 1 1239 63.5 17.5 0!: 1 day s 5 days 3,827. (3,744-3,909) 
HRG 3 Cluster 2 429 22.0 6.0 0!: 6 days s 10 days 9,789 {9,603-9,976) 
HRG 3 Cluster 3 198 10.1 2.8 0!: 11 days s 16 days 17,458 (17,112-17,804) 
HRG 3 Cluster 4 85 4.4 1.2 0!: 17 days s 26 days 25,858 (25,239-26,477) 
HRG 4 Cluster 1 245 48.1 3.5 0!: 1 day s 8 days 5, 797 {5,488-6, 1 06) 
HRG 4 Cluster 2 167 32.8 2.4 0!: 9 days s 16 days 15,021 (14,532-15,509) 
HRG 4 Cluster 3 97 19.1 1.4 0!: 17 days s 37 days 27,361 (26,475-28,248) 
HRG 5 Cluster 1 21 42.9 0.3 0!: 1 day s 11 days 12,830 (10,840-14,819) 
HRG 5 Cluster 2 19 38.8 0.3 0!: 12 days 22 days 25,957 (24,026-27,888) 
HRG 5 Cluster 3 9 18.4 0.1 0!: 23 days s 33 days 44,700 (41,387-48,013) 
HRG6 Cluster 1 2 50.0 0.0 0!: 1 day s 20 days 16,448 (-33,826-66,723) 
HRG6 Cluster 2 2 50.0 0.0 0!: 21 days 28 days 36,006 (11,625-60,387) 
The majority of patients fell into three groups; those requiring 2 organs 
supported with a length of stay greater than 1 day yet less than 4 days 
(HRG 2 Cluster 1) (n=2,088), followed by 1,239 patients 3 organs 
supported with a length of stay greater than 1 day but less than 5 days 
and 1,214 patients with 1 organ supported staying between 1 and 3 
days. Only a very small number of patients had 6 organs supported 
during their stay. 
Appendix 7.1 presents the descriptive statistics of each HRG and 
Appendix 7.2 gives the box-plots and histograms plotted for each HRG 
both in terms of patients' total costs and their length of stay. 
This analysis however had a number of problems. Firstly, not allowing 
for interactions between the different organs meant that the only way 
that patients' daily costs could be determined was to add together the 
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different cost coefficients to reflect multiple organ failure. For 
example, if a patient had advanced respiratory support and neurological 
support, it would be necessary to add £575.72 (the cost of advanced 
respiratory support) to £50.70 (the cost of neurological support). The 
main problem with treating the organs as independent of one another is 
that in practice, it may cost less to support two organ systems at the 
same time than two organs supported at different times and it runs a 
very high risk of eo-linearity within the model. 
Secondly, the standard errors and the 95% confidence intervals were 
very large which caused some concern. 
Thirdly, excluding the constant term from the model was problematic. 
Finally, the clusters themselves presented an additional problem, that 
of introducing a perverse incentive to critical care units to keep patients 
longer in the critical care unit so as to re-coup the higher 
reimbursement tariff associated with a longer length of stay. 
For these reasons, it seemed appropriate to investigate the feasibility of 
modelling the interactions between the different organ systems. Section 
7.8 now describes the models that were subsequently developed to 
improve on the random-effects model where the organs had been 
treated as independent of one another (Section 7 .6.1 ). 
7.8 Additional models explored for the case-mix 
adjusted daily costs 
7. 8. 1 Types and combinations of organ support 
It was decided to model the types and combinations of organ support 
days available from the 46 critical care units, with the exception of 
dermatological support, that due to the very small number of 
observations in the data set was excluded from subsequent models. The 
same type of model was used i.e. a random-effects model but rather 
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than excluding the constant term as in the previous model, the constant 
term was included. 
The 5th model that was developed used the monthly expenditure on 
nurses, drugs and fluids and disposable equipment as the dependent 
variable and the monthly number of patient days stratified by the type 
and combinations of organ support received by patients as the 
independent variables. Table 7.4 shows the frequency of each type of 
organ system support within the data set. The column entitled 'N (total 
sample)' refers to the data used in the model, with the column to the 
right showing how these data compare to the total sample (i.e. the 
7,243 patients). 
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Table 7.4: Frequency of patient days by type and 
combination of organ support 
Number Basle Advanced Circulator Neurologlca Renal N (total N (%of total 
of organ respirator respirator y support I support support sample) sample) 
systems ysupport y support 
0 2 554 1612(63.1) 
1 X 3 611 2 358 (65.3) 
X 2 854 1 910 (66.9) 
1 X 3191 2 241 (70.2) 
1 X 142 102(71.8) 
1 X 33 25 (75.8) 
2 X X 6252 4 621 (73.9) 
2 X X 299 233 (77.9) 
2 X X 121 65 (53.7) 
2 X X 11 864 8 177 (68.9) 
2 X X 396 265 (66.9) 
2 X X 270 84(31.3) 
2 X X 119 110 (92.4) 
2 X X 134 78 (58.2) 
2 X X 0 0 (0.0) 
3 X X X 491 269 (54.8) 
3 X X X 342 241 (70.5) 
3 X X X 4 4 (100.0) 
3 X X X 0 0 (0.0) 
3 X X X 1 959 1165 (59.5) 
3 X X X 2 261 1 294 (57.2) 
3 X X X 26 16 (61.5) 
4 X X X X 6 3 (50.0) 
4 X X X X 241 153 (63.8) 
TOTAL 37170 25 025 (67 .3) 
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The 6th model was similar to the 5th and used the same dependent 
variable, but in model 6, some of the independent variables with 
smaller numbers of observations were grouped together in order to 
reduce the number of variables and the high standard errors produced 
by the independent variables with very few observations. In an attempt 
to produce more meaningful estimates, it was decided to combine some 
of the smaller observations. In doing so, the following decisions were 
taken: 
1. To combine the days where neurological support was given, 
to the days where basic respiratory support was given. The 
rationale for this was based on similar expected resource 
use for both types of organ support. Note that the same 
rationale was applied to subsequent decisions; 
2. To combine the days where renal support was given to the 
days where advanced respiratory support was given; 
3. To combine the days where circulatory and renal support 
was given to days where advanced respiratory, circulatory 
and renal support was given; 
4. To combine the days where basic respiratory, circulatory 
and renal support was given to days where advanced 
respiratory, circulatory and renal support was given; 
5. To combine the days where basic respiratory, circulatory 
and neurological support was given to days where advanced 
respiratory, circulatory and neurological support was given; 
6. To combine the days where basic respiratory, neurological 
and renal support was given to days where advanced 
respiratory, neurological and renal support was given; and 
7. To combine the days where basic respiratory, circulatory, 
neurological and renal support was given to days where 
advanced respiratory, circulatory, neurological and renal 
support was given. 
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7.8.2 Results of mode/5 
The results produced by modelS are shown in table 7.5. In order to 
scale the results produced by the model to a daily level, the following 
formula was used: 
Daily case-mix adjusted costs = Constant term 
Average number of 
Patient days 
+ Coefficients 
The average number of patient days in the sample was 229. 
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Table 7.5: Results of the random-effects model (Model 5) 
Number Basic Ad van Circulat Neurolo Renal Coefficie 95% Standar z P>lzl 
of organ respir ced ory gical nts (£) d errors 
systems atory Suppo Confidence 
suppo Respir Support Support rt 
rt atory 
Intervals (£) 
suppo 
rt 
0 -285 -830-261 278 -1.02 0.306 
X 323 -276-922 306 1.06 0.290 
X 988 449-1526 275 3.60 0.000 
X 155 -253-562 208 0.74 0.457 
X -1 077 -6 723-4 569 2 881 -0.37 0 .709 
X - 3 011 -13 061 -7 038 5127 -0.59 0.557 
2 X X 388 66-709 164 2.36 0.018 
2 X X 934 -2 425-4 293 1 714 0.55 0 .586 
2 X X 578 -6 863-8 018 3 796 0.15 0 .879 
2 X X 702 453-950 127 5.53 0.000 
2 X X 2179 46-4 313 1 088 2.00 0.045 
2 X X 6 514 -654-13 681 3 657 1.78 0 .075 
2 X X 3 487 -1 385- 8 360 2 486 1.40 0.161 
2 X X -1 530 
2 X X 
3 X X X -59 -3 380- 3 262 1 694 -0.03 0 .972 
3 X X X -440 -4 000- 3 121 1 817 -0.24 0.809 
X 
3 X 
3 X X X 649 -404-1 703 538 1.21 0.227 
3 X X X 263 -480-1 005 379 0.69 0.488 
3 X X X 1 332 -11 573-14 6 584 0.20 0.840 
237 
4 X X X X 10 096 -51 490- 71 31 421 0.32 0.748 
681 
4 X X X X 1 668 -1 213-4 549 1 470 1.13 0.257 
Constant 52 599 26 771- 78 13178 3.99 o.ooo 
426 
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Table 7.6 presents the apportioned daily estimates using the above 
formula. 
This model was able to explain 70% of the variation in monthly 
expenditure using the number of days of each type and combination of 
organ support (R2 = 0.70 (R2 within 0.71; R2 between 0.61, p<0.0001). 
Table 7.6: Results of the apportioned estimates for daily 
costs from the random-effects model (Model 5) 
Basic 
respiratory 
support 
Advanced 
Respirator 
y support 
Circulat 
ory 
Support 
Neurolo 
gical 
Support 
Renal 
Suppo 
rt 
Apportioned 
constant 
term(£) 
52 599/229 
Coefficients 
(£) 
-285 
Daily cost 
estimates 
£ 
-56 
X 52 599/229 323 552 
X 52 599/229 988 1 217 
X 52 599/229 155 384 
X 52 599/229 -1 077 -848 
X 52 599/229 - 3 011 -2 782 
X X 52 599/229 388 617 
X X 52 599/229 934 1 163 
X X 52 599/229 578 807 
X X 52 599/229 702 931 
X X 52 599/229 2179 2 408 
X X 52 599/229 6 514 6 743 
X X 52 599/229 3 487 3 716 
X X 52 599/229 -1 530 -1 301 
X X 
X X X 52 599/229 -59 170 
X X X 52 599/229 -440 -211 
X X X 52 599/229 22 995 23 224 
X X 
X X X 52 599/229 649 878 
X X X 52 599/229 263 492 
X X X 52 599/229 1 332 1 561 
X X X X 52 599/229 10 096 10 325 
X X X X 52 599/229 1 668 1897 
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7. 8. 3 Results of Model 6 
Model 6 was able to explain 69% of the variation in monthly 
expenditure (overall R2 = 0.69 (R2 within, 0.69; R2 between, 0.61), 
p<O.OOOl). Table 7.7 presents the results produced by the model. 
Table 7.7: Results of the random-effects model (Model 6) 
Basic Advance Circulat Neurolo 
respiratory d ory gical 
support Respirat Support Support 
ory 
support 
X 
X 
X 
X 
X X 
X X 
X 
X X 
X X 
X 
X X 
Renal 
Support 
X 
X 
X 
Coeffici 
ents (£) 
95"/o 
Confidenc 
e 
Intervals 
£ 
-271 -782-239 
421 -152-995 
988 467-1508 
127 -240-494 
421 -152·995 
988 467-1508 
408 112-703 
-210 -2370-1950 
1487 -5261-8235 
702 467-937 
2023 43-4003 
6069 -222-12360 
3268 -1120-7657 
Standard 
errors 
261 
293 
266 
187 
293 
266 
151 
1102 
3443 
120 
1010 
3210 
2239 
2 X X --=. ____________ __:.,:...._ ______ ...:....:.... ____ 3::..:6:..::....3 -531-1256 456 
2 X X 
3 X X X 205 
3 X X X 363 
3 X X X 4948 
3 X X X 
3 X X X 363 
3 X X X 205 
3 X X X 4948 
4 X X X X 1741 
4 X X X X 1741 
Constant 50872 
340 
-381-791 
-531-1256 
-6294-
16190 
-531-1256 
-381-791 
-6294· 
16190 
-773-4254 
-773-4254 
26134-
75609 
299 
456 
5736 
456 
299 
5736 
1282 
1282 
12621 
z P>lzl 
-1 .04 0.298 
1.44 0.150 
3.72 0.000 
0.68 0.498 
1.44 0.150 
3.72 o.ooo 
2.70 0.007 
-0.19 0.849 
0.43 0.666 
5.86 o.ooo 
2.00 0.045 
1.89 0.059 
1.46 0.144 
0.80 0.426 
0.69 0.493 
0.80 0.426 
0.86 0.388 
0.80 0.426 
0.69 0.493 
0.86 0.388 
1.36 0.175 
1.36 0.175 
4.03 o.ooo 
Changes to the interpretation of the results were as follows: 
1. Estimates produced for basic respiratory support also 
applied to days where neurological support was given; 
2. Estimates produced for advanced respiratory support also 
applied to days where renal support was given; 
3. Estimates produced for advanced respiratory, circulatory 
and renal support also applied to days where just circulatory 
and renal support was given; 
4. Estimates produced for advanced respiratory, circulatory 
and renal support also applied to days where basic 
respiratory, circulatory and renal support was given; 
5. Estimates produced for advanced respiratory, circulatory 
and neurological support also applied to days where basic 
respiratory, circulatory and neurological support was given; 
6. Estimates produced for advanced respiratory, neurological 
and renal support also applied to days where basic 
respiratory, neurological and renal support was given; and 
7. Estimates produced for advanced respiratory, circulatory, 
neurological and renal support also applied to days where 
basic respiratory, circulatory, neurological and renal 
support was given. 
Despite these changes, the R2 value remained largely unaffected. The 
apportioned daily estimates shown in table 7.8. 
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Table 7.8: Results of the apportioned estimates for daily 
costs from the random-effects model (Model 6) 
Number 
of organ 
systems 
0 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
4 
4 
Basic 
respiratory 
support 
Advanced 
Respirator 
y support 
Circulat 
ory 
Support 
Neurolo 
gical 
Support 
Renal 
Suppo 
rt 
Apportioned 
constant 
term(£) 
Coefficients 
(£) 
Daily cost 
estimates 
(£) 
50 872/229 -271 
X 50 872/229 421 
X 
50 872/229 
988 
X 
50 872/229 
127 
X 
50 872/229 
421 
X 
50 872/229 
988 
X X 
50 872/229 
407 
X X 
50 872/229 
-210 
X X 
50 872/229 
1 487 
X X 
50 872/229 
702 
X X 
50 872/229 
2 023 
X X 
50 872/229 
6 069 
X X 
50 872/229 
3 268 
X X 
50 872/229 
X X 
X X X 
50 872/229 
205 
X X X 
50 872/229 
X X X 
X X X 
X X X 
X X X 
50 872/229 
205 
X X X 
50 872/229 
4 948 
X X X X 
50 8721229 
1 741 
X X X X 
50 8721229 
1 741 
7. B. 4 Discussion of Models 5 and 6 
Model 5 produced the highest R2 value of the two models, the 
coefficients produced by the model varied considerably according to 
the type of organ supported. There were large standard errors for some 
of the organs that could be attributed to the very small numbers of 
observations. The coefficients produced by the model were negative for 
some organs, namely: 
• No organ support; 
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-49 
643 
1 210 
340 
643 
1 210 
629 
12 
1 709 
924 
2245 
6 291 
3490 
585 
427 
427 
5170 
1 963 
1 963 
• Neurological support; 
• Renal support, circulatory + renal support; 
• Basic respiratory support, circulatory + neurological 
support and; 
• Basic respiratory, circulatory + renal support. 
Of the 22 different types and combinations of organ support (and the 
constant term), there were very few organs that reached statistical 
significance: 
• Advanced respiratory support; 
• Advanced respiratory + circulatory support; 
• Basic respiratory + circulatory support; 
• Advanced respiratory+ neurological support and; 
• The constant term. 
In Model 6, a negative coefficient was still observed for patients with 
no organs supported and some wide-ranging estimates of cost produced 
for the other organ systems that defied logical sense (insofar that the 3 
organ system combinations were incurring lower costs than some of the 
2 organ system combinations). 
Despite the high degree of predictive power, due to the non-sensible 
coefficients evident through face validity checks it was not felt that 
either of these models could be used as a basis for estimating case-mix 
adjusted costs. For this reason, it was decided to explore the total 
number of organs supported as opposed to the type of organs supported 
(Section 7.8.4). It is important to note that with a much larger sample it 
is anticipated that model 5 would generate meaningful estimates of 
cost, however models that have a high number of variables run the risk 
of an increased possibility of multicollinearity46 and a lack of degrees 
of freedom, therefore a degree of aggregation is often needed which is 
46 Collinearity occurs when there is a linear relationship between the covariates, which can influence stability of 
model coefficients and predictions (Beaver et al., 1998) 
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why it was decided to investigate modelling the total number of organs 
supported instead (Smet, 2002). 
7.8.5 Total Number of Organs Supported 
Based on the high predictive power of the total number of organ 
systems found in the previous analysis (Section 7.7), it seemed 
appropriate to explore this concept further in subsequent models. 
In Models 7, 8 and 9 the total number of organs was determined for 
each patient day and summed for each month in question. The 
independent variables represented the monthly sum of patient days that 
fell into the categories of 0 organs supported, 1 organ supported and so 
on, up to 4. 
Model 7 used the monthly number of patient days stratified by the total 
number of organs supported on that day47 as the independent variables 
(which ranged in this model from 0 organs supported to 4 organs 
supported) and the monthly expenditure on nurses, drugs and fluids and 
disposable equipment as the dependent variable in the model. 
ModelS was very similar to Model7, but in this model the number of 
patient days where 3 organs were supported were added to the number 
of days where 4 organs had been supported to form a new independent 
variable called '3 or more' organs supported. 
Model9 adopted the same independent variables as ModelS, but also 
added the number of patient days were no organs had been supported to 
the number of days where one organ had been supported to form 
another new independent variable called '0 or 1 organ supported'. 
To calculate the total numbers of organs supported per day, basic and advanced respiratory support were 
re-classified into one organ system, which was respiratory support. 
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7. B. 6 Results of Model 7 
Model 7 yielded an R2 of0.58 (R2 within 0.58; R2 between 0.87, 
p<O.OOOl). All ofthe independent variables were found to be 
statistically significant (including the constant term) {Table 7.9). 
Table 7.9: Results of the random-effects model (Model 7) 
Number of 
organ systems 
Coefficle 
nts (£) 
-506 
544 
610 
464 
2 707 
95% 
Confidence 
Intervals (£) 
-984--27 
287-801 
433-786 
47-881 
581-4832 
Standar z P>lzl 
d errors 
244 -2.07 0.038 
131 4.15 0.000 
90 6.78 0.000 
2213 2.18 0.029 
1084 2.50 0.013 
Constant 52 688 26 198-79 178 13 516 3.90 0.000 
The R2 value for this model (0.58) was nevertheless lower than the 
previous 2 models (Models 5 and 6), however the standard errors 
surrounding each estimate were less. When looking at the apportioned 
estimates {Table 7.10) patients having 3 organs supported incurred 
lower daily costs than those with 4 organs supported. Yet again, the 
problem of a negative coefficient occurred for patients with no organs 
supported. It was decided therefore to combine the 3 and 4 organs 
supported category in Model 8. 
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Table 7.10: Results of the apportioned estimates for daily 
costs from the random-effects model (Model 7) 
Number of organ Apportioned Coefficients (£) Daily cost 
systems constant term 
estimates !£} 
52 688/229 -506 
52 688/229 544 
52 688/229 610 
52 688/229 464 
52 688/229 2 707 
7.8. 7 Results of Model 8 
ModelS yielded an overall R2 of0.57 (R2 within 0.57; R2 between 
0.84, p<O.OOOl). This model (like model 7) found all ofthe 
independent variables to be statistically significant (Tables 7.11-
7.12). 
Table 7.11: Results of the random-effects model (Model 
8) 
-277 
773 
839 
693 
2 936 
Number of Coefficie 95% Standar z P>lzl 
organ systems nts (£) Confidence d errors 
Intervals !£} 
0 -569 -1049-- 90 245 -2.33 0.020 
1 553 293-813 133 4.17 0.000 
2 582 406-758 90 6.48 0.000 
3 or more 691 343-1038 177 3.89 0.000 
Constant 53 206 26 399-80 014 13677 3.89 0.000 
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Table 7.12: Results of the apportioned estimates for daily 
costs from the random-effects model (Model 8) 
Number of organ Apportioned Coefficients (£) Daily cost 
systems constant term estimates !£l 
0 53 206/229 -569 -340 
1 
2 
3ormore 
53 206/229 553 782 
53 206/229 582 811 
53 206/229 691 920 
The logical sequencing of cost rising in line with the increasing number 
of organs supported was achieved with this model, however the 
problem of a negative cost coefficient still remained for patients with 
no organs supported. It was thus decided to retain the 3 and 4 organs 
supported category and combine the 0 and 1 organ support categories 
inModel9. 
7. 8. 8 Results of Model 9 
By combining the 0 and 1 organ support variables, the overall R2 
dropped to 0.52 (R2 within 0.52; R2 between 0.89, p<0.0001), however 
the three organ support categories were all statistically significant and 
here, the negative coefficient became positive (Tables 7.13- 7.14). 
Table 7.13: Results of the random-effects model (Model 9) 
Number of organ Coefficient 95'/o Standar z P>lzl 
systems s (£) Confidence d errors 
Intervals !£} 
0 or 1 217 31-402 95 2.29 0.022 
2 654 48-834 92 7.13 0.000 
3 or more 669 304-1 034 186 3.59 0.000 
Constant 53 566 25 398-81 733 14 371 3.73 0.000 
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Table 7.14: Results of the apportioned estimates for daily 
costs from the random-effects model (Model 9) 
Number of organ Apportioned Coefficients (£) Daily cost 
systems constant term estimates(£) 
0 or 1 
2 
3 or more 
l£} 
53 566/229 217 
53 566/229 654 
53 566/229 669 
All 3 organ support categories retained their logical sequencing with 
the 0 or I organ support category being less costly than the 2 and 3 (or 
more) categories. On this basis, it was decided that Model9 provided 
the most logical and reliable estimates of daily cost by organ support, 
despite this model representing the crudest way of classifying patients 
compared to the models so far developed. 
7.9 Evaluation Of The Usefulness of The Findings For 
Use In HRGs 
7.9.1 Accuracy of Model 9 when compared to expenditure 
451 
888 
903 
Table 7.15 shows the actual expenditure on nursing staff, drugs and 
fluids and disposable equipment by critical care unit and compared to 
this, estimated expenditure using the coefficients produced by Model 9. 
Overall, the model predicted 97.6% of expenditure for the 46 critical 
care units as a whole. The square root of the difference in monthly 
observed vs. modelled expenditure was determined for each critical 
care unit and the average of the sum (for the whole sample) calculated. 
(281.83). 
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Table 7.15: Predicted expenditure using Model 9 vs. 
actual expenditure by Critical Care Unit 
iHMPital Exoondlturo 1£1 Modelled Expenditure IIIQ Difference lllodelll£ - Exoondlture £l Sauare Root Dlfferenc" 
!Aberdeen Roval Infirmary 152980 351671 198691 
I Bristol Rovallnfirmarv 762652 610902 -151750 
'Broomfield Hosoital 613105 705()8.4 91979 
; Colchester General Hospital 485915 436619 -49296 
1 Cumberland Infirmary 356823 51503:1 158207 
i East Surrev Hospital 244652 261863 17011 
'Eastboume District General HosPital 328057 352892 24835 
; Frimley Park Hosoital 616909 824528 207619 
i George Eliot Hospbl 349540 472497 1'ZE51 
1 Good HoPe Hospital 628814 432077 -196737 
!Hemel Hempstead Hospbl 324564 350726 26162 
·Hope Hospital 3:11724 372825 71101 
!John Radcliffe Hospital 701478 424527 -276951 
i Leighton Hospital 299638 278907 -20731 
· Uncoln County Hospital 3:17021 373894 66873 
Luton & Dunstable Hospital 400421 389214 -11207 
Monklands District General Hospital 27443:1 343918 69488 
New Cross Hospital 694936 797553 102617 
Northwick Park Hospital 62743:1 562300 -65130 
:Queen Elizabeth HosPital Birminaham 320545 342t78 21633 
! Queen Elizabeth Hospital Gateshead 307716 164856 -142860 
; Queen Elizabeth Hospital Kin a's Lvnn 521769 342292 -179477 
Queen Elizabeth 11 HosPital 226444 182920 -43524 
Queen Marv's Hospital 24fe79 305851 56972 
Royal BromDton Hospital 1141423 866276 -275147 
Royal Devon & Exeter 353170 310162 -43D!ll 
Royal Mansden Hospital 194679 264475 69796 
Royal National Orthopaedic Hospital 120161 1Dl37 10776 
Scunthonoe General Hosohl 209702 245717 36015 
SouthamDton General Hospital 299316 446191 146875 
St. Peta~s Hospital 530047 479867 -591111 
!Taunton & Somerset Hospital 838363 2187~ -619573 
jThe Horton Hospital 143251 211001 67750 
'Torbay Hospital 382284 419197 36913 
iTralford General Hospital 265887 230295 -35592 
'Victoria Infirmary HDU 107285 254138 146853 
!Walton Centna for Neuroloav & Neurosuraery 629253 604235 -25018 
Warrington Hosoital 334860 200805 -1211155 
!Worcester Rovallnfirmary 548236 503:)24 -45212 
[Worthina Hospital 580-446 560169 :;m77 
!Walsarave Hospital C2 HDU 160418 222064 61646 
'Walsarave Hosoital C2 ICU :JJ5007 213568 -91439 
1Walsgrave HosPital CS ITU 229073 230466 1393 
Derriford Hospital 686643 931035 244192 
i Leeds General 300Dl 255114 -45194 
i St. James' Hosoital 620969 626775 5786 
!Total 19016643 11625425 -461219 
IAwrage 
In order to determine total per diem case-mix adjusted costs, it is 
necessary to add to these estimates, the costs of the other resources not 
included in the cost model. These included the costs of: Consultant 
Medical Staff; Other Medical Staff; Administration; Radiology; 
Laboratory Services; Blood and blood products; Nutritional products; 
Specialised bed therapy; Dieticians; Physiotherapists; Speech and 
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445.75 
389.55 
ll3.28 
22203 
397.75 
130.43 
157.59 
455.65 
350.65 
443.55 
161.75 
266.65 
526.26 
143.99 
258.60 
105.87 
263.61 
320.34 
255.21 
147.00 
377.97 
423.65 
200.63 
238.69 
524.55 
207.39 
264.19 
103.81 
189.78 
383.24 
243.27 
787.13 
260.29 
192.13 
1fe.66 
383.21 
158.17 
357.85 
212.63 
142.40 
248.29 
302.39 
37.32 
&.16 
212.59 
76.07 
12'64.02 
281.13 
language therapy; Occupational therapy; Medical Technical Officers; 
Clinical Pharmacists; Infonnation Technologists; Clinical and 
Biomedical Scientists; Clinical Psychologists; Directorate Accountants 
and Personnel Officers {Table 7 .16). Taking out the costs of nursing 
staff, drugs and fluids and disposable equipment from the total cost of 
care, leaves an overhead (non-modelled cost) of £522.50 per day 
(Hibbert et al., 2003). 
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Table 7.16: Mean costs of major resource components 
per calendar day 
Resource Resource Number Number Minimum 25% Mean ±SO 
Number of of cost per lnterquartile cost per 
centres months calendar range cost calendar 
(%) day(£) per day(£) 
calendar 
da~ l£l 
1 Nursing staff 46 (66%) 107 165 462 587 :t 214 
2 Other Medical Staff 27 (39%) 67 14 49 111 ±66 
3 Consultant Medical Staff 25 (36%) 61 16 56 97 :t 55 
4 Administrative su~port 26 (37%) 62 3 8 11 :t 5 
5 Drugs and Fluids 46 (66%) 107 11 59 105 :t 68 
6 DisQosable Egui~ment 46 (66%) 107 9 57 89 :t 51 
7 Blood and blood ~roducts 23 (33%) 59 7 18 38±25 
8 Nutritional Qroducts 29 (41%) 75 0 2 10 :t 16 
9 Laborato!Y services 25 (36%) 64 8 22 42 :t 26 
10 Radio log~ 28 (40%) 70 2 11 24 :t 23 
11 Ph:tsiothera~ists 41 (59%) 103 2 12 21 :t 14 
12 Medical Technical Officers 31 (44%) 78 0 0 10 :t 13 
(MTOs} & Assistant MTOs 
13 Clinical and biomedical 28 (40%) 70 0 0 9 ±23 
scientists 
14 Information Technologists 29 (41%) 74 0 0 6±9 
15 Clinical Pharmacists 42 (60%) 104 0 1 6±7 
16 Dieticians 47 (67%) 115 0 2 5±5 
17 Directorate Accountants 47 (67%) 116 0 1 3±5 
18 Personnel Officers 31 (44%) 77 0 0 2±4 
19 Speech & Language 38(54%) 100 0 0 1 :t 1 
theraQists 
20 Ps~chologists 26 (37%) 68 0 0 0±2 
21 OccuQational thera~~ 28 (40%) 69 0 0 0±1 
22 S~ecialised bed thera~~ 47 (67%) 114 0 0 6 :t 10 
TOTAL COST 1185.14 
23 Capital Equipment 118.51 
l10% of total cost~ 
Total cost 1303.65 
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Table 7.17 shows the total per diem costs that include the organ 
support-weighting factor for nursing staff, drugs and fluids and 
disposable equipment and the overhead (non-modelled cost). The way 
in which these non-modelled costs have been apportioned assumes 
equal use of resources independent of the number of organs supported. 
Table 7.17: Per diem cost estimates that Include the 
case-mix adjusted costs of nursing staff, drugs and 
fluids and disposable equipment and the non-modelled 
costs. 
Number of organ Daily cost Non-Modelled Total Daily Costs 
systems 
estimates ~£} Costs(£) !£} 
0 or 1 
2 
3 or more 
451 522.50 973.50 
888 522.50 1410.50 
903 522.50 1425.50 
The organs were weighted as follows: 
• 0 or 1 organ supported = (Model Coefficient of £451 I 
Mean cost per day of nursing staff, drugs and fluids and 
disposable equipment of £781) = 0.577 
• 2 organs supported= (Model Coefficient of £888 I Mean 
cost per day of nursing staff, drugs and fluids and 
disposable equipment of £781) = 1.137 
• 3 or more organs supported = (Model Coefficient of £903 I 
Mean cost per day of nursing staff, drugs and fluids and 
disposable equipment of £781) = 1.156. 
After having performed the cluster analysis described in Section 7.7, 
and discussed the results of the subsequent models with the NHS 
Information Authority (NHSIA) and the Department of Health Critical 
Care Working Group on Funding, the question of whether formal 
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groupings were needed was mooted. This was because knowing the 
daily costs of patients weighted for case-mix offered a perfectly 
adequate solution to the problems of estimating the costs of patients 
using more traditional methods. The possibility of hospitals abusing 
this method of reimbursement compared to the groupings described in 
Section 7. 7 was also less likely. By the time that these analyses had 
been performed, the focus of the work (being directed towards HRG 
development) became more centred on devising an appropriate method 
for reimbursing costs. The NHSIA believed that patients could be 
assigned to HRGs retrospectively, given their daily profile of organ 
support data, which overcame the need to define specific groups up 
front. 
7.9.2 User SuTVey 
Model 9 met all of the NHS Information Authority criteria described in 
Section 7.4.3. 
The methodology- that being the collection of daily organ support 
data to support this way of estimating total patient costs - was piloted 
for a 3-month period (1st August 2004-1 st October 2004) in 6 adult 
critical care units. Sites were selected through a formal evaluation 
process following a national advertisement seeking Expressions of 
Interest. 
Critical care units were asked to evaluate the use of the method in 
terms of: 
• Its relevance to patient costs; 
• Time taken to record the necessary data; 
• Whether the proposed HRGs were able to capture sufficient 
information to describe the treatments given and the 
differences in treatments given to different patients; 
• The consistency of the data collection process; 
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• Its usefulness as a clinical and management tool beyond its 
primary use as an indicator resource cost. 
The respondents found the amount of time taken to record the 
information acceptable. They were also satisfied that the different types 
of organ support measured what they claimed to measure and that the 
definitions listed for each type of organ support provided about the 
right amount of information. The issue of data definitions falls within 
the scope of the Critical Care Minimum Data Set (CCMDS) authored 
by the Critical Care Information Advisory Group (CCIAG) formed by 
the Department of Health and the NHS Modernization Agency. The 
CCIAG Submission to the Information Standard's Board for the 
CCMDS stated that 'comments pertaining to the definitions have been 
considered by CCIAG and the definitions revisited. The robust CCMDS 
Training Programme that is planned will help to ensure that any 
lingering uncertainty is minimized'. 
The respondents further felt that the different types of organ support 
distinguish between those patients that actually have the organ support 
and those that don't. A high number of respondents stated that they 
believed that (all things constant) they would complete the data 
collection materials in the same way even if they collected the data at a 
different time of the day. 
7.1 0 Discussion 
DRGs have not been found to correspond well to the costs of critical 
care patients because of their emphasis on diagnosis rather than 
treatment (Munoz et al., 1989; Bekes et al., 1988; Hughes et al., 1989; 
Goldman et al., 1989). It was for this reason that a different approach-
such as an emphasis on treatment- the organ support component of 
care- was employed here. 
The first aim of this chapter was to identify an appropriate method 
from which estimates of daily case-mix adjusted costs could be 
determined. The cost per weighted day measure is preferable to the 
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straight per diem cost indicator because it is a more refined indicator 
and is best used when wanting to capture cost difference that arise 
because of cases with different types of organ support (Jacobs & 
Baladi, 1996). The aim was achieved by analysing the organ support 
and expenditure data collected from a sub-set of 46 volunteer critical 
care units. 
Multilevel modelling has wide potential for adapting to a variety of 
data structures and research questions (Carey, 2000) and was the first 
time that data had been analysed in this way within the adult critical 
care setting. The model of choice was informed by the Breusch-Pagan 
and Hausman specification tests that favoured a random-effects model 
based on the number of organs supported on a daily basis; clustered to 
include 0 or 1 organ, 2 organs and 3 or more organs. Whilst the R2 
produced for this final model was less than other models developed, it 
offered a simple and reproducible system that could be implemented 
with ease and coefficients that followed logical sense. The model using 
single and multiple combinations of organ support suffered from 
having too many independent variables in the model that even when 
some re-grouping was undertaken (to reduce the extent of the 
problem), failed to yield cost estimates that made logical sense. It is 
possible, that with a much larger sample, that these problems could 
have been emolliated in the most part, however it is unlikely that 
within the existing data set that this approach would have met the 
NHSIA criteria in terms of the number of groups being 'manageable' 
since many conceivable combinations of organ support were possible. 
The purpose of the Adult Critical Care HRGs is to enable the service to 
collect resource usage for critical care in a standardised manner. The 
HRGs will be used to calculate standard reference costs and tariffs. It is 
the intention of the Financial Flows, Payment By Results team to 
establish a set of national tariffs for the commissioning of critical care 
services from 2006/7. It is intended that the HRG will be used as a 
means of fulfilling the requirement that funding for the majority of 
work carried out by the NHS is funded at a national tariff as specified 
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in Payment By Results. The approval standards for the proposed HRGs 
were based on their purpose (which is their ability to case-mix adjust 
the funding requirements for critical care) and as such, the HRGs 
needed to be: 
• Clinically meaningful; and 
• Homogeneous (as far as homogeneity can be achieved in 
this patient population). 
To be acceptable to people collecting the information from which 
HRGs can be derived, the source data needed to be: 
• Integrated into a routine data set (CCMDS) and 
• Relatively easy to collect (by audit staff that are perhaps not 
clinically trained). 
Ease of collection can be defined in terms of whether the items (and 
definitions) and the HRGs had to: 
• Make sense i.e. did everyone understand basic respiratory 
support from the definition as being basic respiratory 
support as received by the patient) and; 
• Were collectable within existing infrastructures for data 
collection within critical care units. By this, I am referring 
to the quantity of items within the source data set. 
Not all types of organ support were included in the model. 
Dermatological support was excluded due to very small patient 
numbers and liver support was also excluded. Liver was excluded 
deliberately as because of the very high cost of liver support and its 
specialist nature (see below), the Payment By Results team had decided 
that liver support would be reimbursed outside of the HRG based tariff 
system. There is only one treatment available for liver support within 
the critical care setting. It has not been scientifically evaluated and for 
that reason it is not recognised as a conventional treatment for liver 
failure. The treatment in question is called molecular adsorbent 
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recirculating system (MARS®). MARS® employs an albumin-
enriched dialysate to facilitate the removal of albumin-bound toxins 
(ABT). It is thought (through a number of case studies) to remove both 
hydrosoluble substances such as urea, creatinine, and ammonium and 
these so-called ABTs -phenol, bile acids, bilirubine, branched chain 
amino acids and short chain fatty acids. It is used to enable recovery to 
reach pre-decompensation status by liver regeneration, act as a short or 
long term bridge to liver transplantation and to improving the pre-
operation condition of the patient before liver transplantation. 
The work of this chapter shaped the development ofHRGs for the 
purpose of the Department of Health's Financial Flows Policy and was 
formally approved by the following bodies: 
• NHS Information Standard's Board (ISB)4B 
• NHS Information Authority Clinical Working Group 
• Department of Health Funding Working Group 
• The Critical Care Information Advisory Group 
• The Intensive Care Society 
• Department of Health's Payment By Results Team. 
The work went through an extensive review process by the above 
bodies (Hibbert et al., 2004). The NHS Information Standards 
Advisory Board commented in their appraisal summary that 'there was 
a general consensus that the submission was a very good piece of 
work' (See Appendix 7.3). 
Based on these findings, the second aim of this chapter was met; that 
being to propose a set ofHRGs that met both the criteria of the NHS 
Information Authority (2002) and that ofHombrook (1982). 
Two key benefits to Model 9 are that: 
48 The standard will be known as Healthcare Resource Groups (HRGs) for Adult Critical Care, Levels 2 
and 3. Version 3.6. Conditional approval was granted on 4th March 2005- dependent on approval of the 
CCMDS which would be data set capturing the organ support data. See Appendix 7.2. 
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• It does not ignore the recognised trend in resource 
consumption with increasing duration of stay since the 
approach works on daily organ support data and; 
• It avoids all of the problems associated with diagnostic 
grouping due to its focus on grouping patients according to 
resource consumption. Not every patient with the same 
diagnosis will follow the same clinical course and hence 
will have variable resource consumption. 
In conclusion, this Chapter has produced a cost model from which 
daily case-mix adjusted estimates of cost can be determined and 
through a rigorous approval process, can be deemed a reliable and 
acceptable means of supporting the Department's of Health Financial 
Flows reimbursement policy for adult critical care. 
358 
REFERENCES 
Appleby J & Thomas A (2000). Measuring performance in the NHS: 
What really matters? BMJ320, 1464-1467 (27 May) 
Bardsley M, Coles J, Jenkins L (Eds) (1987). DRGs and Health Care. 
The Management of Case Mix. Oxford University Press. 
Bardsley M (1987). 1. Concepts of Case Mix. In: DRGs and Health 
Care. The Management of Case Mix. Eds. Bardsley M, Coles J, 
Jenkins L. Oxford University Press. 
Beacon HJ & Thompson SG (1996). Multi-level models for repeated 
measurement data: application to quality of life data in clinical 
trials. Stat Med, 15, 24, 2717-32. 
Beaver C, Zhao Y, McDermid S, Hindle D (1998). Casemix-based 
funding of Northern Territory Public Hospitals: Adjusting for 
severity and socio-economic variations. Health Econ., 7, 53-61. 
Bekes C, Fleming S, Scott WE (1988). Reimbursement for intensive 
care services under diagnosis-related groups. Crit Care Med., 
Berki SE & Schneier NB (1987). Frequency and cost ofDRG outliers 
among newboms. Pediatrics, 79, 874-81. 
Biom E, Hagen TP, Iversen T, Magnussen J (2003). The effect of 
activity-based financing on hospital efficiency: a panel data 
analysis ofDEA efficiency scores 1992-2000. Health Care 
Management Science, 6, 271-283. 
Cantoni E & Ronchetti E (2006). A robust approach for skewed and 
heavy-tailed outcomes in the analysis of health care 
expenditures. Journal of Health Economics, 25, 198-213. 
Carey K (2000). A multilevel modelling approach to analysis of patient 
costs under managed care. Health Econ., 9, 435-446. 
359 
Cooper LM & Linde-Zwirble WT (2004). Medicare intensive care unit 
use: analysis of incidence, cost and payment. Crit Care Med, 
32, 11, 2247-53. 
Coulton CJS, McClish H, Doremus S, Powell S, Smookler, J ackson 
DL (1985). Implications ofDRG payments for medical 
intensive care. Medical Care, 23,977-85. 
CretinS & Worthman LG (1986). Alternative systems for case mix 
classification in health care financing. R-3457-HCFA, Santa 
Monica, CA: The Rand Corporation. 
Department of Health (2002). Reforming NHS Financial Flows: 
Introducing Payment by Results. London: Department of 
Health, October 2002. 
Department of Health (2003). The Payment by Results Consultation: 
Preparing for 2005. 
Drummond M, Manca A, Sculpher M (2005). Increasing the 
generalizability of economic evaluations: Recommendations for 
the design, analysis, and reporting of studies. International 
Journal of Technology Assessment in Health Care, 21, 2, 165-
171. 
Fetter RB (1997). Introduction. In: Bardsley M, Coles J, Jenkins L 
(Eds). DRGs and Health Care. The Management of Case Mix. 
Oxford University Press. 
Freyaldenhoven S & Campbell R (1996). Discussion of case mix 
systems- DRG versus HRG. IHRIM, 37, 3, 20-1. 
Froehlich H & Jarvis WR (1991). Economic impact of diagnosis-
related groups and severity of illness on reimbursement for 
central nervous system infections. J Pediatr, 118, 693-7. 
360 
Gibson RM & Waldo DR (1981). National Health Expenditures, 1980. 
Health Care Financing Review, 3: Table 5. 
Gilthorpe MS, Maddick IH, Petrie A (2000). Introduction to multilevel 
modelling in dental research. Community Dent Health, 17, 4, 
222-6. 
Goldman ES, Easterling MJ, Sheiner LB (1989). Improving the 
homogeneity of diagnosis-related groups (DRGs) by using 
clinical laboratory demographic and discharge data. American 
Journal of Public Health, 19, 4, 441-44. 
Grimaldi PL & Micheletti JA (1983). Diagnosis Related Groups A 
Practitioner's Guide. Pluribus Press Inc. Division of Teach Em 
lnc). 
Heyse JF, Cook JR, Carides GW (2001). Statistical considerations in 
analysing health care resource utilization and cost data. Chapter 
9 in: Economic evaluation in health care: merging theory with 
practice. Oxford University Press. 
Hibbert C, Coates E, Brazier J, Morris J (2004). Development of 
Healthcare Resource Groups for Adult Critical Care. Report for 
the NHS Information Authority and the Department of Health. 
January 2004. 
Hibbert CL, Coates EJ, Brazier JE (2005). A cost survey of70 adult 
critical care units: Results from a volunteer sample in England, 
Scotland and Northern Ireland. Care of the Critically fll, 21, 1, 
8-16. 
Hindle D (1995). Per case payment by DRG: a fewissues and actions. 
www.imc.net.de/pdfi'icpp.pd£ 
Hombrook MC (1982). Hospital case mix: its definition, measurement 
and use. Part I. The conceptual framework. Medical Care 
361 
Review, 39, 1-43. Part II. Review of alternative measures. 
Medical Care Review, 39, 73-123. 
Hughes JS, Lichtenstein J, Magno L, Fetter RB (1989). Improving 
DRGs. Use of procedure codes for assisted respiration to adjust 
for complexity of illness. Medical Care, 27, 7, 750-57. 
Jackson T (1995). Casemix: the building blocks. Aust Health Rev, 18, 
1, 105-116. 
Jacobs P & Baladi J-F (1996). Biases in Cost Measurement for 
Economic Evaluation Studies in Health Care. Health 
Economics, 5, 525-529. 
Jones A (2000). Chapter 6: Health Econometrics. In: Handbook of 
Health Economics, Volume 1. Eds: A J Culyer & J P 
Newhouse. Elseview Science B. V. 
Joy SA & Yurt RW (1990). An all-payor prospective payment system 
(PPS) based on diagnosis-related groups (DRG): Financial 
impact on reimbursement for trauma care and approaches to 
minimizing loss. The Journal of Trauma 30, 7, 866-873. 
Khoshnood B, Lee K, Corpuz M, Koetting M, Hsieh H, Kim BI 
(1996). Models for determining cost of care and length of stay 
in neonatal intensive care units. International Journal of 
Technology Assessment in Health Care, 12, 1, 62-71. 
Kilian R, Matschinger H, Loeffler W, Roick C, Angermeyer MC 
(2002). A comparison of methods to handle skew distributed 
cost variables in the analysis of the resource consumption of 
schizophrenia treatment. J Ment Health Policy Econ, 5, 1, 21-
31. 
Kleinbaum DG, Kupper LL, Muller JE, Nizam A (1998). Applied 
Regression Analysis and Other Multi variable Methods. 3rd 
Edition. Brooks/Cole Publishing Company. A Division of 
362 
International Thomson Publishing Company. ISBN 0-534-
20910-6. 
Lang TA & Secic M (1997). How to report statistics in medicine. 
Annotated Guidelines for Authors, Editors, and Reviewers. 
American College of Physicians, Philadelphia, Pennsylvania. 
ISBN 0-943126-44-4. 
Liang KY & Zeger S (1986). Longitudinal data analysis using 
generalized linear models. Biometrika, 73, 13-22. 
Lichtig LK, KnaufRA, Bartoletti A, et al. (1989). Revising diagnosis-
related groups for neonates. Pediatrics, 84, 49-61. 
Maniadakis N, Hollingsworth B, Thanassoulis E (1999). The impact of 
the internal market on hospital efficiency, productivity and 
service quality. Health Care Management Science, 2, 75-85. 
Merlo J, Chaix B, Yang M, Lynch J, Rastam L (2005). A brief 
conceptual tutorial of multilevel analysis in social 
epidemiology: linking the statistical concept of clustering to the 
idea of contextual phenomenon. J Epidemiol Community 
Health, 59, 6, 443-. 
Morris J (1995). Intensive Care Evaluation Project- Final Report. The 
National Casemix Office of the Information Management 
Group. 
Munoz E, Josephson J, Tenebaum N et al., (1989). Diagnosis-related 
groups, costs, and outcomes for patients in the intensive care 
unit. Heart & Lung, 18, 627-33. 
Neilson AR, Moerer 0, Burchardi H, Schneider H (2004). A new 
concept for DRG-based reimbursement of services in German 
intensive care units: results of a pilot study. Intensive Care 
Med, 30, 6, 1220-3. Epub 2004 Feb 24. 
363 
NHS Information Authority (2002). HRG Assessment Criteria for 
Version 3.5. Winchester. 
Pasternak LR, Dean JM, Gioia FR, Rogers MC (1986). Lack of 
validity of diagnosis-related group payment systems in an 
intensive care population. J Pediatr, 108, 784-9. 
Phibbs CS, Phibbs RH, Pomerance JJ, Williams RL (1986). Alternative 
to diagnosis-related groups for newborn intensive care. 
Pediatrics, 78, 829-36. 
Plomann M & Shaffer FA (1983). DRGS as one of nine approaches to 
case mix in transition. Nurs Health Care, 4, 10, 438-443. 
Poland RL, Bollinger RO, Bedard MP, Cohen SN (1985). Analysis of 
the effects of applying federal DRG guidelines to a population 
ofhigh-risk newborn infants. Pediatrics, 76, 104-109. 
Preyra C (2004) Coding response to a case-mix measurement system 
based on multiple diagnoses. Health Serv Res 39, 4, 1027-45. 
Resnick MB, Ariet M, Carter RL, et al., 1986). Prospective pricing 
system for tertiary neonatal intensive care. Pediatrics, 78, 820-
28. 
Ridley S, Jones S, Shahani A, Brampton W, Nielsen M, Rowan K 
(1998). Classification trees. A possible method for iso-resource 
grouping in intensive care. Anaesthesia, 53, 833-840. 
Rosko MD (1988). DRGs and severity of illness measures: An analysis 
of patient classification systems. Journal of Medical Systems, 
12, 257-74. 
Sanderson HF (1991). The UK approach to costing by DRG. Joumee 
PCS-DRG: Des Outils Pour Faire Quoi? Lausanne, 1991. 
Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, 
Davies LM, Eastwood A (2004). Generalisability in economic 
364 
evaluation studies in health care: a review and case studies. 
Health Technology Assessment, 8, 49. 
Sharkley PD, Horn SD, Brigham P A, Horn RA, Potts L, Wayne JB, 
Dimick AR ( 1991 ). Classifying patients with bums for hospital 
reimbursement: diagnosis-related groups and modifications for 
severity. J Burn Care Rehabil, 12, 4, 319-29. 
Sics BA & Congdon P (1988). Cost ofneonatal care. Archives of 
Disease in Childhood, 63, 303-306. 
Smet M (2002). Cost characteristics of hospitals. Social Science & 
Medicine, SS, 895-906. 
Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F (2000). 
Methods for meta-analysis in medical research. Chichester: 
Wiley. 
Thompson S, Nixon RM, Grieve R (2006). Assessing the issues that 
arise in analysing multicentre cost data, with application to a 
multinational study. Journal of Health Economics. 
Thompson JD, Fetter RB, Mross CD (1975). Case mix and resource 
use. Inquiry, 12, 300-312. 
365 
CHAPTER 8: APPLICATION OF ORGAN SUPPORT COST 
WEIGHTS TO A TRIAL· BASED ECONOMIC EVALUATION 
8.1 Introduction 
This Chapter considers the application of the organ support weights 
described in Chapter 7 to an ongoing economic evaluation alongside a 
clinical trial. The CESAR trial is one of the first multi-centre trial-
based economic evaluations performed in adult critical care units in the 
U.K, which has been designed to investigate the clinical and cost-
effectiveness of two treatments for severe but potentially reversible, 
respiratory failure. These treatments are Extracorporeal Membrane 
Oxygenation (ECMO) and conventional therapy. At this present time, 
the trial is still recruiting patients. 
ECMO is a specialist treatment to allow lung rest that is currently being 
evaluated in one centre in the U.K. (Glenfield Hospital in Leicester) 
and conventional therapy for respiratory failure (the comparator arm of 
the trial) is provided in a number of different critical care units across 
the country. Whilst the economic evaluation will adopt a full societal 
perspective, the work of this Chapter focuses only on the collection of 
critical care unit costs for the two treatment arms. 
The overall aim of this exercise was to estimate the incremental costs 
ofECMO, over and above the costs of conventional therapy for 
patients with severe, but potentially reversible, respiratory failure 
recruited to the CESAR trial. Organ support data has been collected on 
all recruited patients which will enable us to case-mix adjust the 
average daily costs of participating critical care units using the organ 
support weights described in Chapter 7 (Section 7. 9.1 ). 
Centre-specific estimates of intensive care cost were sought based on 
Raikou et al., (2000) who consider hospitals to operate as cost-
minimizing firms. A survey of participating centres was conducted to 
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obtain centre-specific estimates of critical care units' average daily 
costs that related to the same time period when individual patients had 
been recruited to the trial. The completeness of the returned 
expenditure data was investigated by resource item and the steps taken 
to account for the missing data are also described. Despite difficulties 
in accessing the needed expenditure data relating to the costs of 
providing ECMO at Glenfield Hospital and the limited information 
provided, an attempt was made to derive average daily costs. The 
Chapter closes with a discussion of the main findings. 
8.2 Aims 
The overall aim of this study was to estimate the incremental cost of 
ECMO over and above the costs of conventional therapy for patients 
with severe, but potentially reversible, respiratory failure. 
The objectives of the study were: 
• To collect expenditure data from all critical care units that 
recruited patients to the CESAR trial together with data on 
their unit characteristics (these included both conventional 
treatment centres and the Glenfield ECMO Unit); 
• To compare the daily conventional treatment costs with 
those described in Chapter 6; and 
• To apply the cost weights developed using model 9 
(described in Chapter 7, Section 7.9.1), to the daily costs of 
conventional treatment and ECMO to estimate patient-level 
case-mix adjusted costs for patients in both arms of the trial. 
8.3 Description of the CESAR clinical trial 
CESAR is one of the first multi-centre trial-based economic 
evaluations performed in adult critical care units in the U.K. The trial is 
investigating two treatments for critically ill patients with severe, 
respiratory failure namely, conventional ventilatory support and 
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Extracorporeal Membrane Oxygenation (ECMO) (www.cesar-
trial.org). 
The National Co-ordinating Centre for Health Technology Assessment 
(NCCHTA) and the Department of Health National Specialist 
Commissioning Advisory Group (NSCAG) are jointly funding both the 
clinical trial and the concurrent economic evaluation. 
Recruitment of patients started in July 2000 and the trial is presently 
still recruiting. Trent Multi-Centre Research Ethics Committee 
(MREC/00/4/046) granted ethical approval for the trial in 2000. 
The primary hypotheses of the trial are two-fold: that ECMO will 
increase the rate of survival without severe disability by six months 
post-randomisation and be cost effective from the viewpoints of the 
NHS and society, compared to conventional ventilatory support. A full 
societal perspective has been adopted and a cost-utility analysis is 
anticipated. Analysis of the data collected will be by intention to treat, 
with sub-group analyses based on the minimisation criteria at trial 
entry. 
8.3.1 Treatments under evaluation 
Extracorporeal Membrane Oxygenation (ECMO) 
ECMO uses cardio-pulmonary bypass technology to allow lung rest in 
patients with severe (but potentially reversible) respiratory failure. The 
treatment provides sufficient oxygen transfer and carbon dioxide 
removal so that ventilator settings (inspired oxygen concentration and 
peak inflating pressures) may be decreased to less injurious levels. The 
technique ofveno-venous perfusion is used, where blood is drained 
from the right atrium via a catheter placed via the right internal jugular 
vein, and pumped using a roller pump to the oxygenator; a device 
designed for gas exchange. Blood is returned via the femoral vein 
raising the oxygen content of venous blood before it enters the heart. 
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ECMO is a high cost treatment because specialist nurses and doctor are 
required to oversee the fluid and ventilator management of patients and 
treat any complications. A common complication with ECMO is 
bleeding (and so patients require blood products such as red blood 
cells, platelets and clotting factors) (Lancey & Anderson, 2003). 
Conventional Therapy 
Conventional therapy is any other treatment for severe respiratory 
failure that relies on the lungs to provide gas exchange. 
8.3.2 Study Inclusion Criteria 
There are two types of inclusion criteria for the trial; one for the adult 
critical care units and the other for patients. 
Centre Inclusion Criteria 
ECMO is provided at the Cardio-thoracic Intensive Care Unit (ICU) at 
Glenfield Hospital, Leicester. Note that this is the only specialist centre 
providing ECMO in the U.K. 
Conventional treatment is provided within Adult Critical Care Units 
(hereon after referred to as 'conventional treatment centres' (CTCs)) 
that: 
• Provide an appropriately high standard of care for ECMO-
eligible patients; 
• Treat:;:: 350 patients per year; and 
• Provide pressure controlled ventilation and veno-venous 
haemofiltration. 
In addition to the CTCs, patients meeting the patient inclusion criteria 
can be entered into the trial from other hospitals (so-called referral 
hospitals), if those hospitals concerned are prepared to transfer the 
patient(s) to a designated CTC, should the allocation [of the patient] be 
to conventional management. 
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Patient Inclusion Criteria 
Adult patients (aged between 18-65 years) with severe, but potentially 
reversible respiratory failure are eligible. Severe respiratory failure is 
defined by a Murray score (Murray et al., 1998) of:;:3.0. 
The Murray score is a grading system for adult respiratory distress 
syndrome that uses 4 parameters to give a severity index for the 
syndrome. The parameters are Pa02/FI02 which is the ratio between 
the oxygen tension in the arterial blood and the fraction of inspired 
oxygen), positive end expiratory pressure (PEEP), lung compliance and 
chest x-ray appearance) or uncompensated hypercapnoea with a pH 
<7.20. A Murray score of3.0 is the minimum entry criterion. 
8.3.3 Patient Exclusion Criteria 
The patient exclusion criteria covers patients who have received high 
pressure and high FI02 ventilation > 7 days, patients who have 
experienced severe trauma or undergone surgery within the last 24 
hours with a contra-indication to limited heparinisation; patients with 
intra-cranial bleeding and any other contra-indication to limited 
heparinisation and finally, patients who are moribund and have any 
contra-indication to continuation of active treatment. 
8.3.4 Delivery of Treatment 
ECMO 
Patients randomised to receive ECMO are transferred to the Cardia-
thoracic ICU at Glenfield Hospital for consideration ofECMO support. 
There is no crossover to ECMO for patients allocated to conventional 
management. 
Conventional Management 
Patients randomised to conventional therapy receive standard critical 
care provided in one of a number of participating CTCs. This may 
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occasionally involve transfer from a referring hospital (see Section 
8.3.3). Conventional ventilatory support can include any treatment 
modality thought appropriate by the patient's doctor (excluding 
ECMO). A low volume ventilation strategy (tidal volume ~ 6ml/Kg, 
peak inspiratory pressure ~ 30 cm/H20) is recommended, following a 
ventilation study of lower tidal volumes compared with traditional tidal 
volumes by The Acute Respiratory Distress Syndrome Network 
(2000). 
8. 3. 5 Sample Size 
The sample size calculated for the clinical trial assumes a 10% risk of 
severe disability among survivors in both trial arms, an alpha= 0.05 (2 
sided test) and beta= 0.2. This calculation suggests a sample size of 
120 patients in each group (i.e. a total sample size of240) is required to 
detect a reduction in the rate of primary outcome (mortality) from 73% 
to the 55% which is a conservative estimate based on descriptive 
studies of adult ECMO (Peek et al., 1997). No sample size calculation 
was performed for the economic evaluation. 
8.4 Methods of the CESAR Economic Evaluation 
The primary objective of the economic evaluation was to assess 
incremental cost-effectiveness ofECMO in terms of the incremental 
costs of additional survival with and without disability at six months 
post-randomisation, compared to conventional treatment for severe, 
respiratory failure. The evaluation set out to assess the cost of treatment 
to the health and social services and to patients and their families in 
each treatment group (See Appendix 8.3). The remainder of this 
Chapter will focus on the estimation of critical care unit costs of 
treatment for both arms and the application of the organ support 
weights described in Chapter 8. 
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8.4. 1 Methods for estimating the Critical Care Unit 
Conventional Treatment Costs (CTCs) 
Whilst the economic evaluation adopted a full societal perspective, the 
time span for the estimation of the costs of conventional treatment in 
the critical care unit was confined to the number of days spent by 
patients in the trial in the critical care unit until discharge to a hospital 
ward (or death within the critical care unit). The same rule applied to 
the estimation ofECMO costs. 
Collection of the organ support data 
The cost trigger for patients recruited to the clinical trial was days of 
organ support measured daily from the point of randomisation until 
discharge from the critical care unit (or death) (see Appendix 8.1). 
These data were collected for both arms using the trial proforma which 
once completed by the staff working in the respective critical care units 
was faxed back to the Data Co-ordinating Centre (DCC) at the London 
School of Hygiene & Tropical Medicine in London and the data then 
entered into the clinical trial database. Note that data on the types of 
organ support were defined in the same way as those used in the Cost 
Model described in Chapter 7. The collection of these data was 
coordinated by the DCC and it was not known the extent to which 
missing or inaccurate data presented. It was assumed that for all 
patients a proforma documenting their organ support data was returned 
and that these data were complete. 
Collection of the Cost Data 
The aim of the costing study was to estimate a daily costs from each 
recruiting critical care unit with a view to adjusting this cost according 
to the organ support profile of patients. To this end, critical care unit 
expenditure data from each of the recruiting units (relating to the same 
financial year during which patients were studied within the trial) were 
sought. The Finance Director at each NHS Hospital Trust held 
accountable for the administration of the critical care unit's funds was 
contacted in June 2004. Accompanying a covering letter and a copy of 
372 
the economic evaluation protocol was a cost questionnaire that 
facilitated the entry of the expenditure estimates for the financial year 
in question (Appendix 8.2-8.4). The collection of data covered four 
financial years (1st April 2001-31 st March 2002, 1st April 2002-31 st 
March 2003, 1st April 2003-31 st March 2004, 1st April 2004-31 st March 
2005). Questionnaires were produced for each financial year and the 
content of those matched those described in Chapter 5 (i.e. the 
definitions used for each resource item were the same). In order to 
calculate estimates of daily cost, the unit characteristics questionnaire 
had to be completed as the latter questionnaire provided data on the 
total number of patient days within the same financial year (with which 
the expenditure data could be apportioned down to an average daily 
cost). 
A copy of the covering letter was also sent to the named critical care 
unit collaborator, responsible for the collection of the clinical trial data 
(for their information). As already alluded to above, the same 
definitions for each resource use item were employed for the costing 
study described in Chapter 5. 
The mailing of questionnaires was repeated twice due to poor response 
levels, up until the end of July 2005. 
Coverage of The Costing Study 
The coverage of costs included in this study was exactly the same as 
those resource use items collected in the multi-centre study described 
in Chapters 5 and 6. 
Collection of the Unit Characteristics Data 
A unit characteristics questionnaire was sent to the named critical care 
unit collaborator that sought to elicit descriptive information about the 
critical care unit in terms of its size (number of staffed beds) and 
patient throughput (number of patient days) during the financial year 
when a patient was recruited to the trial. This questionnaire was 
produced for 3 reasons: 1) to describe the characteristics of the critical 
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care units in resultant publications stemming from the work, 2) to be 
able to make comparisons between the sample of units studied in the 
HRG study- Chapters 6 and 7, and finally, 3) to allow the expenditure 
data to be apportioned accurately by obtaining data on the number of 
patient days. 
Fifty-eight unit characteristic questionnaires were sent out to 40 
hospitals (because some units recruited patients in different financial 
years), which produced an average of 1.45 questionnaires per hospital. 
Steps taken to deal with missing data 
No steps were taken to compensate for data missing from the unit 
characteristic questionnaires because it was not possible or appropriate 
to substitute missing data on these characteristics using data from the 
other critical care units. Missing average daily cost data was however 
substituted using the mean estimates obtained from the responding 
CTCs by financial year. 
8.4.2Methods for estimating the costs of ECMO 
Due to difficulties in obtaining expenditure data from Glenfield 
Hospital because of a lack of co-operation from the Hospital 
Accountants, the only available information· that was forwarded by 
them consisted of prospective budget statements for 2 financial years. 
Budget statements differ from expenditure statements by detailing 
anticipated costs for a financial year (1st April- 31st March) instead of 
reporting actual annual expenditures, so are not as informative. 
However, given that this was the only information available, it had to 
suffice. 
Budget statements for the Cardio-thoracic ICU at Glenfield Hospital 
were therefore obtained for the financial years (2002-2003 and 2004-
2005). Statements for the financial years (2001-2002) and (2003-2004) 
were missing. The budget statements related to the costs of looking 
after adult patients alone (as opposed to paediatric and neonatal 
patients who are also treated with ECMO at Glenfield Hospital). 
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In order to apportion the budgeted costs down to a patient-day 
measurement, the Glenfield Hospital Accountants advised an 
anticipated throughput of 1,000 patient days for each financial year in 
question. This throughput estimate was based on the ICU treating 30 
adult patients with ECMO, all of which would stay an average of 33 
days. The sum of all budgeted costs was thus divided by 1 ,000. 
The budget statements covered all of the costs associated with 
treatment with ECMO. 
8.5 Response rates for the cost and unit 
characteristics survey: CTCs 
8.5.1 Response Rates 
Forty hospitals recruited patients up until the 31st March 2005. Given 
that more than one hospital recruited, in some cases, more than one 
patient during each financial year and patients could have received 
treatment in both an ICU and an HDU, one hundred and sixteen cost 
questionnaires were sent out in total to account for this (58 for the ICU 
and combined ICU I High Dependency Units (HDUs) and 58 for the 
separate HDUs- where provided). The types of critical care units i.e. 
which of the participating critical care units had both an ICU and an 
HDU or operated as a combined ICU I HDU, were not known, so each 
critical care unit was sent two cost questionnaires for each financial 
year when a patient was recruited to the trial. 
The response rates by financial year and hospital are shown and report 
the status of the study as of 20th June 2005 (table 8.1). The crosses 
indicate the non-return of the cost questionnaires. As is evident, there 
were a very low number of responses (ticks). 
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Table 8.1: Response rates for the return of cost 
questionnaires by Hospital 
H "t I osp1 a name c tQ os f ues 1onna1res ICU Cost Questionnaires HDU 
2001- 2002- 2003- 2004- 2001· 2002- 2003- 2004-
2002 2003 2004 2005 2002 2003 2004 2005 
Bedford Hos~ital X X X X 
leswich Hos;ital .;' 
Luton & Dunstable Hos:ital I "' I .;' .;' .;' .;' .;' 
West Suffolk Hos~ital .;' X 
North Middlesex Hos~ital X X 
Ro~al London Hos~ital lx I X lx I X 
Aintree Hos~ital .;' 
Arrowe Park Hoseital X X 
Blackeool Victoria Hos~ital .;' .;' 
Leighton Hos~ital .;' .;' .;' .;' 
Macclesfield District General .;' X .;' X 
Hospital 
Manchester Royal Infirmary X X 
Ro~al Albert Edward lnfirma~ .;' .;' 
Ro~al Bolton Hoseital .;' X 
Ro~al Preston Hos~ital X X X X 
Southeort & Formb~ Hos~ital .;' .;' 
Castle Hill Hos ital I X I X X X X X 
Huddersfield Ro~allnfirma~ .;' X 
Hull Royal Infirmary X X 
Queen Elizabeth Hospital, X X X X 
Gateshead 
Ninewells Hospital X X 
Southern General Hoseital X 
1: Kettering General Hos~ital .;' .;' lx lx Milton Ke~nes General Hoseital X 
St. Mary's Hospital, Isle of Wight .;' 
Cheltenham General Hospital X X X X 
Gloucestershire Royal Hospital X X X X X X X X 
Chesterfield & North Derbyshire X X X X 
Hoseital 
Derb~shire Ro~al lnfirma~ X X 
Glenfleld Hoseital X X 
Leicester General Hospital X X 
Leicester Royal Infirmary X X 
Northern General Hospital .;' .;' .;' .;' 
Nottingham Ci~ Hoseital X X 
Rotherham District General X X 
Hoseital 
Ro~al Hallamshlre Hoseital .;' .;' 
Glan Clwyd District General X X 
Hospital 
University Hospital of Wales X X X lx 
Warwick Hospital X X 
Worcester Royal Hospital .;' 
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Table 8.2 lists the hospitals and indicates whether or not they returned 
their unit characteristics questionnaires. Of the 116 distributed 
questionnaires, 34 (29%) were returned. The 34 questionnaires related 
to 26 hospitals. 
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Table 8.2: Response rates for the return of unit 
characteristic questionnaires By Hospital 
H "t I ospl a name U "tCh 
"' 
aractens 1cs ·r Q f ues 1onna1re 
12001- 12002- 2003-2004 2004-2005 
2002 2003 
Bedford Hoseital -/ -/ 
leswich Hos~ital -/ 
Luton & Dunstable Hos=ital I -/ I -/ -/ 
West Suffolk Hoseital -/ 
North Middlesex Hoseital -/ 
Ro~al London Hoseital lx I X 
Aintree Hoseital -/ 
Arrowe Park Hoseital X 
Blackeool Victoria Hoseital 
Leighton Hoseital X X 
X 
Royal Albert Edward Infirmary 1---/----i 
Royal Bolton Hoseital 1---/ __ _ 
Royal Preston Hoseital .....__-/ __ _ X 
Southeort & Formby Hos:ital X 
-/ -/ 
X 
X 
-/ 
Southern General Hoseital 
1: Kettering General Hoseital Milton Keynes General Hospital 
St. Mary's Hospital, Isle of Wight X 
Cheltenham General Hospital I -/ -/ 
Gloucestershire Royal Hospital I -/ -/ -/ -/ 
Chesterfield & North Derb~shire Hoseital -/ X 
Derb~shire Ro:iallnfirma~ X 
Glenfield Hoseital X 
Leicester General Hospital -/ 
-.-· 
Nottingham Ci~ Hoseital -/ 
Rotherham District General Hoseital -/ 
Ro~al Hallamshire Hoseital {ICU and HDU} 1-/ 
Glan Clwvd District General Hospital -/ I 
University Hospital of Wales I X lx 
Warwick Hospital I X 
Worcester Royal Hospital -/ I 
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8.5.2 Return of both unit characteristics and cost data 
Only 11 hospitals returned data on both their unit characteristics and 
expenditures (Table 8.3). Of these 11 hospitals, 13 critical care units 
existed, as the Northern General and Royal Hallamshire Hospitals 
provided both cost and unit characteristics data for their ICUs and 
geographically adjacent HDUs. Some critical care units provided data 
for more than one financial year, resulting in 18 observations in total. 
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Table 8.3: Response rates for the return of both unit 
characteristic and cost questionnaires by Hospital 
Hospital name Unit Characteristics And Cost 
Questionnaires 
12001- 12002- 2003-2004 
2002 2003 
Bedford HosQital X 
IQswich Hos~ital 
Luton & Dunstable Hos=ital I ../ I ../ 
West Suffolk HosQital ../ 
North Middlesex HosQital 
Ro~al London HosQital lx I 
Aintree HosQital 
Arrowe Park HosQital X 
Blackpool Victoria HosQital ../ 
Leighton Hospital X X 
X 
X 
../ 
../ 
Royal Preston HosQital X 
Southport & Formby Hos~ital 
Castle Hill Hos ital I X X 
X 
Southern General HosQital ,, 
Kettering General HosQital 
Milton Keynes General Hospital 
St. Mary's Hospital, Isle of Wight X 
Cheltenham General Hospital I X X 
Gloucestershire Rq~al Hosj:)ital I X X X 
Chesterfield & North Derbyshire HosQital X 
Derb~shire Ro~allnfirma~ X 
Glenfield Hospital X 
Leicester General Hospital X 
Nottingham Ci~ Hospital 
Rotherham District General Hospital 
Royal Hallamshire Hospital ./ 
Glan Clwvd District General Hospital X 
University Hospital of Wales I X 
Warwick Hospital I X 
Worcester Royal Hospital ../ 
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2004-2005 
X 
../ 
../ 
X 
X 
../ 
X 
X 
X 
X 
X 
X 
1: 
X 
X 
X 
X 
lx 
I 
J 
J 
J 
I 
8. 5. 3 Data Completeness 
The completeness of the returned data was first investigated by 
resource item (Table 8.4) and then by critical care unit (Table 8.5). The 
rate of completeness (termed 'data availability' in Table 8.4) was taken 
as the number of responses divided by the total number of 18 possible 
responses and expressed as a percentage. 
The expenditure questionnaires were not fully completed as can be 
seen from Table 8.4. Data on nursing and administrative staff together 
with drugs and fluids yielded the highest number of responses (77%). 
Data on clinical and biomedical scientists and clinical psychologists 
yielded the lowest number of responses at 14%. Some hospitals were 
more adept at providing the expenditure data than others. For example, 
Ipswich hospital was able to provide expenditure data for all of the 
resource items captured within the questionnaire. Other hospitals such 
as the Royal Bolton Hospital and West Suffolk Hospital returned their 
questionnaires with a lot of missing data. 
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Table 8.4: Response rates for the return of resource use 
items contained within the cost questionnaires 
Resource Use Item Number Of Data 
Responses Availability 
% 
Nursing staff 17 77% 
Administrative staff 17 77% 
Drugs and fluids 17 77% 
Nutritional products 12 55% 
Disposable equipment 16 73% 
Consultant medical staff 16 73% 
Other medical staff 15 68% 
Radiology 14 64% 
Laboratory services 16 73% 
Blood and blood products 14 64% 
Specialised bed therapy 13 59% 
Dietician 7 32% 
Physiotherapists 13 59% 
Speech and language therapists 6 27% 
Occupational therapists 6 27% 
Medical Technical Officers 7 32% 
Clinical Pharmacists 5 23% 
Information Technologists 6 27% 
Clinical and Biomedical Scientists 3 14% 
Clinical Psychologists 3 14% 
Directorate Accountants 9 41% 
Personnel Officers 5 23% 
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Table 8.5: Number of Critical Care Units contributing cost data for analysis 
Hospital Name 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
Ipswich HospitaiiCU 
Financial year ./ ./ ./ ./ ./ ./ ./ ./ ./ JC ./ ./ ./ ./ ./ ./ ./ ./ ./ ./ ./ ./ 
200412005 
Luton & Dunstable 
Hospital ICU 
Financial year 
2001/2002 
./ ./ ./ JC ./ ./ ./ ./ ./ ./ ./ ./ JC ./ ./ JC ./ JC JC JC ./ JC 
200312004 ./ ./ ./ JC ./ ./ ./ ./ ./ ./ ./ ./ JC ./ ./ JC ./ JC JC JC ./ JC 
./ ./ ./ JC ./ ./ ./ ./ ./ ./ ./ ./ JC ./ ./ JC ./ X X X ./ JC 
200412005 
West Suffolk Hospital 
ICU 
Financial year ./ ./ ./ JC ./ JC JC JC JC JC ./ JC JC JC JC JC JC JC .tC JC X JC 
200212003 
Aintree HospitaiiCU 
Financial year ./ ./ ./ .tC ./ ./ ./ ./ ./ ./ ./ ./ ./ JC .tC .tC ./ ./ .tC X ./ X 
2003/2004 
Blackpool Victoria 
HospitaiiCU I HDU 
Financial year 
./ ./ ./ .tC ./ ./ ./ JC ./ ./ .tC JC ./ JC .tC .tC .tC .tC JC .tC JC .tC 2003/2004 
Royal Albert Edward 
lnfinnary ICU 
Financial year ./ ./ ./ ./ ./ ./ ./ ./ ./ ./ ./ .tC ./ JC .tC .tC JC JC JC JC X X 
200212003 
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Hospital Name 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
Royal Bolton Hospital 
ICU 
Financial year 
200212003 JC JC .IC 
"' 
JC JC JC 
"' 
.IC JC JC JC JC JC .IC .IC .IC .IC JC JC JC .IC 
Kettering General 
HospitaiiCU 
Financial year 
2002/2003 
"' 
, , , , , , 
"' 
, , 
.IC , , , , , JC , , , 
.IC .IC 
2003/2004 
"' "' "' 
, 
"' 
, 
"' 
, , , JC , 
"' 
, , , Je' , , 
"' 
.IC JC 
Northern General 
HospitaiiCU 
Financial year 
2001/2002 , , 
"' "' 
, 
"' "' 
.IC 
"' 
.IC 
"' 
.IC , JC JC 
"' 
JC JC JC .IC 
"' "' 2002/2003 
, , , , , , , , , , , .IC , JC JC , JC JC JC .IC , 
"' 
Northern General 
Hospital HDU 
Financial year 
"' 
2001/2002 
"' "' "' "' "' 
, 
.IC 
"' 
, 
.IC .IC , JC JC JC JC JC JC .IC , , 
, 
"' 
, , 
"' "' 
, , 
200212003 , , , .IC , JC JC 
"' 
JC JC JC .IC , 
"' 
Royal Hallarnshire 
HospitaiiCU 
Financial year , , , 
"' 
, 
"' "' 
, 
"' "' 
, 
.IC , JC JC 
"' 
JC 
"' 
JC .IC .IC lC 
2003/2004 
Royal Hallarnshire 
Hospital HDU 
Financial year 
"' "' "' "' 
JC 
"' 
JC 
"' "' 
, , JC , JC lC JC JC 
"' 
lC lC lC lC 
--~03/2004_ 
~---
-
~ 
L_ __ 
--
L____ L__ 
-'----· 
L____ 
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Hospital Name 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
Worcester Royal 
Hospital ICU 
200212003 ./ ./ ./ ./ ./ ./ ./ ./ ./_ ./ L__./__ JC L_ '!'___ -L_ __ ~ JC JC JC JC JC JC JC JC 
---
Key 
1 Nursing staff 
2 Administrative staff 
3 Drugs and fluids 
4 Nutritional products 
5 Disposable equipment 
6 Consultant medical staff 
7 Other medical staff 
8 Radiology 
9 Laboratory services 
10 Blood and blood products 
11 Specialised bed therapy 
12 Dieticians 
13 Physiotherapists 
14 Speech and language therapy 
15 Occupational therapy 
16 Medical Technical Officers 
17 Clinical phannacists 
18 lnfonnation Technologists 
19 Clinical and biomedical scientists 
20 Clinical Psychologists 
21 Directorate accountants 
22 Personnel Officers 
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8.6 Characteristics of the CTCs that returned their Unit 
Characteristic Questionnaires 
Although there was a very poor response rate, comparisons were made 
with the responding CTCs, the HRG study and the ICNARC CMPD. 
The results ofthese comparisons need to be interpreted with caution 
because of a) the low response rate and b) neither the HRG nor the 
ICNARC CMPD studies were representative. Comparisons were made 
just to see how valid the application of organ support weights derived 
from the HRG sample would be to the CESAR study. 
8. 6. 1 Geographical location of centres 
Table 8.6 stratifies the responding critical care units by geographical 
region. The North West and Trent had a higher proportion of CTCs 
than the other regions, followed by the Eastern Region and the South 
West and Northern & Yorkshire. The geographical representation of 
the sample was not comparable to the critical care units that 
participated in the HRG study as there were fewer CTCs represented in 
the South East, West Midlands and London. 
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Table 8.6: Geographical location of CESAR centres 
Geographical Location Number of Number of 
Centres Centres (HRG) 
(CESAR) (% of (%)of total 
total} 
Northern & Yorkshire 2 (8) 8 (11) 
Trent 6 (23) 5 (7) 
Eastern 4 (15) 7 (10) 
London 1 (4) 6 (9) 
South East 1 (4) 12 (17) 
South West 2 (8) 10 (14) 
West Midlands 1 (4) 9 (13) 
North West 7 (27) 8 (11) 
Wales 1 (4) 0 (0) 
Scotland 1 (4) 3 (4) 
Northern Ireland 0 (0) 2 (3) 
B. 6. 2 Hospital Type 
Table 8. 7 reports the presence of a medical school within the hospital 
and whether the CTC could be deemed a tertiary referral centre. There 
appeared to be a lower proportion of CTCs with a medical school and 
those regarded as tertiary referral centres than in the HRG study. 
Table 8.7: Hospital Type 
Hospital Type 
Medical School within the hospital 
Tertiary Referral Centre 
Unknown 
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Number of 
Centres 
(CESAR} ('Ye} 
6 (15.0) 
7 (17.5) 
14 (35.0) 
Number of 
Centres (HRGs) 
(%} 
17 (24.0) 
25 (36.0) 
7 (10.0) 
8.6.3Unit Type 
Table 8.8 shows the frequency of CTCs by unit type. The sample was 
spli~ in a similar manner to that ofthe HRG study between adulf 
general intensive care units and combined adult general intensive care 
unit I high dependency units. There was however a much larger 
proportion of the CTC sample listed under the 'unknown' category. 
• The main distinguishing feature of this comparison was the specialist 
critical care units that were absent from the CTC sample when 
compared to the HRG study. 
Table 8.8: Types of Critical Care Unit 
Unit Type Number of centres Number of centres 
Adult General Intensive Care Unit 
Adult General High Dependency Unit 
Adult General Intensive Care Unit/ High Dependency 
Unit 
Adult Surgical Intensive Care Unit 
Adult Surgical High Dependency Unit 
Adult Cardiothoracic Intensive Care Unit 
Adult Coronary Care Unit 
Adult Burns I Plastic Surgery Unit 
Adult I Paediatric Burns Unit 
Adult Neurological Intensive Care Unit I General 
Intensive Care Unit 
Adult Neurological Intensive Care Unit I High 
Dependency Unit 
Adult Combined Intensive Care Unit I High Dependency 
Unit I Coronary Care Unit 
Adult Neurosurgical & Neurological Intensive Care Unit I 
High Dependency Unit 
Adult General Intensive Care Unit I Neuro Critical Care 
Unit 
Adult General Intensive Care Unit I High Dependency 
Unit I Neuro Intensive Care Unit 
(CESAR) (%) 
13 (32.5) 
2* 
13(32.5) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
Unknown 14 (35.0) 
• The HDUs were not included in the % calculations as these were additional units 
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(HRG) (%) 
17(24.0) 
2 (3.0) 
32 (46.0) 
0 (0.0) 
2 (3.0) 
2 (3.0) 
0 (0.0) 
2 (3.0) 
0 (0.0) 
2 (3.0) 
4 (6.0) 
2 (3.0) 
1 (1.0) 
1 (1.0) 
1 (1.0) 
2 (3.0) 
8.6.3Comparisons of unit type with the ICNARC CMP 
database (2005) and HRG centres 
Table 8.9 provides a summarised version of table 8.8 where the unit 
type is grouped together so that comparisons may be made with the 
ICNARC CMP database. The Conventional Treatment Centre sample 
included a lower proportion of combined ICU I HDUs (than that 
represented in the ICNARC database and the HRG study) and had no 
combined ICU I HDU I Coronary Care Units or ICU I HDU I 
Neurological Intensive Care Units. Within the 'Other' category are 
those CTCs for whom the unit type is unknown. 
Table 8.9: Comparisons of unit type with the ICNARC 
CMP database (2005) and HRG Centres 
Type of Critical Care Unit ICNARC (o/o) CESAR HRG centres (%) 
centres!%! 
ICU 71 (42.0} 13 (32.5} 17 {24.3) 
ICUICCU 3 (1.8} 0 {0.0} 0 (0.0} 
ICUI HDU 87 {51.5} 13 {32.5} 38 {54.3} 
ICU I HDU I CCU 7 {4.1} 0 {0.0} 2 {2.9} 
ICU I HDU I NICU 1 {0.6} 0 (0.0} 1 {1.4} 
Other e.g. HDUs, cardiothoracic ICUs, specialist NIA 14 (35.0) 12 (17.1) 
bums etc. 
B. 6. 2 Unit Size 
Table 8.10 compares the respective studies by the numbers of staffed 
beds. There were no CTCs that exceeded 18 beds, nor any with 
between 1 and 3 beds. Most of the CTCs had between 4-6 beds and 7-9 
beds; a pattern reflected in the other studies. 
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Table 8.10: Numbers of staffed critical care beds 
/ 
Unit Size (Numbers of Number of Number of Comparison 
staffed beds) critical care critical care with ICNARC's 
units units(%) CMPo49 
CESAR HRG Study (%of total) 
study 
1-3 beds 0 (0.0) 2 (2.9) 13(7.6) 
4-6 beds 13 (32.5) 19 (27.1) 93 (54.7) 
7-9 beds 7 (17.5) 21 (30.0) 38 (22.4) 
10-12 beds 3 (7.5) 13 (18.6) 19(11.2) 
13-15 beds 2 (5.0) 6 (8.6) 5 (2.9) 
16-18 beds 1 (2.5) 1 (1.4) 1 (0.6) 
19-20 beds 0 (0.0) 1 (1.4) 0 (0.0) 
> 20 beds 0 (0.0) 0 (0.0) 1 (0.6) 
Unknown 14 (35.0) 7 (10.0) 0 (0.0) 
8. 7 Daily costs of conventional therapy 
Descriptive statistics were performed for each of the resource items for 
each financial year that ranged from 2001-2002 to 2004-2005. Table 
8.11 shows the results of this undertaking for the responding CTCs. As 
can be seen from the 'Number of Centres' column, there are only a 
very small number of observations for each resource item. In order that 
average daily costs could be estimated for each CTC for the financial 
year where patients were treated, it was thought appropriate to 
substitute the missing data with mean estimates obtained from the 
responding CTCs by financial year. Table 8.12 shows the results of this 
exercise. The main difference between the two tables relates to the 
variability in cost, with the latter table having much less variability in 
the estimates than the true values. Using these data, it was possible to 
determine for each CTC a set of average daily costs by financial year 
49 Data from 170 critical care units was used between December 1995 and January 2005 
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that could be adjusted using the organ support weightings described in 
Chapter 7. Table 8.13 presents the adjusted daily estimates by centre. 
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Table 8.11: Daily cost data by resource item: Absolute values 
Resource Resource 
Number 
1 Nursing Staff 2001-2002 
Nursing Staff 2002-2003 
Nursing Staff 2003-2004 
Nursing Staff 2004-2005 
2 Other Medical Staff 2001-2002 
Other Medical Staff 2002-2003 
Other Medical Staff 2003-2004 
Other Medical Staff 2004-2005 
3 Consultant Medical Staff 2001-2002 
Consultant Medical Staff 2002-2003 
Consultant Medical Staff 2003-2004 
Consultant Medical Staff 2004-2005 
4 Administrative suppgrt 2001-2002 
Administrative SupQ_ort 2002-2003 
Administrative Sup_l)()__rt 2003-2004 
Administrative Sup_l)()__rt 2004-2005 
5 Drugs and Fluids 2001-2002 
Drugs and Fluids 2002-2003 
Drugs and Fluids 2003-2004 
Drugs and Fluids 2004-2005 
6 Disposable Equipment 2001-2002 
Disposable Equipment 2002-2003 
Disposable Equipment 2003-2004 
Disposable Equipment 2004-2005 
7 Blood and blood products 2001-2002 
Blood and blood products 2002-2003 
Blood and blood products 2003-2004 
Blood and blood products 2004-2005 _ 
Number Minimum 
of cost per 
centres calendar day 
'' 
3 571 
7 439 
7 460 
6 530 
3 144 
7 83 
6 57 
5 23 
3 86 
7 46 
6 35 
5 32 
3 9 
7 11 
7 7 
6 0 
3 110 
7 57 
7 76 
5 63 
3 134 
7 32 
7 42 
6 27 
2 32 
6 11 
7 34 
4 25 
-- - -
25'Y. 
lnterquartile 
range cost per 
__ , ______ -- ,._ 
594 
496 
518 
575 
149 
94 
82 
76 
86 
53 
47 
88 
14 
11 
9 
17 
126 
76 
113 
78 
136 
76 
88 
75 
32 
23 
46 
28 
-- -··-
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Mean (SO) cost per 
calendar day (£) 
683 (156) 
540 (63} 
609 (138) 
607(55} 
152 (7} 
125 37 
120 46 
135 92 
100 24 
77 42 
78 40 
93 37 
18 (8 
16 (5 
17(11 
17(9 
207(142 
93 (27 
167 (85 
99 (44 
140 (8 
87 (33 
119 (56 
81 29 
53J29 
33 16) 
51 (13) 
- - -·--
32 (5} 
Median 
cost per 
calendar 
---
-
618 
569 
587 
608 
153 
117 
127 
147 
86 
59 
71 
105 
19 
12 
13 
18 
141 
86 
130 
83 
139 
82 
127 
90 
53 
35 
47 
L__ _ _]_2_ 
75'Ye 
lnterquartile 
range cost per 
~ ---- - ~-
' 
740 
583 
669 
630 
156 
155 
139 
165 
107 
81 
110 
115 
22 
21 
20 
22 
256 
107 
210 
94 
144 
107 
135 
100 
73 
36 
55 
36 
Maximum 
cost per 
calendar 
862 
612 
843 
690 
158 
175 
189 
263 
128 
168 
137 
127 
25 
22 
37 
24 
370 
140 
318 
175 
149 
130 
218 
105 
73 
59 
72 
38 
\ 
Resource Resource 
Number 
8 Nutritional products 2001-2002 
Nutritional products 2002-2003 
Nutritional products 2003-2004 
Nutritional products 2004-2005 
9 Laboratory services 2001-2002 
Laboratory services 2002-2003 
Laboratory services 2003-2004 
Laboratory_ services 2004-2005 
10 Radiology 2001-2002 
Radiology 2002-2003 
Radiology 2003-2004 
Radiology 2004-2005 
11 Physiotherapists 2001-2002 
Physiotherapists 2002-2003 
Physiotherapists 2003-2004 
Physiotherapists 2004-2005 
12 Medical Technical Officers (MTOs) & Assistant 
MTOs 2001-2002 
Medical Technical Officers (MTOs) & Assistant 
MTOs 2002-2003 
Medical Technical Officers (MTOs) & Assistant 
MTOs 2003-2004 
Medical Technical Officers (MTOs) & Assistant 
MTOs 2004-2005 
13 Clinical and biomedical scientists 2001-2002 
ainical and biomedical scientists 2002-2003 
ainical and biomedical scientists 2003-2004 
Clinical and biomedical scientists 2004-2005 
14 Information Technologists 2001-2002 
Information Technol()glsts 2002-2003 
Information Technol()gists 2003-2004 
lnfoonation Technologists 2004-2005 
15 Clinical Phannacists 2001-2002 
--~--- Clinical_f»hannacists 2002-2003 
Number 
of 
centres 
2 
8 
4 
4 
2 
6 
5 
4 
2 
7 
4 
4 
2 
7 
5 
3 
2 
4 
4 
4 
1 
3 
3 
4 
0 
4 
3 
2 
2 
2 
Minimum 
cost per 
calendar 
day(£) 
8 
2 
6 
4 
29 
15 
3 
16 
1 
9 
8 
3 
36 
10 
9 
22 
0 
0 
0 
0 
0 
0 
0 
0 
-
0 
0 
1 
4 
25% 
lnterquartile 
range cost 
per calendar 
-
8 
6 
8 
6 
29 
36 
28 
22 
1 
9 
9 
6 
36 
13 
11 
24 
0 
0 
0 
0 
0 
0 
0 
0 
-
0 
4 
1 
4 
0 __ __Q_ 
--
393 
Mean (SD) 
cost per 
calendar day 
(£) 
47 (55 
9(5 
25_(32 
8_(3 
34_(8 
44 23 
44 34 
31 15 
4 (5 
14 (8 
17 (11 
9 (4 
37 (2 
24 (12 
19 (12) 
28 (7) 
12 (16) 
6 (9) 
1 (1) 
2 (4) 
0 (0) 
0 (0 
0 (0 
0 (0 
-
6_(8 
10 (10 
3 (3 
5 (0 
19 (27 
---
-
Median 
cost per 
calendar 
day(£) 
47 
9 
11 
9 
34 
41 
40 
28 
4 
10 
13 
10 
37 
25 
12 
27 
12 
4 
0 
0 
0 
0 
0 
0 
-
3 
8 
3 
5 
19 
75"/o 
lnterquartile 
range cost per 
calendar day (£) 
86 
12 
43 
10 
40 
47 
57 
41 
7 
17 
25 
11 
38 
32 
31 
31 
23 
13 
1 
4 
0 
0 
0 
0 
-
12 
14 
5 
5 
38 
Maximum 
cost per 
calendar 
day 
86 
20 
74 
12 
40 
84 
93 
53 
7 
27 
33 
11 
38 
40 
32 
35 
23 
18 
2 
8 
0 
0 
0 
0 
-
16 
21 
7 
5 
38 
Resource Resource 
Number 
Clinical Pharmacists 2003-2004 
Clinical Pharmacists 2004-2005 
16 Dieticians 2001-2002 
Dieticians 2002-2003 
Dieticians 2003-2004 
Dieticians 2004-2005 
17 Directorate Accountants 2001-2002 
Directorate Accountants 2002-2003 
Directorate Accountants 2003-2004 
Directorate Accountants 2004-2005 
18 Personnel Officers 2001-2002 
Personnel Officers 2002-2003 
Personnel Officers 2003-2004 
Personnel Officers 2004-2005 
19 Speech & Language therapists 2001-2002 
Speech & Language therapists 2002-2003 
Speech & Language therapists 2003-2004 
Speech & Language therapists 2004-2005 
20 Psychologists 2001-2002 
Psychologists 2002-2003 
Psychologists 2003-2004 
P~chol<>gists 2004-2005 
21 Occupational therapy 2001-2002 
Occupational therapy 2002-2003 
Occupational theraQY 2003-2004 
Occu_pational therapy 2004-2005 
22 S~cialised bed therapy 2001-2002 
Specialised bed therapy 2002-2003 
Specialised bed therapy 2003-2004 
~cialised bed therapy 2004-2005 
Number 
of 
centres 
3 
6 
2 
3 
4 
5 
2 
4 
2 
6 
1 
3 
1 
4 
2 
3 
4 
5 
2 
4 
3 
4 
2 
4 
4 
4 
3 
7 
6 
6 
-
Minimum 
cost per 
calendar 
day(£) 
4 
5 
3 
0 
3 
0 
0 
0 
0 
0 
-
0 
-
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
3 
4 
3 
0 
25'11. 
lnterquartile 
range cost 
per calendar 
--
-, 
4 
8 
3 
3 
4 
0 
0 
0 
0 
0 
-
1 
-
1 
0 
1 
0 
0 
0 
0 
0 
0 
0 
4 
1 
0 
3 
4 
5 
0 
~·--
394 
Mean (SD) 
cost per 
calendar day 
(£) 
19 (26) 
9 2) 
5 2 
5 5 
6 (3) 
4 5 
1 (1) 
3{4 
6_(8) 
1(1) 
3 
2 (2) 
1 
2 (2 
0 (0 
1 (0 
0 (1 
0 (0 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
2 (2) 
6 (4) 
5 4) 
1 2 
5 3 
8 4 
9 5 
2 (3) 
Median 
cost per 
calendar 
day(£) 
5 
5 
5 
7 
6 
3 
1 
1 
6 
1 
-
2 
-
2 
0 
1 
0 
0 
0 
0 
0 
0 
2 
8 
6 
1 
4 
8. 
9. 
1 
75'11. 
lnterquartile 
range cost per 
calendar day (£) 
27 
11 
6 
8 
8 
7 
2 
5 
12 
2 
-
3 
-
3 
0 
1 
1 
0 
0 
0 
0 
0 
3 
9 
9 
3 
6 
11 
13 
2 
-
Maximum 
cost per 
calendar 
day 
49 
12 
6 
10 
9 
11 
2 
9 
12 
2 
-
3 
-
4 
0 
1 
1 
1 
0 
0 
0 
0 
3 
10 
9 
3 
9 
15 
15 
9 
-
\ 
Table 8.12: Daily cost data by resource item: Substituted values 
Resource 
Number 
1 
2 
3 
4 
5 
6 
7 
Resource 
Nursing Staff 2001-2002 
Nursing_ Staff 2002-2003 
Nursing Staff 2003-2004 
Nursing Staff 2004-2005 
Other Medical Staff 2001-2002 
Other Medical Staff 2002-2003 
Other Medical Staff 2003-2004 
Other Medical Staff 2004-2005 
Consultant Medical Staff 2001-2002 
Consultant Medical Staff 2002-2003 
Consultant Medical Staff 2003-2004 
Consultant Medical Staff 2004-2005 
Administrative suppOrt 2001-2002 
Administrative SI!Pj)Ort 2002-2003 
Administrative SuppOrt 2003-2004 
Administrative SuppOrt 2004-2005 
Drugs and Ruids 2001-2002 
Drugs and Ruids 2002-2003 
Drugs and Fluids 2003-2004 
Drugs and Fluids 2004-2005 
Disposable Equipment 2001-2002 
Disposable Equipment 2002-2003 
Disposable Equipment 2003-2004 
Disposable Equipment 2004-2005 
Blood and blood products 2001-2002 
Blood and blood products 2002-2003 
Blood and blood products 2003-2004 
Blood and blood products 2004-2005 
Number Minimum 
of cost per 
centres calendar day 
11 571 
14 439 
14 460 
19 530 
11 130 
14 83 
14 57 
19 23 
11 85 
14 46 
14 35 
19 32 
11 9 
14 11 
14 7 
19 0 
11 110 
14 57 
14 76 
19 63 
11 102 
14 32 
14 42 
19 27 
11 32 
14 11 
14 34 
19 25 
25% 
lnterquartile 
range cost per 
---~----- -
597 
569 
587 
597 
130 
117 
130 
130 
85 
59 
85 
85 
17 
12 
13 
17 
133 
86 
130 
133 
102 
82 
102 
101 
41 
36 
41 
41 
395 
Mean (SD) cost per 
calendar day (£) 
621 (81) 
568 52 
603 94 
600 29 
136 (11 
127 25 
126 29 
131 43 
89 (13) 
81 29 
82 25 
87 18 
17 (4) 
16 (4) 
17(7) 
17 (5 
153 72 
113 28 
150 61 
124 (26) 
113 (18) 
95 (24) 
111 (39 
95 (18) 
43 (10) 
38 (11) 
46 (10) 
39 (5) 
Median 
cost per 
calendar 
- -
597 
597 
597 
597 
130 
130 
130 
130 
85 
85 
85 
85 
17 
17 
17 
17 
133 
133 
133 
133 
102 
102 
102 
102 
41 
41 
41 
41 
75% 
lnterquartile 
range cost per 
- ---- -
597 
597 
597 
597 
137 
130 
130 
130 
85 
85 
85 
85 
17 
17 
17 
17 
133 
133 
133 
133 
118 
102 
127 
102 
41 
41 
47 
41 
Maximum 
cost per 
calendar 
--
862 
612 
843 
690 
158 
175 
189 
263 
128 
168 
137 
127 
25 
22 
37 
24 
370 
140 
318 
175 
149 
130 
218 
105 
73 
59 
72 
41 
Resource 
Number 
8 
9 
10 
11 
12 
13 
Resource 
Nutritional products 2001-2002 
Nutritional _products 2002-2003 
Nutritional products 2003-2004 
· Nutritional products 2004-2005 
laboratory services 2001-2002 
laborat<>ry services 2002-2003 
laboratory services 2003-2004 
laboratory services 2004-2005 
Radiology 2001-2002 
Radiology 2002-2003 
Radiology 2003-2004 
Radiology 2004-2005 
Physiotherapists 2001-2002 
Ph~iotheraQists 2002-2003 
Physiotherapists 2003-2004 
Physiotherapists 2004-2005 
Medical Technical Officers (MTOs) & Assistant 
MTOs 2001-2002 
Medical Technical Officers (MTOs) & Assistant 
MTOs 2002-2003 
Medical Technical Officers (MTOs) & Assistant 
MTOs 2003-2004 
Medical Technical Officers (MTOs) & Assistant 
MTOs 2004-2005 
Clinical and biomedical scientists 2001-2002 
Clinical and biomedical scientists 2002-2003 
Clinical and biomedical scientists 2003-2004 
Clinical and biomedical scientists 2004-2005 
Number 
of 
centres 
11 
14 
14 
19 
11 
14 
14 
19 
11 
14 
14 
19 
11 
14 
14 
19 
11 
14 
14 
19 
11 
14 
14 
19 
Minimum 
cost per 
calendar 
day(£) 
8 
2 
6 
4 
29 
15 
3 
16 
0 
9 
8 
3 
25 
10 
9 
22 
0 
0 
0 
0 
0 
0 
0 
0 
25% 
lnterquartile 
range cost 
per calendar 
~-~., -, 
17 
8 
17 
17 
40 
40 
40 
40 
12 
10 
12 
12 
25 
25 
25 
25 
4 
4 
2 
4 
0 
0 
0 
0 
396 
Mean (SD) 
cost per 
calendar day 
(£) 
22 (21) 
13 6 
19 (16 
15 (4 
39 (3 
42 (14 
41 (19) 
38 (7 
11 (4 
13 (5 
14 6) 
11 2) 
27 5) 
24 (8) 
23 (7) 
25 (3) 
6 (6) 
5 (4) 
3 (2) 
4 (2) 
0 (0) 
0 0) 
0.(0 
0 (0) 
Median 
cost per 
calendar 
day(£) 
17 
15 
17 
17 
40 
40 
40 
40 
12 
12 
12 
12 
25 
25 
25 
25 
4 
4 
4 
4 
0 
0 
0 
0 
75% 
lnterquartile 
range cost per 
cale'!dar day (£) 
17 
17 
17 
17 
40 
40 
40 
40 
12 
12 
12 
12 
25 
25 
25 
25 
4 
4 
4 
4 
0 
0 
0 
0 
Maximum 
cost per 
calendar 
day 
86 
20 
74 
17 
40 
84 
93 
53 
12 
27 
33 
12 
38 
40 
32 
35 
23 
18 
4 
8 
0 
0 
0 
0 
\ 
Resource Resource Number Minimum 25% Mean (SO) Median 75% Maximum 
Number of cost per lnterquartile cost per cost per lnterquartile cost per 
centres calendar range cost calendar calendar range cost calendar 
day(£) per day(£) day(£) per calendar day 
calendar day(£) 
-- -
14 Information Technologists 2001-2002 11 0 0 0 (0) 0 0 0 
Information Technologists 2002-2003 14 0 6 6 4) 6 6 16 
Information Tedmologists 2003-2004 14 0 6 7 4 6 6 21 
Information Technologists 2004-2005 19 1 6 5 2 6 6 7 
15 Clinical Phannacists 2001-2002 11 4 12 11 3 12 12 12 
Clinical Phannacists 2002-2003 14 0 12 13 (8) 12 12 38 
Clinical Phannacists 2003-2004 14 4 12 14(11) 12 12 49 
Clinical Phannacists 2004-2005 19 5 11 11 (2) 12 12 12 
16 Dieticians 2001-2002 11 3 5 5 (1) 5 5 6 
Dieticians 2002-2003 14 0 5 5 2 5 5 10 
Dieticians 2003-2004 14 3 5 5 1 5 5 9 
Dieticians 2004-2005 19 0 5 5 2 5 5 11 
17 Directorate Accountants 2001-2002 11 0 2 2 (1) 2 2 2 
Directorate Accountants 2002-2003 14 0 2 2 2 2 2 9 
Directorate Accountants 2003-2004 14 0 2 3 3 2 2 12 
Directorate Accountants 2004-2005 19 0 2 2 1 2 2 2 
18 Personnel Officers 2001-2002 11 2 2 2 (0) 2 2 3 
Personnel Officers 2002-2003 14 0 2 2 (0) 2 2 3 
Personnel Officers 2003-2004 14 1 2 2 (0) 2 2 2 
Personnel Officers 2004-2005 19 0 2 2 0) 2 2 4 
19 Speecll & Language therapists 2001-2002 11 0 0 0 0 0 0 1 
Speech & Language therapists 2002-2003 14 0 0 0 0 0 0 0 
Speech & Language therapists 2003-2004 14 0 0 0 (0 0 0 1 
Speech & Language therapists 2004-2005 19 0 0 0 0 0 0 1 
20 Psychologists 2001-2002 11 0 0 0 0 0 0 0 
Ps •sts 2002-2003 14 0 0 0.0 0 0 0 
Psvchologists 2003-2004 14 0 0 0 (0) 0 0 0 
Psvchologists 2004-2005 19 0 0 0 0) 0 0 0 
21 Occuoational therapy 2001-2002 11 0 4 3 1 4 4 4 
Occupational therapy 2002-2003 14 0 4 5 2 4 4 10 
Occupational therapy 2003-2004 14 0 4 4 2 4 4 9 
Occupational therapy 2004-2005 19 0 4 3 (1) 4 4 4 
L_ 
- - - --· -------- ------- -·-··· -----
397 
Resourc Resource Number Minimum 25% Mean (SO) Median 75% Maximum 
e of cost per lnterquartile cost per cost per lnterquartile cost per 
Number centres calendar range cost calendar calendar range cost calendar 
day(£) per day(£) day(£) per calendar day 
calendar day(£) 
-~ \" I 
22 Specialised bed therapy 2001-2002 11 3 6 6 (2) 6 6 9 
Specialised bed therapy 2002-2003 14 4 6 7 (3) 6 8 15 
Specialised bed therapy 2003-2004 14 3 6 8 (3) 6 7 15 
___ Specialised bed therapy ~Q_Q.1..2005 19 
--------
0 6 5 (3) 
.. __§_ 
---------
6 9 
\ 
398 
Table 8.13: Per diem costs by critical care unit and 
financial year 
Hospital Financial Average Dally 0 or 1 organ 2 organs 3 or more 
Year Cost Including supported (£) support organs 
10o/o Equipment ed (£) supported 
Cost i£! i£! 
Aintree Hos~ital 2004-2005 
1,240 
715 1,410 1,433 
Arrowe Park Hos~ital 2002-2003 
1,293 
746 1,470 1,494 
Bedford Hos~ital 2003-2004 
1,404 
810 1,597 1,623 
Bedford Hos~ital 2004-2005 
1,343 
775 1,527 1,553 
Black~ool Victoria Hos~ital 2003-2004 
1,098 
634 1,248 1,269 
Castle Hill Hos~ital 2001-2002 1,436 829 1,633 1,660 
Castle Hill Hos~ital 2003-2004 1,404 810 1,597 1,623 
Castle Hill Hos~ital 2004-2005 1,343 775 1,527 1,553 
Cheltenham General Hos~ital 2001-2002 
1,436 
829 1,633 1,660 
Cheltenham General Hos~ital 2003-2004 1,404 810 1,597 1,623 
Chesterfield & North Derbyshire 2002-2003 1,293 
Hos~ital 746 1,470 1,494 
Chesterfield & North Derbyshire 2004-2005 1,343 
Hos~ital 775 1,527 1,553 
Derb~hire Royal lnfirrna~ 2003-2004 1,404 810 1,597 1,623 
Glan Clwyd District General Hos~ital 2002-2003 1,293 746 1,470 1,494 
Glenfield Hos~ital 2003-2004 1,404 810 1,597 1,623 
Gloucestershire Royal Hos~ital 2001-2002 1,436 829 1,633 1,660 
Gloucestershire Ro~al Hos~ital 2002-2003 1,293 746 1,470 1,494 
Gloucestershire Royal Hos~ital 2003-2004 1,404 810 1,597 1,623 
Gloucestershire Ro~l Hos~ital 2004-2005 1,343 775 1,527 1,553 
Huddersfield Royal lnfirrna~ 2004-2005 1,105 638 1257 1,278 
Hull Ro~allnfirrna~ 2004-2005 1,343 775 1,527 1,553 
l~swich Hos~ital 2004-2005 1,230 710 1,398 1,422 
Kettering General Hos~ital 2002-2003 948 547 1,078 1,096 
Kettering General Hos~ital 2003-2004 1,003 579 1,141 1,160 
Leicester General Hos~ital 2003-2004 1,404 810 1,597 1,623 
Leicester Ro~al lnfirrna~ 2001-2002 1,436 829 1,633 1,660 
Leighton Hos~ital 2002-2003 1,144 660 1,301 1,323 
Leighton Hos~ital 2003-2004 1,234 712 1,403 1,426 
Luton & Dunstable Hos~ital 2001-2002 1,326 765 1,508 1,533 
Luton & Dunstable Hos~ital 2003-2004 1,332 769 1,515 1,540 
Luton & Dunstable Hos~ital 2004-2005 1,531 883 1,741 1,770 
Macclesfield District General 2002-2003 1,299 
Hos~ital 750 1,477 1,502 
399 
Hospital Financial 0 or 1 organ 2 organs /or more 
Year supported (£) support ·· organs 
ed (£) supported 
£ 
Macclesfield District General 2004-2005 
1,437 
Host!ital B29 1,634 1,661 
Manchester Ro~allnfirma~ 2001-2002 1,436 B29 1,633 1,660 
Milton Ke~nes General Host!ital 2004-2005 1,343 775 1,527 1,553 
Ninewells Host!ital 2001-2002 
1,436 
B29 1,633 1,660 
North Middlesex HosQital 2004-2005 
1,343 
775 1,527 1,553 
Northern General HosQital 2001-2002 
1,4B3 
B56 1,6B6 1,715 
Northern General HosQital 2002-2003 
1,401 BOB 1,593 1,619 
Nottingham Ci~ HosQital 2004-2005 
1,343 
775 1,527 1,553 
Queen Elizabeth Hospital, 2001-2002 
2,142 
Gateshead 1,236 2,436 2,476 
Queen Elizabeth Hospital, 2003-2004 
1,B54 
Gateshead 1,070 210B 2143 
Rotherham District General HosQital 2004-2005 
1,343 
775 1,527 1,553 
Ro~al Albert Edward lnfirma~ 2002-2003 1,273 735 144B 1,472 
Ro~al Bolton HosQital 2002-2003 
1,356 
7B3 1542 1,56B 
Rota! Hallamshire HosQital 2003-2004 
1,B04 
1,041 2051 2,0B6 
Rota! London HosQital 2002-2003 
1.293 7B7 1,552 1,57B 
Ro~al London HosQital 2004-2005 1,343 775 1,527 1,553 
Rota! Preston HosQital 2002-2003 
1.293 7B7 1,552 1,57B 
Ro~al Preston HosQital 2004-2005 1,343 775 1,527 1,553 
Southern General HosQital 2004-2005 
1,343 
775 1,527 1,553 
SouthQort & Formbt HosQital 2004-2005 
1,237 
714 1407 1,430 
St. Ma~·s HOSQital, Isle of Wight 2002-2003 
1,379 
796 1,56B 1,594 
Universi~ HosQital of Wales 2001-2002 1,436 B29 1,633 1,660 
Universi~ Host!ital of Wales 2004-2005 1,343 775 1,527 1,553 
Warwick HosQital 2001-2002 
1,436 B29 1,633 1,660 
West Suffolk HosQital 2003-2004 
1,782 
1,02B 2,026 2,060 
Worcester Ro:t:al Hoseital 2002-2003 
1,110 640 1262 1,2B3 
400 
8.8 Daily costs of ECMO 
The budget data provided for 2 financial years is reported in Table 
8.14. There were some resource items that were excluded from the 
estimates on the basis that these items were not collected for the 
conventional treatment costs (See Table 8.15). 
£2,184,652 was budgeted for ECMO in 2002-2003 and £2,637,774 
budgeted in 2004-2005. Apportioned down to a per diem measurement, 
resulted in a cost of £2,184.65 for 2002-2003 and £2,637.77. 
The total cost of these excluded resources was £961,235 for the 
financial year 2002-2003 and £1,088,400 for 2004-2005. The 
overheads represented 97.8% and 97.2% of this for 2002-2003 and 
2004-2005 respectively (Table 8.15). When questioned, the Glenfield 
Accountants were unable to explain what resource items constituted the 
'overhead' component of the budget and so these data were not 
considered to be reliable. 
Table 8.14: Budget data for the 2 financial years for 
ECMO 
Resource Item 2002-2003 2004-2005 (£) 
Budget Items (£) 
Consultants 46,285 142,944 
Consultant Medical Staff Consultant payments 15,000 0 
ECMO Fellows (including on-call 182,365 254,249 
Other Medical Staff payments) 
Senior Manager input 18,976 17,241 
Administration Admin & Clerical Grade 4 16,249 18,534 
CITU Nursing 559,418 623,027 
Nursing Staff 
ECMO Coordinator 25,949 29,617 
ECMO Specialists 104,034 222,677 
Physiotherapy Physiotherapy 9,960 12,542 
Radiology 6,090 7,684 
Radiology - consumables I tests 6,120 0 
lmaging tests - variable costs 0 7,776 
Radiology lmaging tests -fixed costs 0 11,664 
Laboratory services Laboratory Consumables - 0 6,158 
401 
Other 
Pathology costs - variable costs 96,642 
Pathology costs -fixed costs 107,380 
Cardiac Investigations - 0 
Variable Costs* 
Cardiac Investigations - Fixed 0 
Costs* 
Pharmacy I Nutritional 7,710 
products Pharmacy I Nutrition 
Drugs 420,105 
Drugs I nutritional products Drugs I TPN 23,373 
Specialised bed therapy Bed Hire 33,615 
Disposable equipment M&S Consumables - Post-ECMO 275,000 
M&S Consumables - 0 
Catheters 
M&S Consumables - ECMO 150,000 
Blood and blood products Recharges - Blood Products 0 
Other Transport Costs 63,000 
Perfusionists 14,670 
PMT Lung function tests 0 
Theatre Staffing (Bronchs) 0 
Instruments I Equipment 2,711 
Purchases 
Equipment Maintenance (incl. 0 
Bronchoscopes) 
TOTAL 2,184.652 
* Could also be classified under the 'radiology' heading. 
Table 8.15: Additional costs excluded from the 
calculations for ECMO 
Resource item (Budget 2002-2003 
Statement) 
Advertising 0 
Travel & Subsistence 2,033 
Furniture, office & computer equipment 0 
Subscriptions\Consultancy\Training 8,133 
Telecomms recharges 0 
Other Recharges 5,422 
Staff uniforms 1,084 
Printing & stationary I books & journals 4,609 
Overheads 939,954 
TOTAL 961,235 
402 
/ 
31,598 
47,397 
840 
1,260 
9,723 
443,478 
30,542 
275,000 
10,230 
150,000 
135,000 
81,000 
25,616 
6,158 
21,041 
2,463 
12,315 
2,637, 774 
2004-2005 
1,232 
3,695 
5,288 
7,389 
657 
4,926 
985 
6,404 
1,057,824 
1,088,400 
B. 8. 1 Apportionment of budget data 
The budgeted costs of each resource item were apportioned by the 
predicted number of patient days (n = 1 ,000) for the two financial 
years. 
Total costs per day for the financial years 2001-2002, 2003-2004 and 
2005-2006 where budget data were missing, were estimated by taking 
the mid-point cost between the 2 financial years (2002-2003 and 2004-
2005) (Table 8.16). A 10% equipment allowance was not added onto 
the ECMO costs since the costs of equipment were already included in 
the budgeted costs. 
Table 8.16: Daily costs by financial year for ECMO 
2001-2002* (£) 2002-2003 (£) 2003-2004* (£) 2004-2005 (£) 2005-2006* (£) 
1,958 2,185 2,411 2,638 2,864.33 
*Dally costs for the financial years 2001-2002, 2003-2004 and 2005-2006 were estimated by taking 
the mid-point cost between the 2 financial years where data were available. 
8. 8. 2 Application of organ support weightings 
The same organ support weightings were applied to the average daily 
costs ofECMO. The case-mix adjusted daily costs are presented in 
Table 8.17. 
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Table 8.17: Adjusted daily costs of ECMO 
Hospital Financial Average 0 or 1 2 organs 3 or more 
Year Daily Cost organ supported organs 
(£) supported (£) supported 
(£) (£) 
Glenfield 2001-2002 
Cardiothoracic 1,958 1,130 2,226 2,264 ICU 
2002-2003 2,185 1,261 2,484 2 525 
2003-2004 2,411 1,391 2 742 2,787 
2004-2005 2,638 1,522 2,999 3,049 
2005-2006 2,864 1,653 3,257 3,311 
8.9 Discussion 
The CESAR trial was actually the first multi-centre concurrent 
economic evaluation and clinical trial conducted in adult critical care in 
the UK at the time at which it was designed. For this reason, there was 
not any previous studies that could be used to inform the design of the 
economic evaluation to provide a comparable 'benchmark'. For this 
reason, the methods described were new. 
The decision to collect organ support data as part of the trial proforma 
was based on the findings from the exploratory research described in 
Chapter 4. It was always the intention to use the using the data 
collected in Chapter 6 to develop the organ support weights because of 
the quantity of data that this study generated, making it more likely that 
the development of a regression-based model would be possible. In 
order to develop an independent set of organ support weights relating 
to the CESAR CTCs, it would have been necessary to collect the organ 
support data on all patients (irrespective of whether they were in the 
trial) and to have been able to get all of the necessary expenditure data. 
This would have significantly increased the burden of data collection 
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on the participating critical care units and given the poor response rates 
to the expenditure survey, it is highly unlikely that this would have 
worked. 
An appealing and attractive option so as to minimise the work 
conducted for the economic evaluation would have been to apply to 
average daily unit cost estimates reported in Chapter 7 to the recruiting 
CTCs. However, the rationale for collecting centre-specific estimates 
of cost was based on the findings from a simulation exercise that found 
a significant difference in overall costs when using unit costs averaged 
across centres and when using centre-specific costs to value resource 
use measured in a clinical trial (Raikou et al., 2000). This finding goes 
against the standard analytical approach that is to ignore the inter-
dependence between costs and resource use by applying unit cost 
estimates from one or a few centres to pooled resources use and to 
relate costs to pooled outcome data (Sculpher et al., 2000). A site 
selection bias can nevertheless occur when measures of cost can be 
obtained only from a single or small number of centres (Jacobs & 
Baladi, 1996). 
As such, the aim of Chapter 8 was to collect expenditure data from all 
critical care units that recruited patients to the CESAR trial together 
with data on their unit characteristics; the objective being to estimate 
average daily costs of care for each centre relating to the time period 
during which patients were recruited (these included both conventional 
treatment centres and the Glenfield ECMO unit). 
Evidently, there was a very poor response rate with respect to both the 
unit characteristics and cost questionnaires -particularly with the latter 
questionnaire. Attempts made to compensate for the missing cost data 
(by substituting the missing data with the mean estimates by financial 
year) provided each CTC with a set of unit costs. There was a 
considerable amount of missing data, which was a concern. It is 
debatable whether attempting to collect these unit costs by centre added 
any value to the economic evaluation over and above merely applying 
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the average daily cost estimates reported in Chapter 5. However, what 
the study did highlight was just how difficult it is to obtain cost data 
/ 
from 'critical care units and supports the observations of Street & 
Dawson (2002) based on their experience that 'the NHS lags behind 
instutitions in many other countries in terms of the routine cost data 
collected by health care providers' (p.4). The critical care units that 
• participated in the HRG study were offered an important incentive i.e. 
unit-specific reports that summarised and compared their data with the 
other participating units. The absence of a clear incentive in the 
CESAR trial was undoubtedly a contributing factor with respect to the 
poor response rates. The altruistic motivation of contributing to 
research and new knowledge was not a sufficient incentive. This is an 
important research finding for future studies. Pharmaceutical 
companies overcome the likelihood of missing or poor quality data by 
paying critical care units a set amount for each patient they recruit to 
the trial. This amount can extend to up to £5,000 per patient and not 
surprisingly appears to work very effectively in boosting recruitment 
and ensuring high quality data collection. In government-funded trials 
such as CESAR, it is not possible to secure the necessary funds to 
reward hospitals in this way. 
Feedback from some of the critical care units suggested a reluctance to 
complete the questionnaires on the basis that it was for the benefit of 1 
patient. Due to the low incidence of severe, but potentially reversible, 
respiratory failure it was not unusual for some critical care units to 
recruit just one patient in each financial year. With this in mind, it was 
possibly unrealistic to expect staff to complete the unit characteristic 
and cost questionnaire for the purposes of estimating the costs of care 
for one patient. When the economic evaluation was designed, it was 
not anticipated that study recruitment would extend over so many 
financial years as data on the numbers of treated patients provided by 
the Cardio-thoracic ICU at Glenfield Hospital suggested a much higher 
capacity for treating patients using ECMO than was observed in the 
trial. In the first two years of recruitment, it became evident that a large 
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number of patients were not recruited to the trial because ofbed 
shortages at the Cardio-thoracic ICU. This contributed to the need to 
extend recruitment for a much longer time period than was expected 
and further contributed to small numbers of patients recruited over an 
increasing number of financial years. 
Had time permitted, the only sure way of obtaining accurate and timely 
expenditure data from the CTCs would have been to visit each centre. 
The potential problem with this would have been ensuring that the 
directorate accountants and the critical care unit staff were available on 
the day of the visit and sufficiently prepared with the necessary budget 
statements in order to complete the cost questionnaires. Based on 
previous experience of visiting critical care units in this way, it is not 
uncommon on the day of the visit to find staff not available to attend 
meetings due to clinical commitments etc. 
Whilst the cost questionnaire covered the majority of key critical care 
resources, it excluded the capture of data on capital equipment. This 
would have included expenditure on new items of equipment, rental 
and hire charges on equipment (except specialised beds), annual 
depreciation costs and equipment maintenance. This was an obvious 
weakness of the questionnaire but based on the variable completion 
rates, it is unlikely that even had a section on capital equipment been 
included, that data would have been provided. The decision to omit 
capital equipment was based on a priori expectation that these data 
would not be available from the critical care unit (based on pilot studies 
of the Critical Care National Cost Block Programme) (Edbrooke et al., 
1999). It is not known the extent to which this expectation held with 
the CTCs. 
The absence of cost data for the majority of the CTCs was not the only 
problem with the study. In order to estimate the costs ofECMO, the 
only data that was made available was the budget statements for 2 
financial years. Despite several attempts to obtain the expenditure data 
for each financial year in question, no data was forthcoming. One 
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possible reason for this could have related to a discrepancy between the 
agreed budget and the actual expenditure. When the accountant 
/ 
responsible for setting the ECMO budget was questioned as to what 
resources had been included in the 'overhead' budget, he was unable to 
provide any details of this. On these grounds, the overhead costs had to 
be excluded from the cost estimates because of uncertainty as to how 
• the budget for this had been used in the care of patients. The budgeted 
sums were apportioned by the expected number of patient days for 
each financial year (1,000 patient days) rather than the observed 
number of patient days. 
As far as it was possible to consider the generalisability of the 
characteristics of the responding CTCs with the HRG centres and the 
ICNARC CMP described in Chapter 6, as far as geographical 
representation was concerned, there was little evidence to suggest the 
two samples were comparable. It is important to note however that both 
samples were formed on a voluntary basis and not stratified a priori by 
any given characteristics. There was a lower proportion of CTCs with a 
medical school and those critical care units regarded as tertiary referral 
centres. The HRG study also had a much larger number of specialist 
critical care units in the sample than the CESAR study. It is difficult to 
postulate the effect that these characteristics would have on the costs of 
care because of the absence of these data generated by the CESAR 
study. 
The mean costs per day for nursing staff were slightly higher in the 
HRG study (£587.00 vs. £570.92 (2001-2002); £439.48 (2002-2003); 
£459.92 (2003-2004) and £529.98 (2004-2005). The costs of other 
medical staff were highly variable across financial years for the 
CESAR study and appeared to decline over time although this was 
most likely just a sampling problem (£143.81 (2001-2002); £83.33 
(2002-2003); £57.13 (2003-2004) and £22.65 (2004-2005) vs. £111.40 
for the HRG study. A similar phenomenon was observed for the 
Consultant Medical Staff(£85.76 (2001-2002); £45.87 (2002-2003); 
£35.10 (2003-2004) and £31.62 (2004-2005) v~. £97.40 for the HRG 
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study. In fact with all of the different resources, an inconsistent pattern 
was observed across financial years. The data reported for 2001-2002 
appeared to most closely reflect that reported for the HRG study but 
after that time the estimates appeared to drop (most noticeably for 
disposable equipment and physiotherapy). Comparisons are hampered 
by the low number of responses for the CESAR trials however if one 
had to make a definitive statement, it would have to be that the CESAR 
CTCs incurred lower costs than the HRG sample. It is impossible to 
make any judgements as to whether the case-mix of the two studies is 
comparable; suffice to say that patients with severe respiratory failure 
are acutely ill, in multiple organ failure, with a poor chance of survival. 
The final aim of this Chapter was to apply the cost weights developed 
in the model described in Chapter 7 to the daily costs of conventional 
treatment and ECMO in order that case-mix adjusted estimates of daily 
cost for both arms of the trial could be determined. This proved to be a 
straightforward undertaking and enabled a stratification of daily costs 
by the numbers of organs supported. 
In conclusion, this chapter has set out to estimate a set of unit-specific 
costs relating to care received in the adult critical care setting to inform 
an economic evaluation ofECMO versus conventional therapy. The 
short-comings of the study have been well described, in particular, the 
poor response rate to the cost survey that resulted in missing data that 
had to be substituted using mean values obtained from those centres 
best able to provide these data. The organ support weightings described 
in Chapter 7 were applied to these substituted centre-specific estimates 
in order that the average daily costs could be case-mix adjusted. 
Whilst the results of the trial are not as yet known, ECMO was found 
to be more costly than conventional therapy and in order to be shown 
to be cost-effective, will need to demonstrate some form of clinical 
benefit that justifies the additional cost oftreatment. 
Chapter 9 will now examine the contributions of the research reported 
' 
in this thesis, followed by a discussion of future research in this area. 
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CHAPTER 9: CONCLUSIONS 
9.1 Introduction 
The core ofthe thesis is the identification of the key patient 
characteristics and 'cost generating events' in the care of critically ill 
adults, and the development and application of the use of a 'top-down' 
method of costing (the cost block method), that when combined with 
data on these events can be used to generate daily case-mix adjusted 
costs of care. Given that knowledge of the costs of critical care patients 
is extremely limited, the thesis goes some way to describing the costs 
of different critical care units and exploring possible reasons for their 
variation (case-mix and efficiency). 
The systematic literature review established that very little multi-centre 
research has been conducted to inform the debate as to which method 
of estimating costs works best across different settings from a 
reimbursement perspective. The 'bottom-up' method of costing offers 
the most accurate means of cost estimation at the patient level but 
comes with the disadvantage of being both time-consuming and costly 
to perform outside of the research setting. 'Top-down' costing is too 
crude an approach to adopt in isolation of an appropriate case-mix 
adjustment given the heterogeneity of patients both in their length of 
stay and treatment needs. A considerable amount of time was spent 
attempting to identify the best means of describing patients in terms of 
their clinical and cost characteristics because of this heterogeneity and 
the need to curtail the number of explanatory variables in the model. 
The thesis covers both a methodological and empirical component and 
the main contributions are the role that the work has played in shaping 
the Department of Health's reimbursement strategy in adult critical 
care and more generally, providing a means of estimating patient costs 
in a relatively simple way across centres that previously had not been 
achievable. 
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This chapter begins by offering a critical appraisal ofthe work 
performed, then examining the contributions that the research reported 
~ 
in this thesis has made and a discussion of future research in this area 
completes this thesis. 
9.2 Critical appraisal of the research 
There are several learning outcomes from the work performed in this 
thesis. Had resources allowed, it would have been preferable to have 
extended the period of time over which data had been collected from 
critical care units participating in the multi-centre study and to improve 
the representativeness of the sample by investing greater efforts to recruit 
critical care units located in Wales. This would have expanded the data 
set for analysis and as a result, possibly improved the reliability of the 
cost estimates because a large number of organ support combinations 
suffered from having only a very small number of observations which 
only became apparent after the period of data collection had finished. 
Furthermore, it may have been helpful to have conducted some bottom-
up costing of the different types of organ support in some of the 
participating critical care units to better understand the reasons why some 
organs are more costly to support than others - be it related to staffing or 
equipment utilisation (or both) or other factors such as the need for 
additional tests or investigations. Such knowledge may have facilitated 
the interpretation of the coefficients produced by the statistical models to 
a greater extent. 
Data on capital equipment expenditure is not straightforward to capture 
and records relating to the purchase and maintenance of this equipment 
can be difficult to obtain, however it is important not to overlook the fact 
that critical care units use a considerable amount of monitoring and other 
equipment in the care of their patients. The cost of this equipment is 
largely unknown and the expenditure data obtained from the critical care 
units on other resources were inflated by a percentage factor to allow for 
an estimate on capital equipment expenditure. The challenge for the 
critical care units financed under a reimbursement system will be to plan 
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strategically for major capital investments and ensure that there are 
adequate financial plans in place to meet the necessary purchase and 
maintenance costs. It may be more realistic for critical care units to lease 
equipment than to purchase it outright in order to spread the re-payments 
over time (as an example). 
Section V of Chapter 6 explored the relationship between the expenditure 
of a critical care unit in relation to its size and is probably one of the most 
interesting and important areas for further research, which with a larger 
sample of critical care units would have been greatly enhanced. The 
recent financial problems experienced by the NHS mean that how critical 
care units organize their resources in terms of deciding how many beds 
they should have in order to achieve optimal efficiency will be of greater 
importance than ever before. 
Chapter 8 served to illustrate how the cost weights derived from the 
modelling work undertaken could be applied to a trial-based economic 
evaluation. This chapter highlighted the problems of obtaining data under 
trial conditions, particularly when the time span for patient recruitment is 
lengthy in duration and there are few incentives in place to reward timely 
data return. Greater engagement with the staff at Glenfield Hospital at an 
earlier stage may have proved fruitful in obtaining more complete 
financial data on the ECMO costs. Earlier discussions with the 
accountants about the need for accurately estimating the treatment costs 
because of the importance of demonstrating the economic case for 
ECMO may have generated the necessary expenditure as opposed to 
budget data provided. It would have been very helpful to have had these 
data to have been able to investigate possible economies of scale within 
the ECMO provision and if found to be clinically effective, to have 
explored the most cost-effective way of delivering the care to a greater 
number of patients. 
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9.3 Contribution of the research 
. / 
9.3. 1 Development of costing methods for economic 
evaluation 
The originality of academic offerings was demonstrated in a number of 
ways. Firstly, I contributed to the development ofthe cost block 
costing method as both a member of the Critical Care National 
Working Group on Costs (Edbrooke et al., 1999; Edbrooke et al., 
2001) and as the main researcher on this project for 6 years (1995-
2001). Extending the use of method to producing daily case-mix 
adjusted costs was where my contribution can be most clearly defined. 
In its original form, the cost block method can only estimate average 
daily costs, which restricts the use of the method to benchmarking 
expenditure patterns between different critical care units, rather than 
reflecting the variation in daily costs between individual patients. Now, 
it is possible to do both. There have been no studies performed in adult 
critical care units in the U.K. that have been able to estimate the costs 
of individual patients across centres. A recent clinical trial that 
investigated the clinical and cost-effectiveness of pulmonary artery 
catheters in the U.K relied on the use of average daily costs taken from 
the NHS Reference Costs in order to estimate the costs of critical care 
patients, without any form of case-mix adjustment. 
The beauty of the organ support approach in conjunction with the cost 
block method lies in its simplicity and reproducibility. It has the 
potential to be used in both multi-centre and multinational economic 
evaluations, which for critical care patients is particularly 
advantageous. Since its development, the cost block method has been 
used in Hungary, Germany and France to estimate the costs of critical 
care units (Csomos et al., 2005 & Negrini et al., 2006). There is a 
growing trend of multinational clinical trials because of the 
opportunities to recruit large numbers of patients quickly, particularly 
in heterogeneous patient populations such as critical care and it is 
certainly true that collecting detailed cost data from hospitals is 
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extremely difficult. The successfulness of exporting the cost block 
method to different countries further improves the likelihood of its 
potential use for economic studies in critical care units. 
Whilst the very low response rate for the return of the cost and unit 
characteristic questionnaires from the CESAR trial centres detracted 
attention away from the benefits of having organ support weights 
towards the more pressing problem of missing data, the merits of the 
weights still hold. They can easily be applied to national (aggregated) 
tariffs I costs in an attempt to allow for the effect of case-mix variation 
on daily costs of care. This is a particularly appealing use for the organ 
support weights, given the aforementioned difficulties. 
9.3.2/dentification of the key characteristics and cost 
generating events in critical care patients 
Without the exploratory research conducted in the single centre setting, 
it would not have been possible to identify the key cost generating 
events, since the relationship between patients' organ support and their 
costs of care had not been studied previously. Certainly, there have 
been no studies to date that have reported such a relationship. John 
Morris's survey identified the variables that clinicians perceived to be 
important but organ support was not one of them. This is likely to be 
because it had not featured in any of the commonly used scoring 
systems until 1998 when the ACP data set first became mandatory in 
the UK. The ACP data set did not request the collection of daily organ 
support data but instead required critical care unit to record the total 
number of organs supported during a patients' stay. 
Credit for the multivariate analyses of both the fonner variables and the 
daily organ support data, described in Chapter 4 lies with Professor 
Jacobs, however it was my decision to explore the usefulness of daily 
organ support data and the design and conduct of this study was my 
own work. I was also solely responsible for configuring the activities of 
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care that were needed for estimating the costs of patients included in 
these analyses. 
./ 
9.3.3Specifying the cost model for the HRGs 
The specification of a model for iso-cost grouping based on the number 
. of organs supported per day was the result of exhaustive efforts to 
identify the most appropriate model that was capable of generating 
sensible estimates of cost. Whilst the sample of patients studied 
represents the largest prospectively collected cohort of data collected to 
date, the number of explanatory variables had to be kept to the 
minimum in order to produce these estimates of cost. The exploratory 
work on patients' organ support was able to guide what could be 
considered 'sensible' e.g. a logical ordering to the hierarchy of costs, 
with renal support costing more than neurological support etc. 
The ideal model would have been one that was capable of estimating 
daily costs that varied according to the type and combination of organ 
support (Model 5). However, in order to achieve this, a much larger 
sample of data collected over a longer time period would have been 
needed. There were too many independent variables in the model, 
many with a very small number of observations that produced some 
quite spurious estimates. It is likely that a sample of 100 critical care 
units collecting data over a six-month period may have been sufficient 
to generate the volume of necessary data. 
The approach to costing care in this way was however well received by 
the Critical Care Community and the NHS Information Standards 
Board. 
9.4 Peer-reviewed outputs 
The work undertaken as part of this thesis resulted in a number of peer-
reviewed publications and conference presentations. Arising from 
Chapter 2 came was a paper on cost definitions co-authored with Jegers 
et al., (2002) and an invited lecture (Hibbert, 2004\ 
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Outputs from Chapter 3 consisted of one peer-reviewed paper, a book 
chapter and two oral presentations describing the findings from my 
systematic review (Hibbert, 2001, 20021-2; Hibbert & Edbrooke 2002) 
and an invitation to contribute to a closed workshop hosted by the 
American Thoracic Society (Angus et al., 2002). Methods used in the 
systematic review were also applied to a study of sepsis patients that 
resulted in one peer-reviewed publication (Hibbert & Coates, 2004) 
and two invited oral presentations (Hibbert, 20031 & Hibbert, 20042). 
Professor Philip J acobs performed the rnultivariate analyses described 
in Chapter 4, however all remaining analyses were performed by 
myself. This collaboration resulted in a peer-reviewed publication 
stemming from the first rnultivariate analysis described in Chapter 4, 
(Section 4.5.2) looking at APACHE 11 scores, length of critical care 
unit stay, survival at critical care unit discharge, admission status, the 
percentage of patients receiving advanced respiratory support and 
whether patients had received surgery prior to their admission (J acobs 
et al., 2001). The relationship between daily organ support and costs 
(Chapter 4, Section 4.5.3) was published in the form of an NHS 
Information Authority Research Report (Hibbert et al., 1998) and 
presented at two conferences; the European Society of Intensive Care 
Medicine's Annual Conference (Hibbert et al., 1999) and the Trent 
Institute for Health Services Research Annual Conference (Hibbert, 
1999). 
The design of the multi-centre study described in Chapter 6 was 
published in a peer-reviewed journal (Hibbert et al., 2003) and 
presented at 5 conferences (Hibbert, 20032-6). The results from the cost 
survey were also published in a peer-reviewed journal (Hibbert et al., 
2005) and the cost models presented at the European Health Economics 
Conference (Hibbert et al., 20042). The final results of the HRG 
analyses were presented to the Department of Health (Hibbert et al., 
20043) and at a national conference (Hibbert et al., 20044). 
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All of the work performed as part of the HRG study was peer-reviewed 
by th.e Department of Health's Critical Care Funding Working Gymp, 
the NHS Information Authority, the Intensive Care Society, and the 
NHS Information Standards Board. 
9.5 limitations of the research 
I have attempted, at the end of each Chapter, to highlight the 
shortcomings of the work described. However, the most evident 
limitations are summarised as follows: 
The exploratory research described in Chapter 4 that identified the key 
cost-generating events was based on a very small sample of patients 
and used a non-validated costing method. It is not known how 
representative this sample of patients was, compared to the rest of the 
U.K at that time. 
The non-capture of data on capital equipment in the multi-centre study 
was a weakness. These data were neither captured in the costing of 
conventional treatment for the CESAR trial. In both cases, a 10% levy 
was applied to account for this. 
The exclusion of foreign papers from the systematic literature review 
produced a language bias, although it is not anticipated that through 
contact with key opinion leaders5o, any important methodological 
studies were missed as a result. Had resources permitted, a second 
reviewer would have been used to check both the screening of abstracts 
and full papers and the data extraction and quality evaluation tasks. 
The yariable completion of the expenditure questionnaires used in the 
multi-centre study meant that the models developed in Chapter 6 only 
included the costs of nursing staff, drugs and fluids and disposable 
equipment. The remaining costs had to be apportioned on the basis of 
length of stay. More sophisticated econometric methods may have 
50 I am eo-chair of the European Society of Intensive Care Medicine Research Group on Health Economics and 
am in regular contact with all of the active researchers involved in costing studies in Europe. 
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proved useful in the development and evaluation of the cost models 
described in Chapter 7. 
The poor response to the unit characteristic and cost survey described 
in Chapter 8 resulted in the extensive use of substituted data in order to 
estimate an average daily cost of care for many of the conventional 
treatment centres. Furthermore, the limited data provided on ECMO 
was a disappointment, given the importance of the clinical trial for 
Glenfield Hospital. 
Finally, given that much of the work described in this thesis has not 
been attempted before, there wasn't a gold standard as such, against 
which the results produced could be compared. Nevertheless, it 
provides a rich data set against which future studies can be compared 
and improved upon. 
9.6 Further research 
9. 6. 1 Studies of the relationship between expenditure, 
case-mix and outcomes 
Critical care units often attribute their high costs and poor outcomes to 
an atypical case-mix. An interesting area worthy of further research 
relating to the work of this thesis is studies looking at the relationship 
between expenditure levels, standardised mortality rates and case-mix 
now that we have a way of describing and quantifying case-mix by 
organ support. Along similar lines are studies looking at the 
relationship between the duration of patients' organ support (and the 
combinations of such), and their outcomes e.g. quality-adjusted 
survival, to answer questions such as 'which of the types of organ 
support result in the best outcomes and the worst outcomes and what 
role does the time component play?' This sort of research is needed to 
inform evidence-based decision-making on the withdrawal of 
treatment. I would argue that the daily collection of organ support 
parameters is infinitely more informative in quantifying a patient's 
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improvement or decline than physiological severity of illness measures 
rec~~ded within the first 24 hours of admission, such as patients:,... 
APACHE II scores, that do not account for the effect of interventions 
on outcomes. 
9.6.2Studies of efficiency 
Akin to the valuable research performed in neonatal intensive care on 
economies of scale, further research is required in adult critical care on 
determining the optimal size and configuration of critical care units in 
the U.K. In particular, what is the most efficient way of providing a 
service in terms of cost and whether patients achieve a better outcome 
if units operate to a given size? Some preliminary work has been done, 
but it was heavily criticised for not accounting for case-mix and 
outcomes (Jacobs et al., 2004). It is certainly now possible to explore 
this line of research in a large multi-centre study, given the robust data 
generated by the ICNARC Case-Mix Programme on patient outcomes 
and the availability of a reasonable case-mix measure. 
9.6.3Studies of the factors that limit the availability of 
expenditure data in hospitals 
It is important that a greater understanding is gained as to why studies 
such as the CESAR trial, should experience such poor response rates to 
requests for what should be routinely available information. This is 
important as it has the potential to influence the design of future 
studies, if there is a perception that cost data and basic information on 
the characteristics of centres is unobtainable. Based on the success of 
the HRG study with a high number of critical care units able to provide 
data, the issue seems to be linked to incentives but that may not be the 
case in all hospitals. It would be useful to know, for example, the 
times of the year when best to avoid burdening the finance departments 
with requests for data (and vice-versa). 
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9. 7 Conclusion 
In conclusion, the aims of this PhD in Health Services Research were 
to synthesise current knowledge about the different methods used to 
estimate costs and to develop and apply a method for estimating daily 
case-mix adjusted costs of critical care patients to proposing a set of 
HRGs and for use in a trial-based economic evaluation. Through a 
programme of original work, involving a systematic review, a single 
centre study and a large multi-centre study worthy of publication in 
peer-reviewed journals, I believe that the aims of this thesis have been 
achieved. 
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